data_5j17_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5j17 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 63.9 Cg_endo . . . . . 0 N--CA 1.464 -0.247 0 CA-C-O 120.742 0.226 . . . . 99.989999999999995 112.053 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.633 HD11 HG11 ' A' ' 168' ' ' VAL . 2.0 pp -129.75 167.07 25.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.408 -0.36 . . . . 99.989999999999995 110.957 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 46.4 t -127.86 126.24 66.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.443 -0.344 . . . . 99.989999999999995 110.298 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 21.2 mtm180 -93.92 91.59 6.98 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.126 0.488 . . . . 99.989999999999995 111.941 -170.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 222' ' ' LEU . 2.1 t -93.44 162.23 2.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.609 0.718 . . . . 99.989999999999995 111.057 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -125.2 107.31 10.62 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.435 -1.257 . . . . 99.989999999999995 109.795 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.1 mm? -82.22 167.03 33.27 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.542 -0.54 . . . . 99.989999999999995 109.542 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 71.7 Cg_exo -48.18 147.49 8.24 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.521 2.814 . . . . 99.989999999999995 113.566 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 69.56 34.56 2.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.458 -0.792 . . . . 99.989999999999995 111.187 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.484 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 62.12 43.19 8.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.534 -0.757 . . . . 99.989999999999995 111.826 176.181 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 78.2 mm-40 -97.17 165.47 12.03 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.838 -0.619 . . . . 99.989999999999995 109.653 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 159' ' ' VAL . 37.0 ttp180 -145.95 145.62 30.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.88 0.371 . . . . 99.989999999999995 111.022 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.519 HG21 HD23 ' A' ' 161' ' ' LEU . 15.2 t -146.06 150.23 35.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.877 -0.601 . . . . 99.989999999999995 109.522 177.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.633 HG11 HD11 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -120.98 127.25 75.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 119.882 -0.727 . . . . 99.989999999999995 109.231 170.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.4 p -123.75 133.89 24.93 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.367 -0.833 . . . . 99.989999999999995 109.338 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 74.2 Cg_exo -51.49 128.36 25.6 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.383 2.055 . . . . 99.989999999999995 111.973 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.39 79.12 0.75 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.506 -0.77 . . . . 99.989999999999995 110.535 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.42 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 92.1 mtt180 -68.56 115.74 8.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.051 -0.977 . . . . 99.989999999999995 111.726 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 46.8 t -80.44 109.79 15.29 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.959 -0.756 . . . . 99.989999999999995 108.959 172.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.68 19.36 7.43 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.059 -0.817 . . . . 99.989999999999995 111.059 -173.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.42 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 0.9 OUTLIER -140.48 132.7 31.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.448 -0.575 . . . . 99.989999999999995 109.448 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.6 p -74.35 153.3 39.35 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.088 -0.505 . . . . 99.989999999999995 110.242 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.571 ' HA ' ' OG ' ' A' ' 180' ' ' SER . 4.2 m -58.52 -21.84 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.911 -0.774 . . . . 99.989999999999995 108.911 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.589 ' HG2' ' HE2' ' A' ' 182' ' ' LYS . 32.0 ttt180 -58.94 -59.05 6.08 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-N 115.497 -0.774 . . . . 99.989999999999995 110.694 174.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.602 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 25.7 t70 -64.4 -48.6 74.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.209 0.528 . . . . 99.989999999999995 111.417 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.571 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 11.3 p -60.24 -56.87 16.27 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.235 -0.893 . . . . 99.989999999999995 111.489 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 8.3 mp -74.28 -14.85 60.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.418 -0.355 . . . . 99.989999999999995 111.032 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.602 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 5.3 mtmt -59.92 -48.21 82.62 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 108.426 -0.953 . . . . 99.989999999999995 108.426 174.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 187' ' ' MET . 12.0 tppt? -60.13 -49.49 77.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.854 -0.612 . . . . 99.989999999999995 110.175 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.426 ' HB1' HG22 ' A' ' 167' ' ' THR . . . -47.11 -53.44 12.85 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.9 -0.591 . . . . 99.989999999999995 112.583 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.416 HD11 ' O ' ' A' ' 181' ' ' LEU . 1.5 mt -74.19 -43.51 56.95 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.554 0.342 . . . . 99.989999999999995 111.507 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.489 ' HB3' ' O ' ' A' ' 182' ' ' LYS . 18.7 tpp -65.59 -33.92 77.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.292 -0.413 . . . . 99.989999999999995 111.043 -174.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 66.8 mtm -74.02 -9.75 58.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.297 0.57 . . . . 99.989999999999995 109.971 175.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.412 ' CZ ' ' HB ' ' A' ' 167' ' ' THR . 74.7 mtt85 -109.65 1.37 19.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.517 -0.765 . . . . 99.989999999999995 111.18 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 78.62 21.85 68.25 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.833 -0.699 . . . . 99.989999999999995 112.483 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.2 mp -113.99 172.53 6.93 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.891 -0.411 . . . . 99.989999999999995 109.891 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 34.6 pt -132.82 132.5 22.56 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.204 0.526 . . . . 99.989999999999995 111.527 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.497 ' HG2' ' HG3' ' A' ' 182' ' ' LYS . 23.9 Cg_exo -65.7 -21.15 59.05 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.359 2.706 . . . . 99.989999999999995 113.127 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -62.86 -33.38 75.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.517 -0.31 . . . . 99.989999999999995 111.776 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 35.4 t -102.68 31.83 3.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.373 0.606 . . . . 99.989999999999995 109.89 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 225' ' ' GLU . 71.2 m -143.17 167.6 21.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.994 -0.548 . . . . 99.989999999999995 110.983 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -138.0 155.65 48.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 99.989999999999995 110.241 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 223' ' ' HIS . 9.6 t -107.55 136.61 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 123.208 0.318 . . . . 99.989999999999995 110.27 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -130.92 151.95 50.77 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.309 -0.256 . . . . 99.989999999999995 110.309 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.464 ' CG ' ' HB2' ' A' ' 206' ' ' LYS . 1.2 ptm180 . . . . . 0 C--N 1.318 -0.776 0 N-CA-C 108.708 -0.849 . . . . 99.989999999999995 108.708 167.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 110.271 -0.27 . . . . 99.989999999999995 110.271 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.464 ' HB2' ' CG ' ' A' ' 199' ' ' ARG . 75.0 mmtt -111.73 98.13 40.07 Favored Pre-proline 0 N--CA 1.444 -0.736 0 N-CA-C 109.365 -0.605 . . . . 99.989999999999995 109.365 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -65.95 119.15 6.14 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.859 1.706 . . . . 99.989999999999995 111.998 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.414 HD13 HG11 ' A' ' 197' ' ' VAL . 38.3 mt -96.61 154.22 3.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.074 -1.421 . . . . 99.989999999999995 110.615 -177.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.0 145.66 20.02 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.22 -0.752 . . . . 99.989999999999995 111.22 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.514 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 96.2 m95 -68.95 -25.09 64.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.28 0.54 . . . . 99.989999999999995 110.496 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -87.97 9.95 20.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 99.989999999999995 110.743 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.502 ' O ' HG11 ' A' ' 177' ' ' VAL . 94.9 m -83.57 143.22 30.3 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.074 -0.713 . . . . 99.989999999999995 109.074 174.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.438 ' HB3' ' CD1' ' A' ' 216' ' ' TRP . 9.3 t70 -75.27 137.19 41.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.925 0.393 . . . . 99.989999999999995 110.094 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.456 HG13 HG22 ' A' ' 157' ' ' VAL . 0.2 OUTLIER -78.24 -17.55 13.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.046 -0.525 . . . . 99.989999999999995 111.581 -174.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 85.9 p -69.78 -14.09 62.6 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 121.961 -0.462 . . . . 99.989999999999995 110.442 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.438 ' CD1' ' HB3' ' A' ' 213' ' ' ASP . 27.5 m0 -67.71 -40.64 84.26 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.066 -0.716 . . . . 99.989999999999995 109.066 174.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.87 31.64 3.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.965 -1.016 . . . . 99.989999999999995 110.423 -175.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 51.1 m -52.91 113.85 1.23 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.403 0.62 . . . . 99.989999999999995 112.343 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 84.06 2.65 89.4 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.973 -1.012 . . . . 99.989999999999995 113.658 171.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.54 154.92 19.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.683 0.278 . . . . 99.989999999999995 110.392 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 2.1 mp0 -85.97 111.29 20.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.73 -0.47 . . . . 99.989999999999995 109.73 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 35.9 mt -103.83 164.94 11.35 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.885 -0.413 . . . . 99.989999999999995 109.885 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 197' ' ' VAL . 85.4 m-70 -129.34 135.6 48.94 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.341 -0.244 . . . . 99.989999999999995 110.341 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 9.4 t -113.45 109.34 28.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.251 -0.648 . . . . 99.989999999999995 109.251 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 28.5 mt-10 -110.11 155.21 22.21 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.47 -0.786 . . . . 99.989999999999995 110.088 -175.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.99 131.25 34.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.343 -0.39 . . . . 99.989999999999995 110.942 -173.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 121.674 0.75 . . . . 99.989999999999995 109.179 173.052 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.461 -0.413 0 CA-C-O 121.151 0.396 . . . . 99.989999999999995 112.776 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.576 ' O ' ' HA2' ' A' ' 219' ' ' GLY . 1.4 pp -122.12 171.54 10.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.65 -0.705 . . . . 99.989999999999995 110.688 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.7 133.13 57.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 106.785 -1.561 . . . . 99.989999999999995 106.785 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.534 ' HG2' HG11 ' A' ' 168' ' ' VAL . 20.5 mtm180 -99.17 106.83 19.05 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.145 0.497 . . . . 99.989999999999995 111.872 -162.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 222' ' ' LEU . 25.9 t -100.13 145.21 11.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.302 -0.863 . . . . 99.989999999999995 112.634 -172.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -109.27 104.7 13.88 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.656 -1.156 . . . . 99.989999999999995 110.067 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.582 HD23 HG21 ' A' ' 167' ' ' THR . 1.5 mm? -81.57 172.47 9.62 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.152 -0.685 . . . . 99.989999999999995 109.152 -174.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 77.5 Cg_exo -54.47 159.92 7.71 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.614 2.209 . . . . 99.989999999999995 112.183 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 66.03 24.5 11.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.002 0.43 . . . . 99.989999999999995 110.154 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.497 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 56.15 43.98 25.92 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.326 -0.852 . . . . 99.989999999999995 111.191 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 28.8 mm-40 -89.65 167.38 12.97 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.526 -0.761 . . . . 99.989999999999995 109.412 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -146.39 129.73 16.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.434 0.635 . . . . 99.989999999999995 111.42 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.582 HG21 HD23 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -144.5 139.09 28.04 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.738 -1.119 . . . . 99.989999999999995 108.013 178.106 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.534 HG11 ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -116.57 129.27 73.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 119.148 -1.021 . . . . 99.989999999999995 110.632 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.31 136.23 19.57 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 114.613 -1.176 . . . . 99.989999999999995 109.805 -173.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.6 130.01 36.65 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.29 1.993 . . . . 99.989999999999995 111.294 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.13 91.45 0.22 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.841 -0.618 . . . . 99.989999999999995 110.453 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.435 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 92.2 mtt180 -77.08 111.59 12.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.447 -0.797 . . . . 99.989999999999995 111.044 -176.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.582 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 3.3 p -72.45 115.46 11.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.012 -0.54 . . . . 99.989999999999995 110.5 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 98.86 15.58 33.39 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.577 -0.821 . . . . 99.989999999999995 111.948 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.524 ' CG1' ' HG ' ' A' ' 180' ' ' SER . 0.5 OUTLIER -130.15 148.91 33.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.547 -0.538 . . . . 99.989999999999995 109.547 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.4 p -83.45 154.39 23.96 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.209 -0.451 . . . . 99.989999999999995 111.646 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 212' ' ' THR . 64.1 t -53.81 -30.58 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.559 -0.746 . . . . 99.989999999999995 108.992 172.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.552 ' HG3' ' HB3' ' A' ' 210' ' ' TRP . 12.1 ttt180 -53.93 -58.97 5.33 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 115.408 -0.814 . . . . 99.989999999999995 110.66 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.606 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 11.3 t70 -63.26 -47.88 80.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.336 0.588 . . . . 99.989999999999995 111.274 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.524 ' HG ' ' CG1' ' A' ' 175' ' ' VAL . 17.9 m -59.51 -51.59 69.22 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.211 -0.904 . . . . 99.989999999999995 112.166 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.523 ' N ' HD21 ' A' ' 181' ' ' LEU . 0.4 OUTLIER -78.36 -19.03 54.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.651 0.263 . . . . 99.989999999999995 110.407 -178.208 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.606 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 15.5 mtmt -60.65 -48.51 81.45 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 109.134 -0.691 . . . . 99.989999999999995 109.134 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.2 tpmt? -61.45 -41.19 96.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.904 -0.589 . . . . 99.989999999999995 109.802 176.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.454 ' HB1' HG22 ' A' ' 167' ' ' THR . . . -53.66 -57.33 11.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.033 -0.53 . . . . 99.989999999999995 111.767 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.464 HD11 ' O ' ' A' ' 181' ' ' LEU . 1.4 mt -71.55 -41.34 69.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.429 -0.35 . . . . 99.989999999999995 111.483 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.512 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 7.0 mmt -66.29 -28.39 68.66 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.141 0.423 . . . . 99.989999999999995 112.141 -176.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 62.4 mtm -79.64 -9.16 59.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.082 0.468 . . . . 99.989999999999995 109.96 175.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -109.72 -3.2 16.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.636 -0.711 . . . . 99.989999999999995 111.522 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.07 21.21 61.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.987 -0.625 . . . . 99.989999999999995 112.209 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.0 mp -115.04 172.11 7.26 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.934 -0.395 . . . . 99.989999999999995 109.934 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.52 HG13 ' SG ' ' A' ' 194' ' ' CYS . 21.4 pt -128.88 133.1 24.82 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.193 -0.458 . . . . 99.989999999999995 111.526 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.531 ' HB3' ' CZ3' ' A' ' 210' ' ' TRP . 14.9 Cg_exo -69.0 -21.03 37.6 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.027 2.485 . . . . 99.989999999999995 112.133 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -57.82 -41.73 82.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.66 -0.7 . . . . 99.989999999999995 111.736 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . 0.52 ' SG ' HG13 ' A' ' 191' ' ' ILE . 20.9 p -96.89 16.81 18.3 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.119 -0.491 . . . . 99.989999999999995 110.371 -177.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.439 ' HB3' HG11 ' A' ' 224' ' ' VAL . 85.1 m -126.08 166.83 16.28 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.175 0.512 . . . . 99.989999999999995 111.638 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -146.2 159.79 42.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.449 -0.796 . . . . 99.989999999999995 110.065 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.404 HG11 HD13 ' A' ' 208' ' ' ILE . 11.7 t -115.11 138.85 44.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.23 -0.441 . . . . 99.989999999999995 111.118 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 29.9 m-85 -129.72 146.65 51.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 99.989999999999995 110.255 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.493 ' HD2' HD22 ' A' ' 217' ' ' LEU . 7.1 ptm180 . . . . . 0 C--N 1.32 -0.68 0 N-CA-C 108.32 -0.992 . . . . 99.989999999999995 108.32 167.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.451 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 44.6 mtpt . . . . . 0 N--CA 1.445 -0.683 0 N-CA-C 109.424 -0.584 . . . . 99.989999999999995 109.424 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 75.3 mmtt -101.91 102.74 25.04 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.367 -0.379 . . . . 99.989999999999995 110.03 -177.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 8.0 Cg_exo -69.34 119.45 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.101 1.867 . . . . 99.989999999999995 111.634 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.404 HD13 HG11 ' A' ' 197' ' ' VAL . 56.9 mt -93.74 155.8 3.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 114.493 -1.23 . . . . 99.989999999999995 111.283 -174.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -92.42 135.09 12.53 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.097 -0.801 . . . . 99.989999999999995 111.097 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.552 ' HB3' ' HG3' ' A' ' 178' ' ' ARG . 86.5 m95 -64.8 -40.51 95.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.041 0.448 . . . . 99.989999999999995 110.667 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.32 6.04 3.99 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.026 0.38 . . . . 99.989999999999995 112.026 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.522 ' O ' HG21 ' A' ' 177' ' ' VAL . 97.2 m -81.22 145.26 31.06 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.358 -0.608 . . . . 99.989999999999995 109.358 172.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.24 131.24 44.58 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.773 -0.455 . . . . 99.989999999999995 109.773 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.401 HG23 ' CB ' ' A' ' 180' ' ' SER . 0.1 OUTLIER -73.74 -15.18 16.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.781 0.324 . . . . 99.989999999999995 111.356 -174.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.582 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 23.4 m -70.27 -10.51 59.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.052 0.453 . . . . 99.989999999999995 110.579 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.6 m0 -74.97 -27.05 60.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.449 0.642 . . . . 99.989999999999995 109.399 172.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.516 HD13 HD22 ' A' ' 222' ' ' LEU . 7.1 mt -110.8 19.24 18.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.033 -0.985 . . . . 99.989999999999995 110.075 -174.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 100.0 m -51.15 115.5 1.58 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.687 0.756 . . . . 99.989999999999995 112.194 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 85.99 3.77 85.07 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.386 -1.279 . . . . 99.989999999999995 113.244 171.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -87.9 158.2 18.76 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.226 -0.287 . . . . 99.989999999999995 110.226 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -91.61 111.08 22.44 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.524 -0.546 . . . . 99.989999999999995 109.524 173.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 6.7 mp -98.04 150.21 21.65 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.721 -0.672 . . . . 99.989999999999995 110.043 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -120.0 122.02 40.23 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.854 -0.612 . . . . 99.989999999999995 109.751 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.457 ' CG1' ' HD3' ' A' ' 162' ' ' PRO . 4.0 t -100.16 117.05 44.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.582 -0.735 . . . . 99.989999999999995 110.083 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -108.55 137.01 47.2 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.038 -0.983 . . . . 99.989999999999995 108.657 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.7 p -91.18 128.6 42.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.595 0.712 . . . . 99.989999999999995 110.195 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 C--N 1.319 -0.746 0 CA-C-N 114.775 -1.102 . . . . 99.989999999999995 110.627 -176.89 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo . . . . . 0 N--CA 1.456 -0.721 0 N-CA-C 111.051 -0.404 . . . . 99.989999999999995 111.051 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.681 HD11 HG11 ' A' ' 168' ' ' VAL . 2.1 pp -121.06 160.13 22.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.577 -0.283 . . . . 99.989999999999995 110.558 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.68 134.67 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.293 -0.632 . . . . 99.989999999999995 109.293 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.522 ' HA ' HG12 ' A' ' 168' ' ' VAL . 71.5 mtm180 -96.73 101.01 12.53 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.362 0.504 . . . . 99.989999999999995 112.362 -168.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 222' ' ' LEU . 2.8 t -92.97 160.1 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 121.785 0.802 . . . . 99.989999999999995 111.801 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.543 ' CZ ' ' HD2' ' A' ' 166' ' ' ARG . 41.0 m-85 -124.76 105.76 9.54 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.166 -1.379 . . . . 99.989999999999995 109.131 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 3.3 mp -85.7 174.61 5.42 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.229 -0.441 . . . . 99.989999999999995 109.946 -172.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 87.2 Cg_exo -52.86 160.09 4.42 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.744 2.296 . . . . 99.989999999999995 112.835 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 64.12 31.97 12.99 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.072 -0.513 . . . . 99.989999999999995 110.273 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt 56.02 47.79 19.06 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.348 -0.842 . . . . 99.989999999999995 111.357 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 28.2 mt-30 -101.81 166.79 10.47 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.897 -0.592 . . . . 99.989999999999995 110.255 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.543 ' HD2' ' CZ ' ' A' ' 160' ' ' PHE . 38.4 ttt180 -147.67 144.24 28.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.556 0.217 . . . . 99.989999999999995 110.859 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.443 HG22 ' HB1' ' A' ' 184' ' ' ALA . 1.4 t -155.27 152.68 29.54 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 175.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.681 HG11 HD11 ' A' ' 156' ' ' ILE . 0.2 OUTLIER -114.2 128.84 71.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.008 -0.677 . . . . 99.989999999999995 110.255 178.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.9 p -116.5 137.03 23.27 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 115.138 -0.937 . . . . 99.989999999999995 109.562 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.71 135.44 60.2 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.175 1.916 . . . . 99.989999999999995 111.685 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.76 78.34 1.12 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.556 -0.747 . . . . 99.989999999999995 110.104 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.401 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 92.3 mtt180 -69.54 111.92 5.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.926 -1.034 . . . . 99.989999999999995 111.593 -176.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.678 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 8.5 p -76.93 110.09 11.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.992 0.425 . . . . 99.989999999999995 109.872 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 109.07 9.17 26.49 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.608 -0.806 . . . . 99.989999999999995 111.574 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.401 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 0.9 OUTLIER -120.84 137.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.718 -0.475 . . . . 99.989999999999995 109.718 178.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.5 p -79.4 154.47 28.96 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.403 -0.362 . . . . 99.989999999999995 110.96 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.607 HG21 ' O ' ' A' ' 212' ' ' THR . 81.4 t -47.07 -40.95 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.477 0.486 . . . . 99.989999999999995 109.696 175.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.586 ' CG ' ' HB3' ' A' ' 210' ' ' TRP . 92.9 mtt-85 -48.45 -52.57 21.55 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.564 -0.744 . . . . 99.989999999999995 112.483 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.574 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 14.7 t70 -73.98 -45.48 49.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.138 0.494 . . . . 99.989999999999995 111.339 -172.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.449 ' HB2' HG23 ' A' ' 214' ' ' ILE . 0.3 OUTLIER -67.54 -42.87 82.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.704 -0.68 . . . . 99.989999999999995 110.896 -177.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.3 OUTLIER -76.68 -21.17 55.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.143 -0.481 . . . . 99.989999999999995 110.145 177.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.653 ' O ' ' HB2' ' A' ' 186' ' ' MET . 4.4 ttmt -59.23 -48.23 82.4 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.986 -0.746 . . . . 99.989999999999995 108.986 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.1 tpmt? -60.56 -46.2 91.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.171 -0.468 . . . . 99.989999999999995 109.791 175.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.443 ' HB1' HG22 ' A' ' 167' ' ' THR . . . -51.75 -55.94 16.73 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.172 -0.467 . . . . 99.989999999999995 111.984 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.421 HD11 ' O ' ' A' ' 181' ' ' LEU . 1.7 mt -72.58 -43.16 63.77 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.734 0.413 . . . . 99.989999999999995 111.769 -178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.653 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 3.3 mmt -66.02 -26.52 67.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.115 0.413 . . . . 99.989999999999995 112.115 -176.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 64.6 mtm -77.38 -20.35 54.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.359 0.599 . . . . 99.989999999999995 109.724 173.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -106.6 17.59 23.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.461 -0.791 . . . . 99.989999999999995 111.592 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 62.75 35.43 91.92 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.276 -0.487 . . . . 99.989999999999995 112.676 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 21.1 mt -128.41 169.37 14.36 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.531 0.333 . . . . 99.989999999999995 110.171 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 45.8 pt -131.89 135.24 26.35 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.057 0.456 . . . . 99.989999999999995 111.534 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.42 ' HG2' ' HG3' ' A' ' 182' ' ' LYS . 19.6 Cg_exo -66.77 -22.2 50.07 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.102 2.535 . . . . 99.989999999999995 112.645 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.89 -19.98 62.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.134 -0.484 . . . . 99.989999999999995 111.478 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 12.2 t -112.13 25.94 11.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.366 -0.605 . . . . 99.989999999999995 109.366 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.514 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 74.2 m -140.78 166.74 23.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.672 -0.695 . . . . 99.989999999999995 111.096 -175.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -146.66 154.41 41.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.061 -0.518 . . . . 99.989999999999995 110.121 175.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.08 130.62 61.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.597 0.237 . . . . 99.989999999999995 110.776 -176.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.441 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 35.6 m-85 -131.28 152.9 50.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.486 -0.324 . . . . 99.989999999999995 110.759 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.712 ' HG3' HD11 ' A' ' 208' ' ' ILE . 67.2 mtp180 . . . . . 0 C--N 1.327 -0.386 0 N-CA-C 109.162 -0.681 . . . . 99.989999999999995 109.162 168.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.501 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 39.1 mtpt . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 109.756 -0.461 . . . . 99.989999999999995 109.756 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 74.1 mmtt -101.7 100.5 14.53 Favored Pre-proline 0 N--CA 1.444 -0.741 0 N-CA-C 109.029 -0.73 . . . . 99.989999999999995 109.029 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 4.0 Cg_exo -71.26 126.76 12.63 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.868 1.712 . . . . 99.989999999999995 111.316 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.712 HD11 ' HG3' ' A' ' 199' ' ' ARG . 4.7 mt -107.77 149.66 10.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.78 -1.1 . . . . 99.989999999999995 110.77 -173.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.471 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -84.7 136.01 14.15 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 111.442 -0.663 . . . . 99.989999999999995 111.442 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.586 ' HB3' ' CG ' ' A' ' 178' ' ' ARG . 91.1 m95 -65.08 -27.8 69.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.698 0.285 . . . . 99.989999999999995 110.917 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -90.73 12.76 18.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.823 0.344 . . . . 99.989999999999995 111.242 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.607 ' O ' HG21 ' A' ' 177' ' ' VAL . 48.1 m -85.84 154.15 21.75 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.494 -0.928 . . . . 99.989999999999995 108.494 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -78.48 132.18 37.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.74 -0.467 . . . . 99.989999999999995 109.74 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.449 HG23 ' HB2' ' A' ' 180' ' ' SER . 0.3 OUTLIER -70.32 -11.94 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.987 0.422 . . . . 99.989999999999995 110.997 -178.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.678 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 16.4 m -66.38 -18.26 65.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.98 0.419 . . . . 99.989999999999995 110.359 173.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -78.66 -14.79 59.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.455 0.645 . . . . 99.989999999999995 109.888 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 208' ' ' ILE . 17.8 mt -113.34 17.4 18.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.17 -0.923 . . . . 99.989999999999995 109.797 -177.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 91.2 m -53.64 117.59 3.25 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.775 0.798 . . . . 99.989999999999995 112.395 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 74.07 8.14 78.03 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 114.173 -1.376 . . . . 99.989999999999995 113.118 173.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -84.49 148.72 26.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.983 -0.377 . . . . 99.989999999999995 109.983 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 3.2 mp0 -85.26 109.47 18.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.275 -1.009 . . . . 99.989999999999995 108.275 171.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 86.2 mt -98.61 149.93 22.27 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.292 -0.413 . . . . 99.989999999999995 109.994 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -124.05 122.58 38.26 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.323 -0.621 . . . . 99.989999999999995 109.323 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 38.7 t -100.07 143.95 13.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.042 0.449 . . . . 99.989999999999995 110.167 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 8.6 mm-40 -120.91 151.39 39.74 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.377 -0.829 . . . . 99.989999999999995 109.236 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.2 t -89.89 116.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.826 -0.435 . . . . 99.989999999999995 109.826 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 34.3 mt . . . . . 0 C--N 1.323 -0.549 0 N-CA-C 109.856 -0.424 . . . . 99.989999999999995 109.856 178.976 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.468 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 23.8 Cg_exo . . . . . 0 N--CA 1.461 -0.391 0 N-CA-C 110.446 -0.636 . . . . 99.989999999999995 110.446 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.608 HD11 HG11 ' A' ' 168' ' ' VAL . 2.2 pp -131.29 156.61 42.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.166 0.508 . . . . 99.989999999999995 111.417 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.446 HG22 HG13 ' A' ' 214' ' ' ILE . 41.0 t -124.11 123.75 67.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.513 -0.767 . . . . 99.989999999999995 109.756 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.56 ' HA ' HG12 ' A' ' 168' ' ' VAL . 23.6 mtm180 -88.47 96.54 10.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.49 0.662 . . . . 99.989999999999995 111.723 -169.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.645 HG21 ' HB2' ' A' ' 222' ' ' LEU . 3.8 t -96.03 129.98 45.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.961 -1.018 . . . . 99.989999999999995 112.059 -176.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 42.4 m-85 -94.29 103.51 15.53 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.961 -1.018 . . . . 99.989999999999995 108.871 174.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.545 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 2.9 mp -82.59 176.67 3.6 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 110.027 -0.36 . . . . 99.989999999999995 110.027 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 80.2 Cg_exo -50.17 153.73 6.44 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.711 2.274 . . . . 99.989999999999995 112.736 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 65.96 27.26 10.83 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.909 -0.587 . . . . 99.989999999999995 109.661 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 54.07 36.77 25.46 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 114.914 -1.039 . . . . 99.989999999999995 111.745 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.559 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 26.9 mm-40 -75.58 170.24 16.53 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 109.311 -0.625 . . . . 99.989999999999995 109.311 175.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 17.8 ttp180 -148.59 137.46 21.55 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.606 -0.438 . . . . 99.989999999999995 111.151 173.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.12 154.39 41.76 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.03 -1.1 . . . . 99.989999999999995 108.03 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.608 HG11 HD11 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -113.73 127.36 71.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 119.597 -0.841 . . . . 99.989999999999995 110.312 178.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.5 m -104.88 138.74 19.59 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.092 -0.958 . . . . 99.989999999999995 110.053 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 13.0 Cg_exo -65.55 125.14 13.88 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.265 1.31 . . . . 99.989999999999995 110.925 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.12 86.08 0.55 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.571 -0.741 . . . . 99.989999999999995 110.044 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.439 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 97.2 mtt180 -78.98 112.04 15.77 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.889 -1.051 . . . . 99.989999999999995 111.11 -174.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.621 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 4.1 p -67.53 110.02 3.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.095 -0.502 . . . . 99.989999999999995 110.831 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 106.78 8.16 32.63 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.729 -0.748 . . . . 99.989999999999995 112.296 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 179' ' ' ASP . 0.3 OUTLIER -117.16 149.87 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.045 0.45 . . . . 99.989999999999995 109.866 176.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.466 ' HB ' ' HG2' ' A' ' 178' ' ' ARG . 1.7 p -86.1 152.3 22.98 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.247 -0.433 . . . . 99.989999999999995 111.368 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.569 HG21 ' O ' ' A' ' 212' ' ' THR . 92.8 t -49.07 -41.61 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 O-C-N 123.452 0.47 . . . . 99.989999999999995 110.326 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.466 ' HG2' ' HB ' ' A' ' 176' ' ' THR . 30.9 ptt180 -51.24 -47.45 62.38 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 116.087 -0.506 . . . . 99.989999999999995 112.094 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.571 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 11.8 t70 -68.08 -49.79 59.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.121 0.486 . . . . 99.989999999999995 110.967 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.8 t -67.04 -43.99 81.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.823 -0.626 . . . . 99.989999999999995 110.464 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.54 ' N ' HD21 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -73.42 -27.33 61.38 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 116.36 -0.382 . . . . 99.989999999999995 110.206 179.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.571 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 13.0 mtmt -55.29 -45.62 76.22 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 109.24 -0.652 . . . . 99.989999999999995 109.24 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 187' ' ' MET . 1.8 tpmt? -60.01 -42.6 94.64 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.623 -0.51 . . . . 99.989999999999995 109.623 175.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . -55.12 -60.89 2.76 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.932 -0.576 . . . . 99.989999999999995 111.938 178.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.57 HD22 ' N ' ' A' ' 185' ' ' LEU . 1.6 mm? -60.29 -52.01 67.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.005 0.522 . . . . 99.989999999999995 110.904 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.533 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 12.2 mmt -57.96 -42.69 85.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.244 -0.889 . . . . 99.989999999999995 112.53 -174.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 57.6 mtm -71.04 -8.42 53.24 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.045 0.45 . . . . 99.989999999999995 110.533 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.451 ' HD2' HD22 ' A' ' 161' ' ' LEU . 51.2 mtt-85 -113.77 5.07 16.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.879 -0.6 . . . . 99.989999999999995 111.571 -177.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 73.38 21.74 79.32 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.018 -0.61 . . . . 99.989999999999995 112.325 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.41 ' HB3' HD11 ' A' ' 185' ' ' LEU . 0.2 OUTLIER -110.61 173.11 6.48 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.567 -0.531 . . . . 99.989999999999995 109.567 -177.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 32.3 pt -132.15 127.34 20.93 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.176 0.512 . . . . 99.989999999999995 111.873 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.528 ' HB3' ' CZ3' ' A' ' 210' ' ' TRP . 22.5 Cg_exo -65.54 -21.48 59.82 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.307 2.672 . . . . 99.989999999999995 112.331 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.25 -45.4 93.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.836 -0.62 . . . . 99.989999999999995 111.923 -174.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 23.8 t -98.11 37.53 1.42 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.282 0.563 . . . . 99.989999999999995 109.967 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.485 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 71.8 m -138.7 158.56 44.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.811 -0.632 . . . . 99.989999999999995 110.78 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -131.66 150.43 52.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.954 -0.566 . . . . 99.989999999999995 110.014 175.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.4 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 4.1 t -104.59 131.67 53.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 123.239 0.337 . . . . 99.989999999999995 110.508 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -126.56 141.99 51.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.774 0.321 . . . . 99.989999999999995 110.807 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.416 ' CG ' HD11 ' A' ' 208' ' ' ILE . 19.3 ptt180 . . . . . 0 C--N 1.316 -0.881 0 N-CA-C 107.795 -1.187 . . . . 99.989999999999995 107.795 165.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.516 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 45.5 mtpt . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 109.544 -0.539 . . . . 99.989999999999995 109.544 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 206' ' ' LYS . 11.7 tppt? -98.26 102.67 14.79 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.078 -0.51 . . . . 99.989999999999995 110.129 -174.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 10.6 Cg_exo -70.6 127.9 14.54 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.32 2.013 . . . . 99.989999999999995 112.413 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 209' ' ' GLY . 35.1 mt -103.22 161.9 4.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.233 -1.348 . . . . 99.989999999999995 109.963 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -94.48 147.45 18.6 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.716 -0.754 . . . . 99.989999999999995 111.676 176.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.528 ' CZ3' ' HB3' ' A' ' 192' ' ' PRO . 92.1 m95 -74.72 -18.5 60.5 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.545 -0.539 . . . . 99.989999999999995 109.545 176.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.444 ' O ' HG21 ' A' ' 176' ' ' THR . 11.0 m-20 -87.63 -4.21 58.95 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.833 -0.622 . . . . 99.989999999999995 110.343 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.569 ' O ' HG21 ' A' ' 177' ' ' VAL . 89.9 m -70.19 147.89 49.29 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.296 -0.631 . . . . 99.989999999999995 109.296 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -76.61 129.18 36.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.002 -0.74 . . . . 99.989999999999995 109.002 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.446 HG13 HG22 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -68.9 -16.49 20.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.914 0.388 . . . . 99.989999999999995 111.056 -175.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.621 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 13.9 m -67.47 -21.03 65.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.848 0.356 . . . . 99.989999999999995 110.751 177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 24.1 m0 -74.93 -17.53 60.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.324 0.583 . . . . 99.989999999999995 109.583 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.403 HD22 ' HD3' ' A' ' 199' ' ' ARG . 6.0 mt -116.95 17.99 14.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.367 -0.833 . . . . 99.989999999999995 109.444 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 82.1 m -49.88 113.1 0.77 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.346 -0.843 . . . . 99.989999999999995 112.399 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 86.5 6.28 80.9 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.041 -0.982 . . . . 99.989999999999995 113.41 170.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -90.46 158.48 17.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.806 0.336 . . . . 99.989999999999995 110.253 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 3.2 mp0 -90.1 111.15 22.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.958 -0.756 . . . . 99.989999999999995 108.958 173.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.645 ' HB2' HG21 ' A' ' 159' ' ' VAL . 58.5 mt -107.36 133.87 51.26 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.85 0.357 . . . . 99.989999999999995 110.802 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -102.16 123.24 45.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.487 -0.324 . . . . 99.989999999999995 110.489 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 39.4 t -105.95 112.18 38.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.321 0.582 . . . . 99.989999999999995 109.895 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.453 ' CD ' ' HZ1' ' A' ' 205' ' ' LYS . 25.1 mt-10 -109.62 145.27 36.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.32 -0.855 . . . . 99.989999999999995 110.606 -173.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 66.7 t -77.87 129.76 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.949 0.404 . . . . 99.989999999999995 111.025 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 115.784 -0.644 . . . . 99.989999999999995 110.655 177.621 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 N--CA 1.45 -1.073 0 N-CA-C 110.728 -0.528 . . . . 99.989999999999995 110.728 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.668 HD11 HG11 ' A' ' 168' ' ' VAL . 2.0 pp -130.7 161.07 41.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.896 -0.138 . . . . 99.989999999999995 111.116 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.37 134.63 62.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 109.916 -0.402 . . . . 99.989999999999995 109.916 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.491 ' HG2' HG12 ' A' ' 168' ' ' VAL . 85.3 mtm180 -94.61 103.27 15.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.049 0.452 . . . . 99.989999999999995 112.093 -168.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.4 t -96.76 136.93 25.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.798 -0.637 . . . . 99.989999999999995 111.837 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 53.5 m-85 -94.64 104.0 15.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.592 -0.731 . . . . 99.989999999999995 110.63 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 0.7 OUTLIER -81.34 170.56 14.89 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 108.727 -0.842 . . . . 99.989999999999995 108.727 -177.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.494 ' HD3' HG12 ' A' ' 224' ' ' VAL . 53.1 Cg_exo -56.72 156.91 21.06 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.749 2.3 . . . . 99.989999999999995 112.491 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 67.21 37.26 3.73 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.935 -0.575 . . . . 99.989999999999995 110.336 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt 55.13 48.92 18.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.624 -0.716 . . . . 99.989999999999995 111.585 177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.524 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 27.9 mm-40 -104.29 160.89 14.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.265 -0.425 . . . . 99.989999999999995 110.104 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 28.5 ttp180 -147.05 138.99 24.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.898 0.38 . . . . 99.989999999999995 110.687 173.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.506 HG21 HD23 ' A' ' 161' ' ' LEU . 4.8 t -141.47 157.15 45.51 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.626 -0.879 . . . . 99.989999999999995 108.626 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.668 HG11 HD11 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -119.83 127.74 75.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 119.374 -0.93 . . . . 99.989999999999995 110.326 175.36 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.4 p -115.56 134.62 22.62 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 114.758 -1.11 . . . . 99.989999999999995 109.277 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.9 132.25 48.61 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.23 1.953 . . . . 99.989999999999995 111.454 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.9 75.96 0.89 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.525 -0.761 . . . . 99.989999999999995 110.691 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -64.74 111.81 2.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.889 -1.05 . . . . 99.989999999999995 111.922 -176.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 48.2 m -76.44 110.02 10.63 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.415 -0.587 . . . . 99.989999999999995 109.415 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 110.47 11.56 19.34 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.675 -0.774 . . . . 99.989999999999995 111.317 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.407 ' CG1' ' HB3' ' A' ' 180' ' ' SER . 1.1 t -133.05 138.01 52.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.663 -0.495 . . . . 99.989999999999995 109.663 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 21.3 p -81.93 160.2 23.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.098 -0.501 . . . . 99.989999999999995 111.233 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.526 ' HA ' ' OG ' ' A' ' 180' ' ' SER . 86.7 t -52.52 -30.6 14.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.036 -0.529 . . . . 99.989999999999995 109.659 171.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.54 ' CG ' ' HB3' ' A' ' 210' ' ' TRP . 72.6 mtp180 -53.74 -58.38 7.44 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.694 -0.684 . . . . 99.989999999999995 111.283 174.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.583 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 14.5 t70 -74.52 -43.49 55.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.11 0.481 . . . . 99.989999999999995 111.096 -174.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 28.1 p -60.76 -57.68 11.67 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.53 -0.759 . . . . 99.989999999999995 111.28 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.501 HD11 ' N ' ' A' ' 181' ' ' LEU . 9.6 mp -77.08 -11.69 59.84 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 122.102 -0.374 . . . . 99.989999999999995 111.154 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.583 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 4.7 ttmt -58.19 -46.31 86.03 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 107.741 -1.207 . . . . 99.989999999999995 107.741 171.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.4 tpmt? -59.57 -44.47 93.3 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.867 -0.606 . . . . 99.989999999999995 109.792 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.99 -54.93 20.09 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.672 0.619 . . . . 99.989999999999995 112.672 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 5.3 mp -78.22 -38.46 43.02 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.865 0.32 . . . . 99.989999999999995 111.865 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 14.7 mmt -63.48 -28.48 69.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.407 -0.361 . . . . 99.989999999999995 111.557 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 64.8 mtm -77.87 -7.33 56.56 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.355 0.598 . . . . 99.989999999999995 109.961 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.474 ' CZ ' ' HB ' ' A' ' 167' ' ' THR . 55.8 mtt85 -113.06 0.7 15.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.512 -0.767 . . . . 99.989999999999995 111.479 -178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 73.66 25.36 72.4 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.713 -0.756 . . . . 99.989999999999995 112.021 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.1 mp -115.59 152.61 32.75 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.833 -0.432 . . . . 99.989999999999995 109.833 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.473 ' O ' HD12 ' A' ' 191' ' ' ILE . 2.4 pp -108.2 128.67 25.27 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-O 121.067 0.46 . . . . 99.989999999999995 110.898 176.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 16.6 Cg_exo -68.14 -6.76 18.05 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.854 2.369 . . . . 99.989999999999995 112.362 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -75.26 -11.22 60.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 99.989999999999995 111.166 -175.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 27.7 t -126.27 34.65 4.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.01 -0.737 . . . . 99.989999999999995 109.01 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.477 ' HB3' HG11 ' A' ' 224' ' ' VAL . 77.3 m -144.47 158.82 43.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.495 -0.775 . . . . 99.989999999999995 110.188 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -136.29 159.26 42.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.257 -0.429 . . . . 99.989999999999995 110.704 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.489 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 23.8 t -114.06 138.29 44.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.97 -0.559 . . . . 99.989999999999995 111.392 -174.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -129.92 160.75 32.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.705 -0.68 . . . . 99.989999999999995 109.201 173.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.487 ' HD2' HD12 ' A' ' 217' ' ' LEU . 3.8 ptm180 . . . . . 0 C--N 1.316 -0.863 0 N-CA-C 108.255 -1.017 . . . . 99.989999999999995 108.255 164.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.648 0.261 . . . . 99.989999999999995 110.761 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -110.25 102.04 49.93 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.763 -0.458 . . . . 99.989999999999995 109.763 176.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.83 127.85 24.83 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.335 2.023 . . . . 99.989999999999995 112.046 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 197' ' ' VAL . 26.5 mm -91.25 159.18 2.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.119 -0.946 . . . . 99.989999999999995 109.582 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.463 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -97.71 131.55 10.63 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.516 -1.033 . . . . 99.989999999999995 110.516 173.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.54 ' HB3' ' CG ' ' A' ' 178' ' ' ARG . 85.2 m95 -61.49 -33.8 74.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.249 0.525 . . . . 99.989999999999995 111.01 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -86.57 7.37 26.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.852 0.358 . . . . 99.989999999999995 111.176 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.46 ' O ' HG21 ' A' ' 177' ' ' VAL . 89.2 m -82.32 143.1 31.51 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.551 -0.537 . . . . 99.989999999999995 109.551 173.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.08 129.87 41.22 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.792 -0.448 . . . . 99.989999999999995 109.792 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.42 HG23 ' HB3' ' A' ' 180' ' ' SER . 0.4 OUTLIER -66.69 -17.24 22.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.209 -0.45 . . . . 99.989999999999995 111.753 -175.455 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 23.2 t -68.19 -14.0 62.66 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.059 -0.401 . . . . 99.989999999999995 110.331 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.418 ' HB2' HD22 ' A' ' 217' ' ' LEU . 20.6 m0 -76.2 -19.48 58.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.504 0.669 . . . . 99.989999999999995 110.0 175.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.588 HD22 ' N ' ' A' ' 217' ' ' LEU . 1.5 mm? -115.65 20.77 14.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.216 -0.902 . . . . 99.989999999999995 109.333 -174.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.2 m -53.69 119.94 5.58 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.46 -0.791 . . . . 99.989999999999995 112.35 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 76.67 8.51 86.25 Favored Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 114.258 -1.337 . . . . 99.989999999999995 113.678 170.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -87.56 159.89 18.42 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.707 -0.479 . . . . 99.989999999999995 109.707 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 50.3 mt-10 -92.59 110.19 21.61 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.857 -0.794 . . . . 99.989999999999995 108.857 171.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.432 HD23 HG12 ' A' ' 197' ' ' VAL . 7.7 mp -96.22 161.67 13.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.97 -0.559 . . . . 99.989999999999995 109.994 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 197' ' ' VAL . 47.9 m-70 -125.96 122.48 36.07 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.911 -0.586 . . . . 99.989999999999995 110.068 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.494 HG12 ' HD3' ' A' ' 162' ' ' PRO . 2.7 t -100.72 114.17 38.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 108.674 -0.861 . . . . 99.989999999999995 108.674 174.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -108.29 127.81 54.19 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.297 -0.865 . . . . 99.989999999999995 108.919 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.75 129.27 37.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.089 0.471 . . . . 99.989999999999995 110.035 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 115.416 -0.811 . . . . 99.989999999999995 111.318 -176.644 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.506 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 38.7 Cg_exo . . . . . 0 N--CA 1.47 0.138 0 N-CA-C 112.881 0.3 . . . . 99.989999999999995 112.881 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.602 HD11 HG11 ' A' ' 168' ' ' VAL . 2.1 pp -132.32 163.59 37.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.982 -0.553 . . . . 99.989999999999995 110.846 -177.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 39.7 t -128.44 121.09 54.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.17 -0.468 . . . . 99.989999999999995 110.258 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.485 ' HA ' HG12 ' A' ' 168' ' ' VAL . 76.2 mtp180 -86.98 93.95 9.48 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.217 0.532 . . . . 99.989999999999995 111.374 -172.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.0 t -94.8 135.18 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 115.589 -0.732 . . . . 99.989999999999995 111.679 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.675 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 41.5 m-85 -90.18 103.6 16.26 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.071 -0.968 . . . . 99.989999999999995 109.92 175.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.518 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.5 mm? -77.18 174.21 6.24 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.951 -0.759 . . . . 99.989999999999995 108.951 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 84.1 Cg_exo -50.88 154.98 6.27 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.679 2.253 . . . . 99.989999999999995 112.49 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.3 m120 67.09 15.2 10.05 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.953 -0.567 . . . . 99.989999999999995 109.968 -173.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.561 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 58.69 49.97 9.5 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.248 -0.887 . . . . 99.989999999999995 111.016 -177.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.675 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -86.77 178.77 6.91 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.04 -0.982 . . . . 99.989999999999995 108.678 172.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.592 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 7.5 mtm180 -147.4 141.45 26.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 118.548 0.613 . . . . 99.989999999999995 112.146 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.504 HG21 HD23 ' A' ' 161' ' ' LEU . 4.0 t -145.47 150.11 35.89 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.921 -1.141 . . . . 99.989999999999995 107.921 173.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.602 HG11 HD11 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -113.1 126.81 70.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 119.621 -0.832 . . . . 99.989999999999995 110.02 178.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 24.3 t -108.57 131.09 21.99 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.307 -0.86 . . . . 99.989999999999995 109.311 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 34.4 Cg_exo -56.73 118.41 5.25 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.409 1.406 . . . . 99.989999999999995 110.293 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.75 116.06 4.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.76 -0.654 . . . . 99.989999999999995 110.174 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 170' ' ' PRO . 98.1 mtt180 -104.39 112.3 25.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.419 -0.81 . . . . 99.989999999999995 111.643 -172.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 49.5 t -77.76 113.06 15.26 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.498 -0.556 . . . . 99.989999999999995 109.498 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 112.32 -12.7 26.06 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.749 -0.739 . . . . 99.989999999999995 111.407 -177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 176' ' ' THR . 1.2 t -107.49 144.59 16.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.629 -0.508 . . . . 99.989999999999995 109.629 176.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.486 ' O ' HG12 ' A' ' 175' ' ' VAL . 40.1 p -85.89 160.67 19.35 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.029 -0.532 . . . . 99.989999999999995 110.104 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.601 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 15.4 m -57.15 -22.01 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.725 -0.472 . . . . 99.989999999999995 109.725 176.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.654 ' HG3' ' O ' ' A' ' 210' ' ' TRP . 92.2 mtt-85 -52.67 -58.15 7.76 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.407 -0.361 . . . . 99.989999999999995 111.111 172.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.59 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 23.2 t70 -75.54 -41.98 53.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.461 0.648 . . . . 99.989999999999995 111.1 -172.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.587 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 10.8 p -64.2 -52.8 57.11 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.025 -0.989 . . . . 99.989999999999995 111.081 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.491 ' N ' HD21 ' A' ' 181' ' ' LEU . 2.5 mt -76.43 -15.88 59.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.362 -0.381 . . . . 99.989999999999995 110.184 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.59 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 5.2 ttmt -59.69 -47.8 84.21 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.546 -0.909 . . . . 99.989999999999995 108.546 173.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.481 ' HA ' ' HE3' ' A' ' 183' ' ' LYS . 2.2 tpmt? -58.89 -41.86 88.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.085 -0.507 . . . . 99.989999999999995 109.76 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . -51.63 -63.92 0.98 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.2 -0.455 . . . . 99.989999999999995 111.997 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 181' ' ' LEU . 3.9 mp -69.82 -41.26 75.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.614 0.227 . . . . 99.989999999999995 111.614 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.56 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 10.4 mmt -62.79 -31.16 72.08 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.107 0.41 . . . . 99.989999999999995 112.107 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 62.0 mtm -74.4 -26.76 60.3 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.387 0.613 . . . . 99.989999999999995 109.635 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -82.73 -20.32 36.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.122 -0.944 . . . . 99.989999999999995 111.344 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.57 25.14 21.78 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.627 -0.589 . . . . 99.989999999999995 111.627 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.3 mp -118.39 171.0 8.45 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.704 0.402 . . . . 99.989999999999995 110.561 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 42.6 pt -119.47 132.4 24.02 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.271 -0.422 . . . . 99.989999999999995 110.871 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 3.7 Cg_exo -76.87 -12.04 18.04 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.95 2.433 . . . . 99.989999999999995 112.256 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -62.58 -40.11 95.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.95 -0.568 . . . . 99.989999999999995 111.464 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 12.5 t -99.16 34.13 2.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 110.303 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.486 ' HB3' HG11 ' A' ' 224' ' ' VAL . 81.6 m -142.43 166.78 23.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.053 -0.521 . . . . 99.989999999999995 110.735 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.636 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -138.91 160.81 38.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.33 -0.395 . . . . 99.989999999999995 110.558 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.76 128.03 69.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.212 0.32 . . . . 99.989999999999995 110.335 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 33.6 m-85 -123.61 145.22 49.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.571 0.224 . . . . 99.989999999999995 110.398 174.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 206' ' ' LYS . 1.6 ptm180 . . . . . 0 C--N 1.317 -0.834 0 N-CA-C 108.515 -0.92 . . . . 99.989999999999995 108.515 168.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 120.719 0.295 . . . . 99.989999999999995 110.35 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 199' ' ' ARG . 5.3 mptp? -106.34 106.52 57.61 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.257 -0.429 . . . . 99.989999999999995 110.586 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -70.29 118.64 5.8 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.704 1.602 . . . . 99.989999999999995 111.662 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 56.2 mt -95.95 154.01 3.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 114.293 -1.321 . . . . 99.989999999999995 111.07 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.05 142.31 22.25 Favored Glycine 0 N--CA 1.438 -1.186 0 N-CA-C 110.94 -0.864 . . . . 99.989999999999995 110.94 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.654 ' O ' ' HG3' ' A' ' 178' ' ' ARG . 81.9 m95 -66.3 -23.52 66.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 117.47 0.635 . . . . 99.989999999999995 110.532 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.48 19.88 9.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.044 0.45 . . . . 99.989999999999995 110.952 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 69.5 m -86.64 140.19 30.06 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.085 -0.507 . . . . 99.989999999999995 109.806 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.86 121.2 16.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.146 -0.479 . . . . 99.989999999999995 110.616 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.462 HG23 ' CB ' ' A' ' 180' ' ' SER . 0.5 OUTLIER -66.84 -22.38 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.526 . . . . 99.989999999999995 111.744 -176.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.4 t -74.81 -8.78 57.46 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.868 -0.333 . . . . 99.989999999999995 110.375 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -69.75 -38.69 76.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.683 0.754 . . . . 99.989999999999995 108.997 169.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.26 26.32 4.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.863 -1.062 . . . . 99.989999999999995 110.087 -175.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 52.2 m -50.24 114.33 1.09 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.566 0.698 . . . . 99.989999999999995 112.307 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 86.59 -8.41 75.24 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 114.914 -1.039 . . . . 99.989999999999995 113.495 171.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -74.6 156.44 36.76 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.925 -0.398 . . . . 99.989999999999995 109.925 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -87.7 109.85 20.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.04 -0.726 . . . . 99.989999999999995 109.04 173.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 70.1 mt -96.51 152.56 18.51 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.579 -0.526 . . . . 99.989999999999995 109.579 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -118.85 120.35 37.06 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.402 -0.363 . . . . 99.989999999999995 110.096 -175.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 2.6 t -100.1 111.83 30.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 121.568 0.699 . . . . 99.989999999999995 109.307 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -108.91 145.7 34.98 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.045 -0.98 . . . . 99.989999999999995 109.695 -173.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.14 128.75 38.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.22 -0.445 . . . . 99.989999999999995 110.922 -175.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 C--N 1.325 -0.462 0 CA-C-O 121.228 0.537 . . . . 99.989999999999995 109.99 175.715 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo . . . . . 0 N--CA 1.465 -0.196 0 N-CA-C 111.594 -0.194 . . . . 99.989999999999995 111.594 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.5 pp -121.88 169.8 12.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.164 0.507 . . . . 99.989999999999995 111.978 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.514 HG22 HG13 ' A' ' 214' ' ' ILE . 5.4 t -130.88 115.46 30.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 107.545 -1.28 . . . . 99.989999999999995 107.545 175.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.533 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 20.2 mtm180 -92.12 98.08 11.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.223 0.535 . . . . 99.989999999999995 111.632 -166.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.2 t -91.29 141.51 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.704 -0.68 . . . . 99.989999999999995 112.669 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -103.42 103.96 13.99 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.804 -1.089 . . . . 99.989999999999995 109.524 172.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.485 ' CD1' ' HD2' ' A' ' 188' ' ' ARG . 7.3 mt -83.03 169.8 16.53 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.645 -0.707 . . . . 99.989999999999995 110.18 -172.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 88.2 Cg_exo -50.67 149.52 13.73 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.1 2.533 . . . . 99.989999999999995 112.503 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 14.3 m120 69.0 30.11 4.59 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.892 -0.594 . . . . 99.989999999999995 110.538 -176.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 51.9 47.52 24.61 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.441 -0.799 . . . . 99.989999999999995 111.601 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.464 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 15.0 mm100 -95.99 170.67 9.13 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.493 -0.929 . . . . 99.989999999999995 108.493 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 7.9 ttt180 -148.65 135.75 20.1 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.051 -0.66 . . . . 99.989999999999995 111.84 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.459 HG22 ' HB1' ' A' ' 184' ' ' ALA . 1.4 t -151.6 141.77 22.28 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.019 -1.104 . . . . 99.989999999999995 108.019 175.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.533 ' CG1' ' HG2' ' A' ' 158' ' ' ARG . 0.7 OUTLIER -117.26 130.07 72.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 C-N-CA 119.451 -0.899 . . . . 99.989999999999995 110.307 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.4 p -109.53 136.12 20.28 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.505 -1.225 . . . . 99.989999999999995 109.514 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.41 128.61 30.81 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.233 1.955 . . . . 99.989999999999995 111.167 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.16 89.49 0.45 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.836 -0.62 . . . . 99.989999999999995 109.81 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.467 ' HB2' HG13 ' A' ' 175' ' ' VAL . 64.3 mtt180 -77.27 113.96 15.58 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.07 -0.968 . . . . 99.989999999999995 110.989 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.5 t -70.12 115.23 9.09 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.826 -0.435 . . . . 99.989999999999995 109.826 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.03 -3.57 35.58 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.648 -0.787 . . . . 99.989999999999995 112.457 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 179' ' ' ASP . 0.4 OUTLIER -108.42 150.22 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.041 0.448 . . . . 99.989999999999995 109.944 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.8 p -87.93 152.13 22.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.058 -0.519 . . . . 99.989999999999995 111.231 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.615 HG21 ' O ' ' A' ' 212' ' ' THR . 86.6 t -46.53 -42.68 5.46 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 O-C-N 123.512 0.507 . . . . 99.989999999999995 110.46 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 11.0 ptm180 -49.78 -48.65 50.37 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 116.062 -0.517 . . . . 99.989999999999995 112.35 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.567 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 16.2 t70 -70.21 -47.55 60.98 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.346 0.594 . . . . 99.989999999999995 111.039 -176.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.458 ' HB2' HG23 ' A' ' 214' ' ' ILE . 0.5 OUTLIER -66.59 -45.89 77.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.409 -0.814 . . . . 99.989999999999995 111.254 -175.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.446 ' N ' HD21 ' A' ' 181' ' ' LEU . 0.5 OUTLIER -73.1 -28.49 62.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.204 -0.453 . . . . 99.989999999999995 110.325 176.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.567 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 8.6 mtmt -54.04 -49.94 67.81 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.265 -0.643 . . . . 99.989999999999995 109.265 176.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.577 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.3 tpmt? -56.81 -47.37 80.39 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.79 -0.448 . . . . 99.989999999999995 109.79 175.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.459 ' HB1' HG22 ' A' ' 167' ' ' THR . . . -51.36 -60.63 2.91 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.071 -0.513 . . . . 99.989999999999995 112.242 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 5.5 mp -68.0 -48.32 66.09 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 122.619 0.368 . . . . 99.989999999999995 111.557 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.516 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 1.0 OUTLIER -59.51 -34.3 72.44 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.849 -0.614 . . . . 99.989999999999995 111.882 -176.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.577 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 67.4 mtm -71.03 -31.37 67.83 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.23 0.538 . . . . 99.989999999999995 109.691 175.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.485 ' HD2' ' CD1' ' A' ' 161' ' ' LEU . 9.1 mtt180 -86.2 -4.68 59.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.512 -0.767 . . . . 99.989999999999995 111.813 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.37 25.92 49.38 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.796 -0.716 . . . . 99.989999999999995 112.093 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.1 mp -116.0 161.59 18.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.779 -0.452 . . . . 99.989999999999995 109.779 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 29.4 pt -120.65 128.74 25.64 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 116.297 -0.41 . . . . 99.989999999999995 111.142 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 23.4 Cg_exo -66.02 -14.66 45.47 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 123.002 2.468 . . . . 99.989999999999995 112.28 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -60.19 -42.44 95.09 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.183 -0.462 . . . . 99.989999999999995 111.497 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.5 t -104.23 28.84 6.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.392 0.615 . . . . 99.989999999999995 110.028 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.533 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 84.0 m -139.87 165.8 26.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.651 -0.704 . . . . 99.989999999999995 110.443 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -149.53 164.57 34.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.531 -0.304 . . . . 99.989999999999995 111.245 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.439 HG11 HD13 ' A' ' 208' ' ' ILE . 14.7 t -111.1 133.13 57.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.892 -0.595 . . . . 99.989999999999995 111.33 -174.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 25.0 m-85 -126.87 143.94 51.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.071 -0.513 . . . . 99.989999999999995 110.193 172.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 . . . . . 0 C--N 1.314 -0.956 0 N-CA-C 107.713 -1.217 . . . . 99.989999999999995 107.713 168.254 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 110.071 -0.344 . . . . 99.989999999999995 110.071 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 8.4 tptt -109.79 104.84 56.33 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.643 -0.253 . . . . 99.989999999999995 110.771 -175.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.37 124.84 10.74 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.104 1.869 . . . . 99.989999999999995 112.17 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.439 HD13 HG11 ' A' ' 197' ' ' VAL . 46.9 mt -100.01 153.81 4.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 114.396 -1.274 . . . . 99.989999999999995 110.919 -176.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.85 138.85 15.87 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 110.977 -0.849 . . . . 99.989999999999995 110.977 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -67.4 -20.82 65.59 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.103 0.451 . . . . 99.989999999999995 110.154 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -92.62 6.89 45.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 99.989999999999995 110.914 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.615 ' O ' HG21 ' A' ' 177' ' ' VAL . 96.5 m -78.62 147.15 33.75 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.852 -0.795 . . . . 99.989999999999995 108.852 172.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 215' ' ' SER . 12.5 t70 -74.55 130.05 38.87 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.539 -0.541 . . . . 99.989999999999995 109.539 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.514 HG13 HG22 ' A' ' 157' ' ' VAL . 0.2 OUTLIER -72.56 -15.1 17.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.917 0.389 . . . . 99.989999999999995 111.458 -174.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.446 ' HB2' ' OD1' ' A' ' 213' ' ' ASP . 70.8 m -75.01 -8.87 57.75 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.899 -0.5 . . . . 99.989999999999995 110.587 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 30.1 m0 -82.36 -11.46 58.56 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.967 -0.753 . . . . 99.989999999999995 108.967 172.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.461 HD11 HD22 ' A' ' 222' ' ' LEU . 5.6 mt -118.46 19.26 13.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.045 -0.979 . . . . 99.989999999999995 109.022 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 99.5 m -52.27 117.25 2.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.401 -0.818 . . . . 99.989999999999995 112.534 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 86.3 -4.13 86.37 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.992 -1.004 . . . . 99.989999999999995 113.266 170.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -75.84 157.88 32.81 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.946 -0.39 . . . . 99.989999999999995 109.946 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 28.4 mt-10 -98.05 111.62 23.87 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.028 -0.73 . . . . 99.989999999999995 109.028 171.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.461 HD22 HD11 ' A' ' 217' ' ' LEU . 6.4 mp -95.45 164.93 12.6 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.835 -0.621 . . . . 99.989999999999995 110.191 -175.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -133.97 130.09 37.15 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.111 -0.7 . . . . 99.989999999999995 109.111 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 40.9 t -100.86 123.83 54.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.106 0.479 . . . . 99.989999999999995 109.768 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -107.8 146.23 32.5 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.44 -0.8 . . . . 99.989999999999995 109.682 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 85.7 t -84.47 122.68 38.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.93 0.395 . . . . 99.989999999999995 110.075 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 64.6 mt . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.736 -0.666 . . . . 99.989999999999995 110.352 -179.086 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.428 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 41.5 Cg_endo . . . . . 0 N--CA 1.463 -0.306 0 CA-C-O 121.029 0.345 . . . . 99.989999999999995 112.719 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.663 HD11 HG11 ' A' ' 168' ' ' VAL . 1.9 pp -132.83 152.69 36.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.953 -0.567 . . . . 99.989999999999995 110.464 -177.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.32 134.59 66.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.577 -0.527 . . . . 99.989999999999995 109.577 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.494 ' HA ' HG12 ' A' ' 168' ' ' VAL . 1.3 mtp180 -94.2 97.61 10.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 99.989999999999995 112.288 -165.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.0 t -97.64 134.44 35.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.924 -0.58 . . . . 99.989999999999995 112.146 -175.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 2.3 m-85 -92.3 103.67 16.1 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.652 -0.703 . . . . 99.989999999999995 109.391 175.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.1 mm? -78.03 169.62 20.09 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 108.86 -0.793 . . . . 99.989999999999995 108.86 -177.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.435 ' HD3' ' CG1' ' A' ' 224' ' ' VAL . 78.5 Cg_exo -52.78 152.98 15.81 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.71 2.273 . . . . 99.989999999999995 113.228 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.2 t30 65.2 41.11 4.61 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.604 -0.726 . . . . 99.989999999999995 110.746 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 59.88 31.01 20.52 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.271 -0.877 . . . . 99.989999999999995 112.219 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.512 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 26.6 mm-40 -85.3 161.42 19.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.851 -0.426 . . . . 99.989999999999995 109.851 176.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 26.8 ttp180 -149.25 134.94 18.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.393 -0.225 . . . . 99.989999999999995 110.393 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.503 HG21 HD23 ' A' ' 161' ' ' LEU . 1.1 t -145.63 151.64 38.39 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.622 -0.881 . . . . 99.989999999999995 108.622 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.663 HG11 HD11 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -108.05 129.31 62.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 119.404 -0.918 . . . . 99.989999999999995 110.232 178.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 m -105.45 130.99 22.15 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.238 -0.892 . . . . 99.989999999999995 110.257 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.38 121.09 8.59 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.821 1.681 . . . . 99.989999999999995 111.182 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.428 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -69.92 95.16 0.9 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.204 -0.907 . . . . 99.989999999999995 110.262 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -93.25 112.19 24.05 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.132 -0.94 . . . . 99.989999999999995 111.4 -173.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.475 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 49.0 t -70.11 113.39 7.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.723 -0.473 . . . . 99.989999999999995 109.723 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.51 0.01 27.78 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.51 -0.852 . . . . 99.989999999999995 111.742 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.2 152.05 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.026 -0.731 . . . . 99.989999999999995 109.026 176.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 24.3 p -89.01 159.8 17.41 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.091 -0.644 . . . . 99.989999999999995 110.699 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 212' ' ' THR . 87.4 t -50.5 -38.21 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.842 -0.799 . . . . 99.989999999999995 108.842 172.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.557 ' CG ' ' HB3' ' A' ' 210' ' ' TRP . 26.6 mtp180 -45.63 -58.81 3.13 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.385 -0.825 . . . . 99.989999999999995 111.563 175.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.648 ' HA ' ' CE ' ' A' ' 182' ' ' LYS . 32.3 m-20 -67.07 -45.53 77.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.922 0.392 . . . . 99.989999999999995 111.913 -170.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.7 t -71.38 -38.62 71.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.15 0.5 . . . . 99.989999999999995 110.478 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.448 ' N ' HD21 ' A' ' 181' ' ' LEU . 0.4 OUTLIER -75.93 -27.7 57.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.989 -0.55 . . . . 99.989999999999995 110.455 177.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.648 ' CE ' ' HA ' ' A' ' 179' ' ' ASP . 37.1 mtmt -55.22 -52.42 63.43 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.671 -0.492 . . . . 99.989999999999995 109.671 175.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 183' ' ' LYS . 2.2 tpmt? -61.86 -40.46 95.42 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.294 -0.562 . . . . 99.989999999999995 110.316 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.411 ' HB1' HG22 ' A' ' 167' ' ' THR . . . -55.53 -55.85 27.11 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.286 -0.416 . . . . 99.989999999999995 111.751 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.0 mt -70.11 -46.37 64.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.191 -0.459 . . . . 99.989999999999995 111.318 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 12.9 mmt -59.97 -36.67 77.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.395 -0.366 . . . . 99.989999999999995 111.961 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.439 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 58.2 mtm -76.35 -12.91 60.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.062 0.458 . . . . 99.989999999999995 110.251 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -110.33 17.8 20.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.843 -0.617 . . . . 99.989999999999995 111.527 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 62.63 36.94 93.95 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.226 -0.511 . . . . 99.989999999999995 112.198 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 24.2 mt -128.36 166.91 17.76 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.022 -0.362 . . . . 99.989999999999995 110.022 -175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.473 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 37.4 pt -130.64 130.64 22.96 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.053 0.454 . . . . 99.989999999999995 111.85 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 16.2 Cg_exo -68.76 -16.13 41.47 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.088 2.525 . . . . 99.989999999999995 112.341 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -65.34 -37.52 87.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 99.989999999999995 111.071 -177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 16.9 t -109.78 37.0 2.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.415 0.626 . . . . 99.989999999999995 109.992 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.499 ' HB3' HG11 ' A' ' 224' ' ' VAL . 99.1 m -146.73 162.36 38.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.813 -0.631 . . . . 99.989999999999995 110.672 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -142.16 157.29 45.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.155 -0.475 . . . . 99.989999999999995 110.78 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 10.9 t -107.13 123.73 62.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.013 -0.54 . . . . 99.989999999999995 110.584 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 47.8 m-85 -116.14 153.8 31.13 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.07 -0.345 . . . . 99.989999999999995 110.07 173.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.483 ' HB3' ' CD2' ' A' ' 222' ' ' LEU . 12.2 ptt180 . . . . . 0 C--N 1.315 -0.928 0 N-CA-C 108.792 -0.818 . . . . 99.989999999999995 108.792 167.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.5 ' HZ3' ' CD ' ' A' ' 225' ' ' GLU . 52.4 mtpt . . . . . 0 N--CA 1.446 -0.632 0 N-CA-C 109.725 -0.472 . . . . 99.989999999999995 109.725 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 74.9 mmtt -98.4 107.14 40.34 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.485 -0.325 . . . . 99.989999999999995 110.156 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -74.51 118.92 5.52 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.943 1.762 . . . . 99.989999999999995 111.467 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.443 HG21 HD13 ' A' ' 217' ' ' LEU . 22.0 mt -93.83 152.75 3.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.495 -1.23 . . . . 99.989999999999995 111.088 -174.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -85.49 139.95 17.76 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.304 -0.718 . . . . 99.989999999999995 111.304 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.557 ' HB3' ' CG ' ' A' ' 178' ' ' ARG . 88.4 m95 -70.41 -34.99 73.17 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.645 0.26 . . . . 99.989999999999995 111.164 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.48 5.5 23.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.119 0.485 . . . . 99.989999999999995 111.238 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.537 ' O ' HG21 ' A' ' 177' ' ' VAL . 95.6 m -74.8 148.37 40.39 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.693 -0.854 . . . . 99.989999999999995 108.693 170.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -73.49 134.38 43.86 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.377 -0.601 . . . . 99.989999999999995 109.377 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 171' ' ' ALA . 0.1 OUTLIER -69.94 -16.36 20.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.958 0.408 . . . . 99.989999999999995 110.653 -178.396 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 18.7 m -65.49 -15.88 63.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.994 0.426 . . . . 99.989999999999995 110.73 176.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 32.9 m0 -80.54 -17.64 50.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 99.989999999999995 110.22 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.444 ' HB3' HD12 ' A' ' 222' ' ' LEU . 10.4 mt -112.81 19.87 16.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.93 -0.577 . . . . 99.989999999999995 109.724 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 99.7 m -52.1 112.86 0.87 Allowed 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.42 -0.809 . . . . 99.989999999999995 112.413 -177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 80.07 8.93 87.2 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 114.643 -1.162 . . . . 99.989999999999995 113.427 171.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -85.17 151.32 24.19 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.737 -0.468 . . . . 99.989999999999995 109.737 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 36.5 mt-10 -86.99 111.14 20.56 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.812 -0.81 . . . . 99.989999999999995 108.812 171.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.483 ' CD2' ' HB3' ' A' ' 199' ' ' ARG . 61.0 mt -105.56 159.63 15.8 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.884 -0.598 . . . . 99.989999999999995 110.214 -175.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -125.99 122.44 35.9 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.833 0.349 . . . . 99.989999999999995 110.27 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 4.5 t -101.05 115.54 42.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.921 -0.581 . . . . 99.989999999999995 109.566 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.5 ' CD ' ' HZ3' ' A' ' 205' ' ' LYS . 24.6 mt-10 -112.35 141.9 45.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.839 -0.618 . . . . 99.989999999999995 110.78 -175.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.84 127.62 34.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.205 -0.452 . . . . 99.989999999999995 109.831 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 C--N 1.321 -0.632 0 N-CA-C 109.173 -0.677 . . . . 99.989999999999995 109.173 176.671 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.456 -0.711 0 N-CA-C 111.241 -0.33 . . . . 99.989999999999995 111.241 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.704 ' O ' ' HA2' ' A' ' 219' ' ' GLY . 1.8 pp -126.09 156.36 36.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.428 -0.351 . . . . 99.989999999999995 110.493 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -125.23 134.23 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 110.186 -0.301 . . . . 99.989999999999995 110.186 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 81.7 mtm180 -95.41 105.46 17.43 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.332 0.493 . . . . 99.989999999999995 112.332 -167.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.8 t -96.87 135.45 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.155 -0.475 . . . . 99.989999999999995 111.807 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 64.9 m-85 -97.4 103.12 15.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.414 -0.812 . . . . 99.989999999999995 109.788 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.569 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.1 mt -84.52 173.84 6.66 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.645 -0.707 . . . . 99.989999999999995 111.098 -170.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 99.1 Cg_exo -48.66 153.47 3.49 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.128 2.552 . . . . 99.989999999999995 113.236 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 63.16 24.46 14.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.561 -0.745 . . . . 99.989999999999995 110.492 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.558 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 61.18 44.05 10.37 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.55 -0.75 . . . . 99.989999999999995 111.088 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 15.2 mm100 -90.8 177.93 6.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.743 -0.662 . . . . 99.989999999999995 109.781 177.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 38.7 ttp180 -147.36 153.44 39.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.548 0.214 . . . . 99.989999999999995 110.545 176.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.482 HG22 ' HB1' ' A' ' 184' ' ' ALA . 1.4 t -163.31 151.79 13.95 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.956 -0.757 . . . . 99.989999999999995 108.956 170.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.662 HG11 HD11 ' A' ' 156' ' ' ILE . 0.1 OUTLIER -115.06 128.29 72.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 119.965 -0.694 . . . . 99.989999999999995 110.298 177.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.7 p -115.83 133.29 22.86 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.267 -0.879 . . . . 99.989999999999995 109.412 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.41 131.55 43.44 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.281 1.987 . . . . 99.989999999999995 111.924 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.79 75.69 1.59 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.563 -0.744 . . . . 99.989999999999995 110.801 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -68.51 111.99 5.05 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.855 -1.066 . . . . 99.989999999999995 111.536 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.608 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 59.0 m -70.45 116.61 10.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.825 0.345 . . . . 99.989999999999995 110.128 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.03 -6.0 36.76 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.512 -0.852 . . . . 99.989999999999995 111.923 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.69 142.91 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.396 -0.594 . . . . 99.989999999999995 109.396 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.0 p -88.46 155.13 19.84 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.601 -0.44 . . . . 99.989999999999995 111.018 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.575 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 88.5 t -52.96 -34.34 20.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 116.022 -0.536 . . . . 99.989999999999995 110.636 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 16.0 ptt180 -56.67 -47.72 79.19 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 122.256 -0.277 . . . . 99.989999999999995 111.568 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.596 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 20.6 t70 -72.25 -45.49 59.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.174 0.511 . . . . 99.989999999999995 110.867 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.481 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 2.8 p -63.31 -53.24 55.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.304 -0.862 . . . . 99.989999999999995 111.378 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.7 OUTLIER -69.96 -24.41 63.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.685 -0.689 . . . . 99.989999999999995 111.121 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 11.8 mtmt -57.65 -51.25 70.28 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.453 -0.573 . . . . 99.989999999999995 109.453 175.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.543 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.4 tpmt? -61.43 -42.6 98.99 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.344 -0.389 . . . . 99.989999999999995 109.952 177.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.482 ' HB1' HG22 ' A' ' 167' ' ' THR . . . -53.47 -61.11 2.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 99.989999999999995 111.411 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.418 HD11 ' O ' ' A' ' 181' ' ' LEU . 1.5 mt -65.02 -44.68 88.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.057 -0.519 . . . . 99.989999999999995 111.24 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.563 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 6.5 mmt -61.38 -32.19 72.11 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.058 0.392 . . . . 99.989999999999995 112.058 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.543 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 62.5 mtm -77.16 -22.69 52.13 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.213 0.53 . . . . 99.989999999999995 110.02 175.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.1 5.77 50.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.455 -0.793 . . . . 99.989999999999995 111.73 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 69.81 36.69 74.85 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.832 -0.699 . . . . 99.989999999999995 111.966 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 21.4 mt -131.11 165.99 22.06 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 122.87 0.468 . . . . 99.989999999999995 110.021 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 35.7 pt -126.62 135.19 26.91 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.907 0.384 . . . . 99.989999999999995 111.36 177.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 15.9 Cg_exo -69.01 -16.5 40.77 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.029 2.486 . . . . 99.989999999999995 111.985 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -59.13 -45.51 90.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.511 -0.768 . . . . 99.989999999999995 111.534 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 16.2 t -105.41 34.74 3.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.257 0.551 . . . . 99.989999999999995 109.75 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.547 ' HB3' HG11 ' A' ' 224' ' ' VAL . 91.1 m -141.84 162.36 35.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.861 -0.609 . . . . 99.989999999999995 110.991 -176.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.628 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -143.62 154.63 43.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.535 -0.302 . . . . 99.989999999999995 111.133 174.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.495 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 13.3 t -105.92 138.01 33.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 99.989999999999995 110.676 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -129.24 150.32 50.67 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.572 -0.529 . . . . 99.989999999999995 109.572 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.456 ' HG2' HD11 ' A' ' 208' ' ' ILE . 2.9 ptm180 . . . . . 0 C--N 1.321 -0.651 0 N-CA-C 108.381 -0.97 . . . . 99.989999999999995 108.381 166.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt . . . . . 0 N--CA 1.445 -0.712 0 CA-C-O 120.657 0.265 . . . . 99.989999999999995 110.711 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -111.87 103.97 55.65 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.772 -0.825 . . . . 99.989999999999995 108.772 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.19 132.5 41.83 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.361 2.041 . . . . 99.989999999999995 112.155 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.495 ' HB ' ' HB ' ' A' ' 197' ' ' VAL . 20.3 mm -96.77 158.12 3.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.42 -0.809 . . . . 99.989999999999995 110.281 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.459 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -96.0 142.11 15.95 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.425 -1.07 . . . . 99.989999999999995 110.425 172.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -70.27 -22.55 62.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 117.315 0.558 . . . . 99.989999999999995 111.068 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -94.05 9.82 36.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.895 0.379 . . . . 99.989999999999995 110.833 176.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.527 ' O ' HG21 ' A' ' 177' ' ' VAL . 81.4 m -77.71 150.46 34.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.097 -0.705 . . . . 99.989999999999995 109.097 172.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -80.1 124.41 28.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.744 0.783 . . . . 99.989999999999995 109.589 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.403 ' H ' HG23 ' A' ' 214' ' ' ILE . 7.7 tt -53.58 -30.19 18.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 113.998 -1.455 . . . . 99.989999999999995 111.768 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.608 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 12.9 m -62.91 -16.79 60.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.0 -0.546 . . . . 99.989999999999995 111.901 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -79.29 -13.61 59.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.222 0.534 . . . . 99.989999999999995 109.654 175.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.411 HD22 ' HD2' ' A' ' 199' ' ' ARG . 11.5 mt -117.92 16.51 14.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.051 -0.977 . . . . 99.989999999999995 109.83 -176.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 97.4 m -50.63 119.44 3.82 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.864 0.84 . . . . 99.989999999999995 112.865 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.704 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 75.71 8.7 84.62 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 114.214 -1.357 . . . . 99.989999999999995 113.498 170.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -92.78 164.78 13.23 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.751 0.31 . . . . 99.989999999999995 110.409 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 6.4 mp0 -96.35 111.01 23.24 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.312 -0.625 . . . . 99.989999999999995 109.312 176.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 28.7 mt -100.6 165.9 11.18 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.428 -0.582 . . . . 99.989999999999995 109.428 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -136.57 124.92 23.3 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.933 -0.395 . . . . 99.989999999999995 109.933 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 42.4 t -103.69 124.63 58.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.024 0.44 . . . . 99.989999999999995 110.268 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 71.0 mm-40 -110.79 155.05 23.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.391 -0.822 . . . . 99.989999999999995 110.666 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 43.1 t -83.38 129.19 37.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.157 -0.474 . . . . 99.989999999999995 110.532 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 115.983 -0.553 . . . . 99.989999999999995 110.126 176.329 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.437 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 66.6 Cg_endo . . . . . 0 N--CA 1.464 -0.246 0 CA-C-O 121.072 0.363 . . . . 99.989999999999995 112.887 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.671 HD11 HG11 ' A' ' 168' ' ' VAL . 1.9 pp -129.87 157.85 42.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.892 -0.595 . . . . 99.989999999999995 110.622 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.97 133.91 68.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.705 -0.48 . . . . 99.989999999999995 109.705 177.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.542 ' HA ' HG12 ' A' ' 168' ' ' VAL . 18.1 mtm180 -92.31 108.03 19.65 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.476 0.655 . . . . 99.989999999999995 112.09 -168.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.617 HG21 ' HB2' ' A' ' 222' ' ' LEU . 11.6 t -96.1 145.75 8.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.206 -0.906 . . . . 99.989999999999995 111.626 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.546 ' CZ ' ' HD2' ' A' ' 166' ' ' ARG . 21.7 m-85 -112.61 103.01 11.05 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.57 -0.741 . . . . 99.989999999999995 109.822 176.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.5 mm? -76.58 173.99 6.47 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.659 -0.497 . . . . 99.989999999999995 109.659 -172.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.472 ' CD ' ' HB3' ' A' ' 161' ' ' LEU . 74.4 Cg_exo -54.11 155.01 16.31 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.571 2.18 . . . . 99.989999999999995 112.873 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.9 t30 66.74 21.86 10.47 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.334 -0.848 . . . . 99.989999999999995 109.947 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 61.17 44.9 9.52 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.489 -0.778 . . . . 99.989999999999995 111.399 179.083 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 15.1 mm-40 -86.64 171.94 10.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.751 -0.659 . . . . 99.989999999999995 109.329 174.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.546 ' HD2' ' CZ ' ' A' ' 160' ' ' PHE . 47.1 ttt180 -148.4 133.79 18.55 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.401 0.519 . . . . 99.989999999999995 112.401 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.542 HG21 HD23 ' A' ' 161' ' ' LEU . 5.4 t -137.43 174.74 10.27 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.484 -0.932 . . . . 99.989999999999995 108.484 175.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.671 HG11 HD11 ' A' ' 156' ' ' ILE . 0.2 OUTLIER -132.09 128.6 59.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.13 -0.628 . . . . 99.989999999999995 109.632 170.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.48 129.85 23.44 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.672 -0.694 . . . . 99.989999999999995 109.711 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.08 123.48 13.95 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.313 2.009 . . . . 99.989999999999995 111.476 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.437 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -61.75 99.96 0.13 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.628 0.728 . . . . 99.989999999999995 109.286 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.642 ' HG2' ' HB ' ' A' ' 175' ' ' VAL . 17.2 ttp180 -107.81 111.97 24.38 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.515 -1.22 . . . . 99.989999999999995 110.916 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.66 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 42.4 t -70.84 128.3 35.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.762 -0.654 . . . . 99.989999999999995 110.87 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 109.06 -21.18 27.61 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.811 -0.709 . . . . 99.989999999999995 111.767 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.642 ' HB ' ' HG2' ' A' ' 172' ' ' ARG . 0.9 OUTLIER -99.19 142.85 14.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.367 0.603 . . . . 99.989999999999995 110.749 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 5.6 p -81.56 148.69 29.01 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.395 -0.82 . . . . 99.989999999999995 109.641 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.492 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 21.9 m -49.48 -32.09 6.19 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.616 0 CA-C-N 117.904 0.32 . . . . 99.989999999999995 110.319 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 21.3 ptt180 -58.82 -43.38 90.61 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 112.813 0.672 . . . . 99.989999999999995 112.813 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.591 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 21.2 t70 -71.34 -47.64 55.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.964 0.802 . . . . 99.989999999999995 110.477 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.531 ' HB2' HG23 ' A' ' 214' ' ' ILE . 0.6 OUTLIER -62.21 -43.36 99.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.465 -0.789 . . . . 99.989999999999995 111.414 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.427 ' N ' HD21 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -72.42 -36.32 68.58 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.035 -0.53 . . . . 99.989999999999995 110.178 178.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.691 ' O ' ' HB2' ' A' ' 186' ' ' MET . 7.9 mtmt -50.64 -45.07 57.62 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 116.125 -0.489 . . . . 99.989999999999995 109.805 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.515 ' O ' ' HG3' ' A' ' 187' ' ' MET . 10.9 tppt? -67.41 -51.46 51.48 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.7 -0.682 . . . . 99.989999999999995 110.917 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -43.73 -54.13 5.35 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.482 0.489 . . . . 99.989999999999995 111.973 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 5.1 mp -69.24 -52.39 28.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.63 0.372 . . . . 99.989999999999995 111.733 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.691 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 1.3 ttm -54.28 -38.35 65.77 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.272 0.471 . . . . 99.989999999999995 112.272 -176.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 68.7 mtm -74.46 -16.52 60.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.338 0.59 . . . . 99.989999999999995 110.179 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 188' ' ' ARG . 49.8 mtt180 -105.9 12.73 30.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.32 -0.855 . . . . 99.989999999999995 111.324 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 68.6 38.5 86.23 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.783 -0.644 . . . . 99.989999999999995 112.015 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 20.8 mt -132.02 157.93 42.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.743 0.306 . . . . 99.989999999999995 110.676 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.0 pt -122.22 127.32 25.95 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.193 -0.458 . . . . 99.989999999999995 111.349 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.03 -12.84 31.0 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.865 2.377 . . . . 99.989999999999995 111.895 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -58.47 -41.27 84.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.707 -0.679 . . . . 99.989999999999995 111.017 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 74.1 m -105.44 34.88 3.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.97 -0.559 . . . . 99.989999999999995 110.897 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.48 ' HB3' HG11 ' A' ' 224' ' ' VAL . 80.9 m -145.04 164.84 29.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 99.989999999999995 110.866 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -139.2 160.13 40.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.157 -0.474 . . . . 99.989999999999995 110.447 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 17.0 t -109.13 140.69 26.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.092 -0.504 . . . . 99.989999999999995 110.464 -176.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -134.32 142.67 47.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.449 -0.341 . . . . 99.989999999999995 110.09 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.523 ' HD2' HD12 ' A' ' 217' ' ' LEU . 8.0 ptm180 . . . . . 0 C--N 1.317 -0.844 0 N-CA-C 107.772 -1.196 . . . . 99.989999999999995 107.772 166.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.603 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 39.9 mtpt . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 108.613 -0.884 . . . . 99.989999999999995 108.613 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -94.13 98.97 3.22 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.653 -0.703 . . . . 99.989999999999995 109.684 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.603 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 25.3 Cg_exo -62.67 135.95 55.44 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.566 2.177 . . . . 99.989999999999995 112.848 -174.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 197' ' ' VAL . 22.8 mm -98.02 154.44 3.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.812 -1.085 . . . . 99.989999999999995 109.791 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -88.81 134.04 12.18 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.365 -1.094 . . . . 99.989999999999995 110.365 174.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.492 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 86.9 m95 -64.84 -24.55 67.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.325 0.563 . . . . 99.989999999999995 110.97 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -93.57 14.11 19.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.961 0.41 . . . . 99.989999999999995 111.247 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.466 ' O ' HG11 ' A' ' 177' ' ' VAL . 85.4 m -88.11 145.33 25.99 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.316 -0.624 . . . . 99.989999999999995 109.316 173.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -72.81 134.12 44.78 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.939 -0.393 . . . . 99.989999999999995 109.939 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.531 HG23 ' HB2' ' A' ' 180' ' ' SER . 0.1 OUTLIER -69.97 -16.6 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.97 0.414 . . . . 99.989999999999995 110.961 -175.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.66 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 8.3 m -66.51 -19.62 65.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.281 -0.418 . . . . 99.989999999999995 110.744 176.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.499 ' HB2' HD22 ' A' ' 217' ' ' LEU . 27.8 m0 -75.59 -23.63 56.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.545 0.688 . . . . 99.989999999999995 109.815 176.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.614 HD22 ' N ' ' A' ' 217' ' ' LEU . 1.4 mm? -109.32 23.95 13.77 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.945 -1.025 . . . . 99.989999999999995 109.36 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 51.3 m -54.37 114.22 1.57 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.625 0.726 . . . . 99.989999999999995 111.958 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 84.14 -2.84 87.25 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 114.764 -1.107 . . . . 99.989999999999995 112.946 173.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.39 156.94 36.51 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.073 -0.343 . . . . 99.989999999999995 110.073 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 50.3 mt-10 -89.71 108.38 19.65 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.495 -0.928 . . . . 99.989999999999995 108.495 171.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.617 ' HB2' HG21 ' A' ' 159' ' ' VAL . 82.8 mt -102.47 109.68 21.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.74 0.781 . . . . 99.989999999999995 110.478 -175.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -84.22 122.04 28.31 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.253 -0.885 . . . . 99.989999999999995 110.856 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 3.7 t -99.93 109.95 25.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.27 -0.877 . . . . 99.989999999999995 109.51 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -110.27 145.26 37.7 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.718 -1.128 . . . . 99.989999999999995 109.657 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.58 133.52 31.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.802 -0.444 . . . . 99.989999999999995 109.802 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.434 HD23 ' HB2' ' A' ' 196' ' ' ALA . 55.9 mt . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 121.196 0.522 . . . . 99.989999999999995 110.854 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 120.587 0.232 . . . . 99.989999999999995 110.839 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.38 92.6 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.42 2.747 . . . . 99.989999999999995 112.37 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -89.96 103.21 15.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.163 0.506 . . . . 99.989999999999995 111.288 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.65 108.17 31.16 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.69 -0.686 . . . . 99.989999999999995 110.019 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 63.9 Cg_endo -70.09 159.34 53.49 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.514 2.142 . . . . 99.989999999999995 112.053 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.633 HD11 HG11 ' A' ' 168' ' ' VAL . 2.0 pp -129.75 167.07 25.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.408 -0.36 . . . . 99.989999999999995 110.957 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 46.4 t -127.86 126.24 66.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.443 -0.344 . . . . 99.989999999999995 110.298 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 21.2 mtm180 -93.92 91.59 6.98 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.126 0.488 . . . . 99.989999999999995 111.941 -170.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 222' ' ' LEU . 2.1 t -93.44 162.23 2.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.609 0.718 . . . . 99.989999999999995 111.057 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -125.2 107.31 10.62 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.435 -1.257 . . . . 99.989999999999995 109.795 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.1 mm? -82.22 167.03 33.27 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.542 -0.54 . . . . 99.989999999999995 109.542 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 71.7 Cg_exo -48.18 147.49 8.24 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.521 2.814 . . . . 99.989999999999995 113.566 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 69.56 34.56 2.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.458 -0.792 . . . . 99.989999999999995 111.187 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.484 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 62.12 43.19 8.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.534 -0.757 . . . . 99.989999999999995 111.826 176.181 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 78.2 mm-40 -97.17 165.47 12.03 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.838 -0.619 . . . . 99.989999999999995 109.653 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 159' ' ' VAL . 37.0 ttp180 -145.95 145.62 30.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.88 0.371 . . . . 99.989999999999995 111.022 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.519 HG21 HD23 ' A' ' 161' ' ' LEU . 15.2 t -146.06 150.23 35.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.877 -0.601 . . . . 99.989999999999995 109.522 177.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.633 HG11 HD11 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -120.98 127.25 75.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 119.882 -0.727 . . . . 99.989999999999995 109.231 170.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.4 p -123.75 133.89 24.93 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.367 -0.833 . . . . 99.989999999999995 109.338 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 74.2 Cg_exo -51.49 128.36 25.6 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.383 2.055 . . . . 99.989999999999995 111.973 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.39 79.12 0.75 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.506 -0.77 . . . . 99.989999999999995 110.535 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.42 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 92.1 mtt180 -68.56 115.74 8.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.051 -0.977 . . . . 99.989999999999995 111.726 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 46.8 t -80.44 109.79 15.29 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.959 -0.756 . . . . 99.989999999999995 108.959 172.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.68 19.36 7.43 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.059 -0.817 . . . . 99.989999999999995 111.059 -173.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.42 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 0.9 OUTLIER -140.48 132.7 31.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.448 -0.575 . . . . 99.989999999999995 109.448 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.6 p -74.35 153.3 39.35 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.088 -0.505 . . . . 99.989999999999995 110.242 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.571 ' HA ' ' OG ' ' A' ' 180' ' ' SER . 4.2 m -58.52 -21.84 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.911 -0.774 . . . . 99.989999999999995 108.911 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.589 ' HG2' ' HE2' ' A' ' 182' ' ' LYS . 32.0 ttt180 -58.94 -59.05 6.08 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-N 115.497 -0.774 . . . . 99.989999999999995 110.694 174.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.602 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 25.7 t70 -64.4 -48.6 74.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.209 0.528 . . . . 99.989999999999995 111.417 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.571 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 11.3 p -60.24 -56.87 16.27 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.235 -0.893 . . . . 99.989999999999995 111.489 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 8.3 mp -74.28 -14.85 60.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.418 -0.355 . . . . 99.989999999999995 111.032 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.602 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 5.3 mtmt -59.92 -48.21 82.62 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 108.426 -0.953 . . . . 99.989999999999995 108.426 174.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 187' ' ' MET . 12.0 tppt? -60.13 -49.49 77.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.854 -0.612 . . . . 99.989999999999995 110.175 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.426 ' HB1' HG22 ' A' ' 167' ' ' THR . . . -47.11 -53.44 12.85 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.9 -0.591 . . . . 99.989999999999995 112.583 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.416 HD11 ' O ' ' A' ' 181' ' ' LEU . 1.5 mt -74.19 -43.51 56.95 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.554 0.342 . . . . 99.989999999999995 111.507 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.489 ' HB3' ' O ' ' A' ' 182' ' ' LYS . 18.7 tpp -65.59 -33.92 77.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.292 -0.413 . . . . 99.989999999999995 111.043 -174.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 66.8 mtm -74.02 -9.75 58.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.297 0.57 . . . . 99.989999999999995 109.971 175.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.412 ' CZ ' ' HB ' ' A' ' 167' ' ' THR . 74.7 mtt85 -109.65 1.37 19.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.517 -0.765 . . . . 99.989999999999995 111.18 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 78.62 21.85 68.25 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.833 -0.699 . . . . 99.989999999999995 112.483 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.2 mp -113.99 172.53 6.93 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.891 -0.411 . . . . 99.989999999999995 109.891 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 34.6 pt -132.82 132.5 22.56 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.204 0.526 . . . . 99.989999999999995 111.527 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.497 ' HG2' ' HG3' ' A' ' 182' ' ' LYS . 23.9 Cg_exo -65.7 -21.15 59.05 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.359 2.706 . . . . 99.989999999999995 113.127 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -62.86 -33.38 75.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.517 -0.31 . . . . 99.989999999999995 111.776 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 35.4 t -102.68 31.83 3.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.373 0.606 . . . . 99.989999999999995 109.89 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 225' ' ' GLU . 71.2 m -143.17 167.6 21.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.994 -0.548 . . . . 99.989999999999995 110.983 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -138.0 155.65 48.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 99.989999999999995 110.241 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 223' ' ' HIS . 9.6 t -107.55 136.61 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 123.208 0.318 . . . . 99.989999999999995 110.27 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -130.92 151.95 50.77 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.309 -0.256 . . . . 99.989999999999995 110.309 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.464 ' CG ' ' HB2' ' A' ' 206' ' ' LYS . 1.2 ptm180 -120.64 115.51 23.51 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.708 -0.849 . . . . 99.989999999999995 108.708 167.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.691 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 19.6 mm -85.06 112.88 22.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.198 -0.456 . . . . 99.989999999999995 110.833 -175.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.47 ' HB2' ' CG ' ' A' ' 204' ' ' GLU . 22.4 mt-30 -89.14 -149.83 0.19 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.216 -1.031 . . . . 99.989999999999995 108.216 170.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.73 80.36 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.35 0.5 . . . . 99.989999999999995 112.35 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 62.96 18.73 60.32 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 116.012 -0.54 . . . . 99.989999999999995 112.812 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.47 ' CG ' ' HB2' ' A' ' 201' ' ' GLN . 9.9 pt-20 -125.67 135.15 51.81 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.554 -0.459 . . . . 99.989999999999995 111.616 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.691 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 36.2 mtpt -91.84 128.03 37.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.001 -0.545 . . . . 99.989999999999995 110.271 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.464 ' HB2' ' CG ' ' A' ' 199' ' ' ARG . 75.0 mmtt -111.73 98.13 40.07 Favored Pre-proline 0 N--CA 1.444 -0.736 0 N-CA-C 109.365 -0.605 . . . . 99.989999999999995 109.365 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -65.95 119.15 6.14 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.859 1.706 . . . . 99.989999999999995 111.998 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.414 HD13 HG11 ' A' ' 197' ' ' VAL . 38.3 mt -96.61 154.22 3.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.074 -1.421 . . . . 99.989999999999995 110.615 -177.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.0 145.66 20.02 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.22 -0.752 . . . . 99.989999999999995 111.22 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.514 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 96.2 m95 -68.95 -25.09 64.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.28 0.54 . . . . 99.989999999999995 110.496 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -87.97 9.95 20.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 99.989999999999995 110.743 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.502 ' O ' HG11 ' A' ' 177' ' ' VAL . 94.9 m -83.57 143.22 30.3 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.074 -0.713 . . . . 99.989999999999995 109.074 174.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.438 ' HB3' ' CD1' ' A' ' 216' ' ' TRP . 9.3 t70 -75.27 137.19 41.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.925 0.393 . . . . 99.989999999999995 110.094 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.456 HG13 HG22 ' A' ' 157' ' ' VAL . 0.2 OUTLIER -78.24 -17.55 13.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.046 -0.525 . . . . 99.989999999999995 111.581 -174.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 85.9 p -69.78 -14.09 62.6 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 121.961 -0.462 . . . . 99.989999999999995 110.442 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.438 ' CD1' ' HB3' ' A' ' 213' ' ' ASP . 27.5 m0 -67.71 -40.64 84.26 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.066 -0.716 . . . . 99.989999999999995 109.066 174.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.87 31.64 3.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.965 -1.016 . . . . 99.989999999999995 110.423 -175.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 51.1 m -52.91 113.85 1.23 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.403 0.62 . . . . 99.989999999999995 112.343 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 84.06 2.65 89.4 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.973 -1.012 . . . . 99.989999999999995 113.658 171.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.54 154.92 19.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.683 0.278 . . . . 99.989999999999995 110.392 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 2.1 mp0 -85.97 111.29 20.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.73 -0.47 . . . . 99.989999999999995 109.73 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 35.9 mt -103.83 164.94 11.35 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.885 -0.413 . . . . 99.989999999999995 109.885 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 197' ' ' VAL . 85.4 m-70 -129.34 135.6 48.94 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.341 -0.244 . . . . 99.989999999999995 110.341 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 9.4 t -113.45 109.34 28.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.251 -0.648 . . . . 99.989999999999995 109.251 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 28.5 mt-10 -110.11 155.21 22.21 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.47 -0.786 . . . . 99.989999999999995 110.088 -175.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.99 131.25 34.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.343 -0.39 . . . . 99.989999999999995 110.942 -173.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.6 mp -75.72 80.07 2.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.674 0.75 . . . . 99.989999999999995 109.179 173.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -131.86 103.84 6.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.666 -1.152 . . . . 99.989999999999995 108.877 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -81.13 76.97 8.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.79 -0.641 . . . . 99.989999999999995 110.64 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.834 -0.621 . . . . 99.989999999999995 110.63 178.583 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.5 p . . . . . 0 N--CA 1.476 0.871 0 CA-C-O 120.58 0.229 . . . . 99.989999999999995 110.914 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.4 -27.91 83.28 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.253 2.635 . . . . 99.989999999999995 111.592 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -132.07 119.43 20.98 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.055 -0.721 . . . . 99.989999999999995 109.055 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -110.84 99.55 42.7 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.664 -0.495 . . . . 99.989999999999995 109.664 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -72.6 159.79 48.03 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.827 2.351 . . . . 99.989999999999995 112.776 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.576 ' O ' ' HA2' ' A' ' 219' ' ' GLY . 1.4 pp -122.12 171.54 10.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.65 -0.705 . . . . 99.989999999999995 110.688 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.7 133.13 57.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 106.785 -1.561 . . . . 99.989999999999995 106.785 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.534 ' HG2' HG11 ' A' ' 168' ' ' VAL . 20.5 mtm180 -99.17 106.83 19.05 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.145 0.497 . . . . 99.989999999999995 111.872 -162.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 222' ' ' LEU . 25.9 t -100.13 145.21 11.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.302 -0.863 . . . . 99.989999999999995 112.634 -172.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -109.27 104.7 13.88 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.656 -1.156 . . . . 99.989999999999995 110.067 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.582 HD23 HG21 ' A' ' 167' ' ' THR . 1.5 mm? -81.57 172.47 9.62 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.152 -0.685 . . . . 99.989999999999995 109.152 -174.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 77.5 Cg_exo -54.47 159.92 7.71 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.614 2.209 . . . . 99.989999999999995 112.183 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 66.03 24.5 11.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.002 0.43 . . . . 99.989999999999995 110.154 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.497 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 56.15 43.98 25.92 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.326 -0.852 . . . . 99.989999999999995 111.191 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 28.8 mm-40 -89.65 167.38 12.97 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.526 -0.761 . . . . 99.989999999999995 109.412 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -146.39 129.73 16.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.434 0.635 . . . . 99.989999999999995 111.42 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.582 HG21 HD23 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -144.5 139.09 28.04 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.738 -1.119 . . . . 99.989999999999995 108.013 178.106 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.534 HG11 ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -116.57 129.27 73.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 119.148 -1.021 . . . . 99.989999999999995 110.632 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.31 136.23 19.57 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 114.613 -1.176 . . . . 99.989999999999995 109.805 -173.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.6 130.01 36.65 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.29 1.993 . . . . 99.989999999999995 111.294 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.13 91.45 0.22 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.841 -0.618 . . . . 99.989999999999995 110.453 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.435 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 92.2 mtt180 -77.08 111.59 12.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.447 -0.797 . . . . 99.989999999999995 111.044 -176.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.582 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 3.3 p -72.45 115.46 11.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.012 -0.54 . . . . 99.989999999999995 110.5 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 98.86 15.58 33.39 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.577 -0.821 . . . . 99.989999999999995 111.948 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.524 ' CG1' ' HG ' ' A' ' 180' ' ' SER . 0.5 OUTLIER -130.15 148.91 33.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.547 -0.538 . . . . 99.989999999999995 109.547 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.4 p -83.45 154.39 23.96 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.209 -0.451 . . . . 99.989999999999995 111.646 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 212' ' ' THR . 64.1 t -53.81 -30.58 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.559 -0.746 . . . . 99.989999999999995 108.992 172.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.552 ' HG3' ' HB3' ' A' ' 210' ' ' TRP . 12.1 ttt180 -53.93 -58.97 5.33 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 115.408 -0.814 . . . . 99.989999999999995 110.66 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.606 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 11.3 t70 -63.26 -47.88 80.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.336 0.588 . . . . 99.989999999999995 111.274 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.524 ' HG ' ' CG1' ' A' ' 175' ' ' VAL . 17.9 m -59.51 -51.59 69.22 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.211 -0.904 . . . . 99.989999999999995 112.166 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.523 ' N ' HD21 ' A' ' 181' ' ' LEU . 0.4 OUTLIER -78.36 -19.03 54.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.651 0.263 . . . . 99.989999999999995 110.407 -178.208 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.606 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 15.5 mtmt -60.65 -48.51 81.45 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 109.134 -0.691 . . . . 99.989999999999995 109.134 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.2 tpmt? -61.45 -41.19 96.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.904 -0.589 . . . . 99.989999999999995 109.802 176.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.454 ' HB1' HG22 ' A' ' 167' ' ' THR . . . -53.66 -57.33 11.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.033 -0.53 . . . . 99.989999999999995 111.767 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.464 HD11 ' O ' ' A' ' 181' ' ' LEU . 1.4 mt -71.55 -41.34 69.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.429 -0.35 . . . . 99.989999999999995 111.483 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.512 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 7.0 mmt -66.29 -28.39 68.66 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.141 0.423 . . . . 99.989999999999995 112.141 -176.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 62.4 mtm -79.64 -9.16 59.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.082 0.468 . . . . 99.989999999999995 109.96 175.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -109.72 -3.2 16.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.636 -0.711 . . . . 99.989999999999995 111.522 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.07 21.21 61.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.987 -0.625 . . . . 99.989999999999995 112.209 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.0 mp -115.04 172.11 7.26 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.934 -0.395 . . . . 99.989999999999995 109.934 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.52 HG13 ' SG ' ' A' ' 194' ' ' CYS . 21.4 pt -128.88 133.1 24.82 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.193 -0.458 . . . . 99.989999999999995 111.526 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.531 ' HB3' ' CZ3' ' A' ' 210' ' ' TRP . 14.9 Cg_exo -69.0 -21.03 37.6 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.027 2.485 . . . . 99.989999999999995 112.133 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -57.82 -41.73 82.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.66 -0.7 . . . . 99.989999999999995 111.736 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . 0.52 ' SG ' HG13 ' A' ' 191' ' ' ILE . 20.9 p -96.89 16.81 18.3 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.119 -0.491 . . . . 99.989999999999995 110.371 -177.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.439 ' HB3' HG11 ' A' ' 224' ' ' VAL . 85.1 m -126.08 166.83 16.28 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.175 0.512 . . . . 99.989999999999995 111.638 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -146.2 159.79 42.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.449 -0.796 . . . . 99.989999999999995 110.065 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.404 HG11 HD13 ' A' ' 208' ' ' ILE . 11.7 t -115.11 138.85 44.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.23 -0.441 . . . . 99.989999999999995 111.118 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 29.9 m-85 -129.72 146.65 51.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 99.989999999999995 110.255 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.493 ' HD2' HD22 ' A' ' 217' ' ' LEU . 7.1 ptm180 -117.1 115.49 25.47 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.32 -0.992 . . . . 99.989999999999995 108.32 167.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.6 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 4.9 mm -91.37 107.22 18.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.393 -0.523 . . . . 99.989999999999995 110.735 -169.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 203' ' ' GLY . 15.7 mm100 -83.96 -143.65 0.08 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.818 -0.628 . . . . 99.989999999999995 109.847 176.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.444 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 13.3 m-20 -60.26 78.28 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.041 0.448 . . . . 99.989999999999995 111.804 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 63.88 17.0 60.17 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.873 -0.603 . . . . 99.989999999999995 112.193 -176.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.6 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 35.2 mt-10 -113.6 132.58 55.69 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 120.898 0.38 . . . . 99.989999999999995 111.445 -176.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.578 ' HG2' HD11 ' A' ' 200' ' ' ILE . 44.6 mtpt -95.09 112.67 24.35 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.424 -0.584 . . . . 99.989999999999995 109.424 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 75.3 mmtt -101.91 102.74 25.04 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.367 -0.379 . . . . 99.989999999999995 110.03 -177.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 8.0 Cg_exo -69.34 119.45 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.101 1.867 . . . . 99.989999999999995 111.634 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.404 HD13 HG11 ' A' ' 197' ' ' VAL . 56.9 mt -93.74 155.8 3.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 114.493 -1.23 . . . . 99.989999999999995 111.283 -174.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -92.42 135.09 12.53 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.097 -0.801 . . . . 99.989999999999995 111.097 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.552 ' HB3' ' HG3' ' A' ' 178' ' ' ARG . 86.5 m95 -64.8 -40.51 95.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.041 0.448 . . . . 99.989999999999995 110.667 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.32 6.04 3.99 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.026 0.38 . . . . 99.989999999999995 112.026 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.522 ' O ' HG21 ' A' ' 177' ' ' VAL . 97.2 m -81.22 145.26 31.06 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.358 -0.608 . . . . 99.989999999999995 109.358 172.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.24 131.24 44.58 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.773 -0.455 . . . . 99.989999999999995 109.773 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.401 HG23 ' CB ' ' A' ' 180' ' ' SER . 0.1 OUTLIER -73.74 -15.18 16.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.781 0.324 . . . . 99.989999999999995 111.356 -174.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.582 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 23.4 m -70.27 -10.51 59.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.052 0.453 . . . . 99.989999999999995 110.579 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.6 m0 -74.97 -27.05 60.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.449 0.642 . . . . 99.989999999999995 109.399 172.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.516 HD13 HD22 ' A' ' 222' ' ' LEU . 7.1 mt -110.8 19.24 18.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.033 -0.985 . . . . 99.989999999999995 110.075 -174.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 100.0 m -51.15 115.5 1.58 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.687 0.756 . . . . 99.989999999999995 112.194 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 85.99 3.77 85.07 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.386 -1.279 . . . . 99.989999999999995 113.244 171.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -87.9 158.2 18.76 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.226 -0.287 . . . . 99.989999999999995 110.226 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -91.61 111.08 22.44 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.524 -0.546 . . . . 99.989999999999995 109.524 173.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 6.7 mp -98.04 150.21 21.65 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.721 -0.672 . . . . 99.989999999999995 110.043 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . 0.504 ' CD2' HG12 ' A' ' 200' ' ' ILE . 88.6 m-70 -120.0 122.02 40.23 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.854 -0.612 . . . . 99.989999999999995 109.751 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.457 ' CG1' ' HD3' ' A' ' 162' ' ' PRO . 4.0 t -100.16 117.05 44.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.582 -0.735 . . . . 99.989999999999995 110.083 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -108.55 137.01 47.2 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.038 -0.983 . . . . 99.989999999999995 108.657 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.7 p -91.18 128.6 42.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.595 0.712 . . . . 99.989999999999995 110.195 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.8 mp -76.3 82.03 3.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.775 -1.102 . . . . 99.989999999999995 110.627 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -100.71 96.2 7.17 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.427 0.632 . . . . 99.989999999999995 110.288 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -146.05 26.06 1.24 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.969 -1.014 . . . . 99.989999999999995 108.704 174.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 114.895 -1.048 . . . . 99.989999999999995 110.458 -176.012 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.475 0.798 0 CA-C-O 121.019 0.437 . . . . 99.989999999999995 110.82 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.83 -39.64 14.31 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.073 2.516 . . . . 99.989999999999995 111.577 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.571 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 77.9 mt-30 -103.61 137.53 41.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.586 -0.734 . . . . 99.989999999999995 109.354 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -99.27 102.34 15.68 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.335 -0.393 . . . . 99.989999999999995 110.751 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.571 ' HD3' ' O ' ' A' ' 153' ' ' GLN . 3.9 Cg_exo -76.45 151.37 33.11 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.615 2.21 . . . . 99.989999999999995 111.051 176.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.681 HD11 HG11 ' A' ' 168' ' ' VAL . 2.1 pp -121.06 160.13 22.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.577 -0.283 . . . . 99.989999999999995 110.558 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.68 134.67 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.293 -0.632 . . . . 99.989999999999995 109.293 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.522 ' HA ' HG12 ' A' ' 168' ' ' VAL . 71.5 mtm180 -96.73 101.01 12.53 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.362 0.504 . . . . 99.989999999999995 112.362 -168.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 222' ' ' LEU . 2.8 t -92.97 160.1 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 121.785 0.802 . . . . 99.989999999999995 111.801 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.543 ' CZ ' ' HD2' ' A' ' 166' ' ' ARG . 41.0 m-85 -124.76 105.76 9.54 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.166 -1.379 . . . . 99.989999999999995 109.131 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 3.3 mp -85.7 174.61 5.42 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.229 -0.441 . . . . 99.989999999999995 109.946 -172.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 87.2 Cg_exo -52.86 160.09 4.42 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.744 2.296 . . . . 99.989999999999995 112.835 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 64.12 31.97 12.99 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.072 -0.513 . . . . 99.989999999999995 110.273 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt 56.02 47.79 19.06 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.348 -0.842 . . . . 99.989999999999995 111.357 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 28.2 mt-30 -101.81 166.79 10.47 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.897 -0.592 . . . . 99.989999999999995 110.255 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.543 ' HD2' ' CZ ' ' A' ' 160' ' ' PHE . 38.4 ttt180 -147.67 144.24 28.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.556 0.217 . . . . 99.989999999999995 110.859 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.443 HG22 ' HB1' ' A' ' 184' ' ' ALA . 1.4 t -155.27 152.68 29.54 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 175.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.681 HG11 HD11 ' A' ' 156' ' ' ILE . 0.2 OUTLIER -114.2 128.84 71.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.008 -0.677 . . . . 99.989999999999995 110.255 178.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.9 p -116.5 137.03 23.27 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 115.138 -0.937 . . . . 99.989999999999995 109.562 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.71 135.44 60.2 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.175 1.916 . . . . 99.989999999999995 111.685 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.76 78.34 1.12 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.556 -0.747 . . . . 99.989999999999995 110.104 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.401 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 92.3 mtt180 -69.54 111.92 5.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.926 -1.034 . . . . 99.989999999999995 111.593 -176.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.678 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 8.5 p -76.93 110.09 11.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.992 0.425 . . . . 99.989999999999995 109.872 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 109.07 9.17 26.49 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.608 -0.806 . . . . 99.989999999999995 111.574 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.401 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 0.9 OUTLIER -120.84 137.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.718 -0.475 . . . . 99.989999999999995 109.718 178.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.5 p -79.4 154.47 28.96 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.403 -0.362 . . . . 99.989999999999995 110.96 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.607 HG21 ' O ' ' A' ' 212' ' ' THR . 81.4 t -47.07 -40.95 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.477 0.486 . . . . 99.989999999999995 109.696 175.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.586 ' CG ' ' HB3' ' A' ' 210' ' ' TRP . 92.9 mtt-85 -48.45 -52.57 21.55 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.564 -0.744 . . . . 99.989999999999995 112.483 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.574 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 14.7 t70 -73.98 -45.48 49.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.138 0.494 . . . . 99.989999999999995 111.339 -172.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.449 ' HB2' HG23 ' A' ' 214' ' ' ILE . 0.3 OUTLIER -67.54 -42.87 82.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.704 -0.68 . . . . 99.989999999999995 110.896 -177.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.3 OUTLIER -76.68 -21.17 55.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.143 -0.481 . . . . 99.989999999999995 110.145 177.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.653 ' O ' ' HB2' ' A' ' 186' ' ' MET . 4.4 ttmt -59.23 -48.23 82.4 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.986 -0.746 . . . . 99.989999999999995 108.986 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.1 tpmt? -60.56 -46.2 91.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.171 -0.468 . . . . 99.989999999999995 109.791 175.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.443 ' HB1' HG22 ' A' ' 167' ' ' THR . . . -51.75 -55.94 16.73 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.172 -0.467 . . . . 99.989999999999995 111.984 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.421 HD11 ' O ' ' A' ' 181' ' ' LEU . 1.7 mt -72.58 -43.16 63.77 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.734 0.413 . . . . 99.989999999999995 111.769 -178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.653 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 3.3 mmt -66.02 -26.52 67.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.115 0.413 . . . . 99.989999999999995 112.115 -176.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 64.6 mtm -77.38 -20.35 54.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.359 0.599 . . . . 99.989999999999995 109.724 173.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -106.6 17.59 23.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.461 -0.791 . . . . 99.989999999999995 111.592 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 62.75 35.43 91.92 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.276 -0.487 . . . . 99.989999999999995 112.676 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 21.1 mt -128.41 169.37 14.36 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.531 0.333 . . . . 99.989999999999995 110.171 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 45.8 pt -131.89 135.24 26.35 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.057 0.456 . . . . 99.989999999999995 111.534 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.42 ' HG2' ' HG3' ' A' ' 182' ' ' LYS . 19.6 Cg_exo -66.77 -22.2 50.07 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.102 2.535 . . . . 99.989999999999995 112.645 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.89 -19.98 62.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.134 -0.484 . . . . 99.989999999999995 111.478 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 12.2 t -112.13 25.94 11.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.366 -0.605 . . . . 99.989999999999995 109.366 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.514 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 74.2 m -140.78 166.74 23.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.672 -0.695 . . . . 99.989999999999995 111.096 -175.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -146.66 154.41 41.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.061 -0.518 . . . . 99.989999999999995 110.121 175.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.08 130.62 61.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.597 0.237 . . . . 99.989999999999995 110.776 -176.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.441 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 35.6 m-85 -131.28 152.9 50.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.486 -0.324 . . . . 99.989999999999995 110.759 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.712 ' HG3' HD11 ' A' ' 208' ' ' ILE . 67.2 mtp180 -114.6 111.9 22.07 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.162 -0.681 . . . . 99.989999999999995 109.162 168.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.769 HG12 ' CD2' ' A' ' 223' ' ' HIS . 1.7 mm -94.39 106.97 18.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 119.97 -0.692 . . . . 99.989999999999995 110.453 -174.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 203' ' ' GLY . 24.5 mt-30 -88.32 -146.32 0.15 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.219 -1.03 . . . . 99.989999999999995 108.219 172.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.95 79.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.194 0.442 . . . . 99.989999999999995 112.194 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 63.13 17.53 59.16 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 116.032 -0.531 . . . . 99.989999999999995 112.822 -178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 8.4 pt-20 -123.07 133.66 54.3 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.576 -0.45 . . . . 99.989999999999995 110.975 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.54 ' HG2' HD11 ' A' ' 200' ' ' ILE . 39.1 mtpt -102.52 126.48 49.59 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.756 -0.461 . . . . 99.989999999999995 109.756 -175.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 74.1 mmtt -101.7 100.5 14.53 Favored Pre-proline 0 N--CA 1.444 -0.741 0 N-CA-C 109.029 -0.73 . . . . 99.989999999999995 109.029 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 4.0 Cg_exo -71.26 126.76 12.63 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.868 1.712 . . . . 99.989999999999995 111.316 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.712 HD11 ' HG3' ' A' ' 199' ' ' ARG . 4.7 mt -107.77 149.66 10.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.78 -1.1 . . . . 99.989999999999995 110.77 -173.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.471 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -84.7 136.01 14.15 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 111.442 -0.663 . . . . 99.989999999999995 111.442 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.586 ' HB3' ' CG ' ' A' ' 178' ' ' ARG . 91.1 m95 -65.08 -27.8 69.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.698 0.285 . . . . 99.989999999999995 110.917 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -90.73 12.76 18.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.823 0.344 . . . . 99.989999999999995 111.242 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.607 ' O ' HG21 ' A' ' 177' ' ' VAL . 48.1 m -85.84 154.15 21.75 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.494 -0.928 . . . . 99.989999999999995 108.494 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -78.48 132.18 37.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.74 -0.467 . . . . 99.989999999999995 109.74 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.449 HG23 ' HB2' ' A' ' 180' ' ' SER . 0.3 OUTLIER -70.32 -11.94 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.987 0.422 . . . . 99.989999999999995 110.997 -178.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.678 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 16.4 m -66.38 -18.26 65.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.98 0.419 . . . . 99.989999999999995 110.359 173.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -78.66 -14.79 59.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.455 0.645 . . . . 99.989999999999995 109.888 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 208' ' ' ILE . 17.8 mt -113.34 17.4 18.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.17 -0.923 . . . . 99.989999999999995 109.797 -177.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 91.2 m -53.64 117.59 3.25 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.775 0.798 . . . . 99.989999999999995 112.395 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 74.07 8.14 78.03 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 114.173 -1.376 . . . . 99.989999999999995 113.118 173.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -84.49 148.72 26.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.983 -0.377 . . . . 99.989999999999995 109.983 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 3.2 mp0 -85.26 109.47 18.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.275 -1.009 . . . . 99.989999999999995 108.275 171.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 86.2 mt -98.61 149.93 22.27 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.292 -0.413 . . . . 99.989999999999995 109.994 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . 0.769 ' CD2' HG12 ' A' ' 200' ' ' ILE . 59.9 m-70 -124.05 122.58 38.26 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.323 -0.621 . . . . 99.989999999999995 109.323 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 38.7 t -100.07 143.95 13.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.042 0.449 . . . . 99.989999999999995 110.167 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 8.6 mm-40 -120.91 151.39 39.74 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.377 -0.829 . . . . 99.989999999999995 109.236 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.2 t -89.89 116.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.826 -0.435 . . . . 99.989999999999995 109.826 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 34.3 mt -75.79 89.12 2.85 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.856 -0.424 . . . . 99.989999999999995 109.856 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.14 97.06 5.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.069 -0.514 . . . . 99.989999999999995 109.855 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -121.81 71.86 1.0 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.215 0.531 . . . . 99.989999999999995 109.743 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.392 -0.822 . . . . 99.989999999999995 111.504 -178.549 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 20.4 p . . . . . 0 N--CA 1.477 0.902 0 CA-C-O 120.812 0.339 . . . . 99.989999999999995 110.896 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 151' ' ' SER . 39.3 Cg_exo -60.47 -29.49 88.78 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.199 2.599 . . . . 99.989999999999995 111.838 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.43 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 22.4 mt-30 -96.53 141.43 29.82 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.071 -0.714 . . . . 99.989999999999995 109.071 173.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -87.38 113.36 53.66 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 110.317 -0.253 . . . . 99.989999999999995 110.317 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.468 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 23.8 Cg_exo -63.71 168.23 12.14 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.48 2.12 . . . . 99.989999999999995 110.446 174.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.608 HD11 HG11 ' A' ' 168' ' ' VAL . 2.2 pp -131.29 156.61 42.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.166 0.508 . . . . 99.989999999999995 111.417 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.446 HG22 HG13 ' A' ' 214' ' ' ILE . 41.0 t -124.11 123.75 67.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.513 -0.767 . . . . 99.989999999999995 109.756 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.56 ' HA ' HG12 ' A' ' 168' ' ' VAL . 23.6 mtm180 -88.47 96.54 10.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.49 0.662 . . . . 99.989999999999995 111.723 -169.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.645 HG21 ' HB2' ' A' ' 222' ' ' LEU . 3.8 t -96.03 129.98 45.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.961 -1.018 . . . . 99.989999999999995 112.059 -176.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 42.4 m-85 -94.29 103.51 15.53 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.961 -1.018 . . . . 99.989999999999995 108.871 174.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.545 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 2.9 mp -82.59 176.67 3.6 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 110.027 -0.36 . . . . 99.989999999999995 110.027 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 80.2 Cg_exo -50.17 153.73 6.44 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.711 2.274 . . . . 99.989999999999995 112.736 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 65.96 27.26 10.83 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.909 -0.587 . . . . 99.989999999999995 109.661 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 54.07 36.77 25.46 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 114.914 -1.039 . . . . 99.989999999999995 111.745 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.559 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 26.9 mm-40 -75.58 170.24 16.53 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 109.311 -0.625 . . . . 99.989999999999995 109.311 175.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 17.8 ttp180 -148.59 137.46 21.55 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.606 -0.438 . . . . 99.989999999999995 111.151 173.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.12 154.39 41.76 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.03 -1.1 . . . . 99.989999999999995 108.03 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.608 HG11 HD11 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -113.73 127.36 71.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 119.597 -0.841 . . . . 99.989999999999995 110.312 178.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.5 m -104.88 138.74 19.59 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.092 -0.958 . . . . 99.989999999999995 110.053 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 13.0 Cg_exo -65.55 125.14 13.88 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.265 1.31 . . . . 99.989999999999995 110.925 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.12 86.08 0.55 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.571 -0.741 . . . . 99.989999999999995 110.044 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.439 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 97.2 mtt180 -78.98 112.04 15.77 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.889 -1.051 . . . . 99.989999999999995 111.11 -174.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.621 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 4.1 p -67.53 110.02 3.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.095 -0.502 . . . . 99.989999999999995 110.831 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 106.78 8.16 32.63 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.729 -0.748 . . . . 99.989999999999995 112.296 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 179' ' ' ASP . 0.3 OUTLIER -117.16 149.87 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.045 0.45 . . . . 99.989999999999995 109.866 176.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.466 ' HB ' ' HG2' ' A' ' 178' ' ' ARG . 1.7 p -86.1 152.3 22.98 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.247 -0.433 . . . . 99.989999999999995 111.368 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.569 HG21 ' O ' ' A' ' 212' ' ' THR . 92.8 t -49.07 -41.61 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 O-C-N 123.452 0.47 . . . . 99.989999999999995 110.326 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.466 ' HG2' ' HB ' ' A' ' 176' ' ' THR . 30.9 ptt180 -51.24 -47.45 62.38 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 116.087 -0.506 . . . . 99.989999999999995 112.094 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.571 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 11.8 t70 -68.08 -49.79 59.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.121 0.486 . . . . 99.989999999999995 110.967 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.8 t -67.04 -43.99 81.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.823 -0.626 . . . . 99.989999999999995 110.464 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.54 ' N ' HD21 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -73.42 -27.33 61.38 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 116.36 -0.382 . . . . 99.989999999999995 110.206 179.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.571 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 13.0 mtmt -55.29 -45.62 76.22 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 109.24 -0.652 . . . . 99.989999999999995 109.24 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 187' ' ' MET . 1.8 tpmt? -60.01 -42.6 94.64 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.623 -0.51 . . . . 99.989999999999995 109.623 175.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . -55.12 -60.89 2.76 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.932 -0.576 . . . . 99.989999999999995 111.938 178.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.57 HD22 ' N ' ' A' ' 185' ' ' LEU . 1.6 mm? -60.29 -52.01 67.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.005 0.522 . . . . 99.989999999999995 110.904 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.533 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 12.2 mmt -57.96 -42.69 85.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.244 -0.889 . . . . 99.989999999999995 112.53 -174.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 57.6 mtm -71.04 -8.42 53.24 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.045 0.45 . . . . 99.989999999999995 110.533 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.451 ' HD2' HD22 ' A' ' 161' ' ' LEU . 51.2 mtt-85 -113.77 5.07 16.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.879 -0.6 . . . . 99.989999999999995 111.571 -177.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 73.38 21.74 79.32 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.018 -0.61 . . . . 99.989999999999995 112.325 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.41 ' HB3' HD11 ' A' ' 185' ' ' LEU . 0.2 OUTLIER -110.61 173.11 6.48 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.567 -0.531 . . . . 99.989999999999995 109.567 -177.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 32.3 pt -132.15 127.34 20.93 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.176 0.512 . . . . 99.989999999999995 111.873 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.528 ' HB3' ' CZ3' ' A' ' 210' ' ' TRP . 22.5 Cg_exo -65.54 -21.48 59.82 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.307 2.672 . . . . 99.989999999999995 112.331 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.25 -45.4 93.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.836 -0.62 . . . . 99.989999999999995 111.923 -174.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 23.8 t -98.11 37.53 1.42 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.282 0.563 . . . . 99.989999999999995 109.967 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.485 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 71.8 m -138.7 158.56 44.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.811 -0.632 . . . . 99.989999999999995 110.78 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -131.66 150.43 52.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.954 -0.566 . . . . 99.989999999999995 110.014 175.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.4 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 4.1 t -104.59 131.67 53.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 123.239 0.337 . . . . 99.989999999999995 110.508 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -126.56 141.99 51.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.774 0.321 . . . . 99.989999999999995 110.807 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.416 ' CG ' HD11 ' A' ' 208' ' ' ILE . 19.3 ptt180 -117.71 112.16 20.1 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.795 -1.187 . . . . 99.989999999999995 107.795 165.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.537 HD11 ' HG2' ' A' ' 205' ' ' LYS . 6.2 mm -80.18 104.21 8.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 120.391 -0.524 . . . . 99.989999999999995 110.196 -168.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 203' ' ' GLY . 26.3 mt-30 -78.13 -147.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.359 -0.608 . . . . 99.989999999999995 109.359 177.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -55.44 79.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.962 0.505 . . . . 99.989999999999995 112.27 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.41 17.4 52.99 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.639 -0.709 . . . . 99.989999999999995 113.007 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -128.53 133.86 48.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.205 0.502 . . . . 99.989999999999995 111.061 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.537 ' HG2' HD11 ' A' ' 200' ' ' ILE . 45.5 mtpt -79.51 111.3 15.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.868 -0.605 . . . . 99.989999999999995 109.544 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 206' ' ' LYS . 11.7 tppt? -98.26 102.67 14.79 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.078 -0.51 . . . . 99.989999999999995 110.129 -174.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 10.6 Cg_exo -70.6 127.9 14.54 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.32 2.013 . . . . 99.989999999999995 112.413 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 209' ' ' GLY . 35.1 mt -103.22 161.9 4.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.233 -1.348 . . . . 99.989999999999995 109.963 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -94.48 147.45 18.6 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.716 -0.754 . . . . 99.989999999999995 111.676 176.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.528 ' CZ3' ' HB3' ' A' ' 192' ' ' PRO . 92.1 m95 -74.72 -18.5 60.5 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.545 -0.539 . . . . 99.989999999999995 109.545 176.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.444 ' O ' HG21 ' A' ' 176' ' ' THR . 11.0 m-20 -87.63 -4.21 58.95 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.833 -0.622 . . . . 99.989999999999995 110.343 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.569 ' O ' HG21 ' A' ' 177' ' ' VAL . 89.9 m -70.19 147.89 49.29 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.296 -0.631 . . . . 99.989999999999995 109.296 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -76.61 129.18 36.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.002 -0.74 . . . . 99.989999999999995 109.002 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.446 HG13 HG22 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -68.9 -16.49 20.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.914 0.388 . . . . 99.989999999999995 111.056 -175.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.621 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 13.9 m -67.47 -21.03 65.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.848 0.356 . . . . 99.989999999999995 110.751 177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 24.1 m0 -74.93 -17.53 60.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.324 0.583 . . . . 99.989999999999995 109.583 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.403 HD22 ' HD3' ' A' ' 199' ' ' ARG . 6.0 mt -116.95 17.99 14.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.367 -0.833 . . . . 99.989999999999995 109.444 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 82.1 m -49.88 113.1 0.77 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.346 -0.843 . . . . 99.989999999999995 112.399 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 86.5 6.28 80.9 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.041 -0.982 . . . . 99.989999999999995 113.41 170.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -90.46 158.48 17.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.806 0.336 . . . . 99.989999999999995 110.253 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 3.2 mp0 -90.1 111.15 22.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.958 -0.756 . . . . 99.989999999999995 108.958 173.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.645 ' HB2' HG21 ' A' ' 159' ' ' VAL . 58.5 mt -107.36 133.87 51.26 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.85 0.357 . . . . 99.989999999999995 110.802 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -102.16 123.24 45.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.487 -0.324 . . . . 99.989999999999995 110.489 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 39.4 t -105.95 112.18 38.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.321 0.582 . . . . 99.989999999999995 109.895 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.453 ' CD ' ' HZ1' ' A' ' 205' ' ' LYS . 25.1 mt-10 -109.62 145.27 36.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.32 -0.855 . . . . 99.989999999999995 110.606 -173.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 66.7 t -77.87 129.76 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.949 0.404 . . . . 99.989999999999995 111.025 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.2 mp -81.68 81.67 7.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.784 -0.644 . . . . 99.989999999999995 110.655 177.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -91.08 95.01 9.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.08 -0.711 . . . . 99.989999999999995 109.08 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -114.69 76.89 1.02 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.229 -0.896 . . . . 99.989999999999995 109.416 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 6.8 m . . . . . 0 C--N 1.321 -0.674 0 CA-C-N 115.665 -0.698 . . . . 99.989999999999995 111.03 -176.009 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.687 0.279 . . . . 99.989999999999995 110.792 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.86 138.78 81.37 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.056 2.504 . . . . 99.989999999999995 111.98 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.58 112.08 3.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.079 -0.509 . . . . 99.989999999999995 110.185 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -110.27 124.02 34.43 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.25 -0.432 . . . . 99.989999999999995 110.655 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -82.22 152.84 16.21 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.171 1.914 . . . . 99.989999999999995 110.728 173.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.668 HD11 HG11 ' A' ' 168' ' ' VAL . 2.0 pp -130.7 161.07 41.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.896 -0.138 . . . . 99.989999999999995 111.116 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.37 134.63 62.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 109.916 -0.402 . . . . 99.989999999999995 109.916 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.491 ' HG2' HG12 ' A' ' 168' ' ' VAL . 85.3 mtm180 -94.61 103.27 15.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.049 0.452 . . . . 99.989999999999995 112.093 -168.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.4 t -96.76 136.93 25.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.798 -0.637 . . . . 99.989999999999995 111.837 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 53.5 m-85 -94.64 104.0 15.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.592 -0.731 . . . . 99.989999999999995 110.63 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 0.7 OUTLIER -81.34 170.56 14.89 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 108.727 -0.842 . . . . 99.989999999999995 108.727 -177.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.494 ' HD3' HG12 ' A' ' 224' ' ' VAL . 53.1 Cg_exo -56.72 156.91 21.06 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.749 2.3 . . . . 99.989999999999995 112.491 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 67.21 37.26 3.73 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.935 -0.575 . . . . 99.989999999999995 110.336 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt 55.13 48.92 18.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.624 -0.716 . . . . 99.989999999999995 111.585 177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.524 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 27.9 mm-40 -104.29 160.89 14.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.265 -0.425 . . . . 99.989999999999995 110.104 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 28.5 ttp180 -147.05 138.99 24.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.898 0.38 . . . . 99.989999999999995 110.687 173.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.506 HG21 HD23 ' A' ' 161' ' ' LEU . 4.8 t -141.47 157.15 45.51 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.626 -0.879 . . . . 99.989999999999995 108.626 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.668 HG11 HD11 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -119.83 127.74 75.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 119.374 -0.93 . . . . 99.989999999999995 110.326 175.36 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.4 p -115.56 134.62 22.62 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 114.758 -1.11 . . . . 99.989999999999995 109.277 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.9 132.25 48.61 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.23 1.953 . . . . 99.989999999999995 111.454 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.9 75.96 0.89 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.525 -0.761 . . . . 99.989999999999995 110.691 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -64.74 111.81 2.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.889 -1.05 . . . . 99.989999999999995 111.922 -176.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 48.2 m -76.44 110.02 10.63 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.415 -0.587 . . . . 99.989999999999995 109.415 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 110.47 11.56 19.34 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.675 -0.774 . . . . 99.989999999999995 111.317 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.407 ' CG1' ' HB3' ' A' ' 180' ' ' SER . 1.1 t -133.05 138.01 52.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.663 -0.495 . . . . 99.989999999999995 109.663 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 21.3 p -81.93 160.2 23.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.098 -0.501 . . . . 99.989999999999995 111.233 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.526 ' HA ' ' OG ' ' A' ' 180' ' ' SER . 86.7 t -52.52 -30.6 14.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.036 -0.529 . . . . 99.989999999999995 109.659 171.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.54 ' CG ' ' HB3' ' A' ' 210' ' ' TRP . 72.6 mtp180 -53.74 -58.38 7.44 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.694 -0.684 . . . . 99.989999999999995 111.283 174.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.583 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 14.5 t70 -74.52 -43.49 55.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.11 0.481 . . . . 99.989999999999995 111.096 -174.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 28.1 p -60.76 -57.68 11.67 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.53 -0.759 . . . . 99.989999999999995 111.28 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.501 HD11 ' N ' ' A' ' 181' ' ' LEU . 9.6 mp -77.08 -11.69 59.84 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 122.102 -0.374 . . . . 99.989999999999995 111.154 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.583 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 4.7 ttmt -58.19 -46.31 86.03 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 107.741 -1.207 . . . . 99.989999999999995 107.741 171.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.4 tpmt? -59.57 -44.47 93.3 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.867 -0.606 . . . . 99.989999999999995 109.792 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -50.99 -54.93 20.09 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.672 0.619 . . . . 99.989999999999995 112.672 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 5.3 mp -78.22 -38.46 43.02 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.865 0.32 . . . . 99.989999999999995 111.865 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 14.7 mmt -63.48 -28.48 69.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.407 -0.361 . . . . 99.989999999999995 111.557 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 64.8 mtm -77.87 -7.33 56.56 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.355 0.598 . . . . 99.989999999999995 109.961 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.474 ' CZ ' ' HB ' ' A' ' 167' ' ' THR . 55.8 mtt85 -113.06 0.7 15.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.512 -0.767 . . . . 99.989999999999995 111.479 -178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 73.66 25.36 72.4 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.713 -0.756 . . . . 99.989999999999995 112.021 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.1 mp -115.59 152.61 32.75 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.833 -0.432 . . . . 99.989999999999995 109.833 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.473 ' O ' HD12 ' A' ' 191' ' ' ILE . 2.4 pp -108.2 128.67 25.27 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-O 121.067 0.46 . . . . 99.989999999999995 110.898 176.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 16.6 Cg_exo -68.14 -6.76 18.05 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.854 2.369 . . . . 99.989999999999995 112.362 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -75.26 -11.22 60.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 99.989999999999995 111.166 -175.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 27.7 t -126.27 34.65 4.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.01 -0.737 . . . . 99.989999999999995 109.01 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.477 ' HB3' HG11 ' A' ' 224' ' ' VAL . 77.3 m -144.47 158.82 43.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.495 -0.775 . . . . 99.989999999999995 110.188 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -136.29 159.26 42.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.257 -0.429 . . . . 99.989999999999995 110.704 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.489 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 23.8 t -114.06 138.29 44.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.97 -0.559 . . . . 99.989999999999995 111.392 -174.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -129.92 160.75 32.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.705 -0.68 . . . . 99.989999999999995 109.201 173.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.487 ' HD2' HD12 ' A' ' 217' ' ' LEU . 3.8 ptm180 -125.49 128.11 47.51 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.255 -1.017 . . . . 99.989999999999995 108.255 164.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.702 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 23.5 mm -90.88 112.68 25.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.204 0.526 . . . . 99.989999999999995 110.912 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.542 ' OE1' ' HE3' ' A' ' 206' ' ' LYS . 89.5 mt-30 -88.16 -150.31 0.18 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.132 -1.062 . . . . 99.989999999999995 108.132 171.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -58.61 79.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.224 0.535 . . . . 99.989999999999995 112.313 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 64.85 17.56 63.11 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.67 -0.695 . . . . 99.989999999999995 113.179 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -131.47 146.03 52.05 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.081 -0.647 . . . . 99.989999999999995 112.389 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.702 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 35.6 mtpt -94.17 125.45 38.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.306 -0.861 . . . . 99.989999999999995 110.761 -174.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.542 ' HE3' ' OE1' ' A' ' 201' ' ' GLN . 72.3 mmtt -110.25 102.04 49.93 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.763 -0.458 . . . . 99.989999999999995 109.763 176.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.83 127.85 24.83 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.335 2.023 . . . . 99.989999999999995 112.046 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 197' ' ' VAL . 26.5 mm -91.25 159.18 2.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.119 -0.946 . . . . 99.989999999999995 109.582 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.463 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -97.71 131.55 10.63 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.516 -1.033 . . . . 99.989999999999995 110.516 173.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.54 ' HB3' ' CG ' ' A' ' 178' ' ' ARG . 85.2 m95 -61.49 -33.8 74.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.249 0.525 . . . . 99.989999999999995 111.01 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -86.57 7.37 26.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.852 0.358 . . . . 99.989999999999995 111.176 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.46 ' O ' HG21 ' A' ' 177' ' ' VAL . 89.2 m -82.32 143.1 31.51 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.551 -0.537 . . . . 99.989999999999995 109.551 173.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.08 129.87 41.22 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.792 -0.448 . . . . 99.989999999999995 109.792 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.42 HG23 ' HB3' ' A' ' 180' ' ' SER . 0.4 OUTLIER -66.69 -17.24 22.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.209 -0.45 . . . . 99.989999999999995 111.753 -175.455 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 23.2 t -68.19 -14.0 62.66 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.059 -0.401 . . . . 99.989999999999995 110.331 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.418 ' HB2' HD22 ' A' ' 217' ' ' LEU . 20.6 m0 -76.2 -19.48 58.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.504 0.669 . . . . 99.989999999999995 110.0 175.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.588 HD22 ' N ' ' A' ' 217' ' ' LEU . 1.5 mm? -115.65 20.77 14.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.216 -0.902 . . . . 99.989999999999995 109.333 -174.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.2 m -53.69 119.94 5.58 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.46 -0.791 . . . . 99.989999999999995 112.35 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 76.67 8.51 86.25 Favored Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 114.258 -1.337 . . . . 99.989999999999995 113.678 170.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -87.56 159.89 18.42 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.707 -0.479 . . . . 99.989999999999995 109.707 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 50.3 mt-10 -92.59 110.19 21.61 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.857 -0.794 . . . . 99.989999999999995 108.857 171.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.432 HD23 HG12 ' A' ' 197' ' ' VAL . 7.7 mp -96.22 161.67 13.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.97 -0.559 . . . . 99.989999999999995 109.994 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 197' ' ' VAL . 47.9 m-70 -125.96 122.48 36.07 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.911 -0.586 . . . . 99.989999999999995 110.068 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.494 HG12 ' HD3' ' A' ' 162' ' ' PRO . 2.7 t -100.72 114.17 38.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 108.674 -0.861 . . . . 99.989999999999995 108.674 174.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -108.29 127.81 54.19 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.297 -0.865 . . . . 99.989999999999995 108.919 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.75 129.27 37.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.089 0.471 . . . . 99.989999999999995 110.035 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.47 83.37 1.48 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.416 -0.811 . . . . 99.989999999999995 111.318 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -104.99 96.19 6.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.813 -0.63 . . . . 99.989999999999995 109.494 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 9.1 t30 57.55 61.97 2.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.429 -0.805 . . . . 99.989999999999995 110.55 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.896 -0.593 . . . . 99.989999999999995 110.782 178.37 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . 14.5 p . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 120.859 0.361 . . . . 99.989999999999995 110.719 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 151' ' ' SER . 38.7 Cg_endo -65.33 86.44 0.2 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.95 2.434 . . . . 99.989999999999995 112.304 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -71.18 114.05 8.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.249 -0.432 . . . . 99.989999999999995 110.089 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -83.28 121.12 76.75 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.394 -0.595 . . . . 99.989999999999995 109.394 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.506 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 38.7 Cg_exo -59.47 162.49 14.74 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.868 2.379 . . . . 99.989999999999995 112.881 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.602 HD11 HG11 ' A' ' 168' ' ' VAL . 2.1 pp -132.32 163.59 37.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.982 -0.553 . . . . 99.989999999999995 110.846 -177.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 39.7 t -128.44 121.09 54.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.17 -0.468 . . . . 99.989999999999995 110.258 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.485 ' HA ' HG12 ' A' ' 168' ' ' VAL . 76.2 mtp180 -86.98 93.95 9.48 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.217 0.532 . . . . 99.989999999999995 111.374 -172.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.0 t -94.8 135.18 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 115.589 -0.732 . . . . 99.989999999999995 111.679 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.675 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 41.5 m-85 -90.18 103.6 16.26 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.071 -0.968 . . . . 99.989999999999995 109.92 175.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.518 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.5 mm? -77.18 174.21 6.24 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.951 -0.759 . . . . 99.989999999999995 108.951 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 84.1 Cg_exo -50.88 154.98 6.27 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.679 2.253 . . . . 99.989999999999995 112.49 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.3 m120 67.09 15.2 10.05 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.953 -0.567 . . . . 99.989999999999995 109.968 -173.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.561 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 58.69 49.97 9.5 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.248 -0.887 . . . . 99.989999999999995 111.016 -177.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.675 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -86.77 178.77 6.91 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.04 -0.982 . . . . 99.989999999999995 108.678 172.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.592 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 7.5 mtm180 -147.4 141.45 26.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 118.548 0.613 . . . . 99.989999999999995 112.146 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.504 HG21 HD23 ' A' ' 161' ' ' LEU . 4.0 t -145.47 150.11 35.89 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.921 -1.141 . . . . 99.989999999999995 107.921 173.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.602 HG11 HD11 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -113.1 126.81 70.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 119.621 -0.832 . . . . 99.989999999999995 110.02 178.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 24.3 t -108.57 131.09 21.99 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.307 -0.86 . . . . 99.989999999999995 109.311 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 34.4 Cg_exo -56.73 118.41 5.25 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.409 1.406 . . . . 99.989999999999995 110.293 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.75 116.06 4.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.76 -0.654 . . . . 99.989999999999995 110.174 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 170' ' ' PRO . 98.1 mtt180 -104.39 112.3 25.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.419 -0.81 . . . . 99.989999999999995 111.643 -172.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 49.5 t -77.76 113.06 15.26 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.498 -0.556 . . . . 99.989999999999995 109.498 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 112.32 -12.7 26.06 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.749 -0.739 . . . . 99.989999999999995 111.407 -177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 176' ' ' THR . 1.2 t -107.49 144.59 16.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.629 -0.508 . . . . 99.989999999999995 109.629 176.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.486 ' O ' HG12 ' A' ' 175' ' ' VAL . 40.1 p -85.89 160.67 19.35 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.029 -0.532 . . . . 99.989999999999995 110.104 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.601 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 15.4 m -57.15 -22.01 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.725 -0.472 . . . . 99.989999999999995 109.725 176.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.654 ' HG3' ' O ' ' A' ' 210' ' ' TRP . 92.2 mtt-85 -52.67 -58.15 7.76 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.407 -0.361 . . . . 99.989999999999995 111.111 172.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.59 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 23.2 t70 -75.54 -41.98 53.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.461 0.648 . . . . 99.989999999999995 111.1 -172.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.587 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 10.8 p -64.2 -52.8 57.11 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.025 -0.989 . . . . 99.989999999999995 111.081 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.491 ' N ' HD21 ' A' ' 181' ' ' LEU . 2.5 mt -76.43 -15.88 59.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.362 -0.381 . . . . 99.989999999999995 110.184 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.59 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 5.2 ttmt -59.69 -47.8 84.21 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.546 -0.909 . . . . 99.989999999999995 108.546 173.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.481 ' HA ' ' HE3' ' A' ' 183' ' ' LYS . 2.2 tpmt? -58.89 -41.86 88.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.085 -0.507 . . . . 99.989999999999995 109.76 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . -51.63 -63.92 0.98 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.2 -0.455 . . . . 99.989999999999995 111.997 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 181' ' ' LEU . 3.9 mp -69.82 -41.26 75.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.614 0.227 . . . . 99.989999999999995 111.614 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.56 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 10.4 mmt -62.79 -31.16 72.08 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.107 0.41 . . . . 99.989999999999995 112.107 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 62.0 mtm -74.4 -26.76 60.3 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.387 0.613 . . . . 99.989999999999995 109.635 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -82.73 -20.32 36.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.122 -0.944 . . . . 99.989999999999995 111.344 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.57 25.14 21.78 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.627 -0.589 . . . . 99.989999999999995 111.627 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.3 mp -118.39 171.0 8.45 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.704 0.402 . . . . 99.989999999999995 110.561 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 42.6 pt -119.47 132.4 24.02 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.271 -0.422 . . . . 99.989999999999995 110.871 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 3.7 Cg_exo -76.87 -12.04 18.04 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.95 2.433 . . . . 99.989999999999995 112.256 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -62.58 -40.11 95.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.95 -0.568 . . . . 99.989999999999995 111.464 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 12.5 t -99.16 34.13 2.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 110.303 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.486 ' HB3' HG11 ' A' ' 224' ' ' VAL . 81.6 m -142.43 166.78 23.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.053 -0.521 . . . . 99.989999999999995 110.735 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.636 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -138.91 160.81 38.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.33 -0.395 . . . . 99.989999999999995 110.558 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.76 128.03 69.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.212 0.32 . . . . 99.989999999999995 110.335 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 33.6 m-85 -123.61 145.22 49.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.571 0.224 . . . . 99.989999999999995 110.398 174.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 206' ' ' LYS . 1.6 ptm180 -116.51 118.91 33.97 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.515 -0.92 . . . . 99.989999999999995 108.515 168.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.676 HD13 ' N ' ' A' ' 200' ' ' ILE . 1.2 mp -81.2 106.52 12.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 121.324 0.583 . . . . 99.989999999999995 109.969 -176.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 203' ' ' GLY . 24.4 mt-30 -87.11 -141.02 0.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.402 -0.817 . . . . 99.989999999999995 108.94 174.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -59.64 77.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.245 0.545 . . . . 99.989999999999995 112.272 -173.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.3 15.83 46.74 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.482 -0.781 . . . . 99.989999999999995 112.709 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.512 ' OE2' ' HE2' ' A' ' 206' ' ' LYS . 7.3 pt-20 -132.5 137.5 47.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.373 0.606 . . . . 99.989999999999995 111.819 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.5 ' HG2' HD11 ' A' ' 200' ' ' ILE . 51.2 mtpt -82.34 127.47 33.27 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.427 -0.806 . . . . 99.989999999999995 110.35 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.512 ' HE2' ' OE2' ' A' ' 204' ' ' GLU . 5.3 mptp? -106.34 106.52 57.61 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.257 -0.429 . . . . 99.989999999999995 110.586 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -70.29 118.64 5.8 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.704 1.602 . . . . 99.989999999999995 111.662 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 56.2 mt -95.95 154.01 3.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 114.293 -1.321 . . . . 99.989999999999995 111.07 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.05 142.31 22.25 Favored Glycine 0 N--CA 1.438 -1.186 0 N-CA-C 110.94 -0.864 . . . . 99.989999999999995 110.94 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.654 ' O ' ' HG3' ' A' ' 178' ' ' ARG . 81.9 m95 -66.3 -23.52 66.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 117.47 0.635 . . . . 99.989999999999995 110.532 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.48 19.88 9.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.044 0.45 . . . . 99.989999999999995 110.952 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 69.5 m -86.64 140.19 30.06 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.085 -0.507 . . . . 99.989999999999995 109.806 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.86 121.2 16.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.146 -0.479 . . . . 99.989999999999995 110.616 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.462 HG23 ' CB ' ' A' ' 180' ' ' SER . 0.5 OUTLIER -66.84 -22.38 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.526 . . . . 99.989999999999995 111.744 -176.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.4 t -74.81 -8.78 57.46 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.868 -0.333 . . . . 99.989999999999995 110.375 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -69.75 -38.69 76.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.683 0.754 . . . . 99.989999999999995 108.997 169.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.26 26.32 4.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.863 -1.062 . . . . 99.989999999999995 110.087 -175.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 52.2 m -50.24 114.33 1.09 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.566 0.698 . . . . 99.989999999999995 112.307 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 86.59 -8.41 75.24 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 114.914 -1.039 . . . . 99.989999999999995 113.495 171.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -74.6 156.44 36.76 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.925 -0.398 . . . . 99.989999999999995 109.925 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -87.7 109.85 20.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.04 -0.726 . . . . 99.989999999999995 109.04 173.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 70.1 mt -96.51 152.56 18.51 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.579 -0.526 . . . . 99.989999999999995 109.579 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -118.85 120.35 37.06 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.402 -0.363 . . . . 99.989999999999995 110.096 -175.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 2.6 t -100.1 111.83 30.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 121.568 0.699 . . . . 99.989999999999995 109.307 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -108.91 145.7 34.98 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.045 -0.98 . . . . 99.989999999999995 109.695 -173.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.14 128.75 38.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.22 -0.445 . . . . 99.989999999999995 110.922 -175.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.11 80.59 7.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.228 0.537 . . . . 99.989999999999995 109.99 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -136.36 97.46 3.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.689 -0.687 . . . . 99.989999999999995 109.761 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -94.69 24.41 4.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.933 -0.576 . . . . 99.989999999999995 111.314 -176.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 116.35 -0.386 . . . . 99.989999999999995 110.382 176.417 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 121.071 0.462 . . . . 99.989999999999995 110.994 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -59.9 -41.33 54.67 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.329 2.686 . . . . 99.989999999999995 111.92 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -89.11 126.79 35.6 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.164 -0.68 . . . . 99.989999999999995 109.164 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -82.49 124.69 77.59 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.53 -0.305 . . . . 99.989999999999995 110.446 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.7 161.14 33.36 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.722 2.281 . . . . 99.989999999999995 111.594 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.5 pp -121.88 169.8 12.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.164 0.507 . . . . 99.989999999999995 111.978 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.514 HG22 HG13 ' A' ' 214' ' ' ILE . 5.4 t -130.88 115.46 30.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 107.545 -1.28 . . . . 99.989999999999995 107.545 175.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.533 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 20.2 mtm180 -92.12 98.08 11.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.223 0.535 . . . . 99.989999999999995 111.632 -166.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.2 t -91.29 141.51 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.704 -0.68 . . . . 99.989999999999995 112.669 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -103.42 103.96 13.99 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.804 -1.089 . . . . 99.989999999999995 109.524 172.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.485 ' CD1' ' HD2' ' A' ' 188' ' ' ARG . 7.3 mt -83.03 169.8 16.53 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.645 -0.707 . . . . 99.989999999999995 110.18 -172.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 88.2 Cg_exo -50.67 149.52 13.73 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.1 2.533 . . . . 99.989999999999995 112.503 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 14.3 m120 69.0 30.11 4.59 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.892 -0.594 . . . . 99.989999999999995 110.538 -176.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 51.9 47.52 24.61 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.441 -0.799 . . . . 99.989999999999995 111.601 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.464 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 15.0 mm100 -95.99 170.67 9.13 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.493 -0.929 . . . . 99.989999999999995 108.493 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 7.9 ttt180 -148.65 135.75 20.1 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.051 -0.66 . . . . 99.989999999999995 111.84 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.459 HG22 ' HB1' ' A' ' 184' ' ' ALA . 1.4 t -151.6 141.77 22.28 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.019 -1.104 . . . . 99.989999999999995 108.019 175.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.533 ' CG1' ' HG2' ' A' ' 158' ' ' ARG . 0.7 OUTLIER -117.26 130.07 72.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 C-N-CA 119.451 -0.899 . . . . 99.989999999999995 110.307 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.4 p -109.53 136.12 20.28 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.505 -1.225 . . . . 99.989999999999995 109.514 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.41 128.61 30.81 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.233 1.955 . . . . 99.989999999999995 111.167 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.16 89.49 0.45 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.836 -0.62 . . . . 99.989999999999995 109.81 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.467 ' HB2' HG13 ' A' ' 175' ' ' VAL . 64.3 mtt180 -77.27 113.96 15.58 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.07 -0.968 . . . . 99.989999999999995 110.989 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.5 t -70.12 115.23 9.09 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.826 -0.435 . . . . 99.989999999999995 109.826 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.03 -3.57 35.58 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.648 -0.787 . . . . 99.989999999999995 112.457 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 179' ' ' ASP . 0.4 OUTLIER -108.42 150.22 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.041 0.448 . . . . 99.989999999999995 109.944 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.8 p -87.93 152.13 22.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.058 -0.519 . . . . 99.989999999999995 111.231 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.615 HG21 ' O ' ' A' ' 212' ' ' THR . 86.6 t -46.53 -42.68 5.46 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 O-C-N 123.512 0.507 . . . . 99.989999999999995 110.46 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 11.0 ptm180 -49.78 -48.65 50.37 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 116.062 -0.517 . . . . 99.989999999999995 112.35 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.567 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 16.2 t70 -70.21 -47.55 60.98 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.346 0.594 . . . . 99.989999999999995 111.039 -176.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.458 ' HB2' HG23 ' A' ' 214' ' ' ILE . 0.5 OUTLIER -66.59 -45.89 77.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.409 -0.814 . . . . 99.989999999999995 111.254 -175.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.446 ' N ' HD21 ' A' ' 181' ' ' LEU . 0.5 OUTLIER -73.1 -28.49 62.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.204 -0.453 . . . . 99.989999999999995 110.325 176.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.567 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 8.6 mtmt -54.04 -49.94 67.81 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.265 -0.643 . . . . 99.989999999999995 109.265 176.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.577 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.3 tpmt? -56.81 -47.37 80.39 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.79 -0.448 . . . . 99.989999999999995 109.79 175.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.459 ' HB1' HG22 ' A' ' 167' ' ' THR . . . -51.36 -60.63 2.91 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.071 -0.513 . . . . 99.989999999999995 112.242 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 5.5 mp -68.0 -48.32 66.09 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 122.619 0.368 . . . . 99.989999999999995 111.557 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.516 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 1.0 OUTLIER -59.51 -34.3 72.44 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.849 -0.614 . . . . 99.989999999999995 111.882 -176.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.577 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 67.4 mtm -71.03 -31.37 67.83 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.23 0.538 . . . . 99.989999999999995 109.691 175.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.485 ' HD2' ' CD1' ' A' ' 161' ' ' LEU . 9.1 mtt180 -86.2 -4.68 59.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.512 -0.767 . . . . 99.989999999999995 111.813 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.37 25.92 49.38 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.796 -0.716 . . . . 99.989999999999995 112.093 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.1 mp -116.0 161.59 18.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.779 -0.452 . . . . 99.989999999999995 109.779 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 29.4 pt -120.65 128.74 25.64 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 116.297 -0.41 . . . . 99.989999999999995 111.142 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 23.4 Cg_exo -66.02 -14.66 45.47 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 123.002 2.468 . . . . 99.989999999999995 112.28 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -60.19 -42.44 95.09 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.183 -0.462 . . . . 99.989999999999995 111.497 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.5 t -104.23 28.84 6.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.392 0.615 . . . . 99.989999999999995 110.028 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.533 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 84.0 m -139.87 165.8 26.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.651 -0.704 . . . . 99.989999999999995 110.443 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -149.53 164.57 34.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.531 -0.304 . . . . 99.989999999999995 111.245 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.439 HG11 HD13 ' A' ' 208' ' ' ILE . 14.7 t -111.1 133.13 57.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.892 -0.595 . . . . 99.989999999999995 111.33 -174.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 25.0 m-85 -126.87 143.94 51.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.071 -0.513 . . . . 99.989999999999995 110.193 172.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -118.2 114.95 23.8 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.713 -1.217 . . . . 99.989999999999995 107.713 168.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.587 HD11 ' HG2' ' A' ' 205' ' ' LYS . 5.5 mm -81.58 102.66 7.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 C-N-CA 120.089 -0.645 . . . . 99.989999999999995 110.087 -172.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.524 ' OE1' ' HE2' ' A' ' 206' ' ' LYS . 33.2 mt-30 -76.55 -145.15 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.603 -0.726 . . . . 99.989999999999995 109.304 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -57.18 79.82 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.788 0.435 . . . . 99.989999999999995 112.058 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.58 16.97 46.93 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.648 -0.705 . . . . 99.989999999999995 112.8 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -127.25 134.47 50.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.993 0.425 . . . . 99.989999999999995 111.347 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.587 ' HG2' HD11 ' A' ' 200' ' ' ILE . 48.0 mtpt -81.07 119.74 23.94 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.412 -0.358 . . . . 99.989999999999995 110.071 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.524 ' HE2' ' OE1' ' A' ' 201' ' ' GLN . 8.4 tptt -109.79 104.84 56.33 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.643 -0.253 . . . . 99.989999999999995 110.771 -175.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.37 124.84 10.74 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.104 1.869 . . . . 99.989999999999995 112.17 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.439 HD13 HG11 ' A' ' 197' ' ' VAL . 46.9 mt -100.01 153.81 4.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 114.396 -1.274 . . . . 99.989999999999995 110.919 -176.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.85 138.85 15.87 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 110.977 -0.849 . . . . 99.989999999999995 110.977 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -67.4 -20.82 65.59 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.103 0.451 . . . . 99.989999999999995 110.154 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -92.62 6.89 45.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 99.989999999999995 110.914 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.615 ' O ' HG21 ' A' ' 177' ' ' VAL . 96.5 m -78.62 147.15 33.75 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.852 -0.795 . . . . 99.989999999999995 108.852 172.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 215' ' ' SER . 12.5 t70 -74.55 130.05 38.87 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.539 -0.541 . . . . 99.989999999999995 109.539 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.514 HG13 HG22 ' A' ' 157' ' ' VAL . 0.2 OUTLIER -72.56 -15.1 17.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.917 0.389 . . . . 99.989999999999995 111.458 -174.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.446 ' HB2' ' OD1' ' A' ' 213' ' ' ASP . 70.8 m -75.01 -8.87 57.75 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.899 -0.5 . . . . 99.989999999999995 110.587 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 30.1 m0 -82.36 -11.46 58.56 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.967 -0.753 . . . . 99.989999999999995 108.967 172.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.461 HD11 HD22 ' A' ' 222' ' ' LEU . 5.6 mt -118.46 19.26 13.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.045 -0.979 . . . . 99.989999999999995 109.022 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 99.5 m -52.27 117.25 2.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.401 -0.818 . . . . 99.989999999999995 112.534 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 86.3 -4.13 86.37 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.992 -1.004 . . . . 99.989999999999995 113.266 170.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -75.84 157.88 32.81 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.946 -0.39 . . . . 99.989999999999995 109.946 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 28.4 mt-10 -98.05 111.62 23.87 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.028 -0.73 . . . . 99.989999999999995 109.028 171.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.461 HD22 HD11 ' A' ' 217' ' ' LEU . 6.4 mp -95.45 164.93 12.6 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.835 -0.621 . . . . 99.989999999999995 110.191 -175.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -133.97 130.09 37.15 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.111 -0.7 . . . . 99.989999999999995 109.111 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 40.9 t -100.86 123.83 54.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.106 0.479 . . . . 99.989999999999995 109.768 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -107.8 146.23 32.5 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.44 -0.8 . . . . 99.989999999999995 109.682 -175.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 85.7 t -84.47 122.68 38.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.93 0.395 . . . . 99.989999999999995 110.075 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 64.6 mt -72.88 82.7 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.736 -0.666 . . . . 99.989999999999995 110.352 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -129.66 96.91 4.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.748 -0.66 . . . . 99.989999999999995 109.465 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -160.1 23.01 0.17 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.692 -0.685 . . . . 99.989999999999995 110.668 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 116.229 -0.441 . . . . 99.989999999999995 110.762 -177.594 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 10.9 p . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 120.745 0.307 . . . . 99.989999999999995 110.775 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 151' ' ' SER . 16.7 Cg_exo -70.07 60.5 1.85 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.468 2.779 . . . . 99.989999999999995 112.261 177.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -78.13 125.79 29.87 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.925 -0.58 . . . . 99.989999999999995 110.423 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -74.7 114.99 39.77 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.157 -0.682 . . . . 99.989999999999995 109.157 173.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.428 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 41.5 Cg_endo -65.1 166.28 19.28 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.637 2.224 . . . . 99.989999999999995 112.719 -175.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.663 HD11 HG11 ' A' ' 168' ' ' VAL . 1.9 pp -132.83 152.69 36.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.953 -0.567 . . . . 99.989999999999995 110.464 -177.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.32 134.59 66.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.577 -0.527 . . . . 99.989999999999995 109.577 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.494 ' HA ' HG12 ' A' ' 168' ' ' VAL . 1.3 mtp180 -94.2 97.61 10.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 99.989999999999995 112.288 -165.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.0 t -97.64 134.44 35.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.924 -0.58 . . . . 99.989999999999995 112.146 -175.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 2.3 m-85 -92.3 103.67 16.1 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.652 -0.703 . . . . 99.989999999999995 109.391 175.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.1 mm? -78.03 169.62 20.09 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 108.86 -0.793 . . . . 99.989999999999995 108.86 -177.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.435 ' HD3' ' CG1' ' A' ' 224' ' ' VAL . 78.5 Cg_exo -52.78 152.98 15.81 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.71 2.273 . . . . 99.989999999999995 113.228 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.2 t30 65.2 41.11 4.61 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.604 -0.726 . . . . 99.989999999999995 110.746 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 59.88 31.01 20.52 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.271 -0.877 . . . . 99.989999999999995 112.219 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.512 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 26.6 mm-40 -85.3 161.42 19.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.851 -0.426 . . . . 99.989999999999995 109.851 176.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 26.8 ttp180 -149.25 134.94 18.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.393 -0.225 . . . . 99.989999999999995 110.393 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.503 HG21 HD23 ' A' ' 161' ' ' LEU . 1.1 t -145.63 151.64 38.39 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.622 -0.881 . . . . 99.989999999999995 108.622 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.663 HG11 HD11 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -108.05 129.31 62.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 119.404 -0.918 . . . . 99.989999999999995 110.232 178.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 m -105.45 130.99 22.15 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.238 -0.892 . . . . 99.989999999999995 110.257 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.38 121.09 8.59 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.821 1.681 . . . . 99.989999999999995 111.182 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.428 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -69.92 95.16 0.9 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.204 -0.907 . . . . 99.989999999999995 110.262 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -93.25 112.19 24.05 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.132 -0.94 . . . . 99.989999999999995 111.4 -173.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.475 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 49.0 t -70.11 113.39 7.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.723 -0.473 . . . . 99.989999999999995 109.723 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.51 0.01 27.78 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.51 -0.852 . . . . 99.989999999999995 111.742 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.2 152.05 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.026 -0.731 . . . . 99.989999999999995 109.026 176.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 24.3 p -89.01 159.8 17.41 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.091 -0.644 . . . . 99.989999999999995 110.699 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 212' ' ' THR . 87.4 t -50.5 -38.21 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.842 -0.799 . . . . 99.989999999999995 108.842 172.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.557 ' CG ' ' HB3' ' A' ' 210' ' ' TRP . 26.6 mtp180 -45.63 -58.81 3.13 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.385 -0.825 . . . . 99.989999999999995 111.563 175.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.648 ' HA ' ' CE ' ' A' ' 182' ' ' LYS . 32.3 m-20 -67.07 -45.53 77.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.922 0.392 . . . . 99.989999999999995 111.913 -170.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.7 t -71.38 -38.62 71.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.15 0.5 . . . . 99.989999999999995 110.478 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.448 ' N ' HD21 ' A' ' 181' ' ' LEU . 0.4 OUTLIER -75.93 -27.7 57.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.989 -0.55 . . . . 99.989999999999995 110.455 177.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.648 ' CE ' ' HA ' ' A' ' 179' ' ' ASP . 37.1 mtmt -55.22 -52.42 63.43 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.671 -0.492 . . . . 99.989999999999995 109.671 175.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 183' ' ' LYS . 2.2 tpmt? -61.86 -40.46 95.42 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.294 -0.562 . . . . 99.989999999999995 110.316 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.411 ' HB1' HG22 ' A' ' 167' ' ' THR . . . -55.53 -55.85 27.11 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.286 -0.416 . . . . 99.989999999999995 111.751 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.0 mt -70.11 -46.37 64.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.191 -0.459 . . . . 99.989999999999995 111.318 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 12.9 mmt -59.97 -36.67 77.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.395 -0.366 . . . . 99.989999999999995 111.961 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.439 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 58.2 mtm -76.35 -12.91 60.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.062 0.458 . . . . 99.989999999999995 110.251 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -110.33 17.8 20.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.843 -0.617 . . . . 99.989999999999995 111.527 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 62.63 36.94 93.95 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.226 -0.511 . . . . 99.989999999999995 112.198 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 24.2 mt -128.36 166.91 17.76 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.022 -0.362 . . . . 99.989999999999995 110.022 -175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.473 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 37.4 pt -130.64 130.64 22.96 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.053 0.454 . . . . 99.989999999999995 111.85 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 16.2 Cg_exo -68.76 -16.13 41.47 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.088 2.525 . . . . 99.989999999999995 112.341 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -65.34 -37.52 87.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 99.989999999999995 111.071 -177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 16.9 t -109.78 37.0 2.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.415 0.626 . . . . 99.989999999999995 109.992 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.499 ' HB3' HG11 ' A' ' 224' ' ' VAL . 99.1 m -146.73 162.36 38.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.813 -0.631 . . . . 99.989999999999995 110.672 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -142.16 157.29 45.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.155 -0.475 . . . . 99.989999999999995 110.78 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 10.9 t -107.13 123.73 62.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.013 -0.54 . . . . 99.989999999999995 110.584 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 47.8 m-85 -116.14 153.8 31.13 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.07 -0.345 . . . . 99.989999999999995 110.07 173.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.483 ' HB3' ' CD2' ' A' ' 222' ' ' LEU . 12.2 ptt180 -126.33 111.73 14.87 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.792 -0.818 . . . . 99.989999999999995 108.792 167.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 1.2 mp -80.92 110.48 16.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.293 0.568 . . . . 99.989999999999995 110.866 -173.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -83.78 -146.53 0.09 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.267 -0.879 . . . . 99.989999999999995 108.843 172.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 20.6 m-20 -61.31 79.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.837 0.351 . . . . 99.989999999999995 111.868 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.79 14.76 65.8 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 116.083 -0.508 . . . . 99.989999999999995 112.412 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.652 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 30.4 mt-10 -116.89 134.37 54.85 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 120.746 0.308 . . . . 99.989999999999995 111.71 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.5 ' HZ3' ' CD ' ' A' ' 225' ' ' GLU . 52.4 mtpt -95.03 112.45 24.15 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.725 -0.472 . . . . 99.989999999999995 109.725 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 74.9 mmtt -98.4 107.14 40.34 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.485 -0.325 . . . . 99.989999999999995 110.156 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -74.51 118.92 5.52 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.943 1.762 . . . . 99.989999999999995 111.467 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.443 HG21 HD13 ' A' ' 217' ' ' LEU . 22.0 mt -93.83 152.75 3.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.495 -1.23 . . . . 99.989999999999995 111.088 -174.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -85.49 139.95 17.76 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.304 -0.718 . . . . 99.989999999999995 111.304 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.557 ' HB3' ' CG ' ' A' ' 178' ' ' ARG . 88.4 m95 -70.41 -34.99 73.17 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.645 0.26 . . . . 99.989999999999995 111.164 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.48 5.5 23.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.119 0.485 . . . . 99.989999999999995 111.238 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.537 ' O ' HG21 ' A' ' 177' ' ' VAL . 95.6 m -74.8 148.37 40.39 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.693 -0.854 . . . . 99.989999999999995 108.693 170.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -73.49 134.38 43.86 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.377 -0.601 . . . . 99.989999999999995 109.377 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 171' ' ' ALA . 0.1 OUTLIER -69.94 -16.36 20.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.958 0.408 . . . . 99.989999999999995 110.653 -178.396 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 18.7 m -65.49 -15.88 63.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.994 0.426 . . . . 99.989999999999995 110.73 176.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 32.9 m0 -80.54 -17.64 50.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 99.989999999999995 110.22 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.444 ' HB3' HD12 ' A' ' 222' ' ' LEU . 10.4 mt -112.81 19.87 16.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.93 -0.577 . . . . 99.989999999999995 109.724 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 99.7 m -52.1 112.86 0.87 Allowed 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.42 -0.809 . . . . 99.989999999999995 112.413 -177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 80.07 8.93 87.2 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 114.643 -1.162 . . . . 99.989999999999995 113.427 171.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -85.17 151.32 24.19 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.737 -0.468 . . . . 99.989999999999995 109.737 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 36.5 mt-10 -86.99 111.14 20.56 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.812 -0.81 . . . . 99.989999999999995 108.812 171.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.483 ' CD2' ' HB3' ' A' ' 199' ' ' ARG . 61.0 mt -105.56 159.63 15.8 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.884 -0.598 . . . . 99.989999999999995 110.214 -175.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -125.99 122.44 35.9 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.833 0.349 . . . . 99.989999999999995 110.27 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 4.5 t -101.05 115.54 42.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.921 -0.581 . . . . 99.989999999999995 109.566 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.5 ' CD ' ' HZ3' ' A' ' 205' ' ' LYS . 24.6 mt-10 -112.35 141.9 45.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.839 -0.618 . . . . 99.989999999999995 110.78 -175.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.84 127.62 34.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.205 -0.452 . . . . 99.989999999999995 109.831 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 67.3 mt -77.97 81.66 4.36 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.173 -0.677 . . . . 99.989999999999995 109.173 176.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -73.62 94.16 2.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.631 0.729 . . . . 99.989999999999995 110.222 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -161.79 29.52 0.12 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.504 -1.225 . . . . 99.989999999999995 108.385 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.178 -0.919 . . . . 99.989999999999995 110.757 -177.479 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 16.1 p . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.822 0.344 . . . . 99.989999999999995 111.029 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -68.99 -40.95 5.78 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.787 2.325 . . . . 99.989999999999995 111.343 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.533 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 5.8 tp-100 -91.82 106.42 18.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.56 -0.746 . . . . 99.989999999999995 109.499 175.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -108.66 89.97 6.85 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.971 -0.559 . . . . 99.989999999999995 109.951 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 153' ' ' GLN . 3.8 Cg_exo -74.79 152.44 41.9 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.505 2.137 . . . . 99.989999999999995 111.241 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.704 ' O ' ' HA2' ' A' ' 219' ' ' GLY . 1.8 pp -126.09 156.36 36.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.428 -0.351 . . . . 99.989999999999995 110.493 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -125.23 134.23 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 110.186 -0.301 . . . . 99.989999999999995 110.186 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 81.7 mtm180 -95.41 105.46 17.43 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.332 0.493 . . . . 99.989999999999995 112.332 -167.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.8 t -96.87 135.45 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.155 -0.475 . . . . 99.989999999999995 111.807 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 64.9 m-85 -97.4 103.12 15.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.414 -0.812 . . . . 99.989999999999995 109.788 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.569 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.1 mt -84.52 173.84 6.66 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.645 -0.707 . . . . 99.989999999999995 111.098 -170.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 99.1 Cg_exo -48.66 153.47 3.49 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.128 2.552 . . . . 99.989999999999995 113.236 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 63.16 24.46 14.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.561 -0.745 . . . . 99.989999999999995 110.492 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.558 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 61.18 44.05 10.37 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.55 -0.75 . . . . 99.989999999999995 111.088 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 15.2 mm100 -90.8 177.93 6.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.743 -0.662 . . . . 99.989999999999995 109.781 177.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 38.7 ttp180 -147.36 153.44 39.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.548 0.214 . . . . 99.989999999999995 110.545 176.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.482 HG22 ' HB1' ' A' ' 184' ' ' ALA . 1.4 t -163.31 151.79 13.95 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.956 -0.757 . . . . 99.989999999999995 108.956 170.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.662 HG11 HD11 ' A' ' 156' ' ' ILE . 0.1 OUTLIER -115.06 128.29 72.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 119.965 -0.694 . . . . 99.989999999999995 110.298 177.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.7 p -115.83 133.29 22.86 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.267 -0.879 . . . . 99.989999999999995 109.412 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.41 131.55 43.44 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.281 1.987 . . . . 99.989999999999995 111.924 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.79 75.69 1.59 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.563 -0.744 . . . . 99.989999999999995 110.801 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -68.51 111.99 5.05 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.855 -1.066 . . . . 99.989999999999995 111.536 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.608 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 59.0 m -70.45 116.61 10.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.825 0.345 . . . . 99.989999999999995 110.128 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.03 -6.0 36.76 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.512 -0.852 . . . . 99.989999999999995 111.923 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.69 142.91 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.396 -0.594 . . . . 99.989999999999995 109.396 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.0 p -88.46 155.13 19.84 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.601 -0.44 . . . . 99.989999999999995 111.018 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.575 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 88.5 t -52.96 -34.34 20.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 116.022 -0.536 . . . . 99.989999999999995 110.636 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 16.0 ptt180 -56.67 -47.72 79.19 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 122.256 -0.277 . . . . 99.989999999999995 111.568 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.596 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 20.6 t70 -72.25 -45.49 59.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.174 0.511 . . . . 99.989999999999995 110.867 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.481 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 2.8 p -63.31 -53.24 55.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.304 -0.862 . . . . 99.989999999999995 111.378 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.7 OUTLIER -69.96 -24.41 63.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.685 -0.689 . . . . 99.989999999999995 111.121 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 11.8 mtmt -57.65 -51.25 70.28 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.453 -0.573 . . . . 99.989999999999995 109.453 175.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.543 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.4 tpmt? -61.43 -42.6 98.99 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.344 -0.389 . . . . 99.989999999999995 109.952 177.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.482 ' HB1' HG22 ' A' ' 167' ' ' THR . . . -53.47 -61.11 2.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 99.989999999999995 111.411 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.418 HD11 ' O ' ' A' ' 181' ' ' LEU . 1.5 mt -65.02 -44.68 88.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.057 -0.519 . . . . 99.989999999999995 111.24 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.563 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 6.5 mmt -61.38 -32.19 72.11 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.058 0.392 . . . . 99.989999999999995 112.058 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.543 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 62.5 mtm -77.16 -22.69 52.13 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.213 0.53 . . . . 99.989999999999995 110.02 175.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.1 5.77 50.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.455 -0.793 . . . . 99.989999999999995 111.73 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 69.81 36.69 74.85 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.832 -0.699 . . . . 99.989999999999995 111.966 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 21.4 mt -131.11 165.99 22.06 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 122.87 0.468 . . . . 99.989999999999995 110.021 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 35.7 pt -126.62 135.19 26.91 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.907 0.384 . . . . 99.989999999999995 111.36 177.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 15.9 Cg_exo -69.01 -16.5 40.77 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.029 2.486 . . . . 99.989999999999995 111.985 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -59.13 -45.51 90.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.511 -0.768 . . . . 99.989999999999995 111.534 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 16.2 t -105.41 34.74 3.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.257 0.551 . . . . 99.989999999999995 109.75 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.547 ' HB3' HG11 ' A' ' 224' ' ' VAL . 91.1 m -141.84 162.36 35.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.861 -0.609 . . . . 99.989999999999995 110.991 -176.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.628 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -143.62 154.63 43.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.535 -0.302 . . . . 99.989999999999995 111.133 174.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.495 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 13.3 t -105.92 138.01 33.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 99.989999999999995 110.676 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -129.24 150.32 50.67 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.572 -0.529 . . . . 99.989999999999995 109.572 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.456 ' HG2' HD11 ' A' ' 208' ' ' ILE . 2.9 ptm180 -114.31 116.38 28.88 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.381 -0.97 . . . . 99.989999999999995 108.381 166.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.558 HD13 ' N ' ' A' ' 200' ' ' ILE . 1.5 mp -80.63 112.25 18.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.685 0.755 . . . . 99.989999999999995 110.437 -175.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' A' ' 203' ' ' GLY . 25.0 mm-40 -88.52 -142.34 0.13 Allowed 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.529 -1.214 . . . . 99.989999999999995 109.281 174.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -58.22 79.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.47 0.545 . . . . 99.989999999999995 112.47 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.6 18.01 50.43 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.881 -0.6 . . . . 99.989999999999995 112.597 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 13.3 pt-20 -135.0 167.56 20.72 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.82 -0.352 . . . . 99.989999999999995 110.413 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.49 ' HG2' HD11 ' A' ' 200' ' ' ILE . 48.0 mtmt -108.28 133.27 52.73 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.22 -0.446 . . . . 99.989999999999995 110.711 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -111.87 103.97 55.65 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.772 -0.825 . . . . 99.989999999999995 108.772 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.19 132.5 41.83 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.361 2.041 . . . . 99.989999999999995 112.155 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.495 ' HB ' ' HB ' ' A' ' 197' ' ' VAL . 20.3 mm -96.77 158.12 3.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.42 -0.809 . . . . 99.989999999999995 110.281 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.459 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -96.0 142.11 15.95 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.425 -1.07 . . . . 99.989999999999995 110.425 172.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -70.27 -22.55 62.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 117.315 0.558 . . . . 99.989999999999995 111.068 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -94.05 9.82 36.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.895 0.379 . . . . 99.989999999999995 110.833 176.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.527 ' O ' HG21 ' A' ' 177' ' ' VAL . 81.4 m -77.71 150.46 34.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.097 -0.705 . . . . 99.989999999999995 109.097 172.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -80.1 124.41 28.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.744 0.783 . . . . 99.989999999999995 109.589 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.403 ' H ' HG23 ' A' ' 214' ' ' ILE . 7.7 tt -53.58 -30.19 18.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 113.998 -1.455 . . . . 99.989999999999995 111.768 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.608 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 12.9 m -62.91 -16.79 60.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.0 -0.546 . . . . 99.989999999999995 111.901 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -79.29 -13.61 59.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.222 0.534 . . . . 99.989999999999995 109.654 175.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.411 HD22 ' HD2' ' A' ' 199' ' ' ARG . 11.5 mt -117.92 16.51 14.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.051 -0.977 . . . . 99.989999999999995 109.83 -176.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 97.4 m -50.63 119.44 3.82 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.864 0.84 . . . . 99.989999999999995 112.865 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.704 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 75.71 8.7 84.62 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 114.214 -1.357 . . . . 99.989999999999995 113.498 170.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -92.78 164.78 13.23 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.751 0.31 . . . . 99.989999999999995 110.409 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 6.4 mp0 -96.35 111.01 23.24 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.312 -0.625 . . . . 99.989999999999995 109.312 176.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 28.7 mt -100.6 165.9 11.18 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.428 -0.582 . . . . 99.989999999999995 109.428 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -136.57 124.92 23.3 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.933 -0.395 . . . . 99.989999999999995 109.933 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 42.4 t -103.69 124.63 58.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.024 0.44 . . . . 99.989999999999995 110.268 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 71.0 mm-40 -110.79 155.05 23.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.391 -0.822 . . . . 99.989999999999995 110.666 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 43.1 t -83.38 129.19 37.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.157 -0.474 . . . . 99.989999999999995 110.532 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.4 mp -85.83 81.34 8.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.983 -0.553 . . . . 99.989999999999995 110.126 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -100.57 95.69 6.87 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.654 0.74 . . . . 99.989999999999995 109.243 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -132.89 37.04 3.46 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.824 -1.08 . . . . 99.989999999999995 109.636 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.302 -0.863 . . . . 99.989999999999995 110.671 -178.555 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 59.2 p . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 121.041 0.448 . . . . 99.989999999999995 110.359 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.09 -34.52 98.56 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.347 2.698 . . . . 99.989999999999995 111.998 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -100.88 100.02 10.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.105 -0.498 . . . . 99.989999999999995 109.797 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -93.77 112.61 57.61 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.494 -0.558 . . . . 99.989999999999995 109.494 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.437 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 66.6 Cg_endo -71.93 162.52 41.65 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.729 2.286 . . . . 99.989999999999995 112.887 -175.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.671 HD11 HG11 ' A' ' 168' ' ' VAL . 1.9 pp -129.87 157.85 42.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.892 -0.595 . . . . 99.989999999999995 110.622 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.97 133.91 68.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.705 -0.48 . . . . 99.989999999999995 109.705 177.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.542 ' HA ' HG12 ' A' ' 168' ' ' VAL . 18.1 mtm180 -92.31 108.03 19.65 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.476 0.655 . . . . 99.989999999999995 112.09 -168.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.617 HG21 ' HB2' ' A' ' 222' ' ' LEU . 11.6 t -96.1 145.75 8.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.206 -0.906 . . . . 99.989999999999995 111.626 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.546 ' CZ ' ' HD2' ' A' ' 166' ' ' ARG . 21.7 m-85 -112.61 103.01 11.05 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.57 -0.741 . . . . 99.989999999999995 109.822 176.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.5 mm? -76.58 173.99 6.47 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.659 -0.497 . . . . 99.989999999999995 109.659 -172.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.472 ' CD ' ' HB3' ' A' ' 161' ' ' LEU . 74.4 Cg_exo -54.11 155.01 16.31 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.571 2.18 . . . . 99.989999999999995 112.873 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.9 t30 66.74 21.86 10.47 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.334 -0.848 . . . . 99.989999999999995 109.947 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 61.17 44.9 9.52 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.489 -0.778 . . . . 99.989999999999995 111.399 179.083 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 15.1 mm-40 -86.64 171.94 10.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.751 -0.659 . . . . 99.989999999999995 109.329 174.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.546 ' HD2' ' CZ ' ' A' ' 160' ' ' PHE . 47.1 ttt180 -148.4 133.79 18.55 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.401 0.519 . . . . 99.989999999999995 112.401 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.542 HG21 HD23 ' A' ' 161' ' ' LEU . 5.4 t -137.43 174.74 10.27 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.484 -0.932 . . . . 99.989999999999995 108.484 175.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.671 HG11 HD11 ' A' ' 156' ' ' ILE . 0.2 OUTLIER -132.09 128.6 59.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.13 -0.628 . . . . 99.989999999999995 109.632 170.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.48 129.85 23.44 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.672 -0.694 . . . . 99.989999999999995 109.711 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.08 123.48 13.95 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.313 2.009 . . . . 99.989999999999995 111.476 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.437 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -61.75 99.96 0.13 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.628 0.728 . . . . 99.989999999999995 109.286 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.642 ' HG2' ' HB ' ' A' ' 175' ' ' VAL . 17.2 ttp180 -107.81 111.97 24.38 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.515 -1.22 . . . . 99.989999999999995 110.916 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.66 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 42.4 t -70.84 128.3 35.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.762 -0.654 . . . . 99.989999999999995 110.87 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 109.06 -21.18 27.61 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.811 -0.709 . . . . 99.989999999999995 111.767 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.642 ' HB ' ' HG2' ' A' ' 172' ' ' ARG . 0.9 OUTLIER -99.19 142.85 14.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.367 0.603 . . . . 99.989999999999995 110.749 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 5.6 p -81.56 148.69 29.01 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.395 -0.82 . . . . 99.989999999999995 109.641 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.492 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 21.9 m -49.48 -32.09 6.19 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.616 0 CA-C-N 117.904 0.32 . . . . 99.989999999999995 110.319 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 21.3 ptt180 -58.82 -43.38 90.61 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 112.813 0.672 . . . . 99.989999999999995 112.813 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.591 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 21.2 t70 -71.34 -47.64 55.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.964 0.802 . . . . 99.989999999999995 110.477 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.531 ' HB2' HG23 ' A' ' 214' ' ' ILE . 0.6 OUTLIER -62.21 -43.36 99.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.465 -0.789 . . . . 99.989999999999995 111.414 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.427 ' N ' HD21 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -72.42 -36.32 68.58 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.035 -0.53 . . . . 99.989999999999995 110.178 178.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.691 ' O ' ' HB2' ' A' ' 186' ' ' MET . 7.9 mtmt -50.64 -45.07 57.62 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 116.125 -0.489 . . . . 99.989999999999995 109.805 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.515 ' O ' ' HG3' ' A' ' 187' ' ' MET . 10.9 tppt? -67.41 -51.46 51.48 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.7 -0.682 . . . . 99.989999999999995 110.917 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -43.73 -54.13 5.35 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.482 0.489 . . . . 99.989999999999995 111.973 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 5.1 mp -69.24 -52.39 28.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.63 0.372 . . . . 99.989999999999995 111.733 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.691 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 1.3 ttm -54.28 -38.35 65.77 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.272 0.471 . . . . 99.989999999999995 112.272 -176.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 68.7 mtm -74.46 -16.52 60.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.338 0.59 . . . . 99.989999999999995 110.179 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 188' ' ' ARG . 49.8 mtt180 -105.9 12.73 30.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.32 -0.855 . . . . 99.989999999999995 111.324 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 68.6 38.5 86.23 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.783 -0.644 . . . . 99.989999999999995 112.015 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 20.8 mt -132.02 157.93 42.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.743 0.306 . . . . 99.989999999999995 110.676 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.0 pt -122.22 127.32 25.95 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.193 -0.458 . . . . 99.989999999999995 111.349 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.03 -12.84 31.0 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.865 2.377 . . . . 99.989999999999995 111.895 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -58.47 -41.27 84.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.707 -0.679 . . . . 99.989999999999995 111.017 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 74.1 m -105.44 34.88 3.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.97 -0.559 . . . . 99.989999999999995 110.897 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.48 ' HB3' HG11 ' A' ' 224' ' ' VAL . 80.9 m -145.04 164.84 29.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 99.989999999999995 110.866 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -139.2 160.13 40.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.157 -0.474 . . . . 99.989999999999995 110.447 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 17.0 t -109.13 140.69 26.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.092 -0.504 . . . . 99.989999999999995 110.464 -176.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -134.32 142.67 47.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.449 -0.341 . . . . 99.989999999999995 110.09 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.523 ' HD2' HD12 ' A' ' 217' ' ' LEU . 8.0 ptm180 -108.26 117.84 35.21 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.772 -1.196 . . . . 99.989999999999995 107.772 166.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.626 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 13.9 mm -79.92 104.27 7.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.224 0.535 . . . . 99.989999999999995 110.708 -172.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 203' ' ' GLY . 14.0 mm100 -76.82 -147.21 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.16 -0.927 . . . . 99.989999999999995 110.189 173.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -62.41 77.83 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.128 0.49 . . . . 99.989999999999995 111.485 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 64.89 16.69 62.02 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.55 -0.62 . . . . 99.989999999999995 111.55 -176.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 44.1 mt-10 -111.18 133.82 53.25 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.115 0.483 . . . . 99.989999999999995 111.734 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.626 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 39.9 mtpt -84.4 97.48 9.52 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.613 -0.884 . . . . 99.989999999999995 108.613 171.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -94.13 98.97 3.22 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.653 -0.703 . . . . 99.989999999999995 109.684 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.603 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 25.3 Cg_exo -62.67 135.95 55.44 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.566 2.177 . . . . 99.989999999999995 112.848 -174.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 197' ' ' VAL . 22.8 mm -98.02 154.44 3.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.812 -1.085 . . . . 99.989999999999995 109.791 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -88.81 134.04 12.18 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.365 -1.094 . . . . 99.989999999999995 110.365 174.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.492 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 86.9 m95 -64.84 -24.55 67.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.325 0.563 . . . . 99.989999999999995 110.97 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -93.57 14.11 19.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.961 0.41 . . . . 99.989999999999995 111.247 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.466 ' O ' HG11 ' A' ' 177' ' ' VAL . 85.4 m -88.11 145.33 25.99 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.316 -0.624 . . . . 99.989999999999995 109.316 173.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -72.81 134.12 44.78 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.939 -0.393 . . . . 99.989999999999995 109.939 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.531 HG23 ' HB2' ' A' ' 180' ' ' SER . 0.1 OUTLIER -69.97 -16.6 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.97 0.414 . . . . 99.989999999999995 110.961 -175.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.66 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 8.3 m -66.51 -19.62 65.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.281 -0.418 . . . . 99.989999999999995 110.744 176.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.499 ' HB2' HD22 ' A' ' 217' ' ' LEU . 27.8 m0 -75.59 -23.63 56.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.545 0.688 . . . . 99.989999999999995 109.815 176.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.614 HD22 ' N ' ' A' ' 217' ' ' LEU . 1.4 mm? -109.32 23.95 13.77 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.945 -1.025 . . . . 99.989999999999995 109.36 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 51.3 m -54.37 114.22 1.57 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.625 0.726 . . . . 99.989999999999995 111.958 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 84.14 -2.84 87.25 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 114.764 -1.107 . . . . 99.989999999999995 112.946 173.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.39 156.94 36.51 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.073 -0.343 . . . . 99.989999999999995 110.073 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 50.3 mt-10 -89.71 108.38 19.65 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.495 -0.928 . . . . 99.989999999999995 108.495 171.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.617 ' HB2' HG21 ' A' ' 159' ' ' VAL . 82.8 mt -102.47 109.68 21.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.74 0.781 . . . . 99.989999999999995 110.478 -175.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -84.22 122.04 28.31 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.253 -0.885 . . . . 99.989999999999995 110.856 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 3.7 t -99.93 109.95 25.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.27 -0.877 . . . . 99.989999999999995 109.51 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -110.27 145.26 37.7 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.718 -1.128 . . . . 99.989999999999995 109.657 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.58 133.52 31.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.802 -0.444 . . . . 99.989999999999995 109.802 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.434 HD23 ' HB2' ' A' ' 196' ' ' ALA . 55.9 mt -76.56 82.04 3.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.196 0.522 . . . . 99.989999999999995 110.854 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -101.69 93.76 5.5 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.879 -0.785 . . . . 99.989999999999995 108.879 175.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -123.47 23.77 8.84 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.099 -0.955 . . . . 99.989999999999995 110.079 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 115.469 -0.787 . . . . 99.989999999999995 110.22 178.787 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 63.9 Cg_endo . . . . . 0 N--CA 1.464 -0.247 0 CA-C-O 120.742 0.226 . . . . 0.0 112.053 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.78 HD13 HG11 ' A' ' 168' ' ' VAL . 2.0 pp -129.75 167.07 25.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.957 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 46.4 t -127.86 126.24 66.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.298 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 21.2 mtm180 -93.92 91.59 6.98 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.126 0.488 . . . . 0.0 111.941 -170.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 222' ' ' LEU . 2.1 t -93.44 162.23 2.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.609 0.718 . . . . 0.0 111.057 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.49 ' H ' HG12 ' A' ' 159' ' ' VAL . 49.4 m-85 -125.2 107.31 10.62 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.795 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.1 mm? -82.22 167.03 33.27 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 71.7 Cg_exo -48.18 147.49 8.24 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.521 2.814 . . . . 0.0 113.566 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 69.56 34.56 2.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.187 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.489 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 62.12 43.19 8.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.826 176.181 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 78.2 mm-40 -97.17 165.47 12.03 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.653 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 159' ' ' VAL . 37.0 ttp180 -145.95 145.62 30.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.755 HG21 ' HB1' ' A' ' 184' ' ' ALA . 15.2 t -146.06 150.23 35.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.522 177.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.78 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -120.98 127.25 75.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.231 170.092 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.4 p -123.75 133.89 24.93 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.338 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 74.2 Cg_exo -51.49 128.36 25.6 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.383 2.055 . . . . 0.0 111.973 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.39 79.12 0.75 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.535 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.408 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 92.1 mtt180 -68.56 115.74 8.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.726 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 46.8 t -80.44 109.79 15.29 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.68 19.36 7.43 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 -173.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.459 HG12 ' CG2' ' A' ' 214' ' ' ILE . 0.9 OUTLIER -140.48 132.7 31.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.6 p -74.35 153.3 39.35 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.242 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.55 ' HA ' ' OG ' ' A' ' 180' ' ' SER . 4.2 m -58.52 -21.84 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.62 ' HG2' ' HE2' ' A' ' 182' ' ' LYS . 32.0 ttt180 -58.94 -59.05 6.08 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.694 174.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.638 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 25.7 t70 -64.4 -48.6 74.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.209 0.528 . . . . 0.0 111.417 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.55 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 11.3 p -60.24 -56.87 16.27 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.489 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 8.3 mp -74.28 -14.85 60.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.032 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.638 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 5.3 mtmt -59.92 -48.21 82.62 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 187' ' ' MET . 12.0 tppt? -60.13 -49.49 77.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.175 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.755 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -47.11 -53.44 12.85 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.583 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.459 HD21 HG11 ' A' ' 224' ' ' VAL . 1.5 mt -74.19 -43.51 56.95 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.554 0.342 . . . . 0.0 111.507 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.495 ' HB3' ' O ' ' A' ' 182' ' ' LYS . 18.7 tpp -65.59 -33.92 77.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.043 -174.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.498 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 66.8 mtm -74.02 -9.75 58.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.297 0.57 . . . . 0.0 109.971 175.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 167' ' ' THR . 74.7 mtt85 -109.65 1.37 19.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.18 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 78.62 21.85 68.25 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.483 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.2 mp -113.99 172.53 6.93 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 34.6 pt -132.82 132.5 22.56 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.204 0.526 . . . . 0.0 111.527 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.55 ' HG2' ' HG3' ' A' ' 182' ' ' LYS . 23.9 Cg_exo -65.7 -21.15 59.05 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.359 2.706 . . . . 0.0 113.127 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -62.86 -33.38 75.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.776 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 35.4 t -102.68 31.83 3.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.373 0.606 . . . . 0.0 109.89 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.616 ' HB3' HG13 ' A' ' 224' ' ' VAL . 71.2 m -143.17 167.6 21.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.983 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -138.0 155.65 48.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.241 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 223' ' ' HIS . 9.6 t -107.55 136.61 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 123.208 0.318 . . . . 0.0 110.27 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -130.92 151.95 50.77 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.479 ' CG ' ' HB2' ' A' ' 206' ' ' LYS . 1.2 ptm180 . . . . . 0 C--N 1.318 -0.776 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 167.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.479 ' HB2' ' CG ' ' A' ' 199' ' ' ARG . 75.0 mmtt -111.73 98.13 40.07 Favored Pre-proline 0 N--CA 1.444 -0.736 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -65.95 119.15 6.14 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.859 1.706 . . . . 0.0 111.998 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 38.3 mt -96.61 154.22 3.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.615 -177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.0 145.66 20.02 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.529 ' O ' ' HB2' ' A' ' 178' ' ' ARG . 96.2 m95 -68.95 -25.09 64.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.28 0.54 . . . . 0.0 110.496 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -87.97 9.95 20.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.743 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.504 ' O ' HG13 ' A' ' 177' ' ' VAL . 94.9 m -83.57 143.22 30.3 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.445 ' HB3' ' CD1' ' A' ' 216' ' ' TRP . 9.3 t70 -75.27 137.19 41.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.925 0.393 . . . . 0.0 110.094 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.459 ' CG2' HG12 ' A' ' 175' ' ' VAL . 0.2 OUTLIER -78.24 -17.55 13.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.581 -174.398 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 85.9 p -69.78 -14.09 62.6 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 121.961 -0.462 . . . . 0.0 110.442 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.445 ' CD1' ' HB3' ' A' ' 213' ' ' ASP . 27.5 m0 -67.71 -40.64 84.26 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 174.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.41 ' HB3' HD21 ' A' ' 222' ' ' LEU . 0.3 OUTLIER -99.87 31.64 3.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.423 -175.51 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 51.1 m -52.91 113.85 1.23 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.403 0.62 . . . . 0.0 112.343 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 84.06 2.65 89.4 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.973 -1.012 . . . . 0.0 113.658 171.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.54 154.92 19.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.683 0.278 . . . . 0.0 110.392 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 2.1 mp0 -85.97 111.29 20.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 35.9 mt -103.83 164.94 11.35 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 197' ' ' VAL . 85.4 m-70 -129.34 135.6 48.94 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.616 HG13 ' HB3' ' A' ' 195' ' ' CYS . 9.4 t -113.45 109.34 28.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 28.5 mt-10 -110.11 155.21 22.21 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.088 -175.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.99 131.25 34.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.942 -173.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 121.674 0.75 . . . . 0.0 109.179 173.052 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.461 -0.413 0 CA-C-O 121.151 0.396 . . . . 0.0 112.776 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.563 ' O ' ' HA2' ' A' ' 219' ' ' GLY . 1.4 pp -122.12 171.54 10.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.688 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.7 133.13 57.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.598 ' HG2' HG11 ' A' ' 168' ' ' VAL . 20.5 mtm180 -99.17 106.83 19.05 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.145 0.497 . . . . 0.0 111.872 -162.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 222' ' ' LEU . 25.9 t -100.13 145.21 11.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.634 -172.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -109.27 104.7 13.88 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.067 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.627 HD21 HG22 ' A' ' 167' ' ' THR . 1.5 mm? -81.57 172.47 9.62 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -174.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.627 ' HD3' HG12 ' A' ' 224' ' ' VAL . 77.5 Cg_exo -54.47 159.92 7.71 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.614 2.209 . . . . 0.0 112.183 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 66.03 24.5 11.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.002 0.43 . . . . 0.0 110.154 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 56.15 43.98 25.92 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.191 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 28.8 mm-40 -89.65 167.38 12.97 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.412 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -146.39 129.73 16.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.434 0.635 . . . . 0.0 111.42 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.627 HG22 HD21 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -144.5 139.09 28.04 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.013 178.106 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.598 HG11 ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -116.57 129.27 73.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.632 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.31 136.23 19.57 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.805 -173.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.6 130.01 36.65 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.29 1.993 . . . . 0.0 111.294 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.13 91.45 0.22 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.453 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.458 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 92.2 mtt180 -77.08 111.59 12.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.044 -176.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.575 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 3.3 p -72.45 115.46 11.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.5 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 98.86 15.58 33.39 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.948 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.458 ' CG1' ' HB2' ' A' ' 172' ' ' ARG . 0.5 OUTLIER -130.15 148.91 33.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.4 p -83.45 154.39 23.96 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.646 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 212' ' ' THR . 64.1 t -53.81 -30.58 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.559 -0.746 . . . . 0.0 108.992 172.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.584 ' HG3' ' HB3' ' A' ' 210' ' ' TRP . 12.1 ttt180 -53.93 -58.97 5.33 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.66 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.63 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 11.3 t70 -63.26 -47.88 80.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.336 0.588 . . . . 0.0 111.274 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.544 ' OG ' HG21 ' A' ' 214' ' ' ILE . 17.9 m -59.51 -51.59 69.22 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.166 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.483 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.4 OUTLIER -78.36 -19.03 54.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.651 0.263 . . . . 0.0 110.407 -178.208 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.63 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 15.5 mtmt -60.65 -48.51 81.45 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.504 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 2.2 tpmt? -61.45 -41.19 96.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.802 176.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.519 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -53.66 -57.33 11.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.767 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 181' ' ' LEU . 1.4 mt -71.55 -41.34 69.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.483 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 7.0 mmt -66.29 -28.39 68.66 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -176.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 62.4 mtm -79.64 -9.16 59.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.082 0.468 . . . . 0.0 109.96 175.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -109.72 -3.2 16.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.522 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.07 21.21 61.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.209 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.0 mp -115.04 172.11 7.26 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.526 HG13 ' SG ' ' A' ' 194' ' ' CYS . 21.4 pt -128.88 133.1 24.82 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.526 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.544 ' HB3' ' CZ3' ' A' ' 210' ' ' TRP . 14.9 Cg_exo -69.0 -21.03 37.6 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.027 2.485 . . . . 0.0 112.133 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -57.82 -41.73 82.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.736 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' CYS . . . . . 0.526 ' SG ' HG13 ' A' ' 191' ' ' ILE . 20.9 p -96.89 16.81 18.3 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.371 -177.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.481 ' HB3' HG13 ' A' ' 224' ' ' VAL . 85.1 m -126.08 166.83 16.28 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.175 0.512 . . . . 0.0 111.638 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -146.2 159.79 42.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.065 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.678 HG11 HD23 ' A' ' 222' ' ' LEU . 11.7 t -115.11 138.85 44.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.118 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 29.9 m-85 -129.72 146.65 51.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.255 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.53 ' HD2' HD22 ' A' ' 217' ' ' LEU . 7.1 ptm180 . . . . . 0 C--N 1.32 -0.68 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 167.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.455 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 44.6 mtpt . . . . . 0 N--CA 1.445 -0.683 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 75.3 mmtt -101.91 102.74 25.04 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.03 -177.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 8.0 Cg_exo -69.34 119.45 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.101 1.867 . . . . 0.0 111.634 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.452 HD12 HG12 ' A' ' 197' ' ' VAL . 56.9 mt -93.74 155.8 3.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.283 -174.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -92.42 135.09 12.53 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.584 ' HB3' ' HG3' ' A' ' 178' ' ' ARG . 86.5 m95 -64.8 -40.51 95.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.041 0.448 . . . . 0.0 110.667 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.32 6.04 3.99 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 177' ' ' VAL . 97.2 m -81.22 145.26 31.06 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 172.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.24 131.24 44.58 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.544 HG21 ' OG ' ' A' ' 180' ' ' SER . 0.1 OUTLIER -73.74 -15.18 16.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.781 0.324 . . . . 0.0 111.356 -174.714 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.575 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 23.4 m -70.27 -10.51 59.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.052 0.453 . . . . 0.0 110.579 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.6 m0 -74.97 -27.05 60.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.449 0.642 . . . . 0.0 109.399 172.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.756 HD13 HD21 ' A' ' 222' ' ' LEU . 7.1 mt -110.8 19.24 18.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.075 -174.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 215' ' ' SER . 100.0 m -51.15 115.5 1.58 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.687 0.756 . . . . 0.0 112.194 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 85.99 3.77 85.07 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.386 -1.279 . . . . 0.0 113.244 171.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -87.9 158.2 18.76 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -91.61 111.08 22.44 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 173.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.756 HD21 HD13 ' A' ' 217' ' ' LEU . 6.7 mp -98.04 150.21 21.65 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.043 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -120.0 122.02 40.23 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.751 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.627 HG12 ' HD3' ' A' ' 162' ' ' PRO . 4.0 t -100.16 117.05 44.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.083 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -108.55 137.01 47.2 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.657 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.7 p -91.18 128.6 42.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.595 0.712 . . . . 0.0 110.195 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 C--N 1.319 -0.746 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.627 -176.89 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo . . . . . 0 N--CA 1.456 -0.721 0 N-CA-C 111.051 -0.404 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.79 HD13 HG11 ' A' ' 168' ' ' VAL . 2.1 pp -121.06 160.13 22.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.558 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.68 134.67 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.526 ' HG2' HG13 ' A' ' 168' ' ' VAL . 71.5 mtm180 -96.73 101.01 12.53 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -168.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 160' ' ' PHE . 2.8 t -92.97 160.1 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 121.785 0.802 . . . . 0.0 111.801 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.558 ' CZ ' ' HD2' ' A' ' 166' ' ' ARG . 41.0 m-85 -124.76 105.76 9.54 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.131 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.546 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 3.3 mp -85.7 174.61 5.42 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.946 -172.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 87.2 Cg_exo -52.86 160.09 4.42 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.744 2.296 . . . . 0.0 112.835 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 66.7 t30 64.12 31.97 12.99 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.273 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt 56.02 47.79 19.06 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.357 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 99.3 mt-30 -101.81 166.79 10.47 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.255 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.558 ' HD2' ' CZ ' ' A' ' 160' ' ' PHE . 38.4 ttt180 -147.67 144.24 28.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.556 0.217 . . . . 0.0 110.859 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.453 HG22 HD11 ' A' ' 161' ' ' LEU . 1.4 t -155.27 152.68 29.54 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.79 HG11 HD13 ' A' ' 156' ' ' ILE . 0.2 OUTLIER -114.2 128.84 71.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.255 178.351 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.9 p -116.5 137.03 23.27 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.562 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.71 135.44 60.2 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.175 1.916 . . . . 0.0 111.685 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.76 78.34 1.12 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.104 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -69.54 111.92 5.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.593 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.67 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 8.5 p -76.93 110.09 11.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.992 0.425 . . . . 0.0 109.872 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 109.07 9.17 26.49 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.574 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.84 137.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.5 p -79.4 154.47 28.96 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.96 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 212' ' ' THR . 81.4 t -47.07 -40.95 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.477 0.486 . . . . 0.0 109.696 175.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.607 ' CG ' ' HB3' ' A' ' 210' ' ' TRP . 92.9 mtt-85 -48.45 -52.57 21.55 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.483 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.593 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 14.7 t70 -73.98 -45.48 49.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.138 0.494 . . . . 0.0 111.339 -172.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.423 ' CB ' HG21 ' A' ' 214' ' ' ILE . 0.3 OUTLIER -67.54 -42.87 82.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.896 -177.769 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.3 OUTLIER -76.68 -21.17 55.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.145 177.248 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.644 ' O ' ' HB2' ' A' ' 186' ' ' MET . 4.4 ttmt -59.23 -48.23 82.4 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.1 tpmt? -60.56 -46.2 91.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.791 175.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.452 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -51.75 -55.94 16.73 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.984 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 181' ' ' LEU . 1.7 mt -72.58 -43.16 63.77 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.734 0.413 . . . . 0.0 111.769 -178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.644 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 3.3 mmt -66.02 -26.52 67.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -176.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.502 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 64.6 mtm -77.38 -20.35 54.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.359 0.599 . . . . 0.0 109.724 173.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -106.6 17.59 23.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.592 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 62.75 35.43 91.92 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.276 -0.487 . . . . 0.0 112.676 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.446 HD13 ' HD2' ' A' ' 162' ' ' PRO . 21.1 mt -128.41 169.37 14.36 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.531 0.333 . . . . 0.0 110.171 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 45.8 pt -131.89 135.24 26.35 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.057 0.456 . . . . 0.0 111.534 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.476 ' HG2' ' HG3' ' A' ' 182' ' ' LYS . 19.6 Cg_exo -66.77 -22.2 50.07 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.102 2.535 . . . . 0.0 112.645 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.89 -19.98 62.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.478 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 12.2 t -112.13 25.94 11.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.518 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 74.2 m -140.78 166.74 23.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.096 -175.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -146.66 154.41 41.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.121 175.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.08 130.62 61.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.597 0.237 . . . . 0.0 110.776 -176.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 35.6 m-85 -131.28 152.9 50.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.759 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.79 ' HG3' HD11 ' A' ' 208' ' ' ILE . 67.2 mtp180 . . . . . 0 C--N 1.327 -0.386 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 168.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 39.1 mtpt . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 74.1 mmtt -101.7 100.5 14.53 Favored Pre-proline 0 N--CA 1.444 -0.741 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 4.0 Cg_exo -71.26 126.76 12.63 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.868 1.712 . . . . 0.0 111.316 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.79 HD11 ' HG3' ' A' ' 199' ' ' ARG . 4.7 mt -107.77 149.66 10.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.77 -173.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.7 136.01 14.15 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.607 ' HB3' ' CG ' ' A' ' 178' ' ' ARG . 91.1 m95 -65.08 -27.8 69.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.698 0.285 . . . . 0.0 110.917 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.404 ' CG ' ' HE ' ' A' ' 178' ' ' ARG . 11.0 m-20 -90.73 12.76 18.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.823 0.344 . . . . 0.0 111.242 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 177' ' ' VAL . 48.1 m -85.84 154.15 21.75 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -78.48 132.18 37.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.423 HG21 ' CB ' ' A' ' 180' ' ' SER . 0.3 OUTLIER -70.32 -11.94 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.987 0.422 . . . . 0.0 110.997 -178.029 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.67 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 16.4 m -66.38 -18.26 65.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.98 0.419 . . . . 0.0 110.359 173.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -78.66 -14.79 59.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.455 0.645 . . . . 0.0 109.888 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.624 HD11 HG21 ' A' ' 208' ' ' ILE . 17.8 mt -113.34 17.4 18.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.797 -177.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 91.2 m -53.64 117.59 3.25 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.775 0.798 . . . . 0.0 112.395 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 74.07 8.14 78.03 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.118 173.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -84.49 148.72 26.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 3.2 mp0 -85.26 109.47 18.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 171.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 86.2 mt -98.61 149.93 22.27 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.994 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -124.05 122.58 38.26 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 38.7 t -100.07 143.95 13.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.042 0.449 . . . . 0.0 110.167 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 8.6 mm-40 -120.91 151.39 39.74 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.236 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 162' ' ' PRO . 1.2 t -89.89 116.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 34.3 mt . . . . . 0 C--N 1.323 -0.549 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.976 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.496 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 23.8 Cg_exo . . . . . 0 N--CA 1.461 -0.391 0 N-CA-C 110.446 -0.636 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.817 HD13 HG11 ' A' ' 168' ' ' VAL . 2.2 pp -131.29 156.61 42.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.166 0.508 . . . . 0.0 111.417 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.511 HG22 ' H ' ' A' ' 219' ' ' GLY . 41.0 t -124.11 123.75 67.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.756 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.499 ' HA ' HG13 ' A' ' 168' ' ' VAL . 23.6 mtm180 -88.47 96.54 10.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.49 0.662 . . . . 0.0 111.723 -169.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.635 HG22 ' HB2' ' A' ' 222' ' ' LEU . 3.8 t -96.03 129.98 45.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.059 -176.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.573 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 42.4 m-85 -94.29 103.51 15.53 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.871 174.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.604 HD22 ' HD2' ' A' ' 188' ' ' ARG . 2.9 mp -82.59 176.67 3.6 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 80.2 Cg_exo -50.17 153.73 6.44 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.711 2.274 . . . . 0.0 112.736 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 65.96 27.26 10.83 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.661 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 54.07 36.77 25.46 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.745 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 26.9 mm-40 -75.58 170.24 16.53 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 17.8 ttp180 -148.59 137.46 21.55 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.151 173.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.12 154.39 41.76 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.817 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -113.73 127.36 71.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.312 178.423 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.5 m -104.88 138.74 19.59 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.053 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 13.0 Cg_exo -65.55 125.14 13.88 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.265 1.31 . . . . 0.0 110.925 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.12 86.08 0.55 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.044 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.464 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 97.2 mtt180 -78.98 112.04 15.77 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.11 -174.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.618 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 4.1 p -67.53 110.02 3.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.831 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 106.78 8.16 32.63 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.296 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 172' ' ' ARG . 0.3 OUTLIER -117.16 149.87 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.045 0.45 . . . . 0.0 109.866 176.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.48 ' HB ' ' HG2' ' A' ' 178' ' ' ARG . 1.7 p -86.1 152.3 22.98 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.368 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 212' ' ' THR . 92.8 t -49.07 -41.61 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 O-C-N 123.452 0.47 . . . . 0.0 110.326 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.48 ' HG2' ' HB ' ' A' ' 176' ' ' THR . 30.9 ptt180 -51.24 -47.45 62.38 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.094 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.587 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 11.8 t70 -68.08 -49.79 59.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.121 0.486 . . . . 0.0 110.967 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.8 t -67.04 -43.99 81.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.464 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.643 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.3 OUTLIER -73.42 -27.33 61.38 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.206 179.406 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 13.0 mtmt -55.29 -45.62 76.22 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.476 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 1.8 tpmt? -60.01 -42.6 94.64 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 181' ' ' LEU . . . -55.12 -60.89 2.76 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.938 178.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 181' ' ' LEU . 1.6 mm? -60.29 -52.01 67.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.005 0.522 . . . . 0.0 110.904 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 12.2 mmt -57.96 -42.69 85.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.53 -174.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.45 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 57.6 mtm -71.04 -8.42 53.24 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.045 0.45 . . . . 0.0 110.533 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.604 ' HD2' HD22 ' A' ' 161' ' ' LEU . 51.2 mtt-85 -113.77 5.07 16.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.571 -177.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 73.38 21.74 79.32 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.325 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.611 ' HB3' HD12 ' A' ' 185' ' ' LEU . 0.2 OUTLIER -110.61 173.11 6.48 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -177.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 32.3 pt -132.15 127.34 20.93 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.176 0.512 . . . . 0.0 111.873 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.534 ' HB3' ' CZ3' ' A' ' 210' ' ' TRP . 22.5 Cg_exo -65.54 -21.48 59.82 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.307 2.672 . . . . 0.0 112.331 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.25 -45.4 93.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.923 -174.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 23.8 t -98.11 37.53 1.42 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.282 0.563 . . . . 0.0 109.967 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.707 ' HB3' HG13 ' A' ' 224' ' ' VAL . 71.8 m -138.7 158.56 44.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.78 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -131.66 150.43 52.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.014 175.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.425 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 4.1 t -104.59 131.67 53.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 123.239 0.337 . . . . 0.0 110.508 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -126.56 141.99 51.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.774 0.321 . . . . 0.0 110.807 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.444 ' HD3' HD22 ' A' ' 217' ' ' LEU . 19.3 ptt180 . . . . . 0 C--N 1.316 -0.881 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 165.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.514 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 45.5 mtpt . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 206' ' ' LYS . 11.7 tppt? -98.26 102.67 14.79 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.129 -174.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 10.6 Cg_exo -70.6 127.9 14.54 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.32 2.013 . . . . 0.0 112.413 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 217' ' ' LEU . 35.1 mt -103.22 161.9 4.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.233 -1.348 . . . . 0.0 109.963 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.48 147.45 18.6 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.676 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.534 ' CZ3' ' HB3' ' A' ' 192' ' ' PRO . 92.1 m95 -74.72 -18.5 60.5 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -87.63 -4.21 58.95 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.343 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 177' ' ' VAL . 89.9 m -70.19 147.89 49.29 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -76.61 129.18 36.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.432 HG13 HG21 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -68.9 -16.49 20.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.914 0.388 . . . . 0.0 111.056 -175.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.618 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 13.9 m -67.47 -21.03 65.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.848 0.356 . . . . 0.0 110.751 177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 24.1 m0 -74.93 -17.53 60.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.324 0.583 . . . . 0.0 109.583 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.469 HD11 HG21 ' A' ' 208' ' ' ILE . 6.0 mt -116.95 17.99 14.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.444 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 82.1 m -49.88 113.1 0.77 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.399 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.511 ' H ' HG22 ' A' ' 157' ' ' VAL . . . 86.5 6.28 80.9 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.041 -0.982 . . . . 0.0 113.41 170.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -90.46 158.48 17.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.806 0.336 . . . . 0.0 110.253 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 3.2 mp0 -90.1 111.15 22.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.635 ' HB2' HG22 ' A' ' 159' ' ' VAL . 58.5 mt -107.36 133.87 51.26 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.85 0.357 . . . . 0.0 110.802 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -102.16 123.24 45.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.489 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.707 HG13 ' HB3' ' A' ' 195' ' ' CYS . 39.4 t -105.95 112.18 38.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.321 0.582 . . . . 0.0 109.895 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 25.1 mt-10 -109.62 145.27 36.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.606 -173.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 66.7 t -77.87 129.76 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.949 0.404 . . . . 0.0 111.025 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.655 177.621 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 N--CA 1.45 -1.073 0 N-CA-C 110.728 -0.528 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.765 HD13 HG11 ' A' ' 168' ' ' VAL . 2.0 pp -130.7 161.07 41.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.896 -0.138 . . . . 0.0 111.116 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.37 134.63 62.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.612 ' HG2' HG13 ' A' ' 168' ' ' VAL . 85.3 mtm180 -94.61 103.27 15.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.049 0.452 . . . . 0.0 112.093 -168.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.4 t -96.76 136.93 25.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.837 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 53.5 m-85 -94.64 104.0 15.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.63 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.648 HD22 ' H ' ' A' ' 161' ' ' LEU . 0.7 OUTLIER -81.34 170.56 14.89 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.295 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.666 ' HD3' HG12 ' A' ' 224' ' ' VAL . 53.1 Cg_exo -56.72 156.91 21.06 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.749 2.3 . . . . 0.0 112.491 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 66.5 t30 67.21 37.26 3.73 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.336 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt 55.13 48.92 18.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.585 177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.56 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 27.9 mm-40 -104.29 160.89 14.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.104 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 28.5 ttp180 -147.05 138.99 24.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.898 0.38 . . . . 0.0 110.687 173.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.501 HG22 HD21 ' A' ' 161' ' ' LEU . 4.8 t -141.47 157.15 45.51 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.765 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -119.83 127.74 75.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.326 175.36 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.4 p -115.56 134.62 22.62 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.277 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.9 132.25 48.61 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.23 1.953 . . . . 0.0 111.454 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.9 75.96 0.89 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.691 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -64.74 111.81 2.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.922 -176.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 48.2 m -76.44 110.02 10.63 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 110.47 11.56 19.34 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.317 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.403 ' CG1' ' HB3' ' A' ' 180' ' ' SER . 1.1 t -133.05 138.01 52.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 21.3 p -81.93 160.2 23.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.233 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.616 HG13 HD13 ' A' ' 181' ' ' LEU . 86.7 t -52.52 -30.6 14.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.659 171.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.554 ' CG ' ' HB3' ' A' ' 210' ' ' TRP . 72.6 mtp180 -53.74 -58.38 7.44 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.283 174.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.607 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 14.5 t70 -74.52 -43.49 55.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.11 0.481 . . . . 0.0 111.096 -174.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.521 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 28.1 p -60.76 -57.68 11.67 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.28 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.616 HD13 HG13 ' A' ' 177' ' ' VAL . 9.6 mp -77.08 -11.69 59.84 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 122.102 -0.374 . . . . 0.0 111.154 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.607 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 4.7 ttmt -58.19 -46.31 86.03 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 171.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.465 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 2.4 tpmt? -59.57 -44.47 93.3 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.792 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.435 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -50.99 -54.93 20.09 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.465 HD23 ' HB3' ' A' ' 190' ' ' LEU . 5.3 mp -78.22 -38.46 43.02 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 14.7 mmt -63.48 -28.48 69.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.557 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 64.8 mtm -77.87 -7.33 56.56 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.355 0.598 . . . . 0.0 109.961 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.471 ' CZ ' ' HB ' ' A' ' 167' ' ' THR . 55.8 mtt85 -113.06 0.7 15.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.479 -178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 73.66 25.36 72.4 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.021 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.465 ' HB3' HD23 ' A' ' 185' ' ' LEU . 10.1 mp -115.59 152.61 32.75 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.475 ' O ' HD12 ' A' ' 191' ' ' ILE . 2.4 pp -108.2 128.67 25.27 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-O 121.067 0.46 . . . . 0.0 110.898 176.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 16.6 Cg_exo -68.14 -6.76 18.05 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.854 2.369 . . . . 0.0 112.362 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -75.26 -11.22 60.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.166 -175.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 27.7 t -126.27 34.65 4.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.538 ' HB3' HG13 ' A' ' 224' ' ' VAL . 77.3 m -144.47 158.82 43.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.188 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -136.29 159.26 42.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.704 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.537 HG11 HD23 ' A' ' 222' ' ' LEU . 23.8 t -114.06 138.29 44.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.392 -174.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -129.92 160.75 32.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.201 173.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.609 ' HD2' HD12 ' A' ' 217' ' ' LEU . 3.8 ptm180 . . . . . 0 C--N 1.316 -0.863 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 164.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.648 0.261 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -110.25 102.04 49.93 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.83 127.85 24.83 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.335 2.023 . . . . 0.0 112.046 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.513 ' HB ' ' HB ' ' A' ' 197' ' ' VAL . 26.5 mm -91.25 159.18 2.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.582 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.71 131.55 10.63 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.554 ' HB3' ' CG ' ' A' ' 178' ' ' ARG . 85.2 m95 -61.49 -33.8 74.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.249 0.525 . . . . 0.0 111.01 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -86.57 7.37 26.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.852 0.358 . . . . 0.0 111.176 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 177' ' ' VAL . 89.2 m -82.32 143.1 31.51 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.08 129.87 41.22 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.442 HG21 ' HB3' ' A' ' 180' ' ' SER . 0.4 OUTLIER -66.69 -17.24 22.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.753 -175.455 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 23.2 t -68.19 -14.0 62.66 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.059 -0.401 . . . . 0.0 110.331 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.521 ' HB2' HD22 ' A' ' 217' ' ' LEU . 20.6 m0 -76.2 -19.48 58.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.504 0.669 . . . . 0.0 110.0 175.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.609 HD12 ' HD2' ' A' ' 199' ' ' ARG . 1.5 mm? -115.65 20.77 14.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.333 -174.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.2 m -53.69 119.94 5.58 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.35 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 76.67 8.51 86.25 Favored Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 114.258 -1.337 . . . . 0.0 113.678 170.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -87.56 159.89 18.42 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 50.3 mt-10 -92.59 110.19 21.61 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 171.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.537 HD23 HG11 ' A' ' 197' ' ' VAL . 7.7 mp -96.22 161.67 13.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.994 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 197' ' ' VAL . 47.9 m-70 -125.96 122.48 36.07 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.068 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.666 HG12 ' HD3' ' A' ' 162' ' ' PRO . 2.7 t -100.72 114.17 38.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 174.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -108.29 127.81 54.19 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.919 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.75 129.27 37.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.089 0.471 . . . . 0.0 110.035 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.318 -176.644 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 38.7 Cg_exo . . . . . 0 N--CA 1.47 0.138 0 N-CA-C 112.881 0.3 . . . . 0.0 112.881 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.79 HD13 HG11 ' A' ' 168' ' ' VAL . 2.1 pp -132.32 163.59 37.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.846 -177.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 39.7 t -128.44 121.09 54.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.258 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.578 ' HG2' HG13 ' A' ' 168' ' ' VAL . 76.2 mtp180 -86.98 93.95 9.48 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.217 0.532 . . . . 0.0 111.374 -172.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.0 t -94.8 135.18 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.679 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.676 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 41.5 m-85 -90.18 103.6 16.26 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.92 175.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.613 HD22 ' H ' ' A' ' 161' ' ' LEU . 1.5 mm? -77.18 174.21 6.24 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 84.1 Cg_exo -50.88 154.98 6.27 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.679 2.253 . . . . 0.0 112.49 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.3 m120 67.09 15.2 10.05 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.968 -173.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 58.69 49.97 9.5 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.016 -177.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.676 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 22.2 mm-40 -86.77 178.77 6.91 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.678 172.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.6 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 7.5 mtm180 -147.4 141.45 26.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 118.548 0.613 . . . . 0.0 112.146 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.575 HG22 HD21 ' A' ' 161' ' ' LEU . 4.0 t -145.47 150.11 35.89 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 173.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.79 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -113.1 126.81 70.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.02 178.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 24.3 t -108.57 131.09 21.99 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.311 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 34.4 Cg_exo -56.73 118.41 5.25 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.409 1.406 . . . . 0.0 110.293 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.75 116.06 4.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.174 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 170' ' ' PRO . 98.1 mtt180 -104.39 112.3 25.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.643 -172.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 49.5 t -77.76 113.06 15.26 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 112.32 -12.7 26.06 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.407 -177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 176' ' ' THR . 1.2 t -107.49 144.59 16.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 40.1 p -85.89 160.67 19.35 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.104 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.61 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 15.4 m -57.15 -22.01 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' A' ' 210' ' ' TRP . 92.2 mtt-85 -52.67 -58.15 7.76 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.111 172.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.614 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 23.2 t70 -75.54 -41.98 53.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.461 0.648 . . . . 0.0 111.1 -172.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.575 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 10.8 p -64.2 -52.8 57.11 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.081 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 185' ' ' LEU . 2.5 mt -76.43 -15.88 59.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.184 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.614 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 5.2 ttmt -59.69 -47.8 84.21 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 173.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 2.2 tpmt? -58.89 -41.86 88.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.76 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.476 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -51.63 -63.92 0.98 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.997 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 181' ' ' LEU . 3.9 mp -69.82 -41.26 75.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.547 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 10.4 mmt -62.79 -31.16 72.08 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 62.0 mtm -74.4 -26.76 60.3 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.387 0.613 . . . . 0.0 109.635 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -82.73 -20.32 36.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.344 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.57 25.14 21.78 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.3 mp -118.39 171.0 8.45 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.704 0.402 . . . . 0.0 110.561 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 42.6 pt -119.47 132.4 24.02 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.871 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 3.7 Cg_exo -76.87 -12.04 18.04 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.95 2.433 . . . . 0.0 112.256 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -62.58 -40.11 95.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.464 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 12.5 t -99.16 34.13 2.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.35 0.595 . . . . 0.0 110.303 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.55 ' HB3' HG13 ' A' ' 224' ' ' VAL . 81.6 m -142.43 166.78 23.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.735 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.647 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -138.91 160.81 38.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.558 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.76 128.03 69.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.212 0.32 . . . . 0.0 110.335 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 33.6 m-85 -123.61 145.22 49.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.571 0.224 . . . . 0.0 110.398 174.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 206' ' ' LYS . 1.6 ptm180 . . . . . 0 C--N 1.317 -0.834 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 168.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 120.719 0.295 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 199' ' ' ARG . 5.3 mptp? -106.34 106.52 57.61 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.586 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -70.29 118.64 5.8 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.704 1.602 . . . . 0.0 111.662 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 56.2 mt -95.95 154.01 3.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.07 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.05 142.31 22.25 Favored Glycine 0 N--CA 1.438 -1.186 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.661 ' O ' ' HG3' ' A' ' 178' ' ' ARG . 81.9 m95 -66.3 -23.52 66.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 117.47 0.635 . . . . 0.0 110.532 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.48 19.88 9.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.044 0.45 . . . . 0.0 110.952 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 69.5 m -86.64 140.19 30.06 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.806 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.405 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 15.8 t70 -68.86 121.2 16.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.616 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.445 HG21 ' CB ' ' A' ' 180' ' ' SER . 0.5 OUTLIER -66.84 -22.38 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.744 -176.821 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.405 ' HB3' ' OD1' ' A' ' 213' ' ' ASP . 9.4 t -74.81 -8.78 57.46 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.375 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -69.75 -38.69 76.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.683 0.754 . . . . 0.0 108.997 169.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.45 ' HB3' HD21 ' A' ' 222' ' ' LEU . 0.3 OUTLIER -97.26 26.32 4.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.087 -175.466 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 52.2 m -50.24 114.33 1.09 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.566 0.698 . . . . 0.0 112.307 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 86.59 -8.41 75.24 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.495 171.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -74.6 156.44 36.76 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 52.7 mt-10 -87.7 109.85 20.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 70.1 mt -96.51 152.56 18.51 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -118.85 120.35 37.06 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.096 -175.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 2.6 t -100.1 111.83 30.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 121.568 0.699 . . . . 0.0 109.307 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -108.91 145.7 34.98 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.695 -173.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.14 128.75 38.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.922 -175.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 C--N 1.325 -0.462 0 CA-C-O 121.228 0.537 . . . . 0.0 109.99 175.715 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.405 ' HB2' HG23 ' A' ' 218' ' ' THR . 23.5 Cg_exo . . . . . 0 N--CA 1.465 -0.196 0 N-CA-C 111.594 -0.194 . . . . 0.0 111.594 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.476 ' CG2' HG23 ' A' ' 168' ' ' VAL . 1.5 pp -121.88 169.8 12.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.164 0.507 . . . . 0.0 111.978 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.512 HG21 HG13 ' A' ' 214' ' ' ILE . 5.4 t -130.88 115.46 30.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.536 ' HG2' HG11 ' A' ' 168' ' ' VAL . 20.2 mtm180 -92.12 98.08 11.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.223 0.535 . . . . 0.0 111.632 -166.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.2 t -91.29 141.51 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.669 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -103.42 103.96 13.99 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.524 172.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.6 HD13 ' HD2' ' A' ' 188' ' ' ARG . 7.3 mt -83.03 169.8 16.53 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.18 -172.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 88.2 Cg_exo -50.67 149.52 13.73 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.1 2.533 . . . . 0.0 112.503 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 69.0 30.11 4.59 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.538 -176.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 51.9 47.52 24.61 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.601 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.491 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 15.0 mm100 -95.99 170.67 9.13 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 7.9 ttt180 -148.65 135.75 20.1 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.84 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.464 ' CG2' HD11 ' A' ' 161' ' ' LEU . 1.4 t -151.6 141.77 22.28 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.536 HG11 ' HG2' ' A' ' 158' ' ' ARG . 0.7 OUTLIER -117.26 130.07 72.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 C-N-CA 119.451 -0.899 . . . . 0.0 110.307 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.4 p -109.53 136.12 20.28 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.514 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.41 128.61 30.81 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.233 1.955 . . . . 0.0 111.167 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.16 89.49 0.45 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.81 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.483 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 64.3 mtt180 -77.27 113.96 15.58 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.989 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.5 t -70.12 115.23 9.09 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.03 -3.57 35.58 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.457 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.483 ' CG1' ' HB2' ' A' ' 172' ' ' ARG . 0.4 OUTLIER -108.42 150.22 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.041 0.448 . . . . 0.0 109.944 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.8 p -87.93 152.13 22.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.231 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 212' ' ' THR . 86.6 t -46.53 -42.68 5.46 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 O-C-N 123.512 0.507 . . . . 0.0 110.46 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 11.0 ptm180 -49.78 -48.65 50.37 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.35 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.586 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 16.2 t70 -70.21 -47.55 60.98 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.346 0.594 . . . . 0.0 111.039 -176.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.59 -45.89 77.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.254 -175.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -28.49 62.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.325 176.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 8.6 mtmt -54.04 -49.94 67.81 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.567 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.3 tpmt? -56.81 -47.37 80.39 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 175.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.446 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -51.36 -60.63 2.91 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.242 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 5.5 mp -68.0 -48.32 66.09 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 122.619 0.368 . . . . 0.0 111.557 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 1.0 OUTLIER -59.51 -34.3 72.44 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.882 -176.407 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.567 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 67.4 mtm -71.03 -31.37 67.83 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.23 0.538 . . . . 0.0 109.691 175.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.6 ' HD2' HD13 ' A' ' 161' ' ' LEU . 9.1 mtt180 -86.2 -4.68 59.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.813 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.37 25.92 49.38 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.093 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.1 mp -116.0 161.59 18.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 29.4 pt -120.65 128.74 25.64 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.142 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 23.4 Cg_exo -66.02 -14.66 45.47 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 123.002 2.468 . . . . 0.0 112.28 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -60.19 -42.44 95.09 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.497 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.5 t -104.23 28.84 6.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.392 0.615 . . . . 0.0 110.028 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.56 ' HB3' HG13 ' A' ' 224' ' ' VAL . 84.0 m -139.87 165.8 26.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.443 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -149.53 164.57 34.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.245 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.577 HG11 HD23 ' A' ' 222' ' ' LEU . 14.7 t -111.1 133.13 57.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.33 -174.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -126.87 143.94 51.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.193 172.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.458 ' HD2' HD22 ' A' ' 217' ' ' LEU . 7.7 ptm180 . . . . . 0 C--N 1.314 -0.956 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 168.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -109.79 104.84 56.33 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.771 -175.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.37 124.84 10.74 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.104 1.869 . . . . 0.0 112.17 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.487 HD12 HG12 ' A' ' 197' ' ' VAL . 46.9 mt -100.01 153.81 4.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.919 -176.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.85 138.85 15.87 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -67.4 -20.82 65.59 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.103 0.451 . . . . 0.0 110.154 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -92.62 6.89 45.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.914 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.623 ' O ' HG23 ' A' ' 177' ' ' VAL . 96.5 m -78.62 147.15 33.75 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 172.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 215' ' ' SER . 12.5 t70 -74.55 130.05 38.87 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.512 HG13 HG21 ' A' ' 157' ' ' VAL . 0.2 OUTLIER -72.56 -15.1 17.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 111.458 -174.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.431 ' HB2' ' OD1' ' A' ' 213' ' ' ASP . 70.8 m -75.01 -8.87 57.75 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.899 -0.5 . . . . 0.0 110.587 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 30.1 m0 -82.36 -11.46 58.56 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 172.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.623 HD13 HD21 ' A' ' 222' ' ' LEU . 5.6 mt -118.46 19.26 13.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.022 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.405 HG23 ' HB2' ' A' ' 155' ' ' PRO . 99.5 m -52.27 117.25 2.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.534 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 86.3 -4.13 86.37 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.266 170.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -75.84 157.88 32.81 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 28.4 mt-10 -98.05 111.62 23.87 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.623 HD21 HD13 ' A' ' 217' ' ' LEU . 6.4 mp -95.45 164.93 12.6 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.191 -175.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -133.97 130.09 37.15 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 40.9 t -100.86 123.83 54.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.106 0.479 . . . . 0.0 109.768 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 5.9 mm-40 -107.8 146.23 32.5 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.682 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 85.7 t -84.47 122.68 38.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.93 0.395 . . . . 0.0 110.075 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 64.6 mt . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.352 -179.086 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.491 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 41.5 Cg_endo . . . . . 0 N--CA 1.463 -0.306 0 CA-C-O 121.029 0.345 . . . . 0.0 112.719 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.757 HD13 HG11 ' A' ' 168' ' ' VAL . 1.9 pp -132.83 152.69 36.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.464 -177.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.494 HG13 HG23 ' A' ' 169' ' ' VAL . 0.5 OUTLIER -124.32 134.59 66.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.398 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.546 ' HG2' HG13 ' A' ' 168' ' ' VAL . 1.3 mtp180 -94.2 97.61 10.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.288 -165.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.0 t -97.64 134.44 35.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.146 -175.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 2.3 m-85 -92.3 103.67 16.1 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.391 175.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.667 HD22 ' H ' ' A' ' 161' ' ' LEU . 1.1 mm? -78.03 169.62 20.09 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.594 ' HD3' HG12 ' A' ' 224' ' ' VAL . 78.5 Cg_exo -52.78 152.98 15.81 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.71 2.273 . . . . 0.0 113.228 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.2 t30 65.2 41.11 4.61 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.746 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 59.88 31.01 20.52 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.219 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 26.6 mm-40 -85.3 161.42 19.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 26.8 ttp180 -149.25 134.94 18.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.525 HG22 HD21 ' A' ' 161' ' ' LEU . 1.1 t -145.63 151.64 38.39 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.757 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -108.05 129.31 62.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.232 178.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.494 HG23 HG13 ' A' ' 157' ' ' VAL . 14.7 m -105.45 130.99 22.15 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.257 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 27.7 Cg_endo -64.38 121.09 8.59 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.821 1.681 . . . . 0.0 111.182 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.491 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -69.92 95.16 0.9 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.262 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -93.25 112.19 24.05 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.4 -173.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.473 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 49.0 t -70.11 113.39 7.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.51 0.01 27.78 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.742 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 179' ' ' ASP . 0.3 OUTLIER -116.2 152.05 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.125 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 24.3 p -89.01 159.8 17.41 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.699 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 212' ' ' THR . 87.4 t -50.5 -38.21 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.574 ' CG ' ' HB3' ' A' ' 210' ' ' TRP . 26.6 mtp180 -45.63 -58.81 3.13 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.563 175.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.656 ' HA ' ' CE ' ' A' ' 182' ' ' LYS . 32.3 m-20 -67.07 -45.53 77.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.922 0.392 . . . . 0.0 111.913 -170.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.7 t -71.38 -38.62 71.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.15 0.5 . . . . 0.0 110.478 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.444 HD22 HG11 ' A' ' 169' ' ' VAL . 0.4 OUTLIER -75.93 -27.7 57.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.455 177.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.656 ' CE ' ' HA ' ' A' ' 179' ' ' ASP . 37.1 mtmt -55.22 -52.42 63.43 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.508 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 2.2 tpmt? -61.86 -40.46 95.42 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.316 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.484 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -55.53 -55.85 27.11 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.751 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.496 HD21 HG11 ' A' ' 224' ' ' VAL . 2.0 mt -70.11 -46.37 64.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.318 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 12.9 mmt -59.97 -36.67 77.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.961 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 58.2 mtm -76.35 -12.91 60.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.062 0.458 . . . . 0.0 110.251 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -110.33 17.8 20.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.527 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 62.63 36.94 93.95 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.198 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.481 HD13 ' HD2' ' A' ' 162' ' ' PRO . 24.2 mt -128.36 166.91 17.76 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.494 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 37.4 pt -130.64 130.64 22.96 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.053 0.454 . . . . 0.0 111.85 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 16.2 Cg_exo -68.76 -16.13 41.47 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.088 2.525 . . . . 0.0 112.341 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -65.34 -37.52 87.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.071 -177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 16.9 t -109.78 37.0 2.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.415 0.626 . . . . 0.0 109.992 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.588 ' HB3' HG13 ' A' ' 224' ' ' VAL . 99.1 m -146.73 162.36 38.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.672 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -142.16 157.29 45.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.78 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 10.9 t -107.13 123.73 62.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.584 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 47.8 m-85 -116.14 153.8 31.13 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 173.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.503 ' HB3' ' CD2' ' A' ' 222' ' ' LEU . 12.2 ptt180 . . . . . 0 C--N 1.315 -0.928 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 167.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt . . . . . 0 N--CA 1.446 -0.632 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 74.9 mmtt -98.4 107.14 40.34 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.156 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -74.51 118.92 5.52 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.943 1.762 . . . . 0.0 111.467 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.659 HG21 HD11 ' A' ' 217' ' ' LEU . 22.0 mt -93.83 152.75 3.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.088 -174.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -85.49 139.95 17.76 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.574 ' HB3' ' CG ' ' A' ' 178' ' ' ARG . 88.4 m95 -70.41 -34.99 73.17 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.645 0.26 . . . . 0.0 111.164 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.48 5.5 23.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.119 0.485 . . . . 0.0 111.238 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.548 ' O ' HG23 ' A' ' 177' ' ' VAL . 95.6 m -74.8 148.37 40.39 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 170.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -73.49 134.38 43.86 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 171' ' ' ALA . 0.1 OUTLIER -69.94 -16.36 20.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.958 0.408 . . . . 0.0 110.653 -178.396 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 18.7 m -65.49 -15.88 63.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.994 0.426 . . . . 0.0 110.73 176.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 32.9 m0 -80.54 -17.64 50.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.22 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.659 HD11 HG21 ' A' ' 208' ' ' ILE . 10.4 mt -112.81 19.87 16.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.724 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 99.7 m -52.1 112.86 0.87 Allowed 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.413 -177.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 80.07 8.93 87.2 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.427 171.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -85.17 151.32 24.19 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 36.5 mt-10 -86.99 111.14 20.56 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.503 ' CD2' ' HB3' ' A' ' 199' ' ' ARG . 61.0 mt -105.56 159.63 15.8 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.214 -175.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -125.99 122.44 35.9 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.833 0.349 . . . . 0.0 110.27 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.594 HG12 ' HD3' ' A' ' 162' ' ' PRO . 4.5 t -101.05 115.54 42.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.566 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 24.6 mt-10 -112.35 141.9 45.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.78 -175.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.84 127.62 34.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.831 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 C--N 1.321 -0.632 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 176.671 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.456 -0.711 0 N-CA-C 111.241 -0.33 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.709 HD13 HG11 ' A' ' 168' ' ' VAL . 1.8 pp -126.09 156.36 36.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.493 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -125.23 134.23 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.533 ' HG2' HG13 ' A' ' 168' ' ' VAL . 81.7 mtm180 -95.41 105.46 17.43 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -167.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.8 t -96.87 135.45 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.807 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 64.9 m-85 -97.4 103.12 15.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.788 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.611 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.1 mt -84.52 173.84 6.66 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.098 -170.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.611 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 99.1 Cg_exo -48.66 153.47 3.49 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.128 2.552 . . . . 0.0 113.236 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 63.16 24.46 14.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.492 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 61.18 44.05 10.37 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.088 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 15.2 mm100 -90.8 177.93 6.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.781 177.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 38.7 ttp180 -147.36 153.44 39.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.548 0.214 . . . . 0.0 110.545 176.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.479 HG21 ' HB1' ' A' ' 184' ' ' ALA . 1.4 t -163.31 151.79 13.95 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 170.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.709 HG11 HD13 ' A' ' 156' ' ' ILE . 0.1 OUTLIER -115.06 128.29 72.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.298 177.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.7 p -115.83 133.29 22.86 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.412 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.41 131.55 43.44 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.281 1.987 . . . . 0.0 111.924 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.79 75.69 1.59 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.801 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -68.51 111.99 5.05 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.536 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.602 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 59.0 m -70.45 116.61 10.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.825 0.345 . . . . 0.0 110.128 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.03 -6.0 36.76 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.923 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.69 142.91 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.0 p -88.46 155.13 19.84 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.018 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.575 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 88.5 t -52.96 -34.34 20.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.636 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 16.0 ptt180 -56.67 -47.72 79.19 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 122.256 -0.277 . . . . 0.0 111.568 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.614 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 20.6 t70 -72.25 -45.49 59.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.174 0.511 . . . . 0.0 110.867 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.479 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 2.8 p -63.31 -53.24 55.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.378 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.7 OUTLIER -69.96 -24.41 63.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.121 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.614 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 11.8 mtmt -57.65 -51.25 70.28 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.537 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.4 tpmt? -61.43 -42.6 98.99 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.952 177.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.479 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -53.47 -61.11 2.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.411 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 181' ' ' LEU . 1.5 mt -65.02 -44.68 88.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.24 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.538 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 6.5 mmt -61.38 -32.19 72.11 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 62.5 mtm -77.16 -22.69 52.13 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.213 0.53 . . . . 0.0 110.02 175.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.1 5.77 50.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.73 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 69.81 36.69 74.85 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.966 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.412 HD13 ' HD2' ' A' ' 162' ' ' PRO . 21.4 mt -131.11 165.99 22.06 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 122.87 0.468 . . . . 0.0 110.021 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 35.7 pt -126.62 135.19 26.91 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.907 0.384 . . . . 0.0 111.36 177.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 15.9 Cg_exo -69.01 -16.5 40.77 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.029 2.486 . . . . 0.0 111.985 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -59.13 -45.51 90.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.534 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 16.2 t -105.41 34.74 3.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.257 0.551 . . . . 0.0 109.75 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.561 ' HB3' HG13 ' A' ' 224' ' ' VAL . 91.1 m -141.84 162.36 35.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.991 -176.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.632 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -143.62 154.63 43.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.133 174.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 13.3 t -105.92 138.01 33.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.676 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -129.24 150.32 50.67 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.439 ' HD2' HD22 ' A' ' 217' ' ' LEU . 2.9 ptm180 . . . . . 0 C--N 1.321 -0.651 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 166.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt . . . . . 0 N--CA 1.445 -0.712 0 CA-C-O 120.657 0.265 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -111.87 103.97 55.65 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.19 132.5 41.83 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.361 2.041 . . . . 0.0 112.155 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.532 HG21 HD11 ' A' ' 217' ' ' LEU . 20.3 mm -96.77 158.12 3.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.281 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -96.0 142.11 15.95 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -70.27 -22.55 62.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 117.315 0.558 . . . . 0.0 111.068 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -94.05 9.82 36.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.895 0.379 . . . . 0.0 110.833 176.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.536 ' O ' HG23 ' A' ' 177' ' ' VAL . 81.4 m -77.71 150.46 34.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -80.1 124.41 28.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.744 0.783 . . . . 0.0 109.589 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.408 HD12 ' HB2' ' A' ' 180' ' ' SER . 7.7 tt -53.58 -30.19 18.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.768 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.602 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 12.9 m -62.91 -16.79 60.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.901 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -79.29 -13.61 59.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.222 0.534 . . . . 0.0 109.654 175.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.532 HD11 HG21 ' A' ' 208' ' ' ILE . 11.5 mt -117.92 16.51 14.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.83 -176.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 97.4 m -50.63 119.44 3.82 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.864 0.84 . . . . 0.0 112.865 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 75.71 8.7 84.62 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 114.214 -1.357 . . . . 0.0 113.498 170.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -92.78 164.78 13.23 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.751 0.31 . . . . 0.0 110.409 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 6.4 mp0 -96.35 111.01 23.24 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.412 HD21 ' HB3' ' A' ' 217' ' ' LEU . 28.7 mt -100.6 165.9 11.18 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -136.57 124.92 23.3 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 42.4 t -103.69 124.63 58.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.024 0.44 . . . . 0.0 110.268 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 71.0 mm-40 -110.79 155.05 23.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.666 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 43.1 t -83.38 129.19 37.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.532 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.126 176.329 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 66.6 Cg_endo . . . . . 0 N--CA 1.464 -0.246 0 CA-C-O 121.072 0.363 . . . . 0.0 112.887 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.749 HD13 HG11 ' A' ' 168' ' ' VAL . 1.9 pp -129.87 157.85 42.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.622 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.97 133.91 68.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.588 ' HG2' HG13 ' A' ' 168' ' ' VAL . 18.1 mtm180 -92.31 108.03 19.65 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.476 0.655 . . . . 0.0 112.09 -168.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.688 HG22 ' HB2' ' A' ' 222' ' ' LEU . 11.6 t -96.1 145.75 8.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.626 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.563 ' CZ ' ' HD2' ' A' ' 166' ' ' ARG . 21.7 m-85 -112.61 103.01 11.05 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.822 176.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.5 mm? -76.58 173.99 6.47 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -172.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.622 ' HD2' HD13 ' A' ' 190' ' ' LEU . 74.4 Cg_exo -54.11 155.01 16.31 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.571 2.18 . . . . 0.0 112.873 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.9 t30 66.74 21.86 10.47 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.947 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.568 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 61.17 44.9 9.52 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.399 179.083 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.621 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 15.1 mm-40 -86.64 171.94 10.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.329 174.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.563 ' HD2' ' CZ ' ' A' ' 160' ' ' PHE . 47.1 ttt180 -148.4 133.79 18.55 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.448 HG22 HD21 ' A' ' 161' ' ' LEU . 5.4 t -137.43 174.74 10.27 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.749 HG11 HD13 ' A' ' 156' ' ' ILE . 0.2 OUTLIER -132.09 128.6 59.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.632 170.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.48 129.85 23.44 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.711 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.461 ' HA ' HG22 ' A' ' 156' ' ' ILE . 31.5 Cg_exo -57.08 123.48 13.95 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.313 2.009 . . . . 0.0 111.476 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.45 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -61.75 99.96 0.13 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.628 0.728 . . . . 0.0 109.286 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.648 ' HG2' ' HB ' ' A' ' 175' ' ' VAL . 17.2 ttp180 -107.81 111.97 24.38 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.916 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.658 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 42.4 t -70.84 128.3 35.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.87 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 109.06 -21.18 27.61 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.767 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.648 ' HB ' ' HG2' ' A' ' 172' ' ' ARG . 0.9 OUTLIER -99.19 142.85 14.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.367 0.603 . . . . 0.0 110.749 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 5.6 p -81.56 148.69 29.01 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.641 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.497 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 21.9 m -49.48 -32.09 6.19 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.616 0 CA-C-N 117.904 0.32 . . . . 0.0 110.319 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 21.3 ptt180 -58.82 -43.38 90.61 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.613 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 21.2 t70 -71.34 -47.64 55.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.964 0.802 . . . . 0.0 110.477 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.481 ' HA ' HH21 ' A' ' 172' ' ' ARG . 0.6 OUTLIER -62.21 -43.36 99.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.414 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.42 -36.32 68.58 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.178 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.696 ' O ' ' HB2' ' A' ' 186' ' ' MET . 7.9 mtmt -50.64 -45.07 57.62 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.805 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.513 ' O ' ' HG3' ' A' ' 187' ' ' MET . 10.9 tppt? -67.41 -51.46 51.48 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.917 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -43.73 -54.13 5.35 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.482 0.489 . . . . 0.0 111.973 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 5.1 mp -69.24 -52.39 28.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.63 0.372 . . . . 0.0 111.733 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.696 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 1.3 ttm -54.28 -38.35 65.77 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -176.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.513 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 68.7 mtm -74.46 -16.52 60.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.338 0.59 . . . . 0.0 110.179 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 188' ' ' ARG . 49.8 mtt180 -105.9 12.73 30.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.324 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 68.6 38.5 86.23 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.015 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.622 HD13 ' HD2' ' A' ' 162' ' ' PRO . 20.8 mt -132.02 157.93 42.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.743 0.306 . . . . 0.0 110.676 -176.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 14.0 pt -122.22 127.32 25.95 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.349 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 11.6 Cg_exo -71.03 -12.84 31.0 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.865 2.377 . . . . 0.0 111.895 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -58.47 -41.27 84.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.017 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 74.1 m -105.44 34.88 3.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.897 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.513 ' HB3' HG13 ' A' ' 224' ' ' VAL . 80.9 m -145.04 164.84 29.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.866 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.599 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -139.2 160.13 40.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.447 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 17.0 t -109.13 140.69 26.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.464 -176.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.415 ' CD1' ' HB3' ' A' ' 205' ' ' LYS . 22.1 m-85 -134.32 142.67 47.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.09 177.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.504 ' HD2' HD12 ' A' ' 217' ' ' LEU . 8.0 ptm180 . . . . . 0 C--N 1.317 -0.844 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 166.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.599 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 39.9 mtpt . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -94.13 98.97 3.22 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.684 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.599 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 25.3 Cg_exo -62.67 135.95 55.44 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.566 2.177 . . . . 0.0 112.848 -174.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 197' ' ' VAL . 22.8 mm -98.02 154.44 3.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.791 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.81 134.04 12.18 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 174.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.497 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 86.9 m95 -64.84 -24.55 67.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.325 0.563 . . . . 0.0 110.97 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -93.57 14.11 19.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.961 0.41 . . . . 0.0 111.247 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 177' ' ' VAL . 85.4 m -88.11 145.33 25.99 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -72.81 134.12 44.78 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.469 HG21 ' HB2' ' A' ' 180' ' ' SER . 0.1 OUTLIER -69.97 -16.6 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 110.961 -175.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.658 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 8.3 m -66.51 -19.62 65.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.744 176.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.547 ' HB2' HD22 ' A' ' 217' ' ' LEU . 27.8 m0 -75.59 -23.63 56.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.545 0.688 . . . . 0.0 109.815 176.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.548 HD22 ' N ' ' A' ' 217' ' ' LEU . 1.4 mm? -109.32 23.95 13.77 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.36 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 51.3 m -54.37 114.22 1.57 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.625 0.726 . . . . 0.0 111.958 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 84.14 -2.84 87.25 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.946 173.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.39 156.94 36.51 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 50.3 mt-10 -89.71 108.38 19.65 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.688 ' HB2' HG22 ' A' ' 159' ' ' VAL . 82.8 mt -102.47 109.68 21.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.74 0.781 . . . . 0.0 110.478 -175.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -84.22 122.04 28.31 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.856 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 3.7 t -99.93 109.95 25.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.51 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -110.27 145.26 37.7 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.657 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.58 133.52 31.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 196' ' ' ALA . 55.9 mt . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 121.196 0.522 . . . . 0.0 110.854 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 120.587 0.232 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.38 92.6 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.42 2.747 . . . . 0.0 112.37 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -89.96 103.21 15.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.163 0.506 . . . . 0.0 111.288 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.65 108.17 31.16 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.019 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 63.9 Cg_endo -70.09 159.34 53.49 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.514 2.142 . . . . 0.0 112.053 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.78 HD13 HG11 ' A' ' 168' ' ' VAL . 2.0 pp -129.75 167.07 25.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.957 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 46.4 t -127.86 126.24 66.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.298 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 21.2 mtm180 -93.92 91.59 6.98 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.126 0.488 . . . . 0.0 111.941 -170.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 222' ' ' LEU . 2.1 t -93.44 162.23 2.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.609 0.718 . . . . 0.0 111.057 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.49 ' H ' HG12 ' A' ' 159' ' ' VAL . 49.4 m-85 -125.2 107.31 10.62 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.795 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.1 mm? -82.22 167.03 33.27 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 71.7 Cg_exo -48.18 147.49 8.24 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.521 2.814 . . . . 0.0 113.566 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 69.56 34.56 2.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.187 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.489 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 62.12 43.19 8.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.826 176.181 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 78.2 mm-40 -97.17 165.47 12.03 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.653 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 159' ' ' VAL . 37.0 ttp180 -145.95 145.62 30.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.755 HG21 ' HB1' ' A' ' 184' ' ' ALA . 15.2 t -146.06 150.23 35.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.522 177.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.78 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -120.98 127.25 75.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.231 170.092 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.4 p -123.75 133.89 24.93 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.338 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 74.2 Cg_exo -51.49 128.36 25.6 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.383 2.055 . . . . 0.0 111.973 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.39 79.12 0.75 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.535 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.408 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 92.1 mtt180 -68.56 115.74 8.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.726 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 46.8 t -80.44 109.79 15.29 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.68 19.36 7.43 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 -173.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.459 HG12 ' CG2' ' A' ' 214' ' ' ILE . 0.9 OUTLIER -140.48 132.7 31.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.6 p -74.35 153.3 39.35 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.242 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.55 ' HA ' ' OG ' ' A' ' 180' ' ' SER . 4.2 m -58.52 -21.84 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.62 ' HG2' ' HE2' ' A' ' 182' ' ' LYS . 32.0 ttt180 -58.94 -59.05 6.08 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.694 174.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.638 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 25.7 t70 -64.4 -48.6 74.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.209 0.528 . . . . 0.0 111.417 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.55 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 11.3 p -60.24 -56.87 16.27 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.489 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 8.3 mp -74.28 -14.85 60.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.032 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.638 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 5.3 mtmt -59.92 -48.21 82.62 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 187' ' ' MET . 12.0 tppt? -60.13 -49.49 77.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.175 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.755 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -47.11 -53.44 12.85 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.583 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.459 HD21 HG11 ' A' ' 224' ' ' VAL . 1.5 mt -74.19 -43.51 56.95 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.554 0.342 . . . . 0.0 111.507 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.495 ' HB3' ' O ' ' A' ' 182' ' ' LYS . 18.7 tpp -65.59 -33.92 77.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.043 -174.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.498 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 66.8 mtm -74.02 -9.75 58.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.297 0.57 . . . . 0.0 109.971 175.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 167' ' ' THR . 74.7 mtt85 -109.65 1.37 19.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.18 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 78.62 21.85 68.25 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.483 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.2 mp -113.99 172.53 6.93 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 34.6 pt -132.82 132.5 22.56 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.204 0.526 . . . . 0.0 111.527 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.55 ' HG2' ' HG3' ' A' ' 182' ' ' LYS . 23.9 Cg_exo -65.7 -21.15 59.05 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.359 2.706 . . . . 0.0 113.127 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -62.86 -33.38 75.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.776 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 35.4 t -102.68 31.83 3.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.373 0.606 . . . . 0.0 109.89 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.616 ' HB3' HG13 ' A' ' 224' ' ' VAL . 71.2 m -143.17 167.6 21.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.983 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -138.0 155.65 48.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.241 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 223' ' ' HIS . 9.6 t -107.55 136.61 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 123.208 0.318 . . . . 0.0 110.27 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -130.92 151.95 50.77 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.479 ' CG ' ' HB2' ' A' ' 206' ' ' LYS . 1.2 ptm180 -120.64 115.51 23.51 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 167.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.706 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 19.6 mm -85.06 112.88 22.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.833 -175.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.482 ' HB2' ' CG ' ' A' ' 204' ' ' GLU . 84.0 mt-30 -89.14 -149.83 0.19 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 170.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.73 80.36 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 62.96 18.73 60.32 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.812 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.482 ' CG ' ' HB2' ' A' ' 201' ' ' GLN . 9.9 pt-20 -125.67 135.15 51.81 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.616 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.706 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 36.2 mtpt -91.84 128.03 37.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.271 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.479 ' HB2' ' CG ' ' A' ' 199' ' ' ARG . 75.0 mmtt -111.73 98.13 40.07 Favored Pre-proline 0 N--CA 1.444 -0.736 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -65.95 119.15 6.14 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.859 1.706 . . . . 0.0 111.998 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 38.3 mt -96.61 154.22 3.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.615 -177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.0 145.66 20.02 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.529 ' O ' ' HB2' ' A' ' 178' ' ' ARG . 96.2 m95 -68.95 -25.09 64.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.28 0.54 . . . . 0.0 110.496 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -87.97 9.95 20.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.743 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.504 ' O ' HG13 ' A' ' 177' ' ' VAL . 94.9 m -83.57 143.22 30.3 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.445 ' HB3' ' CD1' ' A' ' 216' ' ' TRP . 9.3 t70 -75.27 137.19 41.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.925 0.393 . . . . 0.0 110.094 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.459 ' CG2' HG12 ' A' ' 175' ' ' VAL . 0.2 OUTLIER -78.24 -17.55 13.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.581 -174.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 85.9 p -69.78 -14.09 62.6 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 121.961 -0.462 . . . . 0.0 110.442 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.445 ' CD1' ' HB3' ' A' ' 213' ' ' ASP . 27.5 m0 -67.71 -40.64 84.26 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 174.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.41 ' HB3' HD21 ' A' ' 222' ' ' LEU . 0.3 OUTLIER -99.87 31.64 3.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.423 -175.51 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 51.1 m -52.91 113.85 1.23 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.403 0.62 . . . . 0.0 112.343 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 84.06 2.65 89.4 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.973 -1.012 . . . . 0.0 113.658 171.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.54 154.92 19.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.683 0.278 . . . . 0.0 110.392 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 2.1 mp0 -85.97 111.29 20.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 35.9 mt -103.83 164.94 11.35 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 197' ' ' VAL . 85.4 m-70 -129.34 135.6 48.94 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.616 HG13 ' HB3' ' A' ' 195' ' ' CYS . 9.4 t -113.45 109.34 28.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 28.5 mt-10 -110.11 155.21 22.21 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.088 -175.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.99 131.25 34.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.942 -173.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.6 mp -75.72 80.07 2.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.674 0.75 . . . . 0.0 109.179 173.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -131.86 103.84 6.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.877 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -81.13 76.97 8.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.64 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.834 -0.621 . . . . 99.99 110.63 178.583 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 33.5 p . . . . . 0 N--CA 1.476 0.871 0 CA-C-O 120.58 0.229 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 151' ' ' SER . 31.5 Cg_exo -61.4 -27.91 83.28 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.253 2.635 . . . . 0.0 111.592 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -132.07 119.43 20.98 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.407 ' HE2' ' CB ' ' A' ' 170' ' ' PRO . 83.6 tttt -110.84 99.55 42.7 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -72.6 159.79 48.03 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.827 2.351 . . . . 0.0 112.776 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.563 ' O ' ' HA2' ' A' ' 219' ' ' GLY . 1.4 pp -122.12 171.54 10.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.688 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.7 133.13 57.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.598 ' HG2' HG11 ' A' ' 168' ' ' VAL . 20.5 mtm180 -99.17 106.83 19.05 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.145 0.497 . . . . 0.0 111.872 -162.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 222' ' ' LEU . 25.9 t -100.13 145.21 11.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.634 -172.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -109.27 104.7 13.88 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.067 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.627 HD21 HG22 ' A' ' 167' ' ' THR . 1.5 mm? -81.57 172.47 9.62 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -174.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.627 ' HD3' HG12 ' A' ' 224' ' ' VAL . 77.5 Cg_exo -54.47 159.92 7.71 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.614 2.209 . . . . 0.0 112.183 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 66.03 24.5 11.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.002 0.43 . . . . 0.0 110.154 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 56.15 43.98 25.92 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.191 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 28.8 mm-40 -89.65 167.38 12.97 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.412 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -146.39 129.73 16.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.434 0.635 . . . . 0.0 111.42 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.627 HG22 HD21 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -144.5 139.09 28.04 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.013 178.106 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.598 HG11 ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -116.57 129.27 73.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.632 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.31 136.23 19.57 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.805 -173.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.407 ' CB ' ' HE2' ' A' ' 154' ' ' LYS . 32.0 Cg_exo -57.6 130.01 36.65 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.29 1.993 . . . . 0.0 111.294 177.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.13 91.45 0.22 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.453 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.458 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 92.2 mtt180 -77.08 111.59 12.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.044 -176.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.575 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 3.3 p -72.45 115.46 11.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.5 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 98.86 15.58 33.39 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.948 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.458 ' CG1' ' HB2' ' A' ' 172' ' ' ARG . 0.5 OUTLIER -130.15 148.91 33.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.4 p -83.45 154.39 23.96 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.646 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 212' ' ' THR . 64.1 t -53.81 -30.58 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.559 -0.746 . . . . 0.0 108.992 172.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.584 ' HG3' ' HB3' ' A' ' 210' ' ' TRP . 12.1 ttt180 -53.93 -58.97 5.33 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.66 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.63 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 11.3 t70 -63.26 -47.88 80.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.336 0.588 . . . . 0.0 111.274 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.544 ' OG ' HG21 ' A' ' 214' ' ' ILE . 17.9 m -59.51 -51.59 69.22 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.166 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.483 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.4 OUTLIER -78.36 -19.03 54.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.651 0.263 . . . . 0.0 110.407 -178.208 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.63 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 15.5 mtmt -60.65 -48.51 81.45 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.504 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 2.2 tpmt? -61.45 -41.19 96.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.802 176.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.519 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -53.66 -57.33 11.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.767 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 181' ' ' LEU . 1.4 mt -71.55 -41.34 69.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.483 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 7.0 mmt -66.29 -28.39 68.66 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -176.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 62.4 mtm -79.64 -9.16 59.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.082 0.468 . . . . 0.0 109.96 175.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -109.72 -3.2 16.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.522 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.07 21.21 61.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.209 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.0 mp -115.04 172.11 7.26 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.526 HG13 ' SG ' ' A' ' 194' ' ' CYS . 21.4 pt -128.88 133.1 24.82 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.526 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.544 ' HB3' ' CZ3' ' A' ' 210' ' ' TRP . 14.9 Cg_exo -69.0 -21.03 37.6 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.027 2.485 . . . . 0.0 112.133 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -57.82 -41.73 82.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.736 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' CYS . . . . . 0.526 ' SG ' HG13 ' A' ' 191' ' ' ILE . 20.9 p -96.89 16.81 18.3 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.371 -177.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.481 ' HB3' HG13 ' A' ' 224' ' ' VAL . 85.1 m -126.08 166.83 16.28 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.175 0.512 . . . . 0.0 111.638 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -146.2 159.79 42.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.065 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.678 HG11 HD23 ' A' ' 222' ' ' LEU . 11.7 t -115.11 138.85 44.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.118 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 29.9 m-85 -129.72 146.65 51.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.255 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.53 ' HD2' HD22 ' A' ' 217' ' ' LEU . 7.1 ptm180 -117.1 115.49 25.47 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 167.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 4.9 mm -91.37 107.22 18.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.735 -169.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 203' ' ' GLY . 76.4 mm-40 -83.96 -143.65 0.08 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.847 176.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 13.3 m-20 -60.26 78.28 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.041 0.448 . . . . 0.0 111.804 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 63.88 17.0 60.17 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.193 -176.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 35.2 mt-10 -113.6 132.58 55.69 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 120.898 0.38 . . . . 0.0 111.445 -176.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.57 ' HG2' HD12 ' A' ' 200' ' ' ILE . 44.6 mtpt -95.09 112.67 24.35 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 75.3 mmtt -101.91 102.74 25.04 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.03 -177.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 8.0 Cg_exo -69.34 119.45 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.101 1.867 . . . . 0.0 111.634 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.452 HD12 HG12 ' A' ' 197' ' ' VAL . 56.9 mt -93.74 155.8 3.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.283 -174.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -92.42 135.09 12.53 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.584 ' HB3' ' HG3' ' A' ' 178' ' ' ARG . 86.5 m95 -64.8 -40.51 95.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.041 0.448 . . . . 0.0 110.667 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.32 6.04 3.99 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 177' ' ' VAL . 97.2 m -81.22 145.26 31.06 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 172.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.24 131.24 44.58 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.544 HG21 ' OG ' ' A' ' 180' ' ' SER . 0.1 OUTLIER -73.74 -15.18 16.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.781 0.324 . . . . 0.0 111.356 -174.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.575 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 23.4 m -70.27 -10.51 59.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.052 0.453 . . . . 0.0 110.579 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.6 m0 -74.97 -27.05 60.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.449 0.642 . . . . 0.0 109.399 172.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.756 HD13 HD21 ' A' ' 222' ' ' LEU . 7.1 mt -110.8 19.24 18.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.075 -174.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 215' ' ' SER . 100.0 m -51.15 115.5 1.58 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.687 0.756 . . . . 0.0 112.194 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 85.99 3.77 85.07 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.386 -1.279 . . . . 0.0 113.244 171.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -87.9 158.2 18.76 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -91.61 111.08 22.44 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 173.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.756 HD21 HD13 ' A' ' 217' ' ' LEU . 6.7 mp -98.04 150.21 21.65 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.043 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -120.0 122.02 40.23 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.751 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.627 HG12 ' HD3' ' A' ' 162' ' ' PRO . 4.0 t -100.16 117.05 44.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.083 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -108.55 137.01 47.2 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.657 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.7 p -91.18 128.6 42.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.595 0.712 . . . . 0.0 110.195 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.8 mp -76.3 82.03 3.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.627 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -100.71 96.2 7.17 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.427 0.632 . . . . 0.0 110.288 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -146.05 26.06 1.24 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.704 174.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 114.895 -1.048 . . . . 99.99 110.458 -176.012 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.417 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 9.0 p . . . . . 0 N--CA 1.475 0.798 0 CA-C-O 121.019 0.437 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 151' ' ' SER . 22.5 Cg_exo -66.83 -39.64 14.31 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.073 2.516 . . . . 0.0 111.577 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.578 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 77.9 mt-30 -103.61 137.53 41.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.354 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -99.27 102.34 15.68 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.751 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' A' ' 153' ' ' GLN . 3.9 Cg_exo -76.45 151.37 33.11 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.615 2.21 . . . . 0.0 111.051 176.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.79 HD13 HG11 ' A' ' 168' ' ' VAL . 2.1 pp -121.06 160.13 22.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.558 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.68 134.67 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.526 ' HG2' HG13 ' A' ' 168' ' ' VAL . 71.5 mtm180 -96.73 101.01 12.53 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -168.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 160' ' ' PHE . 2.8 t -92.97 160.1 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 121.785 0.802 . . . . 0.0 111.801 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.558 ' CZ ' ' HD2' ' A' ' 166' ' ' ARG . 41.0 m-85 -124.76 105.76 9.54 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.131 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.546 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 3.3 mp -85.7 174.61 5.42 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.946 -172.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 87.2 Cg_exo -52.86 160.09 4.42 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.744 2.296 . . . . 0.0 112.835 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 66.7 t30 64.12 31.97 12.99 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.273 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt 56.02 47.79 19.06 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.357 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 99.3 mt-30 -101.81 166.79 10.47 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.255 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.558 ' HD2' ' CZ ' ' A' ' 160' ' ' PHE . 38.4 ttt180 -147.67 144.24 28.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.556 0.217 . . . . 0.0 110.859 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.453 HG22 HD11 ' A' ' 161' ' ' LEU . 1.4 t -155.27 152.68 29.54 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.79 HG11 HD13 ' A' ' 156' ' ' ILE . 0.2 OUTLIER -114.2 128.84 71.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.255 178.351 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.9 p -116.5 137.03 23.27 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.562 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.71 135.44 60.2 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.175 1.916 . . . . 0.0 111.685 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.76 78.34 1.12 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.104 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -69.54 111.92 5.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.593 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.67 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 8.5 p -76.93 110.09 11.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.992 0.425 . . . . 0.0 109.872 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 109.07 9.17 26.49 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.574 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.84 137.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.5 p -79.4 154.47 28.96 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.96 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 212' ' ' THR . 81.4 t -47.07 -40.95 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.477 0.486 . . . . 0.0 109.696 175.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.607 ' CG ' ' HB3' ' A' ' 210' ' ' TRP . 92.9 mtt-85 -48.45 -52.57 21.55 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.483 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.593 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 14.7 t70 -73.98 -45.48 49.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.138 0.494 . . . . 0.0 111.339 -172.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.423 ' CB ' HG21 ' A' ' 214' ' ' ILE . 0.3 OUTLIER -67.54 -42.87 82.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.896 -177.769 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.3 OUTLIER -76.68 -21.17 55.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.145 177.248 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.644 ' O ' ' HB2' ' A' ' 186' ' ' MET . 4.4 ttmt -59.23 -48.23 82.4 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.1 tpmt? -60.56 -46.2 91.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.791 175.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.452 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -51.75 -55.94 16.73 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.984 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 181' ' ' LEU . 1.7 mt -72.58 -43.16 63.77 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.734 0.413 . . . . 0.0 111.769 -178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.644 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 3.3 mmt -66.02 -26.52 67.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -176.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.502 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 64.6 mtm -77.38 -20.35 54.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.359 0.599 . . . . 0.0 109.724 173.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -106.6 17.59 23.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.592 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 62.75 35.43 91.92 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.276 -0.487 . . . . 0.0 112.676 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.446 HD13 ' HD2' ' A' ' 162' ' ' PRO . 21.1 mt -128.41 169.37 14.36 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.531 0.333 . . . . 0.0 110.171 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 45.8 pt -131.89 135.24 26.35 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.057 0.456 . . . . 0.0 111.534 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.476 ' HG2' ' HG3' ' A' ' 182' ' ' LYS . 19.6 Cg_exo -66.77 -22.2 50.07 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.102 2.535 . . . . 0.0 112.645 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.89 -19.98 62.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.478 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 12.2 t -112.13 25.94 11.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.518 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 74.2 m -140.78 166.74 23.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.096 -175.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -146.66 154.41 41.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.121 175.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.08 130.62 61.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.597 0.237 . . . . 0.0 110.776 -176.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 35.6 m-85 -131.28 152.9 50.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.759 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.79 ' HG3' HD11 ' A' ' 208' ' ' ILE . 67.2 mtp180 -114.6 111.9 22.07 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 168.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.588 HG12 ' ND1' ' A' ' 223' ' ' HIS . 1.7 mm -94.39 106.97 18.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.453 -174.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.451 ' HB2' ' CG ' ' A' ' 204' ' ' GLU . 24.5 mt-30 -88.32 -146.32 0.15 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 172.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.95 79.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 63.13 17.53 59.16 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.822 -178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 8.4 pt-20 -123.07 133.66 54.3 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.975 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.562 ' HG2' HD12 ' A' ' 200' ' ' ILE . 39.1 mtpt -102.52 126.48 49.59 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -175.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 74.1 mmtt -101.7 100.5 14.53 Favored Pre-proline 0 N--CA 1.444 -0.741 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 4.0 Cg_exo -71.26 126.76 12.63 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.868 1.712 . . . . 0.0 111.316 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.79 HD11 ' HG3' ' A' ' 199' ' ' ARG . 4.7 mt -107.77 149.66 10.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.77 -173.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.7 136.01 14.15 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.607 ' HB3' ' CG ' ' A' ' 178' ' ' ARG . 91.1 m95 -65.08 -27.8 69.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.698 0.285 . . . . 0.0 110.917 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.404 ' CG ' ' HE ' ' A' ' 178' ' ' ARG . 11.0 m-20 -90.73 12.76 18.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.823 0.344 . . . . 0.0 111.242 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 177' ' ' VAL . 48.1 m -85.84 154.15 21.75 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -78.48 132.18 37.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.423 HG21 ' CB ' ' A' ' 180' ' ' SER . 0.3 OUTLIER -70.32 -11.94 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.987 0.422 . . . . 0.0 110.997 -178.029 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.67 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 16.4 m -66.38 -18.26 65.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.98 0.419 . . . . 0.0 110.359 173.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -78.66 -14.79 59.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.455 0.645 . . . . 0.0 109.888 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.624 HD11 HG21 ' A' ' 208' ' ' ILE . 17.8 mt -113.34 17.4 18.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.797 -177.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 91.2 m -53.64 117.59 3.25 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.775 0.798 . . . . 0.0 112.395 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 74.07 8.14 78.03 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.118 173.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -84.49 148.72 26.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 3.2 mp0 -85.26 109.47 18.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 171.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 86.2 mt -98.61 149.93 22.27 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.994 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' HIS . . . . . 0.588 ' ND1' HG12 ' A' ' 200' ' ' ILE . 37.6 m80 -124.05 122.58 38.26 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 38.7 t -100.07 143.95 13.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.042 0.449 . . . . 0.0 110.167 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 8.6 mm-40 -120.91 151.39 39.74 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.236 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 162' ' ' PRO . 1.2 t -89.89 116.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 34.3 mt -75.79 89.12 2.85 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.14 97.06 5.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.855 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -121.81 71.86 1.0 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.215 0.531 . . . . 0.0 109.743 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.392 -0.822 . . . . 99.99 111.504 -178.549 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 20.4 p . . . . . 0 N--CA 1.477 0.902 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 151' ' ' SER . 39.3 Cg_exo -60.47 -29.49 88.78 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.199 2.599 . . . . 0.0 111.838 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.432 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 68.9 mt-30 -96.53 141.43 29.82 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 173.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -87.38 113.36 53.66 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.496 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 23.8 Cg_exo -63.71 168.23 12.14 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.48 2.12 . . . . 0.0 110.446 174.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.817 HD13 HG11 ' A' ' 168' ' ' VAL . 2.2 pp -131.29 156.61 42.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.166 0.508 . . . . 0.0 111.417 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.511 HG22 ' H ' ' A' ' 219' ' ' GLY . 41.0 t -124.11 123.75 67.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.756 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.499 ' HA ' HG13 ' A' ' 168' ' ' VAL . 23.6 mtm180 -88.47 96.54 10.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.49 0.662 . . . . 0.0 111.723 -169.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.635 HG22 ' HB2' ' A' ' 222' ' ' LEU . 3.8 t -96.03 129.98 45.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.059 -176.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.573 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 42.4 m-85 -94.29 103.51 15.53 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.871 174.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.604 HD22 ' HD2' ' A' ' 188' ' ' ARG . 2.9 mp -82.59 176.67 3.6 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 80.2 Cg_exo -50.17 153.73 6.44 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.711 2.274 . . . . 0.0 112.736 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 65.96 27.26 10.83 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.661 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 54.07 36.77 25.46 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.745 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 26.9 mm-40 -75.58 170.24 16.53 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 17.8 ttp180 -148.59 137.46 21.55 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.151 173.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.12 154.39 41.76 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.817 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -113.73 127.36 71.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.312 178.423 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.5 m -104.88 138.74 19.59 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.053 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 13.0 Cg_exo -65.55 125.14 13.88 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.265 1.31 . . . . 0.0 110.925 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.12 86.08 0.55 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.044 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.464 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 97.2 mtt180 -78.98 112.04 15.77 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.11 -174.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.618 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 4.1 p -67.53 110.02 3.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.831 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 106.78 8.16 32.63 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.296 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 172' ' ' ARG . 0.3 OUTLIER -117.16 149.87 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.045 0.45 . . . . 0.0 109.866 176.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.48 ' HB ' ' HG2' ' A' ' 178' ' ' ARG . 1.7 p -86.1 152.3 22.98 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.368 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 212' ' ' THR . 92.8 t -49.07 -41.61 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 O-C-N 123.452 0.47 . . . . 0.0 110.326 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.48 ' HG2' ' HB ' ' A' ' 176' ' ' THR . 30.9 ptt180 -51.24 -47.45 62.38 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.094 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.587 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 11.8 t70 -68.08 -49.79 59.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.121 0.486 . . . . 0.0 110.967 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.8 t -67.04 -43.99 81.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.464 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.643 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.3 OUTLIER -73.42 -27.33 61.38 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.206 179.406 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 13.0 mtmt -55.29 -45.62 76.22 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.476 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 1.8 tpmt? -60.01 -42.6 94.64 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 181' ' ' LEU . . . -55.12 -60.89 2.76 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.938 178.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 181' ' ' LEU . 1.6 mm? -60.29 -52.01 67.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.005 0.522 . . . . 0.0 110.904 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 12.2 mmt -57.96 -42.69 85.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.53 -174.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.45 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 57.6 mtm -71.04 -8.42 53.24 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.045 0.45 . . . . 0.0 110.533 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.604 ' HD2' HD22 ' A' ' 161' ' ' LEU . 51.2 mtt-85 -113.77 5.07 16.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.571 -177.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 73.38 21.74 79.32 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.325 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.611 ' HB3' HD12 ' A' ' 185' ' ' LEU . 0.2 OUTLIER -110.61 173.11 6.48 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -177.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 32.3 pt -132.15 127.34 20.93 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.176 0.512 . . . . 0.0 111.873 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.534 ' HB3' ' CZ3' ' A' ' 210' ' ' TRP . 22.5 Cg_exo -65.54 -21.48 59.82 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.307 2.672 . . . . 0.0 112.331 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.25 -45.4 93.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.923 -174.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 23.8 t -98.11 37.53 1.42 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.282 0.563 . . . . 0.0 109.967 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.707 ' HB3' HG13 ' A' ' 224' ' ' VAL . 71.8 m -138.7 158.56 44.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.78 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -131.66 150.43 52.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.014 175.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.425 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 4.1 t -104.59 131.67 53.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 123.239 0.337 . . . . 0.0 110.508 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -126.56 141.99 51.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.774 0.321 . . . . 0.0 110.807 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.444 ' HD3' HD22 ' A' ' 217' ' ' LEU . 19.3 ptt180 -117.71 112.16 20.1 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 165.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 205' ' ' LYS . 6.2 mm -80.18 104.21 8.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.196 -168.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 203' ' ' GLY . 26.3 mt-30 -78.13 -147.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -55.44 79.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.962 0.505 . . . . 0.0 112.27 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.41 17.4 52.99 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.007 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -128.53 133.86 48.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.205 0.502 . . . . 0.0 111.061 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.514 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 45.5 mtpt -79.51 111.3 15.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.544 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.42 ' HG2' ' OE1' ' A' ' 201' ' ' GLN . 11.7 tppt? -98.26 102.67 14.79 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.129 -174.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 10.6 Cg_exo -70.6 127.9 14.54 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.32 2.013 . . . . 0.0 112.413 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 217' ' ' LEU . 35.1 mt -103.22 161.9 4.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.233 -1.348 . . . . 0.0 109.963 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.48 147.45 18.6 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.676 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.534 ' CZ3' ' HB3' ' A' ' 192' ' ' PRO . 92.1 m95 -74.72 -18.5 60.5 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -87.63 -4.21 58.95 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.343 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 177' ' ' VAL . 89.9 m -70.19 147.89 49.29 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -76.61 129.18 36.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.432 HG13 HG21 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -68.9 -16.49 20.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.914 0.388 . . . . 0.0 111.056 -175.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.618 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 13.9 m -67.47 -21.03 65.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.848 0.356 . . . . 0.0 110.751 177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 24.1 m0 -74.93 -17.53 60.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.324 0.583 . . . . 0.0 109.583 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.469 HD11 HG21 ' A' ' 208' ' ' ILE . 6.0 mt -116.95 17.99 14.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.444 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 82.1 m -49.88 113.1 0.77 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.399 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.511 ' H ' HG22 ' A' ' 157' ' ' VAL . . . 86.5 6.28 80.9 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.041 -0.982 . . . . 0.0 113.41 170.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -90.46 158.48 17.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.806 0.336 . . . . 0.0 110.253 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 3.2 mp0 -90.1 111.15 22.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.635 ' HB2' HG22 ' A' ' 159' ' ' VAL . 58.5 mt -107.36 133.87 51.26 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.85 0.357 . . . . 0.0 110.802 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -102.16 123.24 45.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.489 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.707 HG13 ' HB3' ' A' ' 195' ' ' CYS . 39.4 t -105.95 112.18 38.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.321 0.582 . . . . 0.0 109.895 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 25.1 mt-10 -109.62 145.27 36.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.606 -173.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 66.7 t -77.87 129.76 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.949 0.404 . . . . 0.0 111.025 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.2 mp -81.68 81.67 7.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.655 177.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -91.08 95.01 9.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -114.69 76.89 1.02 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.416 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 6.8 m . . . . . 0 C--N 1.321 -0.674 0 CA-C-N 115.665 -0.698 . . . . 99.99 111.03 -176.009 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.418 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . 12.8 p . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.687 0.279 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 151' ' ' SER . 27.4 Cg_endo -60.86 138.78 81.37 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.056 2.504 . . . . 0.0 111.98 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.58 112.08 3.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.185 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -110.27 124.02 34.43 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.655 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -82.22 152.84 16.21 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.171 1.914 . . . . 0.0 110.728 173.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.765 HD13 HG11 ' A' ' 168' ' ' VAL . 2.0 pp -130.7 161.07 41.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.896 -0.138 . . . . 0.0 111.116 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.37 134.63 62.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.612 ' HG2' HG13 ' A' ' 168' ' ' VAL . 85.3 mtm180 -94.61 103.27 15.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.049 0.452 . . . . 0.0 112.093 -168.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.4 t -96.76 136.93 25.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.837 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 53.5 m-85 -94.64 104.0 15.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.63 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.648 HD22 ' H ' ' A' ' 161' ' ' LEU . 0.7 OUTLIER -81.34 170.56 14.89 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.295 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.666 ' HD3' HG12 ' A' ' 224' ' ' VAL . 53.1 Cg_exo -56.72 156.91 21.06 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.749 2.3 . . . . 0.0 112.491 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 66.5 t30 67.21 37.26 3.73 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.336 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt 55.13 48.92 18.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.585 177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.56 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 27.9 mm-40 -104.29 160.89 14.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.104 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 28.5 ttp180 -147.05 138.99 24.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.898 0.38 . . . . 0.0 110.687 173.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.501 HG22 HD21 ' A' ' 161' ' ' LEU . 4.8 t -141.47 157.15 45.51 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.765 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -119.83 127.74 75.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.326 175.36 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.4 p -115.56 134.62 22.62 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.277 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.9 132.25 48.61 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.23 1.953 . . . . 0.0 111.454 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.9 75.96 0.89 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.691 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -64.74 111.81 2.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.922 -176.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 48.2 m -76.44 110.02 10.63 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 110.47 11.56 19.34 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.317 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.403 ' CG1' ' HB3' ' A' ' 180' ' ' SER . 1.1 t -133.05 138.01 52.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 21.3 p -81.93 160.2 23.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.233 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.616 HG13 HD13 ' A' ' 181' ' ' LEU . 86.7 t -52.52 -30.6 14.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.659 171.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.554 ' CG ' ' HB3' ' A' ' 210' ' ' TRP . 72.6 mtp180 -53.74 -58.38 7.44 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.283 174.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.607 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 14.5 t70 -74.52 -43.49 55.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.11 0.481 . . . . 0.0 111.096 -174.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.521 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 28.1 p -60.76 -57.68 11.67 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.28 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.616 HD13 HG13 ' A' ' 177' ' ' VAL . 9.6 mp -77.08 -11.69 59.84 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 122.102 -0.374 . . . . 0.0 111.154 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.607 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 4.7 ttmt -58.19 -46.31 86.03 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 171.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.465 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 2.4 tpmt? -59.57 -44.47 93.3 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.792 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.435 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -50.99 -54.93 20.09 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.465 HD23 ' HB3' ' A' ' 190' ' ' LEU . 5.3 mp -78.22 -38.46 43.02 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 14.7 mmt -63.48 -28.48 69.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.557 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 64.8 mtm -77.87 -7.33 56.56 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.355 0.598 . . . . 0.0 109.961 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.471 ' CZ ' ' HB ' ' A' ' 167' ' ' THR . 55.8 mtt85 -113.06 0.7 15.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.479 -178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 73.66 25.36 72.4 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.021 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.465 ' HB3' HD23 ' A' ' 185' ' ' LEU . 10.1 mp -115.59 152.61 32.75 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.475 ' O ' HD12 ' A' ' 191' ' ' ILE . 2.4 pp -108.2 128.67 25.27 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-O 121.067 0.46 . . . . 0.0 110.898 176.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 16.6 Cg_exo -68.14 -6.76 18.05 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.854 2.369 . . . . 0.0 112.362 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -75.26 -11.22 60.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.166 -175.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 27.7 t -126.27 34.65 4.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.538 ' HB3' HG13 ' A' ' 224' ' ' VAL . 77.3 m -144.47 158.82 43.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.188 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -136.29 159.26 42.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.704 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.537 HG11 HD23 ' A' ' 222' ' ' LEU . 23.8 t -114.06 138.29 44.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.392 -174.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -129.92 160.75 32.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.201 173.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.609 ' HD2' HD12 ' A' ' 217' ' ' LEU . 3.8 ptm180 -125.49 128.11 47.51 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 164.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.716 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 23.5 mm -90.88 112.68 25.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.204 0.526 . . . . 0.0 110.912 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.556 ' OE1' ' HE3' ' A' ' 206' ' ' LYS . 89.5 mt-30 -88.16 -150.31 0.18 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 171.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -58.61 79.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.224 0.535 . . . . 0.0 112.313 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 64.85 17.56 63.11 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.179 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -131.47 146.03 52.05 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.081 -0.647 . . . . 0.0 112.389 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.716 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 35.6 mtpt -94.17 125.45 38.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.761 -174.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.556 ' HE3' ' OE1' ' A' ' 201' ' ' GLN . 72.3 mmtt -110.25 102.04 49.93 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.83 127.85 24.83 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.335 2.023 . . . . 0.0 112.046 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.513 ' HB ' ' HB ' ' A' ' 197' ' ' VAL . 26.5 mm -91.25 159.18 2.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.582 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.71 131.55 10.63 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.554 ' HB3' ' CG ' ' A' ' 178' ' ' ARG . 85.2 m95 -61.49 -33.8 74.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.249 0.525 . . . . 0.0 111.01 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -86.57 7.37 26.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.852 0.358 . . . . 0.0 111.176 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 177' ' ' VAL . 89.2 m -82.32 143.1 31.51 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.08 129.87 41.22 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.442 HG21 ' HB3' ' A' ' 180' ' ' SER . 0.4 OUTLIER -66.69 -17.24 22.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.753 -175.455 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 23.2 t -68.19 -14.0 62.66 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.059 -0.401 . . . . 0.0 110.331 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.521 ' HB2' HD22 ' A' ' 217' ' ' LEU . 20.6 m0 -76.2 -19.48 58.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.504 0.669 . . . . 0.0 110.0 175.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.609 HD12 ' HD2' ' A' ' 199' ' ' ARG . 1.5 mm? -115.65 20.77 14.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.333 -174.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.2 m -53.69 119.94 5.58 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.35 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 76.67 8.51 86.25 Favored Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 114.258 -1.337 . . . . 0.0 113.678 170.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -87.56 159.89 18.42 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 50.3 mt-10 -92.59 110.19 21.61 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 171.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.537 HD23 HG11 ' A' ' 197' ' ' VAL . 7.7 mp -96.22 161.67 13.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.994 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 197' ' ' VAL . 47.9 m-70 -125.96 122.48 36.07 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.068 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.666 HG12 ' HD3' ' A' ' 162' ' ' PRO . 2.7 t -100.72 114.17 38.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 174.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -108.29 127.81 54.19 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.919 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.75 129.27 37.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.089 0.471 . . . . 0.0 110.035 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.47 83.37 1.48 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.318 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -104.99 96.19 6.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.494 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 9.1 t30 57.55 61.97 2.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.55 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.896 -0.593 . . . . 99.99 110.782 178.37 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . 14.5 p . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 120.859 0.361 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 151' ' ' SER . 38.7 Cg_endo -65.33 86.44 0.2 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.95 2.434 . . . . 0.0 112.304 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -71.18 114.05 8.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.089 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -83.28 121.12 76.75 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 38.7 Cg_exo -59.47 162.49 14.74 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.868 2.379 . . . . 0.0 112.881 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.79 HD13 HG11 ' A' ' 168' ' ' VAL . 2.1 pp -132.32 163.59 37.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.846 -177.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 39.7 t -128.44 121.09 54.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.258 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.578 ' HG2' HG13 ' A' ' 168' ' ' VAL . 76.2 mtp180 -86.98 93.95 9.48 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.217 0.532 . . . . 0.0 111.374 -172.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.0 t -94.8 135.18 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.679 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.676 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 41.5 m-85 -90.18 103.6 16.26 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.92 175.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.613 HD22 ' H ' ' A' ' 161' ' ' LEU . 1.5 mm? -77.18 174.21 6.24 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 84.1 Cg_exo -50.88 154.98 6.27 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.679 2.253 . . . . 0.0 112.49 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.3 m120 67.09 15.2 10.05 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.968 -173.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 58.69 49.97 9.5 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.016 -177.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.676 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 22.2 mm-40 -86.77 178.77 6.91 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.678 172.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.6 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 7.5 mtm180 -147.4 141.45 26.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 118.548 0.613 . . . . 0.0 112.146 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.575 HG22 HD21 ' A' ' 161' ' ' LEU . 4.0 t -145.47 150.11 35.89 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 173.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.79 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -113.1 126.81 70.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.02 178.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 24.3 t -108.57 131.09 21.99 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.311 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 34.4 Cg_exo -56.73 118.41 5.25 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.409 1.406 . . . . 0.0 110.293 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.75 116.06 4.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.174 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 170' ' ' PRO . 98.1 mtt180 -104.39 112.3 25.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.643 -172.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 49.5 t -77.76 113.06 15.26 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 112.32 -12.7 26.06 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.407 -177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 176' ' ' THR . 1.2 t -107.49 144.59 16.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 40.1 p -85.89 160.67 19.35 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.104 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.61 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 15.4 m -57.15 -22.01 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' A' ' 210' ' ' TRP . 92.2 mtt-85 -52.67 -58.15 7.76 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.111 172.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.614 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 23.2 t70 -75.54 -41.98 53.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.461 0.648 . . . . 0.0 111.1 -172.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.575 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 10.8 p -64.2 -52.8 57.11 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.081 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 185' ' ' LEU . 2.5 mt -76.43 -15.88 59.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.184 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.614 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 5.2 ttmt -59.69 -47.8 84.21 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 173.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 2.2 tpmt? -58.89 -41.86 88.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.76 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.476 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -51.63 -63.92 0.98 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.997 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 181' ' ' LEU . 3.9 mp -69.82 -41.26 75.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.547 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 10.4 mmt -62.79 -31.16 72.08 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 62.0 mtm -74.4 -26.76 60.3 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.387 0.613 . . . . 0.0 109.635 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -82.73 -20.32 36.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.344 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.57 25.14 21.78 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.3 mp -118.39 171.0 8.45 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.704 0.402 . . . . 0.0 110.561 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 42.6 pt -119.47 132.4 24.02 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.871 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 3.7 Cg_exo -76.87 -12.04 18.04 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.95 2.433 . . . . 0.0 112.256 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -62.58 -40.11 95.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.464 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 12.5 t -99.16 34.13 2.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.35 0.595 . . . . 0.0 110.303 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.55 ' HB3' HG13 ' A' ' 224' ' ' VAL . 81.6 m -142.43 166.78 23.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.735 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.647 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -138.91 160.81 38.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.558 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.76 128.03 69.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.212 0.32 . . . . 0.0 110.335 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 33.6 m-85 -123.61 145.22 49.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.571 0.224 . . . . 0.0 110.398 174.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 206' ' ' LYS . 1.6 ptm180 -116.51 118.91 33.97 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 168.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 1.2 mp -81.2 106.52 12.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 121.324 0.583 . . . . 0.0 109.969 -176.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 203' ' ' GLY . 24.4 mt-30 -87.11 -141.02 0.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.94 174.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -59.64 77.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.245 0.545 . . . . 0.0 112.272 -173.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.3 15.83 46.74 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.709 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.522 ' OE2' ' HE2' ' A' ' 206' ' ' LYS . 7.3 pt-20 -132.5 137.5 47.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.373 0.606 . . . . 0.0 111.819 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -82.34 127.47 33.27 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.35 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.522 ' HE2' ' OE2' ' A' ' 204' ' ' GLU . 5.3 mptp? -106.34 106.52 57.61 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.586 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -70.29 118.64 5.8 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.704 1.602 . . . . 0.0 111.662 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 56.2 mt -95.95 154.01 3.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.07 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.05 142.31 22.25 Favored Glycine 0 N--CA 1.438 -1.186 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.661 ' O ' ' HG3' ' A' ' 178' ' ' ARG . 81.9 m95 -66.3 -23.52 66.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 117.47 0.635 . . . . 0.0 110.532 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.48 19.88 9.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.044 0.45 . . . . 0.0 110.952 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 69.5 m -86.64 140.19 30.06 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.806 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.405 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 15.8 t70 -68.86 121.2 16.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.616 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.445 HG21 ' CB ' ' A' ' 180' ' ' SER . 0.5 OUTLIER -66.84 -22.38 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.744 -176.821 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.405 ' HB3' ' OD1' ' A' ' 213' ' ' ASP . 9.4 t -74.81 -8.78 57.46 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.375 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -69.75 -38.69 76.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.683 0.754 . . . . 0.0 108.997 169.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.45 ' HB3' HD21 ' A' ' 222' ' ' LEU . 0.3 OUTLIER -97.26 26.32 4.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.087 -175.466 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 52.2 m -50.24 114.33 1.09 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.566 0.698 . . . . 0.0 112.307 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 86.59 -8.41 75.24 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.495 171.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -74.6 156.44 36.76 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 52.7 mt-10 -87.7 109.85 20.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 70.1 mt -96.51 152.56 18.51 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -118.85 120.35 37.06 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.096 -175.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 2.6 t -100.1 111.83 30.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 121.568 0.699 . . . . 0.0 109.307 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -108.91 145.7 34.98 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.695 -173.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.14 128.75 38.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.922 -175.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.11 80.59 7.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.228 0.537 . . . . 0.0 109.99 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -136.36 97.46 3.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.761 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -94.69 24.41 4.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.314 -176.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 116.35 -0.386 . . . . 99.99 110.382 176.417 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 121.071 0.462 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -59.9 -41.33 54.67 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.329 2.686 . . . . 0.0 111.92 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -89.11 126.79 35.6 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -82.49 124.69 77.59 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.446 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.405 ' HB2' HG23 ' A' ' 218' ' ' THR . 23.5 Cg_exo -63.7 161.14 33.36 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.722 2.281 . . . . 0.0 111.594 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.476 ' CG2' HG23 ' A' ' 168' ' ' VAL . 1.5 pp -121.88 169.8 12.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.164 0.507 . . . . 0.0 111.978 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.512 HG21 HG13 ' A' ' 214' ' ' ILE . 5.4 t -130.88 115.46 30.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.536 ' HG2' HG11 ' A' ' 168' ' ' VAL . 20.2 mtm180 -92.12 98.08 11.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.223 0.535 . . . . 0.0 111.632 -166.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.2 t -91.29 141.51 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.669 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -103.42 103.96 13.99 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.524 172.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.6 HD13 ' HD2' ' A' ' 188' ' ' ARG . 7.3 mt -83.03 169.8 16.53 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.18 -172.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 88.2 Cg_exo -50.67 149.52 13.73 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.1 2.533 . . . . 0.0 112.503 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 69.0 30.11 4.59 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.538 -176.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 51.9 47.52 24.61 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.601 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.491 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 15.0 mm100 -95.99 170.67 9.13 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 7.9 ttt180 -148.65 135.75 20.1 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.84 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.464 ' CG2' HD11 ' A' ' 161' ' ' LEU . 1.4 t -151.6 141.77 22.28 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.536 HG11 ' HG2' ' A' ' 158' ' ' ARG . 0.7 OUTLIER -117.26 130.07 72.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 C-N-CA 119.451 -0.899 . . . . 0.0 110.307 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.4 p -109.53 136.12 20.28 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.514 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.41 128.61 30.81 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.233 1.955 . . . . 0.0 111.167 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.16 89.49 0.45 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.81 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.483 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 64.3 mtt180 -77.27 113.96 15.58 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.989 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.5 t -70.12 115.23 9.09 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.03 -3.57 35.58 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.457 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.483 ' CG1' ' HB2' ' A' ' 172' ' ' ARG . 0.4 OUTLIER -108.42 150.22 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.041 0.448 . . . . 0.0 109.944 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.8 p -87.93 152.13 22.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.231 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 212' ' ' THR . 86.6 t -46.53 -42.68 5.46 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 O-C-N 123.512 0.507 . . . . 0.0 110.46 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 11.0 ptm180 -49.78 -48.65 50.37 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.35 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.586 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 16.2 t70 -70.21 -47.55 60.98 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.346 0.594 . . . . 0.0 111.039 -176.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.59 -45.89 77.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.254 -175.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -28.49 62.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.325 176.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 8.6 mtmt -54.04 -49.94 67.81 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.567 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.3 tpmt? -56.81 -47.37 80.39 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 175.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.446 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -51.36 -60.63 2.91 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.242 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 5.5 mp -68.0 -48.32 66.09 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 122.619 0.368 . . . . 0.0 111.557 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 1.0 OUTLIER -59.51 -34.3 72.44 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.882 -176.407 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.567 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 67.4 mtm -71.03 -31.37 67.83 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.23 0.538 . . . . 0.0 109.691 175.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.6 ' HD2' HD13 ' A' ' 161' ' ' LEU . 9.1 mtt180 -86.2 -4.68 59.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.813 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.37 25.92 49.38 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.093 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.1 mp -116.0 161.59 18.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 29.4 pt -120.65 128.74 25.64 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.142 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 23.4 Cg_exo -66.02 -14.66 45.47 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 123.002 2.468 . . . . 0.0 112.28 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -60.19 -42.44 95.09 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.497 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.5 t -104.23 28.84 6.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.392 0.615 . . . . 0.0 110.028 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.56 ' HB3' HG13 ' A' ' 224' ' ' VAL . 84.0 m -139.87 165.8 26.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.443 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -149.53 164.57 34.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.245 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.577 HG11 HD23 ' A' ' 222' ' ' LEU . 14.7 t -111.1 133.13 57.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.33 -174.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -126.87 143.94 51.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.193 172.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.458 ' HD2' HD22 ' A' ' 217' ' ' LEU . 7.7 ptm180 -118.2 114.95 23.8 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 168.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.538 HD12 ' HG2' ' A' ' 205' ' ' LYS . 5.5 mm -81.58 102.66 7.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 C-N-CA 120.089 -0.645 . . . . 0.0 110.087 -172.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.533 ' OE1' ' HE2' ' A' ' 206' ' ' LYS . 33.2 mt-30 -76.55 -145.15 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.304 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -57.18 79.82 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.788 0.435 . . . . 0.0 112.058 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.58 16.97 46.93 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.8 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -127.25 134.47 50.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.993 0.425 . . . . 0.0 111.347 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.538 ' HG2' HD12 ' A' ' 200' ' ' ILE . 48.0 mtpt -81.07 119.74 23.94 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.071 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.533 ' HE2' ' OE1' ' A' ' 201' ' ' GLN . 8.4 tptt -109.79 104.84 56.33 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.771 -175.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.37 124.84 10.74 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.104 1.869 . . . . 0.0 112.17 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.487 HD12 HG12 ' A' ' 197' ' ' VAL . 46.9 mt -100.01 153.81 4.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.919 -176.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.85 138.85 15.87 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -67.4 -20.82 65.59 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.103 0.451 . . . . 0.0 110.154 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -92.62 6.89 45.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.914 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.623 ' O ' HG23 ' A' ' 177' ' ' VAL . 96.5 m -78.62 147.15 33.75 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 172.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 215' ' ' SER . 12.5 t70 -74.55 130.05 38.87 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.512 HG13 HG21 ' A' ' 157' ' ' VAL . 0.2 OUTLIER -72.56 -15.1 17.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 111.458 -174.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.431 ' HB2' ' OD1' ' A' ' 213' ' ' ASP . 70.8 m -75.01 -8.87 57.75 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.899 -0.5 . . . . 0.0 110.587 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 30.1 m0 -82.36 -11.46 58.56 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 172.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.623 HD13 HD21 ' A' ' 222' ' ' LEU . 5.6 mt -118.46 19.26 13.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.022 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.405 HG23 ' HB2' ' A' ' 155' ' ' PRO . 99.5 m -52.27 117.25 2.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.534 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 86.3 -4.13 86.37 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.266 170.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -75.84 157.88 32.81 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 28.4 mt-10 -98.05 111.62 23.87 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.623 HD21 HD13 ' A' ' 217' ' ' LEU . 6.4 mp -95.45 164.93 12.6 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.191 -175.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -133.97 130.09 37.15 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 40.9 t -100.86 123.83 54.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.106 0.479 . . . . 0.0 109.768 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 5.9 mm-40 -107.8 146.23 32.5 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.682 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 85.7 t -84.47 122.68 38.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.93 0.395 . . . . 0.0 110.075 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 64.6 mt -72.88 82.7 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.352 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -129.66 96.91 4.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.465 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -160.1 23.01 0.17 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.668 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 116.229 -0.441 . . . . 99.99 110.762 -177.594 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.464 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 10.9 p . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 120.745 0.307 . . . . 0.0 110.775 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 151' ' ' SER . 16.7 Cg_exo -70.07 60.5 1.85 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.468 2.779 . . . . 0.0 112.261 177.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -78.13 125.79 29.87 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.423 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -74.7 114.99 39.77 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 173.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.491 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 41.5 Cg_endo -65.1 166.28 19.28 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.637 2.224 . . . . 0.0 112.719 -175.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.757 HD13 HG11 ' A' ' 168' ' ' VAL . 1.9 pp -132.83 152.69 36.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.464 -177.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.494 HG13 HG23 ' A' ' 169' ' ' VAL . 0.5 OUTLIER -124.32 134.59 66.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.398 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.546 ' HG2' HG13 ' A' ' 168' ' ' VAL . 1.3 mtp180 -94.2 97.61 10.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.288 -165.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.0 t -97.64 134.44 35.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.146 -175.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 2.3 m-85 -92.3 103.67 16.1 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.391 175.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.667 HD22 ' H ' ' A' ' 161' ' ' LEU . 1.1 mm? -78.03 169.62 20.09 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.594 ' HD3' HG12 ' A' ' 224' ' ' VAL . 78.5 Cg_exo -52.78 152.98 15.81 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.71 2.273 . . . . 0.0 113.228 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.2 t30 65.2 41.11 4.61 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.746 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 59.88 31.01 20.52 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.219 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 26.6 mm-40 -85.3 161.42 19.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 26.8 ttp180 -149.25 134.94 18.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.525 HG22 HD21 ' A' ' 161' ' ' LEU . 1.1 t -145.63 151.64 38.39 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.757 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -108.05 129.31 62.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.232 178.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.494 HG23 HG13 ' A' ' 157' ' ' VAL . 14.7 m -105.45 130.99 22.15 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.257 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 27.7 Cg_endo -64.38 121.09 8.59 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.821 1.681 . . . . 0.0 111.182 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.491 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -69.92 95.16 0.9 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.262 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -93.25 112.19 24.05 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.4 -173.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.473 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 49.0 t -70.11 113.39 7.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.51 0.01 27.78 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.742 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 179' ' ' ASP . 0.3 OUTLIER -116.2 152.05 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.125 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 24.3 p -89.01 159.8 17.41 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.699 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 212' ' ' THR . 87.4 t -50.5 -38.21 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.574 ' CG ' ' HB3' ' A' ' 210' ' ' TRP . 26.6 mtp180 -45.63 -58.81 3.13 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.563 175.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.656 ' HA ' ' CE ' ' A' ' 182' ' ' LYS . 32.3 m-20 -67.07 -45.53 77.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.922 0.392 . . . . 0.0 111.913 -170.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.7 t -71.38 -38.62 71.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.15 0.5 . . . . 0.0 110.478 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.444 HD22 HG11 ' A' ' 169' ' ' VAL . 0.4 OUTLIER -75.93 -27.7 57.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.455 177.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.656 ' CE ' ' HA ' ' A' ' 179' ' ' ASP . 37.1 mtmt -55.22 -52.42 63.43 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.508 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 2.2 tpmt? -61.86 -40.46 95.42 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.316 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.484 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -55.53 -55.85 27.11 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.751 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.496 HD21 HG11 ' A' ' 224' ' ' VAL . 2.0 mt -70.11 -46.37 64.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.318 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 12.9 mmt -59.97 -36.67 77.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.961 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 58.2 mtm -76.35 -12.91 60.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.062 0.458 . . . . 0.0 110.251 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -110.33 17.8 20.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.527 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 62.63 36.94 93.95 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.198 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.481 HD13 ' HD2' ' A' ' 162' ' ' PRO . 24.2 mt -128.36 166.91 17.76 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.494 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 37.4 pt -130.64 130.64 22.96 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.053 0.454 . . . . 0.0 111.85 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 16.2 Cg_exo -68.76 -16.13 41.47 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.088 2.525 . . . . 0.0 112.341 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -65.34 -37.52 87.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.071 -177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 16.9 t -109.78 37.0 2.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.415 0.626 . . . . 0.0 109.992 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.588 ' HB3' HG13 ' A' ' 224' ' ' VAL . 99.1 m -146.73 162.36 38.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.672 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -142.16 157.29 45.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.78 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 10.9 t -107.13 123.73 62.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.584 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 47.8 m-85 -116.14 153.8 31.13 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 173.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.503 ' HB3' ' CD2' ' A' ' 222' ' ' LEU . 12.2 ptt180 -126.33 111.73 14.87 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 167.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.656 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 1.2 mp -80.92 110.48 16.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.293 0.568 . . . . 0.0 110.866 -173.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -83.78 -146.53 0.09 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.843 172.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 20.6 m-20 -61.31 79.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.837 0.351 . . . . 0.0 111.868 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.79 14.76 65.8 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.412 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.656 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 30.4 mt-10 -116.89 134.37 54.85 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 120.746 0.308 . . . . 0.0 111.71 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -95.03 112.45 24.15 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 74.9 mmtt -98.4 107.14 40.34 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.156 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -74.51 118.92 5.52 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.943 1.762 . . . . 0.0 111.467 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.659 HG21 HD11 ' A' ' 217' ' ' LEU . 22.0 mt -93.83 152.75 3.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.088 -174.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -85.49 139.95 17.76 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.574 ' HB3' ' CG ' ' A' ' 178' ' ' ARG . 88.4 m95 -70.41 -34.99 73.17 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.645 0.26 . . . . 0.0 111.164 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.48 5.5 23.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.119 0.485 . . . . 0.0 111.238 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.548 ' O ' HG23 ' A' ' 177' ' ' VAL . 95.6 m -74.8 148.37 40.39 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 170.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -73.49 134.38 43.86 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 171' ' ' ALA . 0.1 OUTLIER -69.94 -16.36 20.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.958 0.408 . . . . 0.0 110.653 -178.396 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 18.7 m -65.49 -15.88 63.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.994 0.426 . . . . 0.0 110.73 176.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 32.9 m0 -80.54 -17.64 50.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.22 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.659 HD11 HG21 ' A' ' 208' ' ' ILE . 10.4 mt -112.81 19.87 16.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.724 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 99.7 m -52.1 112.86 0.87 Allowed 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.413 -177.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 80.07 8.93 87.2 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.427 171.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -85.17 151.32 24.19 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 36.5 mt-10 -86.99 111.14 20.56 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.503 ' CD2' ' HB3' ' A' ' 199' ' ' ARG . 61.0 mt -105.56 159.63 15.8 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.214 -175.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -125.99 122.44 35.9 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.833 0.349 . . . . 0.0 110.27 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.594 HG12 ' HD3' ' A' ' 162' ' ' PRO . 4.5 t -101.05 115.54 42.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.566 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 24.6 mt-10 -112.35 141.9 45.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.78 -175.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.84 127.62 34.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.831 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 67.3 mt -77.97 81.66 4.36 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 176.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -73.62 94.16 2.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.631 0.729 . . . . 0.0 110.222 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -161.79 29.52 0.12 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.385 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.178 -0.919 . . . . 99.99 110.757 -177.479 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.421 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . 16.1 p . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.822 0.344 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 151' ' ' SER . 52.1 Cg_endo -68.99 -40.95 5.78 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.787 2.325 . . . . 0.0 111.343 176.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.549 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 5.8 tp-100 -91.82 106.42 18.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.499 175.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -108.66 89.97 6.85 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.951 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 153' ' ' GLN . 3.8 Cg_exo -74.79 152.44 41.9 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.505 2.137 . . . . 0.0 111.241 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.709 HD13 HG11 ' A' ' 168' ' ' VAL . 1.8 pp -126.09 156.36 36.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.493 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -125.23 134.23 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.533 ' HG2' HG13 ' A' ' 168' ' ' VAL . 81.7 mtm180 -95.41 105.46 17.43 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -167.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.8 t -96.87 135.45 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.807 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 64.9 m-85 -97.4 103.12 15.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.788 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.611 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.1 mt -84.52 173.84 6.66 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.098 -170.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.611 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 99.1 Cg_exo -48.66 153.47 3.49 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.128 2.552 . . . . 0.0 113.236 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 63.16 24.46 14.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.492 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 61.18 44.05 10.37 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.088 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 15.2 mm100 -90.8 177.93 6.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.781 177.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 38.7 ttp180 -147.36 153.44 39.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.548 0.214 . . . . 0.0 110.545 176.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.479 HG21 ' HB1' ' A' ' 184' ' ' ALA . 1.4 t -163.31 151.79 13.95 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 170.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.709 HG11 HD13 ' A' ' 156' ' ' ILE . 0.1 OUTLIER -115.06 128.29 72.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.298 177.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.7 p -115.83 133.29 22.86 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.412 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.41 131.55 43.44 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.281 1.987 . . . . 0.0 111.924 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.79 75.69 1.59 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.801 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -68.51 111.99 5.05 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.536 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.602 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 59.0 m -70.45 116.61 10.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.825 0.345 . . . . 0.0 110.128 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.03 -6.0 36.76 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.923 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.69 142.91 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.0 p -88.46 155.13 19.84 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.018 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.575 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 88.5 t -52.96 -34.34 20.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.636 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 16.0 ptt180 -56.67 -47.72 79.19 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 122.256 -0.277 . . . . 0.0 111.568 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.614 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 20.6 t70 -72.25 -45.49 59.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.174 0.511 . . . . 0.0 110.867 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.479 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 2.8 p -63.31 -53.24 55.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.378 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.7 OUTLIER -69.96 -24.41 63.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.121 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.614 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 11.8 mtmt -57.65 -51.25 70.28 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.537 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.4 tpmt? -61.43 -42.6 98.99 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.952 177.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.479 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -53.47 -61.11 2.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.411 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 181' ' ' LEU . 1.5 mt -65.02 -44.68 88.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.24 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.538 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 6.5 mmt -61.38 -32.19 72.11 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 62.5 mtm -77.16 -22.69 52.13 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.213 0.53 . . . . 0.0 110.02 175.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.1 5.77 50.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.73 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 69.81 36.69 74.85 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.966 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.412 HD13 ' HD2' ' A' ' 162' ' ' PRO . 21.4 mt -131.11 165.99 22.06 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 122.87 0.468 . . . . 0.0 110.021 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 35.7 pt -126.62 135.19 26.91 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.907 0.384 . . . . 0.0 111.36 177.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 15.9 Cg_exo -69.01 -16.5 40.77 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.029 2.486 . . . . 0.0 111.985 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -59.13 -45.51 90.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.534 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 16.2 t -105.41 34.74 3.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.257 0.551 . . . . 0.0 109.75 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.561 ' HB3' HG13 ' A' ' 224' ' ' VAL . 91.1 m -141.84 162.36 35.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.991 -176.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.632 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -143.62 154.63 43.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.133 174.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 13.3 t -105.92 138.01 33.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.676 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -129.24 150.32 50.67 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.439 ' HD2' HD22 ' A' ' 217' ' ' LEU . 2.9 ptm180 -114.31 116.38 28.88 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 166.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.521 HD13 ' CD2' ' A' ' 223' ' ' HIS . 1.5 mp -80.63 112.25 18.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.685 0.755 . . . . 0.0 110.437 -175.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' A' ' 203' ' ' GLY . 25.0 mm-40 -88.52 -142.34 0.13 Allowed 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.281 174.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -58.22 79.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.6 18.01 50.43 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.597 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 13.3 pt-20 -135.0 167.56 20.72 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.413 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.406 ' HG2' HD11 ' A' ' 200' ' ' ILE . 48.0 mtmt -108.28 133.27 52.73 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.711 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -111.87 103.97 55.65 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.19 132.5 41.83 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.361 2.041 . . . . 0.0 112.155 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.532 HG21 HD11 ' A' ' 217' ' ' LEU . 20.3 mm -96.77 158.12 3.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.281 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -96.0 142.11 15.95 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -70.27 -22.55 62.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 117.315 0.558 . . . . 0.0 111.068 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -94.05 9.82 36.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.895 0.379 . . . . 0.0 110.833 176.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.536 ' O ' HG23 ' A' ' 177' ' ' VAL . 81.4 m -77.71 150.46 34.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -80.1 124.41 28.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.744 0.783 . . . . 0.0 109.589 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.408 HD12 ' HB2' ' A' ' 180' ' ' SER . 7.7 tt -53.58 -30.19 18.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.768 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.602 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 12.9 m -62.91 -16.79 60.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.901 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -79.29 -13.61 59.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.222 0.534 . . . . 0.0 109.654 175.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.532 HD11 HG21 ' A' ' 208' ' ' ILE . 11.5 mt -117.92 16.51 14.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.83 -176.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 97.4 m -50.63 119.44 3.82 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.864 0.84 . . . . 0.0 112.865 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 75.71 8.7 84.62 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 114.214 -1.357 . . . . 0.0 113.498 170.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -92.78 164.78 13.23 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.751 0.31 . . . . 0.0 110.409 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 6.4 mp0 -96.35 111.01 23.24 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.412 HD21 ' HB3' ' A' ' 217' ' ' LEU . 28.7 mt -100.6 165.9 11.18 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' HIS . . . . . 0.521 ' CD2' HD13 ' A' ' 200' ' ' ILE . 55.5 m-70 -136.57 124.92 23.3 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 42.4 t -103.69 124.63 58.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.024 0.44 . . . . 0.0 110.268 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 71.0 mm-40 -110.79 155.05 23.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.666 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 43.1 t -83.38 129.19 37.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.532 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.4 mp -85.83 81.34 8.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.126 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -100.57 95.69 6.87 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.654 0.74 . . . . 0.0 109.243 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -132.89 37.04 3.46 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.636 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.302 -0.863 . . . . 99.99 110.671 -178.555 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.419 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . 59.2 p . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 121.041 0.448 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 151' ' ' SER . 17.9 Cg_endo -58.09 -34.52 98.56 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.347 2.698 . . . . 0.0 111.998 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -100.88 100.02 10.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.797 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -93.77 112.61 57.61 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 66.6 Cg_endo -71.93 162.52 41.65 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.729 2.286 . . . . 0.0 112.887 -175.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.749 HD13 HG11 ' A' ' 168' ' ' VAL . 1.9 pp -129.87 157.85 42.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.622 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.97 133.91 68.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.588 ' HG2' HG13 ' A' ' 168' ' ' VAL . 18.1 mtm180 -92.31 108.03 19.65 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.476 0.655 . . . . 0.0 112.09 -168.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.688 HG22 ' HB2' ' A' ' 222' ' ' LEU . 11.6 t -96.1 145.75 8.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.626 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.563 ' CZ ' ' HD2' ' A' ' 166' ' ' ARG . 21.7 m-85 -112.61 103.01 11.05 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.822 176.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.5 mm? -76.58 173.99 6.47 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -172.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.622 ' HD2' HD13 ' A' ' 190' ' ' LEU . 74.4 Cg_exo -54.11 155.01 16.31 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.571 2.18 . . . . 0.0 112.873 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.9 t30 66.74 21.86 10.47 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.947 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.568 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 61.17 44.9 9.52 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.399 179.083 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.621 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 15.1 mm-40 -86.64 171.94 10.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.329 174.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.563 ' HD2' ' CZ ' ' A' ' 160' ' ' PHE . 47.1 ttt180 -148.4 133.79 18.55 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.448 HG22 HD21 ' A' ' 161' ' ' LEU . 5.4 t -137.43 174.74 10.27 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.749 HG11 HD13 ' A' ' 156' ' ' ILE . 0.2 OUTLIER -132.09 128.6 59.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.632 170.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.48 129.85 23.44 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.711 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.461 ' HA ' HG22 ' A' ' 156' ' ' ILE . 31.5 Cg_exo -57.08 123.48 13.95 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.313 2.009 . . . . 0.0 111.476 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.45 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -61.75 99.96 0.13 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.628 0.728 . . . . 0.0 109.286 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.648 ' HG2' ' HB ' ' A' ' 175' ' ' VAL . 17.2 ttp180 -107.81 111.97 24.38 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.916 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.658 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 42.4 t -70.84 128.3 35.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.87 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 109.06 -21.18 27.61 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.767 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.648 ' HB ' ' HG2' ' A' ' 172' ' ' ARG . 0.9 OUTLIER -99.19 142.85 14.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.367 0.603 . . . . 0.0 110.749 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 5.6 p -81.56 148.69 29.01 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.641 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.497 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 21.9 m -49.48 -32.09 6.19 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.616 0 CA-C-N 117.904 0.32 . . . . 0.0 110.319 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 21.3 ptt180 -58.82 -43.38 90.61 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.613 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 21.2 t70 -71.34 -47.64 55.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.964 0.802 . . . . 0.0 110.477 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.481 ' HA ' HH21 ' A' ' 172' ' ' ARG . 0.6 OUTLIER -62.21 -43.36 99.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.414 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.42 -36.32 68.58 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.178 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.696 ' O ' ' HB2' ' A' ' 186' ' ' MET . 7.9 mtmt -50.64 -45.07 57.62 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.805 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.513 ' O ' ' HG3' ' A' ' 187' ' ' MET . 10.9 tppt? -67.41 -51.46 51.48 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.917 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -43.73 -54.13 5.35 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.482 0.489 . . . . 0.0 111.973 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 5.1 mp -69.24 -52.39 28.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.63 0.372 . . . . 0.0 111.733 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.696 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 1.3 ttm -54.28 -38.35 65.77 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -176.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.513 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 68.7 mtm -74.46 -16.52 60.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.338 0.59 . . . . 0.0 110.179 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 188' ' ' ARG . 49.8 mtt180 -105.9 12.73 30.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.324 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 68.6 38.5 86.23 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.015 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.622 HD13 ' HD2' ' A' ' 162' ' ' PRO . 20.8 mt -132.02 157.93 42.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.743 0.306 . . . . 0.0 110.676 -176.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 14.0 pt -122.22 127.32 25.95 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.349 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 11.6 Cg_exo -71.03 -12.84 31.0 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.865 2.377 . . . . 0.0 111.895 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -58.47 -41.27 84.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.017 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 74.1 m -105.44 34.88 3.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.897 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.513 ' HB3' HG13 ' A' ' 224' ' ' VAL . 80.9 m -145.04 164.84 29.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.866 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.599 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -139.2 160.13 40.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.447 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 17.0 t -109.13 140.69 26.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.464 -176.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.415 ' CD1' ' HB3' ' A' ' 205' ' ' LYS . 22.1 m-85 -134.32 142.67 47.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.09 177.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.504 ' HD2' HD12 ' A' ' 217' ' ' LEU . 8.0 ptm180 -108.26 117.84 35.21 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 166.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.854 HD13 ' HA ' ' A' ' 205' ' ' LYS . 13.9 mm -79.92 104.27 7.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.224 0.535 . . . . 0.0 110.708 -172.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 203' ' ' GLY . 14.0 mm100 -76.82 -147.21 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.189 173.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -62.41 77.83 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.128 0.49 . . . . 0.0 111.485 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 64.89 16.69 62.02 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -176.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 44.1 mt-10 -111.18 133.82 53.25 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.115 0.483 . . . . 0.0 111.734 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.854 ' HA ' HD13 ' A' ' 200' ' ' ILE . 39.9 mtpt -84.4 97.48 9.52 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 171.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -94.13 98.97 3.22 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.684 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.599 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 25.3 Cg_exo -62.67 135.95 55.44 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.566 2.177 . . . . 0.0 112.848 -174.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 197' ' ' VAL . 22.8 mm -98.02 154.44 3.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.791 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.81 134.04 12.18 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 174.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.497 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 86.9 m95 -64.84 -24.55 67.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.325 0.563 . . . . 0.0 110.97 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -93.57 14.11 19.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.961 0.41 . . . . 0.0 111.247 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 177' ' ' VAL . 85.4 m -88.11 145.33 25.99 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -72.81 134.12 44.78 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.469 HG21 ' HB2' ' A' ' 180' ' ' SER . 0.1 OUTLIER -69.97 -16.6 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 110.961 -175.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.658 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 8.3 m -66.51 -19.62 65.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.744 176.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.547 ' HB2' HD22 ' A' ' 217' ' ' LEU . 27.8 m0 -75.59 -23.63 56.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.545 0.688 . . . . 0.0 109.815 176.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.548 HD22 ' N ' ' A' ' 217' ' ' LEU . 1.4 mm? -109.32 23.95 13.77 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.36 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 51.3 m -54.37 114.22 1.57 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.625 0.726 . . . . 0.0 111.958 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 84.14 -2.84 87.25 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.946 173.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.39 156.94 36.51 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 50.3 mt-10 -89.71 108.38 19.65 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.688 ' HB2' HG22 ' A' ' 159' ' ' VAL . 82.8 mt -102.47 109.68 21.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.74 0.781 . . . . 0.0 110.478 -175.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -84.22 122.04 28.31 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.856 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 3.7 t -99.93 109.95 25.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.51 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -110.27 145.26 37.7 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.657 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.58 133.52 31.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 196' ' ' ALA . 55.9 mt -76.56 82.04 3.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.196 0.522 . . . . 0.0 110.854 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -101.69 93.76 5.5 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -123.47 23.77 8.84 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.079 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 115.469 -0.787 . . . . 99.99 110.22 178.787 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 63.9 Cg_endo . . . . . 0 N--CA 1.464 -0.247 0 CA-C-O 120.742 0.226 . . . . 0.0 112.053 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.78 HD13 HG11 ' A' ' 168' ' ' VAL . 2.0 pp -129.75 167.07 25.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.957 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 46.4 t -127.86 126.24 66.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.298 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 21.2 mtm180 -93.92 91.59 6.98 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.126 0.488 . . . . 0.0 111.941 -170.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 222' ' ' LEU . 2.1 t -93.44 162.23 2.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.609 0.718 . . . . 0.0 111.057 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.49 ' H ' HG12 ' A' ' 159' ' ' VAL . 49.4 m-85 -125.2 107.31 10.62 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.795 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.1 mm? -82.22 167.03 33.27 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 71.7 Cg_exo -48.18 147.49 8.24 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.521 2.814 . . . . 0.0 113.566 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 69.56 34.56 2.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.187 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.489 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 62.12 43.19 8.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.826 176.181 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 78.2 mm-40 -97.17 165.47 12.03 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.653 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 159' ' ' VAL . 37.0 ttp180 -145.95 145.62 30.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.755 HG21 ' HB1' ' A' ' 184' ' ' ALA . 15.2 t -146.06 150.23 35.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.522 177.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.78 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -120.98 127.25 75.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.231 170.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.4 p -123.75 133.89 24.93 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.338 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 74.2 Cg_exo -51.49 128.36 25.6 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.383 2.055 . . . . 0.0 111.973 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.39 79.12 0.75 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.535 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.408 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 92.1 mtt180 -68.56 115.74 8.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.726 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 46.8 t -80.44 109.79 15.29 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.68 19.36 7.43 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 -173.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.459 HG12 ' CG2' ' A' ' 214' ' ' ILE . 0.9 OUTLIER -140.48 132.7 31.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.6 p -74.35 153.3 39.35 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.242 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.55 ' HA ' ' OG ' ' A' ' 180' ' ' SER . 4.2 m -58.52 -21.84 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.62 ' HG2' ' HE2' ' A' ' 182' ' ' LYS . 32.0 ttt180 -58.94 -59.05 6.08 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.694 174.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.638 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 25.7 t70 -64.4 -48.6 74.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.209 0.528 . . . . 0.0 111.417 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.55 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 11.3 p -60.24 -56.87 16.27 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.489 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 8.3 mp -74.28 -14.85 60.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.032 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.638 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 5.3 mtmt -59.92 -48.21 82.62 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 187' ' ' MET . 12.0 tppt? -60.13 -49.49 77.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.175 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.755 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -47.11 -53.44 12.85 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.583 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.459 HD21 HG11 ' A' ' 224' ' ' VAL . 1.5 mt -74.19 -43.51 56.95 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.554 0.342 . . . . 0.0 111.507 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.495 ' HB3' ' O ' ' A' ' 182' ' ' LYS . 18.7 tpp -65.59 -33.92 77.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.043 -174.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.498 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 66.8 mtm -74.02 -9.75 58.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.297 0.57 . . . . 0.0 109.971 175.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 167' ' ' THR . 74.7 mtt85 -109.65 1.37 19.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.18 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 78.62 21.85 68.25 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.483 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.2 mp -113.99 172.53 6.93 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 34.6 pt -132.82 132.5 22.56 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.204 0.526 . . . . 0.0 111.527 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.55 ' HG2' ' HG3' ' A' ' 182' ' ' LYS . 23.9 Cg_exo -65.7 -21.15 59.05 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.359 2.706 . . . . 0.0 113.127 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -62.86 -33.38 75.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.776 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 35.4 t -102.68 31.83 3.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.373 0.606 . . . . 0.0 109.89 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.616 ' HB3' HG13 ' A' ' 224' ' ' VAL . 71.2 m -143.17 167.6 21.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.983 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -138.0 155.65 48.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.241 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 223' ' ' HIS . 9.6 t -107.55 136.61 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 123.208 0.318 . . . . 0.0 110.27 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -130.92 151.95 50.77 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.479 ' CG ' ' HB2' ' A' ' 206' ' ' LYS . 1.2 ptm180 . . . . . 0 C--N 1.318 -0.776 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 167.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.479 ' HB2' ' CG ' ' A' ' 199' ' ' ARG . 75.0 mmtt -111.73 98.13 40.07 Favored Pre-proline 0 N--CA 1.444 -0.736 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -65.95 119.15 6.14 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.859 1.706 . . . . 0.0 111.998 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 38.3 mt -96.61 154.22 3.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.615 -177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.0 145.66 20.02 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.529 ' O ' ' HB2' ' A' ' 178' ' ' ARG . 96.2 m95 -68.95 -25.09 64.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.28 0.54 . . . . 0.0 110.496 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -87.97 9.95 20.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.743 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.504 ' O ' HG13 ' A' ' 177' ' ' VAL . 94.9 m -83.57 143.22 30.3 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.445 ' HB3' ' CD1' ' A' ' 216' ' ' TRP . 9.3 t70 -75.27 137.19 41.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.925 0.393 . . . . 0.0 110.094 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.459 ' CG2' HG12 ' A' ' 175' ' ' VAL . 0.2 OUTLIER -78.24 -17.55 13.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.581 -174.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 85.9 p -69.78 -14.09 62.6 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 121.961 -0.462 . . . . 0.0 110.442 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.445 ' CD1' ' HB3' ' A' ' 213' ' ' ASP . 27.5 m0 -67.71 -40.64 84.26 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 174.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.41 ' HB3' HD21 ' A' ' 222' ' ' LEU . 0.3 OUTLIER -99.87 31.64 3.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.423 -175.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 51.1 m -52.91 113.85 1.23 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.403 0.62 . . . . 0.0 112.343 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 84.06 2.65 89.4 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.973 -1.012 . . . . 0.0 113.658 171.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.54 154.92 19.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.683 0.278 . . . . 0.0 110.392 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 2.1 mp0 -85.97 111.29 20.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 35.9 mt -103.83 164.94 11.35 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 197' ' ' VAL . 85.4 m-70 -129.34 135.6 48.94 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.616 HG13 ' HB3' ' A' ' 195' ' ' CYS . 9.4 t -113.45 109.34 28.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 28.5 mt-10 -110.11 155.21 22.21 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.088 -175.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.99 131.25 34.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.942 -173.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 121.674 0.75 . . . . 0.0 109.179 173.052 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.461 -0.413 0 CA-C-O 121.151 0.396 . . . . 0.0 112.776 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.563 ' O ' ' HA2' ' A' ' 219' ' ' GLY . 1.4 pp -122.12 171.54 10.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.688 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.7 133.13 57.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.598 ' HG2' HG11 ' A' ' 168' ' ' VAL . 20.5 mtm180 -99.17 106.83 19.05 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.145 0.497 . . . . 0.0 111.872 -162.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 222' ' ' LEU . 25.9 t -100.13 145.21 11.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.634 -172.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -109.27 104.7 13.88 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.067 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.627 HD21 HG22 ' A' ' 167' ' ' THR . 1.5 mm? -81.57 172.47 9.62 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -174.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.627 ' HD3' HG12 ' A' ' 224' ' ' VAL . 77.5 Cg_exo -54.47 159.92 7.71 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.614 2.209 . . . . 0.0 112.183 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 66.03 24.5 11.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.002 0.43 . . . . 0.0 110.154 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 56.15 43.98 25.92 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.191 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 28.8 mm-40 -89.65 167.38 12.97 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.412 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -146.39 129.73 16.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.434 0.635 . . . . 0.0 111.42 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.627 HG22 HD21 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -144.5 139.09 28.04 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.013 178.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.598 HG11 ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -116.57 129.27 73.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.632 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.31 136.23 19.57 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.805 -173.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.6 130.01 36.65 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.29 1.993 . . . . 0.0 111.294 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.13 91.45 0.22 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.453 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.458 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 92.2 mtt180 -77.08 111.59 12.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.044 -176.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.575 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 3.3 p -72.45 115.46 11.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.5 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 98.86 15.58 33.39 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.948 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.458 ' CG1' ' HB2' ' A' ' 172' ' ' ARG . 0.5 OUTLIER -130.15 148.91 33.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.4 p -83.45 154.39 23.96 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.646 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 212' ' ' THR . 64.1 t -53.81 -30.58 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.559 -0.746 . . . . 0.0 108.992 172.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.584 ' HG3' ' HB3' ' A' ' 210' ' ' TRP . 12.1 ttt180 -53.93 -58.97 5.33 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.66 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.63 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 11.3 t70 -63.26 -47.88 80.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.336 0.588 . . . . 0.0 111.274 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.544 ' OG ' HG21 ' A' ' 214' ' ' ILE . 17.9 m -59.51 -51.59 69.22 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.166 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.483 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.4 OUTLIER -78.36 -19.03 54.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.651 0.263 . . . . 0.0 110.407 -178.208 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.63 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 15.5 mtmt -60.65 -48.51 81.45 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.504 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 2.2 tpmt? -61.45 -41.19 96.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.802 176.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.519 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -53.66 -57.33 11.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.767 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 181' ' ' LEU . 1.4 mt -71.55 -41.34 69.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.483 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 7.0 mmt -66.29 -28.39 68.66 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -176.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 62.4 mtm -79.64 -9.16 59.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.082 0.468 . . . . 0.0 109.96 175.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -109.72 -3.2 16.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.522 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.07 21.21 61.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.209 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.0 mp -115.04 172.11 7.26 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.526 HG13 ' SG ' ' A' ' 194' ' ' CYS . 21.4 pt -128.88 133.1 24.82 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.526 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.544 ' HB3' ' CZ3' ' A' ' 210' ' ' TRP . 14.9 Cg_exo -69.0 -21.03 37.6 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.027 2.485 . . . . 0.0 112.133 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -57.82 -41.73 82.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.736 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . 0.526 ' SG ' HG13 ' A' ' 191' ' ' ILE . 20.9 p -96.89 16.81 18.3 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.371 -177.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.481 ' HB3' HG13 ' A' ' 224' ' ' VAL . 85.1 m -126.08 166.83 16.28 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.175 0.512 . . . . 0.0 111.638 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -146.2 159.79 42.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.065 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.678 HG11 HD23 ' A' ' 222' ' ' LEU . 11.7 t -115.11 138.85 44.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.118 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 29.9 m-85 -129.72 146.65 51.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.255 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.53 ' HD2' HD22 ' A' ' 217' ' ' LEU . 7.1 ptm180 . . . . . 0 C--N 1.32 -0.68 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 167.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.455 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 44.6 mtpt . . . . . 0 N--CA 1.445 -0.683 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 75.3 mmtt -101.91 102.74 25.04 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.03 -177.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 8.0 Cg_exo -69.34 119.45 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.101 1.867 . . . . 0.0 111.634 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.452 HD12 HG12 ' A' ' 197' ' ' VAL . 56.9 mt -93.74 155.8 3.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.283 -174.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -92.42 135.09 12.53 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.584 ' HB3' ' HG3' ' A' ' 178' ' ' ARG . 86.5 m95 -64.8 -40.51 95.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.041 0.448 . . . . 0.0 110.667 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.32 6.04 3.99 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 177' ' ' VAL . 97.2 m -81.22 145.26 31.06 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 172.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.24 131.24 44.58 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.544 HG21 ' OG ' ' A' ' 180' ' ' SER . 0.1 OUTLIER -73.74 -15.18 16.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.781 0.324 . . . . 0.0 111.356 -174.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.575 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 23.4 m -70.27 -10.51 59.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.052 0.453 . . . . 0.0 110.579 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.6 m0 -74.97 -27.05 60.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.449 0.642 . . . . 0.0 109.399 172.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.756 HD13 HD21 ' A' ' 222' ' ' LEU . 7.1 mt -110.8 19.24 18.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.075 -174.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 215' ' ' SER . 100.0 m -51.15 115.5 1.58 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.687 0.756 . . . . 0.0 112.194 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 85.99 3.77 85.07 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.386 -1.279 . . . . 0.0 113.244 171.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -87.9 158.2 18.76 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -91.61 111.08 22.44 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 173.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.756 HD21 HD13 ' A' ' 217' ' ' LEU . 6.7 mp -98.04 150.21 21.65 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.043 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -120.0 122.02 40.23 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.751 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.627 HG12 ' HD3' ' A' ' 162' ' ' PRO . 4.0 t -100.16 117.05 44.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.083 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -108.55 137.01 47.2 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.657 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.7 p -91.18 128.6 42.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.595 0.712 . . . . 0.0 110.195 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 C--N 1.319 -0.746 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.627 -176.89 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo . . . . . 0 N--CA 1.456 -0.721 0 N-CA-C 111.051 -0.404 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.79 HD13 HG11 ' A' ' 168' ' ' VAL . 2.1 pp -121.06 160.13 22.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.558 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.68 134.67 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.526 ' HG2' HG13 ' A' ' 168' ' ' VAL . 71.5 mtm180 -96.73 101.01 12.53 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -168.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 160' ' ' PHE . 2.8 t -92.97 160.1 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 121.785 0.802 . . . . 0.0 111.801 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.558 ' CZ ' ' HD2' ' A' ' 166' ' ' ARG . 41.0 m-85 -124.76 105.76 9.54 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.131 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.546 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 3.3 mp -85.7 174.61 5.42 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.946 -172.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 87.2 Cg_exo -52.86 160.09 4.42 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.744 2.296 . . . . 0.0 112.835 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 64.12 31.97 12.99 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.273 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt 56.02 47.79 19.06 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.357 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.578 HE22 HD11 ' A' ' 190' ' ' LEU . 28.2 mt-30 -101.81 166.79 10.47 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.255 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.558 ' HD2' ' CZ ' ' A' ' 160' ' ' PHE . 38.4 ttt180 -147.67 144.24 28.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.556 0.217 . . . . 0.0 110.859 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.453 HG22 HD11 ' A' ' 161' ' ' LEU . 1.4 t -155.27 152.68 29.54 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.79 HG11 HD13 ' A' ' 156' ' ' ILE . 0.2 OUTLIER -114.2 128.84 71.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.255 178.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.9 p -116.5 137.03 23.27 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.562 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.71 135.44 60.2 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.175 1.916 . . . . 0.0 111.685 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.76 78.34 1.12 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.104 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -69.54 111.92 5.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.593 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.67 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 8.5 p -76.93 110.09 11.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.992 0.425 . . . . 0.0 109.872 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 109.07 9.17 26.49 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.574 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.84 137.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.5 p -79.4 154.47 28.96 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.96 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 212' ' ' THR . 81.4 t -47.07 -40.95 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.477 0.486 . . . . 0.0 109.696 175.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.607 ' CG ' ' HB3' ' A' ' 210' ' ' TRP . 92.9 mtt-85 -48.45 -52.57 21.55 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.483 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.593 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 14.7 t70 -73.98 -45.48 49.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.138 0.494 . . . . 0.0 111.339 -172.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.423 ' CB ' HG21 ' A' ' 214' ' ' ILE . 0.3 OUTLIER -67.54 -42.87 82.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.896 -177.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.3 OUTLIER -76.68 -21.17 55.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.145 177.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.644 ' O ' ' HB2' ' A' ' 186' ' ' MET . 4.4 ttmt -59.23 -48.23 82.4 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.1 tpmt? -60.56 -46.2 91.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.791 175.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.452 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -51.75 -55.94 16.73 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.984 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 181' ' ' LEU . 1.7 mt -72.58 -43.16 63.77 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.734 0.413 . . . . 0.0 111.769 -178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.644 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 3.3 mmt -66.02 -26.52 67.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -176.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.502 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 64.6 mtm -77.38 -20.35 54.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.359 0.599 . . . . 0.0 109.724 173.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -106.6 17.59 23.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.592 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 62.75 35.43 91.92 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.276 -0.487 . . . . 0.0 112.676 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.578 HD11 HE22 ' A' ' 165' ' ' GLN . 21.1 mt -128.41 169.37 14.36 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.531 0.333 . . . . 0.0 110.171 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 45.8 pt -131.89 135.24 26.35 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.057 0.456 . . . . 0.0 111.534 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.476 ' HG2' ' HG3' ' A' ' 182' ' ' LYS . 19.6 Cg_exo -66.77 -22.2 50.07 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.102 2.535 . . . . 0.0 112.645 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.89 -19.98 62.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.478 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 12.2 t -112.13 25.94 11.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.518 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 74.2 m -140.78 166.74 23.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.096 -175.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -146.66 154.41 41.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.121 175.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.08 130.62 61.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.597 0.237 . . . . 0.0 110.776 -176.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 35.6 m-85 -131.28 152.9 50.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.759 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.79 ' HG3' HD11 ' A' ' 208' ' ' ILE . 67.2 mtp180 . . . . . 0 C--N 1.327 -0.386 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 168.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 39.1 mtpt . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 74.1 mmtt -101.7 100.5 14.53 Favored Pre-proline 0 N--CA 1.444 -0.741 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 4.0 Cg_exo -71.26 126.76 12.63 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.868 1.712 . . . . 0.0 111.316 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.79 HD11 ' HG3' ' A' ' 199' ' ' ARG . 4.7 mt -107.77 149.66 10.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.77 -173.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.7 136.01 14.15 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.607 ' HB3' ' CG ' ' A' ' 178' ' ' ARG . 91.1 m95 -65.08 -27.8 69.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.698 0.285 . . . . 0.0 110.917 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.404 ' CG ' ' HE ' ' A' ' 178' ' ' ARG . 11.0 m-20 -90.73 12.76 18.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.823 0.344 . . . . 0.0 111.242 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 177' ' ' VAL . 48.1 m -85.84 154.15 21.75 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -78.48 132.18 37.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.423 HG21 ' CB ' ' A' ' 180' ' ' SER . 0.3 OUTLIER -70.32 -11.94 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.987 0.422 . . . . 0.0 110.997 -178.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.67 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 16.4 m -66.38 -18.26 65.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.98 0.419 . . . . 0.0 110.359 173.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -78.66 -14.79 59.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.455 0.645 . . . . 0.0 109.888 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.624 HD11 HG21 ' A' ' 208' ' ' ILE . 17.8 mt -113.34 17.4 18.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.797 -177.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 91.2 m -53.64 117.59 3.25 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.775 0.798 . . . . 0.0 112.395 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 74.07 8.14 78.03 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.118 173.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -84.49 148.72 26.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 3.2 mp0 -85.26 109.47 18.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 171.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 86.2 mt -98.61 149.93 22.27 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.994 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -124.05 122.58 38.26 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 38.7 t -100.07 143.95 13.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.042 0.449 . . . . 0.0 110.167 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 8.6 mm-40 -120.91 151.39 39.74 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.236 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 162' ' ' PRO . 1.2 t -89.89 116.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 34.3 mt . . . . . 0 C--N 1.323 -0.549 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.976 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.496 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 23.8 Cg_exo . . . . . 0 N--CA 1.461 -0.391 0 N-CA-C 110.446 -0.636 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.817 HD13 HG11 ' A' ' 168' ' ' VAL . 2.2 pp -131.29 156.61 42.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.166 0.508 . . . . 0.0 111.417 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.511 HG22 ' H ' ' A' ' 219' ' ' GLY . 41.0 t -124.11 123.75 67.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.756 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.499 ' HA ' HG13 ' A' ' 168' ' ' VAL . 23.6 mtm180 -88.47 96.54 10.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.49 0.662 . . . . 0.0 111.723 -169.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.635 HG22 ' HB2' ' A' ' 222' ' ' LEU . 3.8 t -96.03 129.98 45.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.059 -176.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.573 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 42.4 m-85 -94.29 103.51 15.53 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.871 174.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.604 HD22 ' HD2' ' A' ' 188' ' ' ARG . 2.9 mp -82.59 176.67 3.6 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 80.2 Cg_exo -50.17 153.73 6.44 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.711 2.274 . . . . 0.0 112.736 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 65.96 27.26 10.83 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.661 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 54.07 36.77 25.46 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.745 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 26.9 mm-40 -75.58 170.24 16.53 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 17.8 ttp180 -148.59 137.46 21.55 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.151 173.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.12 154.39 41.76 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.817 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -113.73 127.36 71.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.312 178.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.5 m -104.88 138.74 19.59 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.053 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 13.0 Cg_exo -65.55 125.14 13.88 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.265 1.31 . . . . 0.0 110.925 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.12 86.08 0.55 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.044 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.464 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 97.2 mtt180 -78.98 112.04 15.77 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.11 -174.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.618 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 4.1 p -67.53 110.02 3.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.831 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 106.78 8.16 32.63 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.296 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 172' ' ' ARG . 0.3 OUTLIER -117.16 149.87 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.045 0.45 . . . . 0.0 109.866 176.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.48 ' HB ' ' HG2' ' A' ' 178' ' ' ARG . 1.7 p -86.1 152.3 22.98 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.368 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 212' ' ' THR . 92.8 t -49.07 -41.61 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 O-C-N 123.452 0.47 . . . . 0.0 110.326 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.48 ' HG2' ' HB ' ' A' ' 176' ' ' THR . 30.9 ptt180 -51.24 -47.45 62.38 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.094 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.587 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 11.8 t70 -68.08 -49.79 59.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.121 0.486 . . . . 0.0 110.967 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.8 t -67.04 -43.99 81.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.464 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.643 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.3 OUTLIER -73.42 -27.33 61.38 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.206 179.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 13.0 mtmt -55.29 -45.62 76.22 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.476 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 1.8 tpmt? -60.01 -42.6 94.64 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 181' ' ' LEU . . . -55.12 -60.89 2.76 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.938 178.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 181' ' ' LEU . 1.6 mm? -60.29 -52.01 67.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.005 0.522 . . . . 0.0 110.904 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 12.2 mmt -57.96 -42.69 85.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.53 -174.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.45 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 57.6 mtm -71.04 -8.42 53.24 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.045 0.45 . . . . 0.0 110.533 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.604 ' HD2' HD22 ' A' ' 161' ' ' LEU . 51.2 mtt-85 -113.77 5.07 16.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.571 -177.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 73.38 21.74 79.32 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.325 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.611 ' HB3' HD12 ' A' ' 185' ' ' LEU . 0.2 OUTLIER -110.61 173.11 6.48 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -177.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 32.3 pt -132.15 127.34 20.93 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.176 0.512 . . . . 0.0 111.873 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.534 ' HB3' ' CZ3' ' A' ' 210' ' ' TRP . 22.5 Cg_exo -65.54 -21.48 59.82 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.307 2.672 . . . . 0.0 112.331 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.25 -45.4 93.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.923 -174.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 23.8 t -98.11 37.53 1.42 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.282 0.563 . . . . 0.0 109.967 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.707 ' HB3' HG13 ' A' ' 224' ' ' VAL . 71.8 m -138.7 158.56 44.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.78 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -131.66 150.43 52.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.014 175.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.425 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 4.1 t -104.59 131.67 53.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 123.239 0.337 . . . . 0.0 110.508 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -126.56 141.99 51.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.774 0.321 . . . . 0.0 110.807 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.444 ' HD3' HD22 ' A' ' 217' ' ' LEU . 19.3 ptt180 . . . . . 0 C--N 1.316 -0.881 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 165.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.514 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 45.5 mtpt . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 206' ' ' LYS . 11.7 tppt? -98.26 102.67 14.79 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.129 -174.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 10.6 Cg_exo -70.6 127.9 14.54 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.32 2.013 . . . . 0.0 112.413 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 217' ' ' LEU . 35.1 mt -103.22 161.9 4.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.233 -1.348 . . . . 0.0 109.963 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.48 147.45 18.6 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.676 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.534 ' CZ3' ' HB3' ' A' ' 192' ' ' PRO . 92.1 m95 -74.72 -18.5 60.5 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -87.63 -4.21 58.95 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.343 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 177' ' ' VAL . 89.9 m -70.19 147.89 49.29 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -76.61 129.18 36.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.432 HG13 HG21 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -68.9 -16.49 20.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.914 0.388 . . . . 0.0 111.056 -175.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.618 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 13.9 m -67.47 -21.03 65.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.848 0.356 . . . . 0.0 110.751 177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 24.1 m0 -74.93 -17.53 60.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.324 0.583 . . . . 0.0 109.583 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.469 HD11 HG21 ' A' ' 208' ' ' ILE . 6.0 mt -116.95 17.99 14.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.444 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 82.1 m -49.88 113.1 0.77 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.399 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.511 ' H ' HG22 ' A' ' 157' ' ' VAL . . . 86.5 6.28 80.9 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.041 -0.982 . . . . 0.0 113.41 170.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -90.46 158.48 17.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.806 0.336 . . . . 0.0 110.253 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 3.2 mp0 -90.1 111.15 22.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.635 ' HB2' HG22 ' A' ' 159' ' ' VAL . 58.5 mt -107.36 133.87 51.26 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.85 0.357 . . . . 0.0 110.802 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -102.16 123.24 45.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.489 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.707 HG13 ' HB3' ' A' ' 195' ' ' CYS . 39.4 t -105.95 112.18 38.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.321 0.582 . . . . 0.0 109.895 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 25.1 mt-10 -109.62 145.27 36.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.606 -173.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 66.7 t -77.87 129.76 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.949 0.404 . . . . 0.0 111.025 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.655 177.621 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 N--CA 1.45 -1.073 0 N-CA-C 110.728 -0.528 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.765 HD13 HG11 ' A' ' 168' ' ' VAL . 2.0 pp -130.7 161.07 41.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.896 -0.138 . . . . 0.0 111.116 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.37 134.63 62.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.612 ' HG2' HG13 ' A' ' 168' ' ' VAL . 85.3 mtm180 -94.61 103.27 15.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.049 0.452 . . . . 0.0 112.093 -168.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.4 t -96.76 136.93 25.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.837 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 53.5 m-85 -94.64 104.0 15.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.63 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.648 HD22 ' H ' ' A' ' 161' ' ' LEU . 0.7 OUTLIER -81.34 170.56 14.89 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.666 ' HD3' HG12 ' A' ' 224' ' ' VAL . 53.1 Cg_exo -56.72 156.91 21.06 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.749 2.3 . . . . 0.0 112.491 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 67.21 37.26 3.73 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.336 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt 55.13 48.92 18.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.585 177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.56 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 27.9 mm-40 -104.29 160.89 14.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.104 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 28.5 ttp180 -147.05 138.99 24.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.898 0.38 . . . . 0.0 110.687 173.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.501 HG22 HD21 ' A' ' 161' ' ' LEU . 4.8 t -141.47 157.15 45.51 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.765 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -119.83 127.74 75.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.326 175.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.4 p -115.56 134.62 22.62 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.277 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.9 132.25 48.61 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.23 1.953 . . . . 0.0 111.454 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.9 75.96 0.89 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.691 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -64.74 111.81 2.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.922 -176.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 48.2 m -76.44 110.02 10.63 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 110.47 11.56 19.34 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.317 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.403 ' CG1' ' HB3' ' A' ' 180' ' ' SER . 1.1 t -133.05 138.01 52.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 21.3 p -81.93 160.2 23.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.233 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.616 HG13 HD13 ' A' ' 181' ' ' LEU . 86.7 t -52.52 -30.6 14.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.659 171.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.554 ' CG ' ' HB3' ' A' ' 210' ' ' TRP . 72.6 mtp180 -53.74 -58.38 7.44 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.283 174.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.607 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 14.5 t70 -74.52 -43.49 55.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.11 0.481 . . . . 0.0 111.096 -174.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.521 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 28.1 p -60.76 -57.68 11.67 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.28 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.616 HD13 HG13 ' A' ' 177' ' ' VAL . 9.6 mp -77.08 -11.69 59.84 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 122.102 -0.374 . . . . 0.0 111.154 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.607 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 4.7 ttmt -58.19 -46.31 86.03 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 171.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.465 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 2.4 tpmt? -59.57 -44.47 93.3 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.792 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.435 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -50.99 -54.93 20.09 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.465 HD23 ' HB3' ' A' ' 190' ' ' LEU . 5.3 mp -78.22 -38.46 43.02 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 14.7 mmt -63.48 -28.48 69.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.557 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 64.8 mtm -77.87 -7.33 56.56 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.355 0.598 . . . . 0.0 109.961 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.471 ' CZ ' ' HB ' ' A' ' 167' ' ' THR . 55.8 mtt85 -113.06 0.7 15.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.479 -178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 73.66 25.36 72.4 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.021 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.465 ' HB3' HD23 ' A' ' 185' ' ' LEU . 10.1 mp -115.59 152.61 32.75 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.475 ' O ' HD12 ' A' ' 191' ' ' ILE . 2.4 pp -108.2 128.67 25.27 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-O 121.067 0.46 . . . . 0.0 110.898 176.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 16.6 Cg_exo -68.14 -6.76 18.05 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.854 2.369 . . . . 0.0 112.362 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -75.26 -11.22 60.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.166 -175.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 27.7 t -126.27 34.65 4.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.538 ' HB3' HG13 ' A' ' 224' ' ' VAL . 77.3 m -144.47 158.82 43.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.188 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -136.29 159.26 42.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.704 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.537 HG11 HD23 ' A' ' 222' ' ' LEU . 23.8 t -114.06 138.29 44.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.392 -174.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -129.92 160.75 32.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.201 173.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.609 ' HD2' HD12 ' A' ' 217' ' ' LEU . 3.8 ptm180 . . . . . 0 C--N 1.316 -0.863 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 164.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.648 0.261 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -110.25 102.04 49.93 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.83 127.85 24.83 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.335 2.023 . . . . 0.0 112.046 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.513 ' HB ' ' HB ' ' A' ' 197' ' ' VAL . 26.5 mm -91.25 159.18 2.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.582 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.71 131.55 10.63 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.554 ' HB3' ' CG ' ' A' ' 178' ' ' ARG . 85.2 m95 -61.49 -33.8 74.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.249 0.525 . . . . 0.0 111.01 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -86.57 7.37 26.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.852 0.358 . . . . 0.0 111.176 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 177' ' ' VAL . 89.2 m -82.32 143.1 31.51 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.08 129.87 41.22 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.442 HG21 ' HB3' ' A' ' 180' ' ' SER . 0.4 OUTLIER -66.69 -17.24 22.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.753 -175.455 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 23.2 t -68.19 -14.0 62.66 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.059 -0.401 . . . . 0.0 110.331 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.521 ' HB2' HD22 ' A' ' 217' ' ' LEU . 20.6 m0 -76.2 -19.48 58.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.504 0.669 . . . . 0.0 110.0 175.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.609 HD12 ' HD2' ' A' ' 199' ' ' ARG . 1.5 mm? -115.65 20.77 14.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.333 -174.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.2 m -53.69 119.94 5.58 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.35 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 76.67 8.51 86.25 Favored Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 114.258 -1.337 . . . . 0.0 113.678 170.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -87.56 159.89 18.42 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 50.3 mt-10 -92.59 110.19 21.61 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 171.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.537 HD23 HG11 ' A' ' 197' ' ' VAL . 7.7 mp -96.22 161.67 13.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.994 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 197' ' ' VAL . 47.9 m-70 -125.96 122.48 36.07 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.068 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.666 HG12 ' HD3' ' A' ' 162' ' ' PRO . 2.7 t -100.72 114.17 38.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 174.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -108.29 127.81 54.19 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.919 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.75 129.27 37.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.089 0.471 . . . . 0.0 110.035 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.318 -176.644 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 38.7 Cg_exo . . . . . 0 N--CA 1.47 0.138 0 N-CA-C 112.881 0.3 . . . . 0.0 112.881 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.79 HD13 HG11 ' A' ' 168' ' ' VAL . 2.1 pp -132.32 163.59 37.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.846 -177.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 39.7 t -128.44 121.09 54.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.258 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.578 ' HG2' HG13 ' A' ' 168' ' ' VAL . 76.2 mtp180 -86.98 93.95 9.48 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.217 0.532 . . . . 0.0 111.374 -172.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.0 t -94.8 135.18 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.679 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.676 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 41.5 m-85 -90.18 103.6 16.26 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.92 175.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.613 HD22 ' H ' ' A' ' 161' ' ' LEU . 1.5 mm? -77.18 174.21 6.24 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 84.1 Cg_exo -50.88 154.98 6.27 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.679 2.253 . . . . 0.0 112.49 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.3 m120 67.09 15.2 10.05 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.968 -173.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 58.69 49.97 9.5 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.016 -177.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.676 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -86.77 178.77 6.91 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.678 172.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.6 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 7.5 mtm180 -147.4 141.45 26.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 118.548 0.613 . . . . 0.0 112.146 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.575 HG22 HD21 ' A' ' 161' ' ' LEU . 4.0 t -145.47 150.11 35.89 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 173.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.79 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -113.1 126.81 70.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.02 178.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 24.3 t -108.57 131.09 21.99 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.311 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 34.4 Cg_exo -56.73 118.41 5.25 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.409 1.406 . . . . 0.0 110.293 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.75 116.06 4.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.174 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 170' ' ' PRO . 98.1 mtt180 -104.39 112.3 25.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.643 -172.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 49.5 t -77.76 113.06 15.26 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 112.32 -12.7 26.06 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.407 -177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 176' ' ' THR . 1.2 t -107.49 144.59 16.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 40.1 p -85.89 160.67 19.35 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.104 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.61 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 15.4 m -57.15 -22.01 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' A' ' 210' ' ' TRP . 92.2 mtt-85 -52.67 -58.15 7.76 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.111 172.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.614 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 23.2 t70 -75.54 -41.98 53.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.461 0.648 . . . . 0.0 111.1 -172.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.575 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 10.8 p -64.2 -52.8 57.11 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.081 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 185' ' ' LEU . 2.5 mt -76.43 -15.88 59.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.184 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.614 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 5.2 ttmt -59.69 -47.8 84.21 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 173.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 2.2 tpmt? -58.89 -41.86 88.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.76 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.476 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -51.63 -63.92 0.98 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.997 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 181' ' ' LEU . 3.9 mp -69.82 -41.26 75.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.547 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 10.4 mmt -62.79 -31.16 72.08 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 62.0 mtm -74.4 -26.76 60.3 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.387 0.613 . . . . 0.0 109.635 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -82.73 -20.32 36.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.344 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.57 25.14 21.78 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.3 mp -118.39 171.0 8.45 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.704 0.402 . . . . 0.0 110.561 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 42.6 pt -119.47 132.4 24.02 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.871 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 3.7 Cg_exo -76.87 -12.04 18.04 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.95 2.433 . . . . 0.0 112.256 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -62.58 -40.11 95.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.464 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 12.5 t -99.16 34.13 2.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.35 0.595 . . . . 0.0 110.303 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.55 ' HB3' HG13 ' A' ' 224' ' ' VAL . 81.6 m -142.43 166.78 23.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.735 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.647 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -138.91 160.81 38.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.558 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.76 128.03 69.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.212 0.32 . . . . 0.0 110.335 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 33.6 m-85 -123.61 145.22 49.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.571 0.224 . . . . 0.0 110.398 174.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 206' ' ' LYS . 1.6 ptm180 . . . . . 0 C--N 1.317 -0.834 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 168.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 120.719 0.295 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 199' ' ' ARG . 5.3 mptp? -106.34 106.52 57.61 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.586 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -70.29 118.64 5.8 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.704 1.602 . . . . 0.0 111.662 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 56.2 mt -95.95 154.01 3.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.07 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.05 142.31 22.25 Favored Glycine 0 N--CA 1.438 -1.186 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.661 ' O ' ' HG3' ' A' ' 178' ' ' ARG . 81.9 m95 -66.3 -23.52 66.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 117.47 0.635 . . . . 0.0 110.532 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.48 19.88 9.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.044 0.45 . . . . 0.0 110.952 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 69.5 m -86.64 140.19 30.06 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.806 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.405 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 15.8 t70 -68.86 121.2 16.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.616 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.445 HG21 ' CB ' ' A' ' 180' ' ' SER . 0.5 OUTLIER -66.84 -22.38 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.744 -176.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.405 ' HB3' ' OD1' ' A' ' 213' ' ' ASP . 9.4 t -74.81 -8.78 57.46 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.375 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -69.75 -38.69 76.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.683 0.754 . . . . 0.0 108.997 169.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.45 ' HB3' HD21 ' A' ' 222' ' ' LEU . 0.3 OUTLIER -97.26 26.32 4.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.087 -175.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 52.2 m -50.24 114.33 1.09 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.566 0.698 . . . . 0.0 112.307 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 86.59 -8.41 75.24 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.495 171.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -74.6 156.44 36.76 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 52.7 mt-10 -87.7 109.85 20.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 70.1 mt -96.51 152.56 18.51 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -118.85 120.35 37.06 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.096 -175.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 2.6 t -100.1 111.83 30.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 121.568 0.699 . . . . 0.0 109.307 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -108.91 145.7 34.98 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.695 -173.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.14 128.75 38.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.922 -175.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 C--N 1.325 -0.462 0 CA-C-O 121.228 0.537 . . . . 0.0 109.99 175.715 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.405 ' HB2' HG23 ' A' ' 218' ' ' THR . 23.5 Cg_exo . . . . . 0 N--CA 1.465 -0.196 0 N-CA-C 111.594 -0.194 . . . . 0.0 111.594 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.476 ' CG2' HG23 ' A' ' 168' ' ' VAL . 1.5 pp -121.88 169.8 12.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.164 0.507 . . . . 0.0 111.978 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.512 HG21 HG13 ' A' ' 214' ' ' ILE . 5.4 t -130.88 115.46 30.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.536 ' HG2' HG11 ' A' ' 168' ' ' VAL . 20.2 mtm180 -92.12 98.08 11.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.223 0.535 . . . . 0.0 111.632 -166.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.2 t -91.29 141.51 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.669 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -103.42 103.96 13.99 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.524 172.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.6 HD13 ' HD2' ' A' ' 188' ' ' ARG . 7.3 mt -83.03 169.8 16.53 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.18 -172.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 88.2 Cg_exo -50.67 149.52 13.73 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.1 2.533 . . . . 0.0 112.503 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 14.3 m120 69.0 30.11 4.59 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.538 -176.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 51.9 47.52 24.61 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.601 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.491 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 15.0 mm100 -95.99 170.67 9.13 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 7.9 ttt180 -148.65 135.75 20.1 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.84 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.464 ' CG2' HD11 ' A' ' 161' ' ' LEU . 1.4 t -151.6 141.77 22.28 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.536 HG11 ' HG2' ' A' ' 158' ' ' ARG . 0.7 OUTLIER -117.26 130.07 72.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 C-N-CA 119.451 -0.899 . . . . 0.0 110.307 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.4 p -109.53 136.12 20.28 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.514 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.41 128.61 30.81 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.233 1.955 . . . . 0.0 111.167 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.16 89.49 0.45 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.81 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.483 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 64.3 mtt180 -77.27 113.96 15.58 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.989 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.5 t -70.12 115.23 9.09 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.03 -3.57 35.58 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.457 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.483 ' CG1' ' HB2' ' A' ' 172' ' ' ARG . 0.4 OUTLIER -108.42 150.22 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.041 0.448 . . . . 0.0 109.944 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.8 p -87.93 152.13 22.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.231 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 212' ' ' THR . 86.6 t -46.53 -42.68 5.46 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 O-C-N 123.512 0.507 . . . . 0.0 110.46 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 11.0 ptm180 -49.78 -48.65 50.37 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.35 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.586 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 16.2 t70 -70.21 -47.55 60.98 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.346 0.594 . . . . 0.0 111.039 -176.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.59 -45.89 77.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.254 -175.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -28.49 62.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.325 176.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 8.6 mtmt -54.04 -49.94 67.81 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.567 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.3 tpmt? -56.81 -47.37 80.39 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 175.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.446 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -51.36 -60.63 2.91 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.242 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 5.5 mp -68.0 -48.32 66.09 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 122.619 0.368 . . . . 0.0 111.557 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 1.0 OUTLIER -59.51 -34.3 72.44 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.882 -176.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.567 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 67.4 mtm -71.03 -31.37 67.83 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.23 0.538 . . . . 0.0 109.691 175.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.6 ' HD2' HD13 ' A' ' 161' ' ' LEU . 9.1 mtt180 -86.2 -4.68 59.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.813 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.37 25.92 49.38 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.093 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.1 mp -116.0 161.59 18.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 29.4 pt -120.65 128.74 25.64 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.142 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 23.4 Cg_exo -66.02 -14.66 45.47 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 123.002 2.468 . . . . 0.0 112.28 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -60.19 -42.44 95.09 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.497 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.5 t -104.23 28.84 6.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.392 0.615 . . . . 0.0 110.028 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.56 ' HB3' HG13 ' A' ' 224' ' ' VAL . 84.0 m -139.87 165.8 26.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.443 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -149.53 164.57 34.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.245 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.577 HG11 HD23 ' A' ' 222' ' ' LEU . 14.7 t -111.1 133.13 57.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.33 -174.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -126.87 143.94 51.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.193 172.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.458 ' HD2' HD22 ' A' ' 217' ' ' LEU . 7.7 ptm180 . . . . . 0 C--N 1.314 -0.956 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 168.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -109.79 104.84 56.33 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.771 -175.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.37 124.84 10.74 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.104 1.869 . . . . 0.0 112.17 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.487 HD12 HG12 ' A' ' 197' ' ' VAL . 46.9 mt -100.01 153.81 4.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.919 -176.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.85 138.85 15.87 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -67.4 -20.82 65.59 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.103 0.451 . . . . 0.0 110.154 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -92.62 6.89 45.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.914 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.623 ' O ' HG23 ' A' ' 177' ' ' VAL . 96.5 m -78.62 147.15 33.75 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 172.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 215' ' ' SER . 12.5 t70 -74.55 130.05 38.87 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.512 HG13 HG21 ' A' ' 157' ' ' VAL . 0.2 OUTLIER -72.56 -15.1 17.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 111.458 -174.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.431 ' HB2' ' OD1' ' A' ' 213' ' ' ASP . 70.8 m -75.01 -8.87 57.75 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.899 -0.5 . . . . 0.0 110.587 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 30.1 m0 -82.36 -11.46 58.56 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 172.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.623 HD13 HD21 ' A' ' 222' ' ' LEU . 5.6 mt -118.46 19.26 13.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.022 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.405 HG23 ' HB2' ' A' ' 155' ' ' PRO . 99.5 m -52.27 117.25 2.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.534 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 86.3 -4.13 86.37 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.266 170.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -75.84 157.88 32.81 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 28.4 mt-10 -98.05 111.62 23.87 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.623 HD21 HD13 ' A' ' 217' ' ' LEU . 6.4 mp -95.45 164.93 12.6 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.191 -175.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -133.97 130.09 37.15 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 40.9 t -100.86 123.83 54.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.106 0.479 . . . . 0.0 109.768 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 5.9 mm-40 -107.8 146.23 32.5 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.682 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 85.7 t -84.47 122.68 38.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.93 0.395 . . . . 0.0 110.075 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 64.6 mt . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.352 -179.086 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.491 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 41.5 Cg_endo . . . . . 0 N--CA 1.463 -0.306 0 CA-C-O 121.029 0.345 . . . . 0.0 112.719 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.757 HD13 HG11 ' A' ' 168' ' ' VAL . 1.9 pp -132.83 152.69 36.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.464 -177.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.494 HG13 HG23 ' A' ' 169' ' ' VAL . 0.5 OUTLIER -124.32 134.59 66.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.398 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.546 ' HG2' HG13 ' A' ' 168' ' ' VAL . 1.3 mtp180 -94.2 97.61 10.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.288 -165.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.0 t -97.64 134.44 35.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.146 -175.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 2.3 m-85 -92.3 103.67 16.1 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.391 175.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.667 HD22 ' H ' ' A' ' 161' ' ' LEU . 1.1 mm? -78.03 169.62 20.09 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.594 ' HD3' HG12 ' A' ' 224' ' ' VAL . 78.5 Cg_exo -52.78 152.98 15.81 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.71 2.273 . . . . 0.0 113.228 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.2 t30 65.2 41.11 4.61 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.746 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 59.88 31.01 20.52 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.219 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 26.6 mm-40 -85.3 161.42 19.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 26.8 ttp180 -149.25 134.94 18.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.525 HG22 HD21 ' A' ' 161' ' ' LEU . 1.1 t -145.63 151.64 38.39 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.757 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -108.05 129.31 62.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.232 178.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.494 HG23 HG13 ' A' ' 157' ' ' VAL . 14.7 m -105.45 130.99 22.15 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.257 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 27.7 Cg_endo -64.38 121.09 8.59 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.821 1.681 . . . . 0.0 111.182 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.491 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -69.92 95.16 0.9 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.262 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -93.25 112.19 24.05 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.4 -173.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.473 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 49.0 t -70.11 113.39 7.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.51 0.01 27.78 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.742 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 179' ' ' ASP . 0.3 OUTLIER -116.2 152.05 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 24.3 p -89.01 159.8 17.41 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.699 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 212' ' ' THR . 87.4 t -50.5 -38.21 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.574 ' CG ' ' HB3' ' A' ' 210' ' ' TRP . 26.6 mtp180 -45.63 -58.81 3.13 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.563 175.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.656 ' HA ' ' CE ' ' A' ' 182' ' ' LYS . 32.3 m-20 -67.07 -45.53 77.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.922 0.392 . . . . 0.0 111.913 -170.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.7 t -71.38 -38.62 71.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.15 0.5 . . . . 0.0 110.478 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.444 HD22 HG11 ' A' ' 169' ' ' VAL . 0.4 OUTLIER -75.93 -27.7 57.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.455 177.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.656 ' CE ' ' HA ' ' A' ' 179' ' ' ASP . 37.1 mtmt -55.22 -52.42 63.43 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.508 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 2.2 tpmt? -61.86 -40.46 95.42 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.316 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.484 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -55.53 -55.85 27.11 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.751 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.496 HD21 HG11 ' A' ' 224' ' ' VAL . 2.0 mt -70.11 -46.37 64.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.318 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 12.9 mmt -59.97 -36.67 77.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.961 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 58.2 mtm -76.35 -12.91 60.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.062 0.458 . . . . 0.0 110.251 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -110.33 17.8 20.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.527 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 62.63 36.94 93.95 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.198 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.481 HD13 ' HD2' ' A' ' 162' ' ' PRO . 24.2 mt -128.36 166.91 17.76 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.494 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 37.4 pt -130.64 130.64 22.96 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.053 0.454 . . . . 0.0 111.85 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 16.2 Cg_exo -68.76 -16.13 41.47 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.088 2.525 . . . . 0.0 112.341 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -65.34 -37.52 87.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.071 -177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 16.9 t -109.78 37.0 2.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.415 0.626 . . . . 0.0 109.992 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.588 ' HB3' HG13 ' A' ' 224' ' ' VAL . 99.1 m -146.73 162.36 38.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.672 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -142.16 157.29 45.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.78 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 10.9 t -107.13 123.73 62.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.584 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 47.8 m-85 -116.14 153.8 31.13 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 173.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.503 ' HB3' ' CD2' ' A' ' 222' ' ' LEU . 12.2 ptt180 . . . . . 0 C--N 1.315 -0.928 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 167.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt . . . . . 0 N--CA 1.446 -0.632 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 74.9 mmtt -98.4 107.14 40.34 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.156 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -74.51 118.92 5.52 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.943 1.762 . . . . 0.0 111.467 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.659 HG21 HD11 ' A' ' 217' ' ' LEU . 22.0 mt -93.83 152.75 3.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.088 -174.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -85.49 139.95 17.76 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.574 ' HB3' ' CG ' ' A' ' 178' ' ' ARG . 88.4 m95 -70.41 -34.99 73.17 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.645 0.26 . . . . 0.0 111.164 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.48 5.5 23.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.119 0.485 . . . . 0.0 111.238 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.548 ' O ' HG23 ' A' ' 177' ' ' VAL . 95.6 m -74.8 148.37 40.39 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 170.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -73.49 134.38 43.86 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 171' ' ' ALA . 0.1 OUTLIER -69.94 -16.36 20.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.958 0.408 . . . . 0.0 110.653 -178.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 18.7 m -65.49 -15.88 63.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.994 0.426 . . . . 0.0 110.73 176.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 32.9 m0 -80.54 -17.64 50.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.22 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.659 HD11 HG21 ' A' ' 208' ' ' ILE . 10.4 mt -112.81 19.87 16.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.724 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 99.7 m -52.1 112.86 0.87 Allowed 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.413 -177.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 80.07 8.93 87.2 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.427 171.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -85.17 151.32 24.19 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 36.5 mt-10 -86.99 111.14 20.56 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.503 ' CD2' ' HB3' ' A' ' 199' ' ' ARG . 61.0 mt -105.56 159.63 15.8 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.214 -175.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -125.99 122.44 35.9 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.833 0.349 . . . . 0.0 110.27 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.594 HG12 ' HD3' ' A' ' 162' ' ' PRO . 4.5 t -101.05 115.54 42.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.566 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 24.6 mt-10 -112.35 141.9 45.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.78 -175.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.84 127.62 34.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.831 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 C--N 1.321 -0.632 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 176.671 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.456 -0.711 0 N-CA-C 111.241 -0.33 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.709 HD13 HG11 ' A' ' 168' ' ' VAL . 1.8 pp -126.09 156.36 36.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.493 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -125.23 134.23 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.533 ' HG2' HG13 ' A' ' 168' ' ' VAL . 81.7 mtm180 -95.41 105.46 17.43 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -167.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.8 t -96.87 135.45 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.807 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 64.9 m-85 -97.4 103.12 15.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.788 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.611 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.1 mt -84.52 173.84 6.66 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.098 -170.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.611 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 99.1 Cg_exo -48.66 153.47 3.49 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.128 2.552 . . . . 0.0 113.236 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 63.16 24.46 14.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.492 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 61.18 44.05 10.37 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.088 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 15.2 mm100 -90.8 177.93 6.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.781 177.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 38.7 ttp180 -147.36 153.44 39.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.548 0.214 . . . . 0.0 110.545 176.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.479 HG21 ' HB1' ' A' ' 184' ' ' ALA . 1.4 t -163.31 151.79 13.95 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 170.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.709 HG11 HD13 ' A' ' 156' ' ' ILE . 0.1 OUTLIER -115.06 128.29 72.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.298 177.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.7 p -115.83 133.29 22.86 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.412 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.41 131.55 43.44 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.281 1.987 . . . . 0.0 111.924 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.79 75.69 1.59 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.801 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -68.51 111.99 5.05 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.536 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.602 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 59.0 m -70.45 116.61 10.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.825 0.345 . . . . 0.0 110.128 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.03 -6.0 36.76 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.923 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.69 142.91 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.0 p -88.46 155.13 19.84 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.018 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.575 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 88.5 t -52.96 -34.34 20.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.636 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 16.0 ptt180 -56.67 -47.72 79.19 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 122.256 -0.277 . . . . 0.0 111.568 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.614 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 20.6 t70 -72.25 -45.49 59.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.174 0.511 . . . . 0.0 110.867 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.479 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 2.8 p -63.31 -53.24 55.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.378 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.7 OUTLIER -69.96 -24.41 63.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.121 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.614 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 11.8 mtmt -57.65 -51.25 70.28 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.537 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.4 tpmt? -61.43 -42.6 98.99 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.952 177.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.479 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -53.47 -61.11 2.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.411 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 181' ' ' LEU . 1.5 mt -65.02 -44.68 88.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.24 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.538 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 6.5 mmt -61.38 -32.19 72.11 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 62.5 mtm -77.16 -22.69 52.13 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.213 0.53 . . . . 0.0 110.02 175.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.1 5.77 50.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.73 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 69.81 36.69 74.85 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.966 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.412 HD13 ' HD2' ' A' ' 162' ' ' PRO . 21.4 mt -131.11 165.99 22.06 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 122.87 0.468 . . . . 0.0 110.021 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 35.7 pt -126.62 135.19 26.91 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.907 0.384 . . . . 0.0 111.36 177.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 15.9 Cg_exo -69.01 -16.5 40.77 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.029 2.486 . . . . 0.0 111.985 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -59.13 -45.51 90.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.534 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 16.2 t -105.41 34.74 3.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.257 0.551 . . . . 0.0 109.75 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.561 ' HB3' HG13 ' A' ' 224' ' ' VAL . 91.1 m -141.84 162.36 35.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.991 -176.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.632 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -143.62 154.63 43.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.133 174.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 13.3 t -105.92 138.01 33.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.676 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -129.24 150.32 50.67 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.439 ' HD2' HD22 ' A' ' 217' ' ' LEU . 2.9 ptm180 . . . . . 0 C--N 1.321 -0.651 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 166.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt . . . . . 0 N--CA 1.445 -0.712 0 CA-C-O 120.657 0.265 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -111.87 103.97 55.65 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.19 132.5 41.83 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.361 2.041 . . . . 0.0 112.155 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.532 HG21 HD11 ' A' ' 217' ' ' LEU . 20.3 mm -96.77 158.12 3.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.281 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -96.0 142.11 15.95 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -70.27 -22.55 62.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 117.315 0.558 . . . . 0.0 111.068 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -94.05 9.82 36.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.895 0.379 . . . . 0.0 110.833 176.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.536 ' O ' HG23 ' A' ' 177' ' ' VAL . 81.4 m -77.71 150.46 34.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -80.1 124.41 28.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.744 0.783 . . . . 0.0 109.589 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.408 HD12 ' HB2' ' A' ' 180' ' ' SER . 7.7 tt -53.58 -30.19 18.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.768 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.602 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 12.9 m -62.91 -16.79 60.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.901 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -79.29 -13.61 59.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.222 0.534 . . . . 0.0 109.654 175.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.532 HD11 HG21 ' A' ' 208' ' ' ILE . 11.5 mt -117.92 16.51 14.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.83 -176.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 97.4 m -50.63 119.44 3.82 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.864 0.84 . . . . 0.0 112.865 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 75.71 8.7 84.62 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 114.214 -1.357 . . . . 0.0 113.498 170.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -92.78 164.78 13.23 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.751 0.31 . . . . 0.0 110.409 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 6.4 mp0 -96.35 111.01 23.24 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.412 HD21 ' HB3' ' A' ' 217' ' ' LEU . 28.7 mt -100.6 165.9 11.18 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -136.57 124.92 23.3 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 42.4 t -103.69 124.63 58.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.024 0.44 . . . . 0.0 110.268 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 71.0 mm-40 -110.79 155.05 23.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.666 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 43.1 t -83.38 129.19 37.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.532 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.126 176.329 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 66.6 Cg_endo . . . . . 0 N--CA 1.464 -0.246 0 CA-C-O 121.072 0.363 . . . . 0.0 112.887 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.749 HD13 HG11 ' A' ' 168' ' ' VAL . 1.9 pp -129.87 157.85 42.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.622 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.97 133.91 68.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.588 ' HG2' HG13 ' A' ' 168' ' ' VAL . 18.1 mtm180 -92.31 108.03 19.65 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.476 0.655 . . . . 0.0 112.09 -168.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.688 HG22 ' HB2' ' A' ' 222' ' ' LEU . 11.6 t -96.1 145.75 8.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.626 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.563 ' CZ ' ' HD2' ' A' ' 166' ' ' ARG . 21.7 m-85 -112.61 103.01 11.05 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.822 176.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.5 mm? -76.58 173.99 6.47 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -172.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.622 ' HD2' HD13 ' A' ' 190' ' ' LEU . 74.4 Cg_exo -54.11 155.01 16.31 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.571 2.18 . . . . 0.0 112.873 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.9 t30 66.74 21.86 10.47 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.947 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.568 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 61.17 44.9 9.52 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.399 179.083 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.621 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 15.1 mm-40 -86.64 171.94 10.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.329 174.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.563 ' HD2' ' CZ ' ' A' ' 160' ' ' PHE . 47.1 ttt180 -148.4 133.79 18.55 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.448 HG22 HD21 ' A' ' 161' ' ' LEU . 5.4 t -137.43 174.74 10.27 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.749 HG11 HD13 ' A' ' 156' ' ' ILE . 0.2 OUTLIER -132.09 128.6 59.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.632 170.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.48 129.85 23.44 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.711 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.461 ' HA ' HG22 ' A' ' 156' ' ' ILE . 31.5 Cg_exo -57.08 123.48 13.95 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.313 2.009 . . . . 0.0 111.476 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.45 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -61.75 99.96 0.13 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.628 0.728 . . . . 0.0 109.286 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.648 ' HG2' ' HB ' ' A' ' 175' ' ' VAL . 17.2 ttp180 -107.81 111.97 24.38 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.916 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.658 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 42.4 t -70.84 128.3 35.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.87 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 109.06 -21.18 27.61 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.767 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.648 ' HB ' ' HG2' ' A' ' 172' ' ' ARG . 0.9 OUTLIER -99.19 142.85 14.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.367 0.603 . . . . 0.0 110.749 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 5.6 p -81.56 148.69 29.01 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.641 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.497 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 21.9 m -49.48 -32.09 6.19 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.616 0 CA-C-N 117.904 0.32 . . . . 0.0 110.319 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 21.3 ptt180 -58.82 -43.38 90.61 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.613 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 21.2 t70 -71.34 -47.64 55.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.964 0.802 . . . . 0.0 110.477 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.481 ' HA ' HH21 ' A' ' 172' ' ' ARG . 0.6 OUTLIER -62.21 -43.36 99.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.414 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.42 -36.32 68.58 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.178 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.696 ' O ' ' HB2' ' A' ' 186' ' ' MET . 7.9 mtmt -50.64 -45.07 57.62 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.805 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.513 ' O ' ' HG3' ' A' ' 187' ' ' MET . 10.9 tppt? -67.41 -51.46 51.48 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.917 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -43.73 -54.13 5.35 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.482 0.489 . . . . 0.0 111.973 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 5.1 mp -69.24 -52.39 28.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.63 0.372 . . . . 0.0 111.733 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.696 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 1.3 ttm -54.28 -38.35 65.77 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -176.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.513 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 68.7 mtm -74.46 -16.52 60.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.338 0.59 . . . . 0.0 110.179 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 188' ' ' ARG . 49.8 mtt180 -105.9 12.73 30.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.324 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 68.6 38.5 86.23 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.015 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.622 HD13 ' HD2' ' A' ' 162' ' ' PRO . 20.8 mt -132.02 157.93 42.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.743 0.306 . . . . 0.0 110.676 -176.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 14.0 pt -122.22 127.32 25.95 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.349 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 11.6 Cg_exo -71.03 -12.84 31.0 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.865 2.377 . . . . 0.0 111.895 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -58.47 -41.27 84.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.017 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 74.1 m -105.44 34.88 3.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.897 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.513 ' HB3' HG13 ' A' ' 224' ' ' VAL . 80.9 m -145.04 164.84 29.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.866 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.599 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -139.2 160.13 40.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.447 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 17.0 t -109.13 140.69 26.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.464 -176.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.415 ' CD1' ' HB3' ' A' ' 205' ' ' LYS . 22.1 m-85 -134.32 142.67 47.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.09 177.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.504 ' HD2' HD12 ' A' ' 217' ' ' LEU . 8.0 ptm180 . . . . . 0 C--N 1.317 -0.844 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 166.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.599 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 39.9 mtpt . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -94.13 98.97 3.22 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.684 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.599 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 25.3 Cg_exo -62.67 135.95 55.44 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.566 2.177 . . . . 0.0 112.848 -174.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 197' ' ' VAL . 22.8 mm -98.02 154.44 3.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.791 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.81 134.04 12.18 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 174.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.497 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 86.9 m95 -64.84 -24.55 67.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.325 0.563 . . . . 0.0 110.97 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -93.57 14.11 19.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.961 0.41 . . . . 0.0 111.247 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 177' ' ' VAL . 85.4 m -88.11 145.33 25.99 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -72.81 134.12 44.78 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.469 HG21 ' HB2' ' A' ' 180' ' ' SER . 0.1 OUTLIER -69.97 -16.6 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 110.961 -175.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.658 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 8.3 m -66.51 -19.62 65.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.744 176.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.547 ' HB2' HD22 ' A' ' 217' ' ' LEU . 27.8 m0 -75.59 -23.63 56.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.545 0.688 . . . . 0.0 109.815 176.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.548 HD22 ' N ' ' A' ' 217' ' ' LEU . 1.4 mm? -109.32 23.95 13.77 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.36 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 51.3 m -54.37 114.22 1.57 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.625 0.726 . . . . 0.0 111.958 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 84.14 -2.84 87.25 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.946 173.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.39 156.94 36.51 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 50.3 mt-10 -89.71 108.38 19.65 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.688 ' HB2' HG22 ' A' ' 159' ' ' VAL . 82.8 mt -102.47 109.68 21.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.74 0.781 . . . . 0.0 110.478 -175.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -84.22 122.04 28.31 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.856 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 3.7 t -99.93 109.95 25.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.51 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -110.27 145.26 37.7 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.657 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.58 133.52 31.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 196' ' ' ALA . 55.9 mt . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 121.196 0.522 . . . . 0.0 110.854 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 120.587 0.232 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.38 92.6 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.42 2.747 . . . . 0.0 112.37 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -89.96 103.21 15.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.163 0.506 . . . . 0.0 111.288 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.65 108.17 31.16 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.019 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 63.9 Cg_endo -70.09 159.34 53.49 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.514 2.142 . . . . 0.0 112.053 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.78 HD13 HG11 ' A' ' 168' ' ' VAL . 2.0 pp -129.75 167.07 25.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.957 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 46.4 t -127.86 126.24 66.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.298 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 21.2 mtm180 -93.92 91.59 6.98 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.126 0.488 . . . . 0.0 111.941 -170.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 222' ' ' LEU . 2.1 t -93.44 162.23 2.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.609 0.718 . . . . 0.0 111.057 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.49 ' H ' HG12 ' A' ' 159' ' ' VAL . 49.4 m-85 -125.2 107.31 10.62 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.795 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.1 mm? -82.22 167.03 33.27 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 71.7 Cg_exo -48.18 147.49 8.24 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.521 2.814 . . . . 0.0 113.566 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 69.56 34.56 2.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.187 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.489 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 62.12 43.19 8.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.826 176.181 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 78.2 mm-40 -97.17 165.47 12.03 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.653 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 159' ' ' VAL . 37.0 ttp180 -145.95 145.62 30.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.755 HG21 ' HB1' ' A' ' 184' ' ' ALA . 15.2 t -146.06 150.23 35.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.522 177.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.78 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -120.98 127.25 75.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.231 170.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.4 p -123.75 133.89 24.93 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.338 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 74.2 Cg_exo -51.49 128.36 25.6 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.383 2.055 . . . . 0.0 111.973 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.39 79.12 0.75 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.535 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.408 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 92.1 mtt180 -68.56 115.74 8.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.726 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 46.8 t -80.44 109.79 15.29 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.68 19.36 7.43 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 -173.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.459 HG12 ' CG2' ' A' ' 214' ' ' ILE . 0.9 OUTLIER -140.48 132.7 31.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.6 p -74.35 153.3 39.35 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.242 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.55 ' HA ' ' OG ' ' A' ' 180' ' ' SER . 4.2 m -58.52 -21.84 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.62 ' HG2' ' HE2' ' A' ' 182' ' ' LYS . 32.0 ttt180 -58.94 -59.05 6.08 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.694 174.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.638 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 25.7 t70 -64.4 -48.6 74.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.209 0.528 . . . . 0.0 111.417 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.55 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 11.3 p -60.24 -56.87 16.27 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.489 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 8.3 mp -74.28 -14.85 60.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.032 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.638 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 5.3 mtmt -59.92 -48.21 82.62 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 187' ' ' MET . 12.0 tppt? -60.13 -49.49 77.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.175 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.755 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -47.11 -53.44 12.85 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.583 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.459 HD21 HG11 ' A' ' 224' ' ' VAL . 1.5 mt -74.19 -43.51 56.95 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.554 0.342 . . . . 0.0 111.507 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.495 ' HB3' ' O ' ' A' ' 182' ' ' LYS . 18.7 tpp -65.59 -33.92 77.04 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.043 -174.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.498 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 66.8 mtm -74.02 -9.75 58.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.297 0.57 . . . . 0.0 109.971 175.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 167' ' ' THR . 74.7 mtt85 -109.65 1.37 19.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.18 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 78.62 21.85 68.25 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.483 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.2 mp -113.99 172.53 6.93 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 34.6 pt -132.82 132.5 22.56 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.204 0.526 . . . . 0.0 111.527 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.55 ' HG2' ' HG3' ' A' ' 182' ' ' LYS . 23.9 Cg_exo -65.7 -21.15 59.05 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.359 2.706 . . . . 0.0 113.127 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -62.86 -33.38 75.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.776 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 35.4 t -102.68 31.83 3.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.373 0.606 . . . . 0.0 109.89 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.616 ' HB3' HG13 ' A' ' 224' ' ' VAL . 71.2 m -143.17 167.6 21.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.983 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -138.0 155.65 48.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.241 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 223' ' ' HIS . 9.6 t -107.55 136.61 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 123.208 0.318 . . . . 0.0 110.27 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -130.92 151.95 50.77 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.479 ' CG ' ' HB2' ' A' ' 206' ' ' LYS . 1.2 ptm180 -120.64 115.51 23.51 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 167.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.706 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 19.6 mm -85.06 112.88 22.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.833 -175.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.482 ' HB2' ' CG ' ' A' ' 204' ' ' GLU . 22.4 mt-30 -89.14 -149.83 0.19 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 170.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.73 80.36 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 62.96 18.73 60.32 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.812 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.482 ' CG ' ' HB2' ' A' ' 201' ' ' GLN . 9.9 pt-20 -125.67 135.15 51.81 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.616 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.706 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 36.2 mtpt -91.84 128.03 37.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.271 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.479 ' HB2' ' CG ' ' A' ' 199' ' ' ARG . 75.0 mmtt -111.73 98.13 40.07 Favored Pre-proline 0 N--CA 1.444 -0.736 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -65.95 119.15 6.14 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.859 1.706 . . . . 0.0 111.998 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 38.3 mt -96.61 154.22 3.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.615 -177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.0 145.66 20.02 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.529 ' O ' ' HB2' ' A' ' 178' ' ' ARG . 96.2 m95 -68.95 -25.09 64.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.28 0.54 . . . . 0.0 110.496 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -87.97 9.95 20.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.743 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.504 ' O ' HG13 ' A' ' 177' ' ' VAL . 94.9 m -83.57 143.22 30.3 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.445 ' HB3' ' CD1' ' A' ' 216' ' ' TRP . 9.3 t70 -75.27 137.19 41.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.925 0.393 . . . . 0.0 110.094 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.459 ' CG2' HG12 ' A' ' 175' ' ' VAL . 0.2 OUTLIER -78.24 -17.55 13.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.581 -174.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 85.9 p -69.78 -14.09 62.6 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 121.961 -0.462 . . . . 0.0 110.442 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.445 ' CD1' ' HB3' ' A' ' 213' ' ' ASP . 27.5 m0 -67.71 -40.64 84.26 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 174.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.41 ' HB3' HD21 ' A' ' 222' ' ' LEU . 0.3 OUTLIER -99.87 31.64 3.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.423 -175.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 51.1 m -52.91 113.85 1.23 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.403 0.62 . . . . 0.0 112.343 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 84.06 2.65 89.4 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.973 -1.012 . . . . 0.0 113.658 171.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.54 154.92 19.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.683 0.278 . . . . 0.0 110.392 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 2.1 mp0 -85.97 111.29 20.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 35.9 mt -103.83 164.94 11.35 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 197' ' ' VAL . 85.4 m-70 -129.34 135.6 48.94 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.616 HG13 ' HB3' ' A' ' 195' ' ' CYS . 9.4 t -113.45 109.34 28.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 28.5 mt-10 -110.11 155.21 22.21 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.088 -175.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.99 131.25 34.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.942 -173.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.6 mp -75.72 80.07 2.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.674 0.75 . . . . 0.0 109.179 173.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -131.86 103.84 6.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.877 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -81.13 76.97 8.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.64 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.834 -0.621 . . . . 99.99 110.63 178.583 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 33.5 p . . . . . 0 N--CA 1.476 0.871 0 CA-C-O 120.58 0.229 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 151' ' ' SER . 31.5 Cg_exo -61.4 -27.91 83.28 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.253 2.635 . . . . 0.0 111.592 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -132.07 119.43 20.98 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.407 ' HE2' ' CB ' ' A' ' 170' ' ' PRO . 83.6 tttt -110.84 99.55 42.7 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -72.6 159.79 48.03 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.827 2.351 . . . . 0.0 112.776 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.563 ' O ' ' HA2' ' A' ' 219' ' ' GLY . 1.4 pp -122.12 171.54 10.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.688 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.7 133.13 57.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.598 ' HG2' HG11 ' A' ' 168' ' ' VAL . 20.5 mtm180 -99.17 106.83 19.05 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.145 0.497 . . . . 0.0 111.872 -162.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 222' ' ' LEU . 25.9 t -100.13 145.21 11.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.634 -172.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -109.27 104.7 13.88 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.067 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.627 HD21 HG22 ' A' ' 167' ' ' THR . 1.5 mm? -81.57 172.47 9.62 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -174.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.627 ' HD3' HG12 ' A' ' 224' ' ' VAL . 77.5 Cg_exo -54.47 159.92 7.71 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.614 2.209 . . . . 0.0 112.183 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 66.03 24.5 11.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.002 0.43 . . . . 0.0 110.154 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 56.15 43.98 25.92 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.191 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.603 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 28.8 mm-40 -89.65 167.38 12.97 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.412 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -146.39 129.73 16.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.434 0.635 . . . . 0.0 111.42 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.627 HG22 HD21 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -144.5 139.09 28.04 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.013 178.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.598 HG11 ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -116.57 129.27 73.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.632 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.31 136.23 19.57 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.805 -173.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.407 ' CB ' ' HE2' ' A' ' 154' ' ' LYS . 32.0 Cg_exo -57.6 130.01 36.65 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.29 1.993 . . . . 0.0 111.294 177.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.13 91.45 0.22 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.453 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.458 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 92.2 mtt180 -77.08 111.59 12.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.044 -176.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.575 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 3.3 p -72.45 115.46 11.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.5 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 98.86 15.58 33.39 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.948 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.458 ' CG1' ' HB2' ' A' ' 172' ' ' ARG . 0.5 OUTLIER -130.15 148.91 33.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.4 p -83.45 154.39 23.96 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.646 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 212' ' ' THR . 64.1 t -53.81 -30.58 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.559 -0.746 . . . . 0.0 108.992 172.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.584 ' HG3' ' HB3' ' A' ' 210' ' ' TRP . 12.1 ttt180 -53.93 -58.97 5.33 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.66 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.63 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 11.3 t70 -63.26 -47.88 80.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.336 0.588 . . . . 0.0 111.274 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.544 ' OG ' HG21 ' A' ' 214' ' ' ILE . 17.9 m -59.51 -51.59 69.22 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.166 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.483 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.4 OUTLIER -78.36 -19.03 54.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.651 0.263 . . . . 0.0 110.407 -178.208 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.63 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 15.5 mtmt -60.65 -48.51 81.45 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.504 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 2.2 tpmt? -61.45 -41.19 96.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.802 176.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.519 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -53.66 -57.33 11.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.767 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 181' ' ' LEU . 1.4 mt -71.55 -41.34 69.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.483 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 7.0 mmt -66.29 -28.39 68.66 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -176.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 62.4 mtm -79.64 -9.16 59.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.082 0.468 . . . . 0.0 109.96 175.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -109.72 -3.2 16.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.522 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.07 21.21 61.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.209 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.0 mp -115.04 172.11 7.26 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.526 HG13 ' SG ' ' A' ' 194' ' ' CYS . 21.4 pt -128.88 133.1 24.82 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.526 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.544 ' HB3' ' CZ3' ' A' ' 210' ' ' TRP . 14.9 Cg_exo -69.0 -21.03 37.6 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.027 2.485 . . . . 0.0 112.133 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -57.82 -41.73 82.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.736 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . 0.526 ' SG ' HG13 ' A' ' 191' ' ' ILE . 20.9 p -96.89 16.81 18.3 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.371 -177.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.481 ' HB3' HG13 ' A' ' 224' ' ' VAL . 85.1 m -126.08 166.83 16.28 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.175 0.512 . . . . 0.0 111.638 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -146.2 159.79 42.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.065 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.678 HG11 HD23 ' A' ' 222' ' ' LEU . 11.7 t -115.11 138.85 44.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.118 -175.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 29.9 m-85 -129.72 146.65 51.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.255 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.53 ' HD2' HD22 ' A' ' 217' ' ' LEU . 7.1 ptm180 -117.1 115.49 25.47 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 167.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 4.9 mm -91.37 107.22 18.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.735 -169.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 203' ' ' GLY . 15.7 mm100 -83.96 -143.65 0.08 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.847 176.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 13.3 m-20 -60.26 78.28 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.041 0.448 . . . . 0.0 111.804 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 63.88 17.0 60.17 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.193 -176.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 35.2 mt-10 -113.6 132.58 55.69 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 120.898 0.38 . . . . 0.0 111.445 -176.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.57 ' HG2' HD12 ' A' ' 200' ' ' ILE . 44.6 mtpt -95.09 112.67 24.35 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 75.3 mmtt -101.91 102.74 25.04 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.03 -177.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 8.0 Cg_exo -69.34 119.45 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.101 1.867 . . . . 0.0 111.634 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.452 HD12 HG12 ' A' ' 197' ' ' VAL . 56.9 mt -93.74 155.8 3.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.283 -174.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -92.42 135.09 12.53 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.584 ' HB3' ' HG3' ' A' ' 178' ' ' ARG . 86.5 m95 -64.8 -40.51 95.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.041 0.448 . . . . 0.0 110.667 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.32 6.04 3.99 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 177' ' ' VAL . 97.2 m -81.22 145.26 31.06 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 172.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.24 131.24 44.58 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.544 HG21 ' OG ' ' A' ' 180' ' ' SER . 0.1 OUTLIER -73.74 -15.18 16.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.781 0.324 . . . . 0.0 111.356 -174.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.575 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 23.4 m -70.27 -10.51 59.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.052 0.453 . . . . 0.0 110.579 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.6 m0 -74.97 -27.05 60.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.449 0.642 . . . . 0.0 109.399 172.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.756 HD13 HD21 ' A' ' 222' ' ' LEU . 7.1 mt -110.8 19.24 18.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.075 -174.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 215' ' ' SER . 100.0 m -51.15 115.5 1.58 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.687 0.756 . . . . 0.0 112.194 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 85.99 3.77 85.07 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.386 -1.279 . . . . 0.0 113.244 171.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -87.9 158.2 18.76 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -91.61 111.08 22.44 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 173.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.756 HD21 HD13 ' A' ' 217' ' ' LEU . 6.7 mp -98.04 150.21 21.65 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.043 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . 0.522 ' CD2' HG12 ' A' ' 200' ' ' ILE . 88.6 m-70 -120.0 122.02 40.23 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.751 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.627 HG12 ' HD3' ' A' ' 162' ' ' PRO . 4.0 t -100.16 117.05 44.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.083 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -108.55 137.01 47.2 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.657 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.7 p -91.18 128.6 42.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.595 0.712 . . . . 0.0 110.195 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.8 mp -76.3 82.03 3.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.627 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -100.71 96.2 7.17 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.427 0.632 . . . . 0.0 110.288 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -146.05 26.06 1.24 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.704 174.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 114.895 -1.048 . . . . 99.99 110.458 -176.012 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.417 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 9.0 p . . . . . 0 N--CA 1.475 0.798 0 CA-C-O 121.019 0.437 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 151' ' ' SER . 22.5 Cg_exo -66.83 -39.64 14.31 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.073 2.516 . . . . 0.0 111.577 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.578 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 77.9 mt-30 -103.61 137.53 41.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.354 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -99.27 102.34 15.68 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.751 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' A' ' 153' ' ' GLN . 3.9 Cg_exo -76.45 151.37 33.11 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.615 2.21 . . . . 0.0 111.051 176.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.79 HD13 HG11 ' A' ' 168' ' ' VAL . 2.1 pp -121.06 160.13 22.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.558 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.68 134.67 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.526 ' HG2' HG13 ' A' ' 168' ' ' VAL . 71.5 mtm180 -96.73 101.01 12.53 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -168.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 160' ' ' PHE . 2.8 t -92.97 160.1 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 121.785 0.802 . . . . 0.0 111.801 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.558 ' CZ ' ' HD2' ' A' ' 166' ' ' ARG . 41.0 m-85 -124.76 105.76 9.54 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.131 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.546 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 3.3 mp -85.7 174.61 5.42 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.946 -172.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 87.2 Cg_exo -52.86 160.09 4.42 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.744 2.296 . . . . 0.0 112.835 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 64.12 31.97 12.99 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.273 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt 56.02 47.79 19.06 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.357 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.578 HE22 HD11 ' A' ' 190' ' ' LEU . 28.2 mt-30 -101.81 166.79 10.47 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.255 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.558 ' HD2' ' CZ ' ' A' ' 160' ' ' PHE . 38.4 ttt180 -147.67 144.24 28.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.556 0.217 . . . . 0.0 110.859 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.453 HG22 HD11 ' A' ' 161' ' ' LEU . 1.4 t -155.27 152.68 29.54 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.79 HG11 HD13 ' A' ' 156' ' ' ILE . 0.2 OUTLIER -114.2 128.84 71.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.255 178.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.9 p -116.5 137.03 23.27 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.562 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.71 135.44 60.2 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.175 1.916 . . . . 0.0 111.685 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.76 78.34 1.12 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.104 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -69.54 111.92 5.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.593 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.67 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 8.5 p -76.93 110.09 11.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.992 0.425 . . . . 0.0 109.872 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 109.07 9.17 26.49 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.574 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.84 137.99 52.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.5 p -79.4 154.47 28.96 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.96 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 212' ' ' THR . 81.4 t -47.07 -40.95 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.477 0.486 . . . . 0.0 109.696 175.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.607 ' CG ' ' HB3' ' A' ' 210' ' ' TRP . 92.9 mtt-85 -48.45 -52.57 21.55 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.483 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.593 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 14.7 t70 -73.98 -45.48 49.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.138 0.494 . . . . 0.0 111.339 -172.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.423 ' CB ' HG21 ' A' ' 214' ' ' ILE . 0.3 OUTLIER -67.54 -42.87 82.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.896 -177.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.3 OUTLIER -76.68 -21.17 55.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.145 177.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.644 ' O ' ' HB2' ' A' ' 186' ' ' MET . 4.4 ttmt -59.23 -48.23 82.4 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.1 tpmt? -60.56 -46.2 91.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.791 175.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.452 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -51.75 -55.94 16.73 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.984 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 181' ' ' LEU . 1.7 mt -72.58 -43.16 63.77 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.734 0.413 . . . . 0.0 111.769 -178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.644 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 3.3 mmt -66.02 -26.52 67.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -176.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.502 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 64.6 mtm -77.38 -20.35 54.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.359 0.599 . . . . 0.0 109.724 173.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -106.6 17.59 23.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.592 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 62.75 35.43 91.92 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.276 -0.487 . . . . 0.0 112.676 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.578 HD11 HE22 ' A' ' 165' ' ' GLN . 21.1 mt -128.41 169.37 14.36 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.531 0.333 . . . . 0.0 110.171 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 45.8 pt -131.89 135.24 26.35 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.057 0.456 . . . . 0.0 111.534 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.476 ' HG2' ' HG3' ' A' ' 182' ' ' LYS . 19.6 Cg_exo -66.77 -22.2 50.07 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.102 2.535 . . . . 0.0 112.645 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.89 -19.98 62.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.478 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 12.2 t -112.13 25.94 11.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.518 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 74.2 m -140.78 166.74 23.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.096 -175.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -146.66 154.41 41.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.121 175.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.08 130.62 61.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.597 0.237 . . . . 0.0 110.776 -176.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 35.6 m-85 -131.28 152.9 50.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.759 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.79 ' HG3' HD11 ' A' ' 208' ' ' ILE . 67.2 mtp180 -114.6 111.9 22.07 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 168.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.788 HG12 ' CD2' ' A' ' 223' ' ' HIS . 1.7 mm -94.39 106.97 18.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.453 -174.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.451 ' HB2' ' CG ' ' A' ' 204' ' ' GLU . 24.5 mt-30 -88.32 -146.32 0.15 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 172.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.95 79.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 63.13 17.53 59.16 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.822 -178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 8.4 pt-20 -123.07 133.66 54.3 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.975 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.562 ' HG2' HD12 ' A' ' 200' ' ' ILE . 39.1 mtpt -102.52 126.48 49.59 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -175.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 74.1 mmtt -101.7 100.5 14.53 Favored Pre-proline 0 N--CA 1.444 -0.741 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 4.0 Cg_exo -71.26 126.76 12.63 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.868 1.712 . . . . 0.0 111.316 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.79 HD11 ' HG3' ' A' ' 199' ' ' ARG . 4.7 mt -107.77 149.66 10.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.77 -173.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.7 136.01 14.15 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.607 ' HB3' ' CG ' ' A' ' 178' ' ' ARG . 91.1 m95 -65.08 -27.8 69.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.698 0.285 . . . . 0.0 110.917 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.404 ' CG ' ' HE ' ' A' ' 178' ' ' ARG . 11.0 m-20 -90.73 12.76 18.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.823 0.344 . . . . 0.0 111.242 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 177' ' ' VAL . 48.1 m -85.84 154.15 21.75 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -78.48 132.18 37.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.423 HG21 ' CB ' ' A' ' 180' ' ' SER . 0.3 OUTLIER -70.32 -11.94 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.987 0.422 . . . . 0.0 110.997 -178.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.67 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 16.4 m -66.38 -18.26 65.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.98 0.419 . . . . 0.0 110.359 173.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -78.66 -14.79 59.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.455 0.645 . . . . 0.0 109.888 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.624 HD11 HG21 ' A' ' 208' ' ' ILE . 17.8 mt -113.34 17.4 18.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.797 -177.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 91.2 m -53.64 117.59 3.25 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.775 0.798 . . . . 0.0 112.395 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 74.07 8.14 78.03 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.118 173.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -84.49 148.72 26.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 3.2 mp0 -85.26 109.47 18.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 171.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 86.2 mt -98.61 149.93 22.27 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.994 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . 0.788 ' CD2' HG12 ' A' ' 200' ' ' ILE . 59.9 m-70 -124.05 122.58 38.26 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 38.7 t -100.07 143.95 13.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.042 0.449 . . . . 0.0 110.167 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 8.6 mm-40 -120.91 151.39 39.74 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.236 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 162' ' ' PRO . 1.2 t -89.89 116.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 34.3 mt -75.79 89.12 2.85 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.14 97.06 5.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.855 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -121.81 71.86 1.0 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.215 0.531 . . . . 0.0 109.743 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.392 -0.822 . . . . 99.99 111.504 -178.549 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 20.4 p . . . . . 0 N--CA 1.477 0.902 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 151' ' ' SER . 39.3 Cg_exo -60.47 -29.49 88.78 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.199 2.599 . . . . 0.0 111.838 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.432 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 22.4 mt-30 -96.53 141.43 29.82 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 173.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -87.38 113.36 53.66 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.496 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 23.8 Cg_exo -63.71 168.23 12.14 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.48 2.12 . . . . 0.0 110.446 174.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.817 HD13 HG11 ' A' ' 168' ' ' VAL . 2.2 pp -131.29 156.61 42.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.166 0.508 . . . . 0.0 111.417 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.511 HG22 ' H ' ' A' ' 219' ' ' GLY . 41.0 t -124.11 123.75 67.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.756 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.499 ' HA ' HG13 ' A' ' 168' ' ' VAL . 23.6 mtm180 -88.47 96.54 10.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.49 0.662 . . . . 0.0 111.723 -169.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.635 HG22 ' HB2' ' A' ' 222' ' ' LEU . 3.8 t -96.03 129.98 45.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.059 -176.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.573 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 42.4 m-85 -94.29 103.51 15.53 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.871 174.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.604 HD22 ' HD2' ' A' ' 188' ' ' ARG . 2.9 mp -82.59 176.67 3.6 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -174.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 80.2 Cg_exo -50.17 153.73 6.44 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.711 2.274 . . . . 0.0 112.736 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 65.96 27.26 10.83 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.661 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 54.07 36.77 25.46 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.745 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 26.9 mm-40 -75.58 170.24 16.53 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 175.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 17.8 ttp180 -148.59 137.46 21.55 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.151 173.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.12 154.39 41.76 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.817 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -113.73 127.36 71.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.312 178.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.5 m -104.88 138.74 19.59 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.053 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 13.0 Cg_exo -65.55 125.14 13.88 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.265 1.31 . . . . 0.0 110.925 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.12 86.08 0.55 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.044 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.464 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 97.2 mtt180 -78.98 112.04 15.77 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.11 -174.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.618 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 4.1 p -67.53 110.02 3.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.831 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 106.78 8.16 32.63 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.296 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 172' ' ' ARG . 0.3 OUTLIER -117.16 149.87 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.045 0.45 . . . . 0.0 109.866 176.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.48 ' HB ' ' HG2' ' A' ' 178' ' ' ARG . 1.7 p -86.1 152.3 22.98 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.368 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 212' ' ' THR . 92.8 t -49.07 -41.61 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 O-C-N 123.452 0.47 . . . . 0.0 110.326 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.48 ' HG2' ' HB ' ' A' ' 176' ' ' THR . 30.9 ptt180 -51.24 -47.45 62.38 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.094 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.587 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 11.8 t70 -68.08 -49.79 59.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.121 0.486 . . . . 0.0 110.967 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.8 t -67.04 -43.99 81.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.464 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.643 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.3 OUTLIER -73.42 -27.33 61.38 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.206 179.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 13.0 mtmt -55.29 -45.62 76.22 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.476 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 1.8 tpmt? -60.01 -42.6 94.64 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 181' ' ' LEU . . . -55.12 -60.89 2.76 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.938 178.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 181' ' ' LEU . 1.6 mm? -60.29 -52.01 67.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.005 0.522 . . . . 0.0 110.904 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 12.2 mmt -57.96 -42.69 85.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.53 -174.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.45 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 57.6 mtm -71.04 -8.42 53.24 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.045 0.45 . . . . 0.0 110.533 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.604 ' HD2' HD22 ' A' ' 161' ' ' LEU . 51.2 mtt-85 -113.77 5.07 16.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.571 -177.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 73.38 21.74 79.32 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.325 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.611 ' HB3' HD12 ' A' ' 185' ' ' LEU . 0.2 OUTLIER -110.61 173.11 6.48 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -177.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 32.3 pt -132.15 127.34 20.93 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.176 0.512 . . . . 0.0 111.873 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.534 ' HB3' ' CZ3' ' A' ' 210' ' ' TRP . 22.5 Cg_exo -65.54 -21.48 59.82 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.307 2.672 . . . . 0.0 112.331 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.25 -45.4 93.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.923 -174.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 23.8 t -98.11 37.53 1.42 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.282 0.563 . . . . 0.0 109.967 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.707 ' HB3' HG13 ' A' ' 224' ' ' VAL . 71.8 m -138.7 158.56 44.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.78 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -131.66 150.43 52.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.014 175.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.425 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 4.1 t -104.59 131.67 53.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 123.239 0.337 . . . . 0.0 110.508 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -126.56 141.99 51.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.774 0.321 . . . . 0.0 110.807 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.444 ' HD3' HD22 ' A' ' 217' ' ' LEU . 19.3 ptt180 -117.71 112.16 20.1 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 165.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 205' ' ' LYS . 6.2 mm -80.18 104.21 8.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.196 -168.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 203' ' ' GLY . 26.3 mt-30 -78.13 -147.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -55.44 79.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.962 0.505 . . . . 0.0 112.27 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.41 17.4 52.99 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.007 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -128.53 133.86 48.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.205 0.502 . . . . 0.0 111.061 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.514 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 45.5 mtpt -79.51 111.3 15.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.544 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.42 ' HG2' ' OE1' ' A' ' 201' ' ' GLN . 11.7 tppt? -98.26 102.67 14.79 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.129 -174.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 10.6 Cg_exo -70.6 127.9 14.54 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.32 2.013 . . . . 0.0 112.413 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 217' ' ' LEU . 35.1 mt -103.22 161.9 4.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.233 -1.348 . . . . 0.0 109.963 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.48 147.45 18.6 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.676 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.534 ' CZ3' ' HB3' ' A' ' 192' ' ' PRO . 92.1 m95 -74.72 -18.5 60.5 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -87.63 -4.21 58.95 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.343 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 177' ' ' VAL . 89.9 m -70.19 147.89 49.29 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -76.61 129.18 36.05 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.432 HG13 HG21 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -68.9 -16.49 20.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.914 0.388 . . . . 0.0 111.056 -175.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.618 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 13.9 m -67.47 -21.03 65.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.848 0.356 . . . . 0.0 110.751 177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 24.1 m0 -74.93 -17.53 60.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.324 0.583 . . . . 0.0 109.583 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.469 HD11 HG21 ' A' ' 208' ' ' ILE . 6.0 mt -116.95 17.99 14.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.444 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 82.1 m -49.88 113.1 0.77 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.399 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.511 ' H ' HG22 ' A' ' 157' ' ' VAL . . . 86.5 6.28 80.9 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.041 -0.982 . . . . 0.0 113.41 170.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -90.46 158.48 17.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.806 0.336 . . . . 0.0 110.253 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 3.2 mp0 -90.1 111.15 22.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.635 ' HB2' HG22 ' A' ' 159' ' ' VAL . 58.5 mt -107.36 133.87 51.26 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.85 0.357 . . . . 0.0 110.802 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -102.16 123.24 45.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.489 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.707 HG13 ' HB3' ' A' ' 195' ' ' CYS . 39.4 t -105.95 112.18 38.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.321 0.582 . . . . 0.0 109.895 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 25.1 mt-10 -109.62 145.27 36.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.606 -173.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 66.7 t -77.87 129.76 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.949 0.404 . . . . 0.0 111.025 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.2 mp -81.68 81.67 7.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.655 177.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -91.08 95.01 9.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -114.69 76.89 1.02 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.416 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 6.8 m . . . . . 0 C--N 1.321 -0.674 0 CA-C-N 115.665 -0.698 . . . . 99.99 111.03 -176.009 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.418 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . 12.8 p . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.687 0.279 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 151' ' ' SER . 27.4 Cg_endo -60.86 138.78 81.37 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.056 2.504 . . . . 0.0 111.98 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.58 112.08 3.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.185 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -110.27 124.02 34.43 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.655 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -82.22 152.84 16.21 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.171 1.914 . . . . 0.0 110.728 173.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.765 HD13 HG11 ' A' ' 168' ' ' VAL . 2.0 pp -130.7 161.07 41.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.896 -0.138 . . . . 0.0 111.116 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.37 134.63 62.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.612 ' HG2' HG13 ' A' ' 168' ' ' VAL . 85.3 mtm180 -94.61 103.27 15.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.049 0.452 . . . . 0.0 112.093 -168.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.4 t -96.76 136.93 25.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.837 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 53.5 m-85 -94.64 104.0 15.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.63 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.648 HD22 ' H ' ' A' ' 161' ' ' LEU . 0.7 OUTLIER -81.34 170.56 14.89 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.666 ' HD3' HG12 ' A' ' 224' ' ' VAL . 53.1 Cg_exo -56.72 156.91 21.06 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.749 2.3 . . . . 0.0 112.491 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 67.21 37.26 3.73 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.336 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt 55.13 48.92 18.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.585 177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.56 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 27.9 mm-40 -104.29 160.89 14.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.104 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 28.5 ttp180 -147.05 138.99 24.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.898 0.38 . . . . 0.0 110.687 173.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.501 HG22 HD21 ' A' ' 161' ' ' LEU . 4.8 t -141.47 157.15 45.51 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.765 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -119.83 127.74 75.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.326 175.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.4 p -115.56 134.62 22.62 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.277 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.9 132.25 48.61 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.23 1.953 . . . . 0.0 111.454 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.9 75.96 0.89 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.691 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -64.74 111.81 2.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.922 -176.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 48.2 m -76.44 110.02 10.63 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 110.47 11.56 19.34 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.317 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.403 ' CG1' ' HB3' ' A' ' 180' ' ' SER . 1.1 t -133.05 138.01 52.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 21.3 p -81.93 160.2 23.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.233 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.616 HG13 HD13 ' A' ' 181' ' ' LEU . 86.7 t -52.52 -30.6 14.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.659 171.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.554 ' CG ' ' HB3' ' A' ' 210' ' ' TRP . 72.6 mtp180 -53.74 -58.38 7.44 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.283 174.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.607 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 14.5 t70 -74.52 -43.49 55.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.11 0.481 . . . . 0.0 111.096 -174.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.521 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 28.1 p -60.76 -57.68 11.67 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.28 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.616 HD13 HG13 ' A' ' 177' ' ' VAL . 9.6 mp -77.08 -11.69 59.84 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 122.102 -0.374 . . . . 0.0 111.154 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.607 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 4.7 ttmt -58.19 -46.31 86.03 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 171.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.465 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 2.4 tpmt? -59.57 -44.47 93.3 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.792 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.435 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -50.99 -54.93 20.09 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.465 HD23 ' HB3' ' A' ' 190' ' ' LEU . 5.3 mp -78.22 -38.46 43.02 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 14.7 mmt -63.48 -28.48 69.99 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.557 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 64.8 mtm -77.87 -7.33 56.56 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.355 0.598 . . . . 0.0 109.961 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.471 ' CZ ' ' HB ' ' A' ' 167' ' ' THR . 55.8 mtt85 -113.06 0.7 15.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.479 -178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 73.66 25.36 72.4 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.021 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.465 ' HB3' HD23 ' A' ' 185' ' ' LEU . 10.1 mp -115.59 152.61 32.75 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.475 ' O ' HD12 ' A' ' 191' ' ' ILE . 2.4 pp -108.2 128.67 25.27 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-O 121.067 0.46 . . . . 0.0 110.898 176.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 16.6 Cg_exo -68.14 -6.76 18.05 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.854 2.369 . . . . 0.0 112.362 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -75.26 -11.22 60.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.166 -175.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 27.7 t -126.27 34.65 4.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.538 ' HB3' HG13 ' A' ' 224' ' ' VAL . 77.3 m -144.47 158.82 43.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.188 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -136.29 159.26 42.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.704 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.537 HG11 HD23 ' A' ' 222' ' ' LEU . 23.8 t -114.06 138.29 44.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.392 -174.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -129.92 160.75 32.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.201 173.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.609 ' HD2' HD12 ' A' ' 217' ' ' LEU . 3.8 ptm180 -125.49 128.11 47.51 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 164.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.716 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 23.5 mm -90.88 112.68 25.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.204 0.526 . . . . 0.0 110.912 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.556 ' OE1' ' HE3' ' A' ' 206' ' ' LYS . 89.5 mt-30 -88.16 -150.31 0.18 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 171.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -58.61 79.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.224 0.535 . . . . 0.0 112.313 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 64.85 17.56 63.11 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.179 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -131.47 146.03 52.05 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.081 -0.647 . . . . 0.0 112.389 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.716 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 35.6 mtpt -94.17 125.45 38.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.761 -174.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.556 ' HE3' ' OE1' ' A' ' 201' ' ' GLN . 72.3 mmtt -110.25 102.04 49.93 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.83 127.85 24.83 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.335 2.023 . . . . 0.0 112.046 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.513 ' HB ' ' HB ' ' A' ' 197' ' ' VAL . 26.5 mm -91.25 159.18 2.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.582 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.71 131.55 10.63 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.554 ' HB3' ' CG ' ' A' ' 178' ' ' ARG . 85.2 m95 -61.49 -33.8 74.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.249 0.525 . . . . 0.0 111.01 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -86.57 7.37 26.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.852 0.358 . . . . 0.0 111.176 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 177' ' ' VAL . 89.2 m -82.32 143.1 31.51 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.08 129.87 41.22 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.442 HG21 ' HB3' ' A' ' 180' ' ' SER . 0.4 OUTLIER -66.69 -17.24 22.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.753 -175.455 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 23.2 t -68.19 -14.0 62.66 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.059 -0.401 . . . . 0.0 110.331 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.521 ' HB2' HD22 ' A' ' 217' ' ' LEU . 20.6 m0 -76.2 -19.48 58.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.504 0.669 . . . . 0.0 110.0 175.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.609 HD12 ' HD2' ' A' ' 199' ' ' ARG . 1.5 mm? -115.65 20.77 14.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.333 -174.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.2 m -53.69 119.94 5.58 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.35 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 76.67 8.51 86.25 Favored Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 114.258 -1.337 . . . . 0.0 113.678 170.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -87.56 159.89 18.42 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 50.3 mt-10 -92.59 110.19 21.61 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 171.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.537 HD23 HG11 ' A' ' 197' ' ' VAL . 7.7 mp -96.22 161.67 13.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.994 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 197' ' ' VAL . 47.9 m-70 -125.96 122.48 36.07 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.068 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.666 HG12 ' HD3' ' A' ' 162' ' ' PRO . 2.7 t -100.72 114.17 38.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 174.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -108.29 127.81 54.19 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.919 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.75 129.27 37.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.089 0.471 . . . . 0.0 110.035 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.47 83.37 1.48 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.318 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -104.99 96.19 6.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.494 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 9.1 t30 57.55 61.97 2.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.55 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.896 -0.593 . . . . 99.99 110.782 178.37 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . 14.5 p . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 120.859 0.361 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 151' ' ' SER . 38.7 Cg_endo -65.33 86.44 0.2 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.95 2.434 . . . . 0.0 112.304 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -71.18 114.05 8.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.089 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -83.28 121.12 76.75 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 38.7 Cg_exo -59.47 162.49 14.74 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.868 2.379 . . . . 0.0 112.881 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.79 HD13 HG11 ' A' ' 168' ' ' VAL . 2.1 pp -132.32 163.59 37.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.846 -177.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 39.7 t -128.44 121.09 54.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.258 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.578 ' HG2' HG13 ' A' ' 168' ' ' VAL . 76.2 mtp180 -86.98 93.95 9.48 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.217 0.532 . . . . 0.0 111.374 -172.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.0 t -94.8 135.18 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.679 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.676 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 41.5 m-85 -90.18 103.6 16.26 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.92 175.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.613 HD22 ' H ' ' A' ' 161' ' ' LEU . 1.5 mm? -77.18 174.21 6.24 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 84.1 Cg_exo -50.88 154.98 6.27 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.679 2.253 . . . . 0.0 112.49 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.3 m120 67.09 15.2 10.05 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.968 -173.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 58.69 49.97 9.5 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.016 -177.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.676 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -86.77 178.77 6.91 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.678 172.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.6 ' HD3' ' CZ ' ' A' ' 160' ' ' PHE . 7.5 mtm180 -147.4 141.45 26.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 118.548 0.613 . . . . 0.0 112.146 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.575 HG22 HD21 ' A' ' 161' ' ' LEU . 4.0 t -145.47 150.11 35.89 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 173.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.79 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -113.1 126.81 70.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.02 178.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 24.3 t -108.57 131.09 21.99 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.311 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 34.4 Cg_exo -56.73 118.41 5.25 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.409 1.406 . . . . 0.0 110.293 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.75 116.06 4.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.174 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 170' ' ' PRO . 98.1 mtt180 -104.39 112.3 25.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.643 -172.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 49.5 t -77.76 113.06 15.26 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 112.32 -12.7 26.06 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.407 -177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 176' ' ' THR . 1.2 t -107.49 144.59 16.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 40.1 p -85.89 160.67 19.35 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.104 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.61 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 15.4 m -57.15 -22.01 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' A' ' 210' ' ' TRP . 92.2 mtt-85 -52.67 -58.15 7.76 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.111 172.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.614 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 23.2 t70 -75.54 -41.98 53.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.461 0.648 . . . . 0.0 111.1 -172.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.575 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 10.8 p -64.2 -52.8 57.11 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.081 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 185' ' ' LEU . 2.5 mt -76.43 -15.88 59.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.184 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.614 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 5.2 ttmt -59.69 -47.8 84.21 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 173.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 2.2 tpmt? -58.89 -41.86 88.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.76 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.476 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -51.63 -63.92 0.98 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.997 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 181' ' ' LEU . 3.9 mp -69.82 -41.26 75.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.547 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 10.4 mmt -62.79 -31.16 72.08 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 62.0 mtm -74.4 -26.76 60.3 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.387 0.613 . . . . 0.0 109.635 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -82.73 -20.32 36.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.344 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.57 25.14 21.78 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.3 mp -118.39 171.0 8.45 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.704 0.402 . . . . 0.0 110.561 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 42.6 pt -119.47 132.4 24.02 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.871 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 3.7 Cg_exo -76.87 -12.04 18.04 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.95 2.433 . . . . 0.0 112.256 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -62.58 -40.11 95.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.464 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 12.5 t -99.16 34.13 2.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.35 0.595 . . . . 0.0 110.303 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.55 ' HB3' HG13 ' A' ' 224' ' ' VAL . 81.6 m -142.43 166.78 23.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.735 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.647 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -138.91 160.81 38.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.558 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.76 128.03 69.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.212 0.32 . . . . 0.0 110.335 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 33.6 m-85 -123.61 145.22 49.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.571 0.224 . . . . 0.0 110.398 174.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 206' ' ' LYS . 1.6 ptm180 -116.51 118.91 33.97 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 168.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.48 HD13 ' CD2' ' A' ' 223' ' ' HIS . 1.2 mp -81.2 106.52 12.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 121.324 0.583 . . . . 0.0 109.969 -176.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 203' ' ' GLY . 24.4 mt-30 -87.11 -141.02 0.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.94 174.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -59.64 77.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.245 0.545 . . . . 0.0 112.272 -173.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.3 15.83 46.74 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.709 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.522 ' OE2' ' HE2' ' A' ' 206' ' ' LYS . 7.3 pt-20 -132.5 137.5 47.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.373 0.606 . . . . 0.0 111.819 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -82.34 127.47 33.27 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.35 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.522 ' HE2' ' OE2' ' A' ' 204' ' ' GLU . 5.3 mptp? -106.34 106.52 57.61 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.586 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -70.29 118.64 5.8 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.704 1.602 . . . . 0.0 111.662 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 56.2 mt -95.95 154.01 3.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.07 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.05 142.31 22.25 Favored Glycine 0 N--CA 1.438 -1.186 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.661 ' O ' ' HG3' ' A' ' 178' ' ' ARG . 81.9 m95 -66.3 -23.52 66.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 117.47 0.635 . . . . 0.0 110.532 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.48 19.88 9.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.044 0.45 . . . . 0.0 110.952 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 69.5 m -86.64 140.19 30.06 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.806 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.405 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 15.8 t70 -68.86 121.2 16.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.616 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.445 HG21 ' CB ' ' A' ' 180' ' ' SER . 0.5 OUTLIER -66.84 -22.38 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.744 -176.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.405 ' HB3' ' OD1' ' A' ' 213' ' ' ASP . 9.4 t -74.81 -8.78 57.46 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.375 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -69.75 -38.69 76.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.683 0.754 . . . . 0.0 108.997 169.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.45 ' HB3' HD21 ' A' ' 222' ' ' LEU . 0.3 OUTLIER -97.26 26.32 4.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.087 -175.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 52.2 m -50.24 114.33 1.09 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.566 0.698 . . . . 0.0 112.307 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 86.59 -8.41 75.24 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.495 171.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -74.6 156.44 36.76 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 52.7 mt-10 -87.7 109.85 20.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 159' ' ' VAL . 70.1 mt -96.51 152.56 18.51 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . 0.48 ' CD2' HD13 ' A' ' 200' ' ' ILE . 35.1 m-70 -118.85 120.35 37.06 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.096 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 2.6 t -100.1 111.83 30.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 121.568 0.699 . . . . 0.0 109.307 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -108.91 145.7 34.98 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.695 -173.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.14 128.75 38.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.922 -175.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.11 80.59 7.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.228 0.537 . . . . 0.0 109.99 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -136.36 97.46 3.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.761 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -94.69 24.41 4.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.314 -176.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 116.35 -0.386 . . . . 99.99 110.382 176.417 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 121.071 0.462 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -59.9 -41.33 54.67 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.329 2.686 . . . . 0.0 111.92 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -89.11 126.79 35.6 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -82.49 124.69 77.59 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.446 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.405 ' HB2' HG23 ' A' ' 218' ' ' THR . 23.5 Cg_exo -63.7 161.14 33.36 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.722 2.281 . . . . 0.0 111.594 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.476 ' CG2' HG23 ' A' ' 168' ' ' VAL . 1.5 pp -121.88 169.8 12.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.164 0.507 . . . . 0.0 111.978 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.512 HG21 HG13 ' A' ' 214' ' ' ILE . 5.4 t -130.88 115.46 30.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.536 ' HG2' HG11 ' A' ' 168' ' ' VAL . 20.2 mtm180 -92.12 98.08 11.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.223 0.535 . . . . 0.0 111.632 -166.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.2 t -91.29 141.51 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.669 -173.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -103.42 103.96 13.99 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.524 172.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.6 HD13 ' HD2' ' A' ' 188' ' ' ARG . 7.3 mt -83.03 169.8 16.53 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.18 -172.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 88.2 Cg_exo -50.67 149.52 13.73 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.1 2.533 . . . . 0.0 112.503 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 14.3 m120 69.0 30.11 4.59 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.538 -176.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 51.9 47.52 24.61 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.601 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.491 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 15.0 mm100 -95.99 170.67 9.13 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 7.9 ttt180 -148.65 135.75 20.1 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.84 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.464 ' CG2' HD11 ' A' ' 161' ' ' LEU . 1.4 t -151.6 141.77 22.28 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.536 HG11 ' HG2' ' A' ' 158' ' ' ARG . 0.7 OUTLIER -117.26 130.07 72.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 C-N-CA 119.451 -0.899 . . . . 0.0 110.307 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.4 p -109.53 136.12 20.28 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.514 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.41 128.61 30.81 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.233 1.955 . . . . 0.0 111.167 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.16 89.49 0.45 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.81 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.483 ' HB2' ' CG1' ' A' ' 175' ' ' VAL . 64.3 mtt180 -77.27 113.96 15.58 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.989 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.5 t -70.12 115.23 9.09 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.03 -3.57 35.58 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.457 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.483 ' CG1' ' HB2' ' A' ' 172' ' ' ARG . 0.4 OUTLIER -108.42 150.22 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.041 0.448 . . . . 0.0 109.944 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.8 p -87.93 152.13 22.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.231 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 212' ' ' THR . 86.6 t -46.53 -42.68 5.46 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 O-C-N 123.512 0.507 . . . . 0.0 110.46 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 11.0 ptm180 -49.78 -48.65 50.37 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.35 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.586 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 16.2 t70 -70.21 -47.55 60.98 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.346 0.594 . . . . 0.0 111.039 -176.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.59 -45.89 77.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.254 -175.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -28.49 62.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.325 176.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 8.6 mtmt -54.04 -49.94 67.81 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.567 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.3 tpmt? -56.81 -47.37 80.39 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 175.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.446 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -51.36 -60.63 2.91 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.242 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 5.5 mp -68.0 -48.32 66.09 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 122.619 0.368 . . . . 0.0 111.557 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 1.0 OUTLIER -59.51 -34.3 72.44 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.882 -176.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.567 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 67.4 mtm -71.03 -31.37 67.83 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.23 0.538 . . . . 0.0 109.691 175.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.6 ' HD2' HD13 ' A' ' 161' ' ' LEU . 9.1 mtt180 -86.2 -4.68 59.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.813 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.37 25.92 49.38 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.093 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.1 mp -116.0 161.59 18.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 29.4 pt -120.65 128.74 25.64 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.142 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 23.4 Cg_exo -66.02 -14.66 45.47 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 123.002 2.468 . . . . 0.0 112.28 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -60.19 -42.44 95.09 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.497 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.5 t -104.23 28.84 6.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.392 0.615 . . . . 0.0 110.028 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.56 ' HB3' HG13 ' A' ' 224' ' ' VAL . 84.0 m -139.87 165.8 26.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.443 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -149.53 164.57 34.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.245 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.577 HG11 HD23 ' A' ' 222' ' ' LEU . 14.7 t -111.1 133.13 57.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.33 -174.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -126.87 143.94 51.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.193 172.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.458 ' HD2' HD22 ' A' ' 217' ' ' LEU . 7.7 ptm180 -118.2 114.95 23.8 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 168.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.538 HD12 ' HG2' ' A' ' 205' ' ' LYS . 5.5 mm -81.58 102.66 7.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 C-N-CA 120.089 -0.645 . . . . 0.0 110.087 -172.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.533 ' OE1' ' HE2' ' A' ' 206' ' ' LYS . 33.2 mt-30 -76.55 -145.15 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.304 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -57.18 79.82 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.788 0.435 . . . . 0.0 112.058 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.58 16.97 46.93 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.8 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -127.25 134.47 50.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.993 0.425 . . . . 0.0 111.347 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.538 ' HG2' HD12 ' A' ' 200' ' ' ILE . 48.0 mtpt -81.07 119.74 23.94 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.071 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.533 ' HE2' ' OE1' ' A' ' 201' ' ' GLN . 8.4 tptt -109.79 104.84 56.33 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.771 -175.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.37 124.84 10.74 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.104 1.869 . . . . 0.0 112.17 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.487 HD12 HG12 ' A' ' 197' ' ' VAL . 46.9 mt -100.01 153.81 4.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.919 -176.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.85 138.85 15.87 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -67.4 -20.82 65.59 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.103 0.451 . . . . 0.0 110.154 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -92.62 6.89 45.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.914 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.623 ' O ' HG23 ' A' ' 177' ' ' VAL . 96.5 m -78.62 147.15 33.75 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 172.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 215' ' ' SER . 12.5 t70 -74.55 130.05 38.87 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.512 HG13 HG21 ' A' ' 157' ' ' VAL . 0.2 OUTLIER -72.56 -15.1 17.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 111.458 -174.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.431 ' HB2' ' OD1' ' A' ' 213' ' ' ASP . 70.8 m -75.01 -8.87 57.75 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.899 -0.5 . . . . 0.0 110.587 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 30.1 m0 -82.36 -11.46 58.56 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 172.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.623 HD13 HD21 ' A' ' 222' ' ' LEU . 5.6 mt -118.46 19.26 13.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.022 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.405 HG23 ' HB2' ' A' ' 155' ' ' PRO . 99.5 m -52.27 117.25 2.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.534 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 86.3 -4.13 86.37 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.266 170.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -75.84 157.88 32.81 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 28.4 mt-10 -98.05 111.62 23.87 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.623 HD21 HD13 ' A' ' 217' ' ' LEU . 6.4 mp -95.45 164.93 12.6 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.191 -175.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -133.97 130.09 37.15 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 40.9 t -100.86 123.83 54.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.106 0.479 . . . . 0.0 109.768 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 5.9 mm-40 -107.8 146.23 32.5 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.682 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 85.7 t -84.47 122.68 38.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.93 0.395 . . . . 0.0 110.075 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 64.6 mt -72.88 82.7 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.352 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -129.66 96.91 4.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.465 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -160.1 23.01 0.17 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.668 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 116.229 -0.441 . . . . 99.99 110.762 -177.594 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.464 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 10.9 p . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 120.745 0.307 . . . . 0.0 110.775 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 151' ' ' SER . 16.7 Cg_exo -70.07 60.5 1.85 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.468 2.779 . . . . 0.0 112.261 177.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -78.13 125.79 29.87 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.423 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -74.7 114.99 39.77 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 173.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.491 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 41.5 Cg_endo -65.1 166.28 19.28 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.637 2.224 . . . . 0.0 112.719 -175.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.757 HD13 HG11 ' A' ' 168' ' ' VAL . 1.9 pp -132.83 152.69 36.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.464 -177.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.494 HG13 HG23 ' A' ' 169' ' ' VAL . 0.5 OUTLIER -124.32 134.59 66.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.398 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.546 ' HG2' HG13 ' A' ' 168' ' ' VAL . 1.3 mtp180 -94.2 97.61 10.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.288 -165.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.0 t -97.64 134.44 35.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.146 -175.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 2.3 m-85 -92.3 103.67 16.1 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.391 175.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.667 HD22 ' H ' ' A' ' 161' ' ' LEU . 1.1 mm? -78.03 169.62 20.09 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.594 ' HD3' HG12 ' A' ' 224' ' ' VAL . 78.5 Cg_exo -52.78 152.98 15.81 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.71 2.273 . . . . 0.0 113.228 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.2 t30 65.2 41.11 4.61 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.746 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 59.88 31.01 20.52 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.219 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 26.6 mm-40 -85.3 161.42 19.53 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 26.8 ttp180 -149.25 134.94 18.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.525 HG22 HD21 ' A' ' 161' ' ' LEU . 1.1 t -145.63 151.64 38.39 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.757 HG11 HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -108.05 129.31 62.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.232 178.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.494 HG23 HG13 ' A' ' 157' ' ' VAL . 14.7 m -105.45 130.99 22.15 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.257 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 27.7 Cg_endo -64.38 121.09 8.59 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.821 1.681 . . . . 0.0 111.182 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.491 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -69.92 95.16 0.9 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.262 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -93.25 112.19 24.05 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.4 -173.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.473 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 49.0 t -70.11 113.39 7.25 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.51 0.01 27.78 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.742 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 179' ' ' ASP . 0.3 OUTLIER -116.2 152.05 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 24.3 p -89.01 159.8 17.41 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.699 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 212' ' ' THR . 87.4 t -50.5 -38.21 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.574 ' CG ' ' HB3' ' A' ' 210' ' ' TRP . 26.6 mtp180 -45.63 -58.81 3.13 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.563 175.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.656 ' HA ' ' CE ' ' A' ' 182' ' ' LYS . 32.3 m-20 -67.07 -45.53 77.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.922 0.392 . . . . 0.0 111.913 -170.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.7 t -71.38 -38.62 71.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.15 0.5 . . . . 0.0 110.478 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.444 HD22 HG11 ' A' ' 169' ' ' VAL . 0.4 OUTLIER -75.93 -27.7 57.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.455 177.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.656 ' CE ' ' HA ' ' A' ' 179' ' ' ASP . 37.1 mtmt -55.22 -52.42 63.43 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.508 ' HE3' ' HA ' ' A' ' 183' ' ' LYS . 2.2 tpmt? -61.86 -40.46 95.42 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.316 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.484 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -55.53 -55.85 27.11 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.751 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.496 HD21 HG11 ' A' ' 224' ' ' VAL . 2.0 mt -70.11 -46.37 64.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.318 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 12.9 mmt -59.97 -36.67 77.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.961 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 58.2 mtm -76.35 -12.91 60.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.062 0.458 . . . . 0.0 110.251 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -110.33 17.8 20.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.527 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 62.63 36.94 93.95 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.198 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.481 HD13 ' HD2' ' A' ' 162' ' ' PRO . 24.2 mt -128.36 166.91 17.76 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.494 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 37.4 pt -130.64 130.64 22.96 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.053 0.454 . . . . 0.0 111.85 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 16.2 Cg_exo -68.76 -16.13 41.47 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.088 2.525 . . . . 0.0 112.341 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -65.34 -37.52 87.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.071 -177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 16.9 t -109.78 37.0 2.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.415 0.626 . . . . 0.0 109.992 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.588 ' HB3' HG13 ' A' ' 224' ' ' VAL . 99.1 m -146.73 162.36 38.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.672 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -142.16 157.29 45.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.78 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 10.9 t -107.13 123.73 62.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.584 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 206' ' ' LYS . 47.8 m-85 -116.14 153.8 31.13 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 173.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.503 ' HB3' ' CD2' ' A' ' 222' ' ' LEU . 12.2 ptt180 -126.33 111.73 14.87 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 167.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.656 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 1.2 mp -80.92 110.48 16.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.293 0.568 . . . . 0.0 110.866 -173.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -83.78 -146.53 0.09 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.843 172.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 20.6 m-20 -61.31 79.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.837 0.351 . . . . 0.0 111.868 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.79 14.76 65.8 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.412 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.656 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 30.4 mt-10 -116.89 134.37 54.85 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 120.746 0.308 . . . . 0.0 111.71 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -95.03 112.45 24.15 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 198' ' ' TYR . 74.9 mmtt -98.4 107.14 40.34 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.156 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -74.51 118.92 5.52 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.943 1.762 . . . . 0.0 111.467 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.659 HG21 HD11 ' A' ' 217' ' ' LEU . 22.0 mt -93.83 152.75 3.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.088 -174.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -85.49 139.95 17.76 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.574 ' HB3' ' CG ' ' A' ' 178' ' ' ARG . 88.4 m95 -70.41 -34.99 73.17 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.645 0.26 . . . . 0.0 111.164 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.48 5.5 23.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.119 0.485 . . . . 0.0 111.238 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.548 ' O ' HG23 ' A' ' 177' ' ' VAL . 95.6 m -74.8 148.37 40.39 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 170.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -73.49 134.38 43.86 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 171' ' ' ALA . 0.1 OUTLIER -69.94 -16.36 20.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.958 0.408 . . . . 0.0 110.653 -178.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 18.7 m -65.49 -15.88 63.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.994 0.426 . . . . 0.0 110.73 176.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 32.9 m0 -80.54 -17.64 50.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.22 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.659 HD11 HG21 ' A' ' 208' ' ' ILE . 10.4 mt -112.81 19.87 16.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.724 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 99.7 m -52.1 112.86 0.87 Allowed 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.413 -177.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 80.07 8.93 87.2 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.427 171.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -85.17 151.32 24.19 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 36.5 mt-10 -86.99 111.14 20.56 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.503 ' CD2' ' HB3' ' A' ' 199' ' ' ARG . 61.0 mt -105.56 159.63 15.8 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.214 -175.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -125.99 122.44 35.9 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.833 0.349 . . . . 0.0 110.27 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.594 HG12 ' HD3' ' A' ' 162' ' ' PRO . 4.5 t -101.05 115.54 42.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.566 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 24.6 mt-10 -112.35 141.9 45.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.78 -175.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.84 127.62 34.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.831 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 67.3 mt -77.97 81.66 4.36 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 176.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -73.62 94.16 2.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.631 0.729 . . . . 0.0 110.222 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -161.79 29.52 0.12 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.385 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.178 -0.919 . . . . 99.99 110.757 -177.479 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.421 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . 16.1 p . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.822 0.344 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 151' ' ' SER . 52.1 Cg_endo -68.99 -40.95 5.78 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.787 2.325 . . . . 0.0 111.343 176.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.549 ' O ' ' HD3' ' A' ' 155' ' ' PRO . 5.8 tp-100 -91.82 106.42 18.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.499 175.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -108.66 89.97 6.85 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.951 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 153' ' ' GLN . 3.8 Cg_exo -74.79 152.44 41.9 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.505 2.137 . . . . 0.0 111.241 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.709 HD13 HG11 ' A' ' 168' ' ' VAL . 1.8 pp -126.09 156.36 36.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.493 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -125.23 134.23 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.533 ' HG2' HG13 ' A' ' 168' ' ' VAL . 81.7 mtm180 -95.41 105.46 17.43 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -167.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 166' ' ' ARG . 3.8 t -96.87 135.45 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.807 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 64.9 m-85 -97.4 103.12 15.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.788 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.611 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.1 mt -84.52 173.84 6.66 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.098 -170.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.611 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 99.1 Cg_exo -48.66 153.47 3.49 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.128 2.552 . . . . 0.0 113.236 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 63.16 24.46 14.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.492 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 61.18 44.05 10.37 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.088 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 15.2 mm100 -90.8 177.93 6.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.781 177.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 38.7 ttp180 -147.36 153.44 39.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.548 0.214 . . . . 0.0 110.545 176.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.479 HG21 ' HB1' ' A' ' 184' ' ' ALA . 1.4 t -163.31 151.79 13.95 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 170.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.709 HG11 HD13 ' A' ' 156' ' ' ILE . 0.1 OUTLIER -115.06 128.29 72.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.298 177.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.7 p -115.83 133.29 22.86 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.412 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.41 131.55 43.44 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.281 1.987 . . . . 0.0 111.924 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.79 75.69 1.59 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.801 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -68.51 111.99 5.05 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.536 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.602 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 59.0 m -70.45 116.61 10.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.825 0.345 . . . . 0.0 110.128 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.03 -6.0 36.76 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.923 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.69 142.91 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.0 p -88.46 155.13 19.84 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.018 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.575 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 88.5 t -52.96 -34.34 20.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.636 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 16.0 ptt180 -56.67 -47.72 79.19 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 122.256 -0.277 . . . . 0.0 111.568 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.614 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 20.6 t70 -72.25 -45.49 59.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.174 0.511 . . . . 0.0 110.867 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.479 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 2.8 p -63.31 -53.24 55.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.378 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.7 OUTLIER -69.96 -24.41 63.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.121 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.614 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 11.8 mtmt -57.65 -51.25 70.28 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.537 ' O ' ' HG3' ' A' ' 187' ' ' MET . 2.4 tpmt? -61.43 -42.6 98.99 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.952 177.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.479 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -53.47 -61.11 2.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.411 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 181' ' ' LEU . 1.5 mt -65.02 -44.68 88.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.24 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.538 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 6.5 mmt -61.38 -32.19 72.11 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 62.5 mtm -77.16 -22.69 52.13 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.213 0.53 . . . . 0.0 110.02 175.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.1 5.77 50.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.73 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 69.81 36.69 74.85 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.966 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.412 HD13 ' HD2' ' A' ' 162' ' ' PRO . 21.4 mt -131.11 165.99 22.06 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 122.87 0.468 . . . . 0.0 110.021 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 35.7 pt -126.62 135.19 26.91 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.907 0.384 . . . . 0.0 111.36 177.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 15.9 Cg_exo -69.01 -16.5 40.77 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.029 2.486 . . . . 0.0 111.985 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -59.13 -45.51 90.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.534 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 16.2 t -105.41 34.74 3.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.257 0.551 . . . . 0.0 109.75 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.561 ' HB3' HG13 ' A' ' 224' ' ' VAL . 91.1 m -141.84 162.36 35.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.991 -176.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.632 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -143.62 154.63 43.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.133 174.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 13.3 t -105.92 138.01 33.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.676 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -129.24 150.32 50.67 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.439 ' HD2' HD22 ' A' ' 217' ' ' LEU . 2.9 ptm180 -114.31 116.38 28.88 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 166.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.521 HD13 ' CD2' ' A' ' 223' ' ' HIS . 1.5 mp -80.63 112.25 18.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.685 0.755 . . . . 0.0 110.437 -175.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' A' ' 203' ' ' GLY . 25.0 mm-40 -88.52 -142.34 0.13 Allowed 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.281 174.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -58.22 79.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.6 18.01 50.43 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.597 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 13.3 pt-20 -135.0 167.56 20.72 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.413 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.406 ' HG2' HD11 ' A' ' 200' ' ' ILE . 48.0 mtmt -108.28 133.27 52.73 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.711 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -111.87 103.97 55.65 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.19 132.5 41.83 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.361 2.041 . . . . 0.0 112.155 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.532 HG21 HD11 ' A' ' 217' ' ' LEU . 20.3 mm -96.77 158.12 3.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.281 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -96.0 142.11 15.95 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -70.27 -22.55 62.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 117.315 0.558 . . . . 0.0 111.068 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -94.05 9.82 36.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.895 0.379 . . . . 0.0 110.833 176.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.536 ' O ' HG23 ' A' ' 177' ' ' VAL . 81.4 m -77.71 150.46 34.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -80.1 124.41 28.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.744 0.783 . . . . 0.0 109.589 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.408 HD12 ' HB2' ' A' ' 180' ' ' SER . 7.7 tt -53.58 -30.19 18.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.768 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.602 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 12.9 m -62.91 -16.79 60.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.901 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -79.29 -13.61 59.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.222 0.534 . . . . 0.0 109.654 175.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.532 HD11 HG21 ' A' ' 208' ' ' ILE . 11.5 mt -117.92 16.51 14.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.83 -176.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 97.4 m -50.63 119.44 3.82 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.864 0.84 . . . . 0.0 112.865 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 75.71 8.7 84.62 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 114.214 -1.357 . . . . 0.0 113.498 170.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -92.78 164.78 13.23 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.751 0.31 . . . . 0.0 110.409 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 6.4 mp0 -96.35 111.01 23.24 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.412 HD21 ' HB3' ' A' ' 217' ' ' LEU . 28.7 mt -100.6 165.9 11.18 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . 0.521 ' CD2' HD13 ' A' ' 200' ' ' ILE . 55.5 m-70 -136.57 124.92 23.3 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 42.4 t -103.69 124.63 58.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.024 0.44 . . . . 0.0 110.268 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 195' ' ' CYS . 71.0 mm-40 -110.79 155.05 23.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.666 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 43.1 t -83.38 129.19 37.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.532 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.4 mp -85.83 81.34 8.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.126 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -100.57 95.69 6.87 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.654 0.74 . . . . 0.0 109.243 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -132.89 37.04 3.46 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.636 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.302 -0.863 . . . . 99.99 110.671 -178.555 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.419 ' HA ' ' HD2' ' A' ' 152' ' ' PRO . 59.2 p . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 121.041 0.448 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 151' ' ' SER . 17.9 Cg_endo -58.09 -34.52 98.56 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.347 2.698 . . . . 0.0 111.998 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -100.88 100.02 10.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.797 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -93.77 112.61 57.61 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' A' ' 171' ' ' ALA . 66.6 Cg_endo -71.93 162.52 41.65 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.729 2.286 . . . . 0.0 112.887 -175.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.749 HD13 HG11 ' A' ' 168' ' ' VAL . 1.9 pp -129.87 157.85 42.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.622 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.97 133.91 68.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.588 ' HG2' HG13 ' A' ' 168' ' ' VAL . 18.1 mtm180 -92.31 108.03 19.65 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.476 0.655 . . . . 0.0 112.09 -168.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.688 HG22 ' HB2' ' A' ' 222' ' ' LEU . 11.6 t -96.1 145.75 8.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.626 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.563 ' CZ ' ' HD2' ' A' ' 166' ' ' ARG . 21.7 m-85 -112.61 103.01 11.05 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.822 176.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 1.5 mm? -76.58 173.99 6.47 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -172.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.622 ' HD2' HD13 ' A' ' 190' ' ' LEU . 74.4 Cg_exo -54.11 155.01 16.31 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.571 2.18 . . . . 0.0 112.873 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.9 t30 66.74 21.86 10.47 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.947 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.568 ' HE3' ' HA ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 61.17 44.9 9.52 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.399 179.083 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.621 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 15.1 mm-40 -86.64 171.94 10.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.329 174.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.563 ' HD2' ' CZ ' ' A' ' 160' ' ' PHE . 47.1 ttt180 -148.4 133.79 18.55 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.448 HG22 HD21 ' A' ' 161' ' ' LEU . 5.4 t -137.43 174.74 10.27 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.749 HG11 HD13 ' A' ' 156' ' ' ILE . 0.2 OUTLIER -132.09 128.6 59.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.632 170.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.48 129.85 23.44 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.711 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.461 ' HA ' HG22 ' A' ' 156' ' ' ILE . 31.5 Cg_exo -57.08 123.48 13.95 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.313 2.009 . . . . 0.0 111.476 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.45 ' HB3' ' HG2' ' A' ' 155' ' ' PRO . . . -61.75 99.96 0.13 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.628 0.728 . . . . 0.0 109.286 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.648 ' HG2' ' HB ' ' A' ' 175' ' ' VAL . 17.2 ttp180 -107.81 111.97 24.38 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.916 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.658 ' HA ' ' OG ' ' A' ' 215' ' ' SER . 42.4 t -70.84 128.3 35.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.87 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 109.06 -21.18 27.61 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.767 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.648 ' HB ' ' HG2' ' A' ' 172' ' ' ARG . 0.9 OUTLIER -99.19 142.85 14.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.367 0.603 . . . . 0.0 110.749 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 5.6 p -81.56 148.69 29.01 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.641 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.497 ' CG2' ' HA ' ' A' ' 210' ' ' TRP . 21.9 m -49.48 -32.09 6.19 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.616 0 CA-C-N 117.904 0.32 . . . . 0.0 110.319 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 21.3 ptt180 -58.82 -43.38 90.61 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.613 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 21.2 t70 -71.34 -47.64 55.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.964 0.802 . . . . 0.0 110.477 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.481 ' HA ' HH21 ' A' ' 172' ' ' ARG . 0.6 OUTLIER -62.21 -43.36 99.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.414 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.42 -36.32 68.58 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.178 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.696 ' O ' ' HB2' ' A' ' 186' ' ' MET . 7.9 mtmt -50.64 -45.07 57.62 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.805 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.513 ' O ' ' HG3' ' A' ' 187' ' ' MET . 10.9 tppt? -67.41 -51.46 51.48 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.917 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' ' 167' ' ' THR . . . -43.73 -54.13 5.35 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.482 0.489 . . . . 0.0 111.973 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 5.1 mp -69.24 -52.39 28.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.63 0.372 . . . . 0.0 111.733 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.696 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 1.3 ttm -54.28 -38.35 65.77 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -176.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.513 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 68.7 mtm -74.46 -16.52 60.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.338 0.59 . . . . 0.0 110.179 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 188' ' ' ARG . 49.8 mtt180 -105.9 12.73 30.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.324 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 68.6 38.5 86.23 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.015 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.622 HD13 ' HD2' ' A' ' 162' ' ' PRO . 20.8 mt -132.02 157.93 42.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.743 0.306 . . . . 0.0 110.676 -176.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 192' ' ' PRO . 14.0 pt -122.22 127.32 25.95 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.349 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 191' ' ' ILE . 11.6 Cg_exo -71.03 -12.84 31.0 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.865 2.377 . . . . 0.0 111.895 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -58.47 -41.27 84.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.017 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 74.1 m -105.44 34.88 3.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.897 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.513 ' HB3' HG13 ' A' ' 224' ' ' VAL . 80.9 m -145.04 164.84 29.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.866 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.599 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -139.2 160.13 40.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.447 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 208' ' ' ILE . 17.0 t -109.13 140.69 26.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.464 -176.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.415 ' CD1' ' HB3' ' A' ' 205' ' ' LYS . 22.1 m-85 -134.32 142.67 47.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.09 177.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.504 ' HD2' HD12 ' A' ' 217' ' ' LEU . 8.0 ptm180 -108.26 117.84 35.21 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 166.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.854 HD13 ' HA ' ' A' ' 205' ' ' LYS . 13.9 mm -79.92 104.27 7.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.224 0.535 . . . . 0.0 110.708 -172.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 203' ' ' GLY . 14.0 mm100 -76.82 -147.21 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.189 173.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -62.41 77.83 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.128 0.49 . . . . 0.0 111.485 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 64.89 16.69 62.02 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -176.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 44.1 mt-10 -111.18 133.82 53.25 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.115 0.483 . . . . 0.0 111.734 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.854 ' HA ' HD13 ' A' ' 200' ' ' ILE . 39.9 mtpt -84.4 97.48 9.52 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 171.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -94.13 98.97 3.22 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.684 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.599 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 25.3 Cg_exo -62.67 135.95 55.44 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.566 2.177 . . . . 0.0 112.848 -174.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 197' ' ' VAL . 22.8 mm -98.02 154.44 3.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.791 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.81 134.04 12.18 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 174.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.497 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 86.9 m95 -64.84 -24.55 67.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.325 0.563 . . . . 0.0 110.97 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -93.57 14.11 19.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.961 0.41 . . . . 0.0 111.247 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 177' ' ' VAL . 85.4 m -88.11 145.33 25.99 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -72.81 134.12 44.78 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.469 HG21 ' HB2' ' A' ' 180' ' ' SER . 0.1 OUTLIER -69.97 -16.6 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 110.961 -175.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.658 ' OG ' ' HA ' ' A' ' 173' ' ' CYS . 8.3 m -66.51 -19.62 65.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.744 176.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.547 ' HB2' HD22 ' A' ' 217' ' ' LEU . 27.8 m0 -75.59 -23.63 56.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.545 0.688 . . . . 0.0 109.815 176.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.548 HD22 ' N ' ' A' ' 217' ' ' LEU . 1.4 mm? -109.32 23.95 13.77 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.36 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 51.3 m -54.37 114.22 1.57 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.625 0.726 . . . . 0.0 111.958 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 156' ' ' ILE . . . 84.14 -2.84 87.25 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.946 173.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.39 156.94 36.51 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 50.3 mt-10 -89.71 108.38 19.65 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.688 ' HB2' HG22 ' A' ' 159' ' ' VAL . 82.8 mt -102.47 109.68 21.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.74 0.781 . . . . 0.0 110.478 -175.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -84.22 122.04 28.31 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.856 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 3.7 t -99.93 109.95 25.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.51 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -110.27 145.26 37.7 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.657 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.58 133.52 31.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 196' ' ' ALA . 55.9 mt -76.56 82.04 3.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.196 0.522 . . . . 0.0 110.854 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -101.69 93.76 5.5 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -123.47 23.77 8.84 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.079 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 115.469 -0.787 . . . . 99.99 110.22 178.787 . . . . . . . . 0 0 . 1 stop_ save_